2015 American Transplant Congress » 2015 ATC Sessions

Date & Time:
None. Available on demand

Location: None listed

Session Type:

Meeting: 2015 American Transplant Congress

A Common Gene Signature Across Multiple Studies Identifies Biomarkers and Functional Regulation in Tolerance to Renal Allograft

D. Baron,^1,2,3 G. Ramstein,⁴ M. Chesneau,^1,2,3 Y. Echasseriau,^1,2,3 A. Pallier,^1,2,3 C. Paul,^1,2,3 N. Degauque,^1,2,3 M. Hernandez-Fuentes,⁵ A. Sanchez-Fueyo,⁶ K. Newell,⁷ M. Giral,^1,2,3 J.-P. Soulillou,^1,2,3 R. Houlgatte,^8,9 S. Brouard.^1,2,3
APOL1 Risk Alleles in Live and Deceased Kidney Donors Are Associated With Shorter Renal Allograft Survival

M. Doshi,¹ M. Goggins,² S. Norman,³ S. Ho,⁴ C. Winkler,⁵ J. Kopp.⁶
Aquaporin 4 Blockade Is a Novel Strategy Targeting Ischemia/Reperfusion Injury in Heart Transplantation

K. Ayasoufi,¹ N. Kohei,¹ G. Farr,² P. McGuirk,² M. Pelletier,² R. Fairchild,¹ A. Valujskikh.¹
Arterial Blood Pressure at Time of Liver Transplant (LT) Evaluation Correlates With Kidney Biopsy Findings in LT Candidates With Renal Dysfunction

H. Wadei, A. Peguero, A. Alsaad, M. Mai, K. Oshel, T. Gonwa, C. Taner, A. Keaveny.
B-Cell Tolerance to Donor Alloantigens

A. Patil, M. Climov, A. Matar, A. Musa, E. Harrington, D. Sachs, R. Duran-Struuck, C. Huang.
CD27^low NK Cells Prolong Allograft Survival in Mice By Inhibiting CD8⁺ T Cell Responses Through Controlling Graft-Derived Donor DCs

A. Kroemer,^1,2 M. Lantow,¹ E. Eggenhofer,¹ M. Sabet-Baktach,¹ P. Renner,¹ H. Schlitt,¹ E. Geissler.¹
CD3+CD4+ROR gamma t+ TH17 Cells Do Not Play a Critical Role in Islet Allograft Rejection

M. Koulmanda, Z. Fan.
Can Post-Transplant C-Peptide Be Used as an Indicator of Pancreas Graft Failure?

R. Carrico,¹ J. Fridell,² J. Odorico,³ R. Stratta,⁴ K. Tyler,¹ S. Niederhaus,⁵ R. Kandaswamy,⁶ J. Fisher,⁷ O. Olaitan,⁸ M. Mujtaba.²
Combination of Non-HLA and HLA-DSA Antibodies Identifies Liver Transplants Recipients With Highest Risk for Fibrosis Progression and Mortality

J. O'Leary,¹ J. Cai,² H. Heidecke,³ L. Jennings,¹ A. Philippe,⁴ V. Harbour,¹ R. Catar,⁴ P. Terasaki,² G. Klintmalm,¹ D. Dragun.⁴
Domino Liver Transplant from Donors With MSUD: Operative Strategy and Long-Term Outcomes

B. Kelly,¹ K. Soltys,¹ G. Bond,¹ J. Vockley,² K. Strauss,³ H. Morton,³ R. Sindhi,¹ G. Mazariegos.¹
Donor-Derived Tumor Transmission Events. A Summary of 2008-2013 Data from the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

M. Nalesnik,¹ S. Taranto,² S. Covington,² E. Blumberg,¹ M. Green,¹ T. Gross,¹ M. Klassen-Fischer,¹ M. Pavlakis,¹ C. Wolfe,¹ D. Kaul.¹
Early Hospital Readmissions After Kidney Transplantation

M. Lubetzky, M. Ajaimy, L. Kamal, G. DeBoccardo, E. Akalin, L. Kayler.
Elevated ST2 Levels Are Associated With Increased Risk of Antibody Mediated Rejection in Heart Transplant Recipients

A. Grupper,¹ S. Kushwaha,¹ O. Abou Ezzeddine,¹ J. Geske,² W. Kremers,² B. Edwards,¹ N. Pereira.¹
Epidemiology and Outcomes of Non Tuberculous Mycobacterial (NTM) Infections in Solid Organ Transplant (SOT) Recipients

I. George, C. Santos, M. Olsen, T. Bailey.
Extended Analysis of Tocilizumab (anti-IL-6R) + Intravenous Immunoglobulin (IVIG) as Desensitization (DES) Agents for Reduction of Donor Specific Antibodies (DSA) in Patients Resistant to DES With IVIG + Rituximab

A. Vo, J. Choi, I. Kim, J. Kahwaji, A. Peng, R. Villicana, S. Jordan.
Histology and Not Donor Specific Antibody Helps Predict 5-Year Kidney Transplant Failure Using 1 Year Post-Transplant Data

M. Moreno Gonzales,¹ A. Bentall,^2,3 M. Stegall,¹ R. Borrows.²
Hospital Re-Admission After Intestinal Transplantation

Y. Kwon,¹ R. Girlanda,¹ A. Sharp,² K. Etesami,¹ J. Hawksworth,¹ C. Desai,¹ E. Island,¹ C. Matsumoto,¹ T. Fishbein.¹
Human Leukocyte Antigen Mismatch and Steroid Maintenace in Kidney Transplantation

K. Sureshkumar, R. Marcus, B. Chopra.
Immunological Characterization of Full Facial Transplant Recipients

T. Borges,¹ J. Azzi,¹ S. Tullius,¹ A. Chandraker,¹ B. Pomahac,² N. Najafian,¹ L. Riella.¹
Impact of Anatomic Variation and Reconstructive Technique on Complications Following Living Liver Donor Transplantation – A Report from the A2ALL Consortium

T. Baker,¹ M. Zimmerman,² B. Samstein,³ E. Pomfret,⁴ J. Pomposelli,⁴ C. Berg,⁵ N. Goodrich,⁶ B. Gillespie,⁷ J. Emond.³
Impact of Elevated BMI on Allograft Outcomes: A Competing Risks Regression Analysis

A. Naik, A. Sakhuja, M. Samaniego, P. Shrivastava, D. Cibrik.
Increasing the Number of Organ Transplants in the United States by Optimizing Donor Authorization Rates

D. Goldberg,¹ B. French,² P. Abt,³ R. Gilroy.⁴
Induction Therapy (IT) in Simultaneous Pancreas and Kidney Transplantation (SPK) according to Patient Risk – A Registry Analysis

R. Gruessner,¹ A. Gruessner.²
New SRTR Risk-Adjustment Models for Adult Kidney Transplant Outcomes

J. Snyder,¹ N. Salkowski,¹ D. Zaun,¹ H. Xiong,¹ S. Leppke,¹ B. Thompson,¹ D. Segev,^1,2 L. Hunsicker,¹ A. Israni,¹ B. Kasiske.¹
Outcomes of Kidney Transplantation of ABO- and Crossmatch-Incompatible Recipient-Donor Pairs Entered in Kidney Paired Donation Program

D. Dadhania, M. Charlton, M. Aull, R. Friedlander, T. Muthukumar, J. Lee, M. Goris, D. Serur, S. Kapur, V. Sharma.
Pre-Transplant Anti-LG3 Antibodies Enhance Allograft Dysfunction in Kidney Transplant Recipients With Delayed or Slow Graft Function

H. Cardinal, M. Hénault-Rondeau, S. Morissette, K. Hamelin, M.-J. Hébert.
Preservation Solution Impacts Short- and Long-Term Survival in Orthotopic Heart Transplant Recipients

C. Lewis,¹ S. Jayarajan,¹ S. Taghavi,¹ S. Kadakia,¹ V. Ambur,¹ A. Shiose,³ G. Wheatley,³ L. Kaiser,² T. Guy,³ Y. Toyoda.³
Regional Efficiency in Deceased Donor Utilization for Kidney Transplantation

K. Schnier,¹ N. Turgeon.²
Repurposing Jak/STAT Signaling Inhibition to Enhance Costimulation Blockade and Promote Transplant Acceptance

G. Raimondi, S. Khalifian, D. Miller, B. Oh, G. Furtmueller, M. Fryer, W. Lee, G. Brandacher.
Robotic Kidney Transplantation in Obese Recipients Can Lead to Superior Outcomes in Terms of Wound Infection and Graft Survival

I. Tzvetanov, G. D'Amico, G. Georgiev, P. Giulianotti, H. Jeon, R. Garcia-Roca, J. Oberholzer, E. Benedetti.
Screening Recipients of Increased Risk Donor Organs: A Multicenter Study

N. Theodoropoulos,¹ K. Brizendine,² M. Ison.³
Serum Proteins Are Significantly Upregulated in Patients With Clinical Antibody-Mediated Rejection

A. Gareau,¹ I. Gibson,² C. Wiebe,¹ J. Ho,¹ D. Rush,¹ P. Nickerson.¹
Significant Association Between Foxp3 Gene Polymorphism and Outcomes in HBV-Related Liver Transplant Patients

Y. Tanaka, V. Sapana, H. Ohdan.
The Impact of Duration of Brain Death on Outcomes in Abdominal Organ Transplantation: Rush and Retrieve or Rather Relax and Repair?

C. Boffa,¹ E. Curnow,² K. Martin,² R. Johnson,² R. Ploeg.¹
Timing of Pregnancy and Risk of Kidney Allograft Failure

C. Rose, O. Johnston, A. Mehrotra, C. Kennedy, T. Myint, E. Hendren, J. Gill, J. Gill.
Variables Related to the Development of Donor Specific Antibodies (DSA) Post-Kidney Transplant (KTx): Implications for Late Graft Histology and Survival

F. Cosio,¹ C. Schinstock,¹ M. Stegall.²
ASKP1240 in De Novo Kidney Transplant Recipients

R. Harland,¹ G. Klintmalm,² H. Yang,³ S. Jensik,⁴ T. Shah,⁵ P. West-Thielke,⁶ F. Shihab,⁷ W. Zhang,⁸ V. Santos,⁸ R. Tainaka,⁸ X. Wang,⁸ R. First,⁸ J. Holman.⁸
Assessment of IgG Subclass Significance for Early Graft Rejection and Long-Term Survival in HLA-Antibody Incompatible Renal Transplantation: Multivariate Approach

N. Khovanova,¹ D. Lowe,² S. Daga,^1,3 T. Shaikhina,¹ N. Krishnan,³ D. Mitchell,¹ D. Zehnder,¹ D. Briggs,² R. Higgins.³
Clinical and Immunological Update 15 Years After the First VCA – Subsequent Kidney Transplantation After a Bilateral Hand Transplant

A. Weissenbacher,¹ G. Pierer,² M. Gabl,³ M. Ninkovic,¹ T. Hautz,¹ J. Grahammer,¹ B. Zelger,⁴ B. Zelger,⁵ G. Brandacher,⁶ S. Schneeberger.¹
Clinical and Virologic Outcomes in High-Risk Adult EBV D+/R- Organ Transplant Recipients

D. Kumar, N. Patil, S. Husain, C. Chaparro, A. Humar.
Combined Robotic Kidney Transplantation and Sleeve Gastrectomy in Obese Recipients: Initial Results from Prospective Randomized Study

I. Tzvetanov, G. D'Amico, G. Georgiev, H. Jeon, R. Garcia-Roca, E. Benedetti, J. Oberholzer.
Deep Surgical Site Infections (dSSI) After Liver Transplantation (LTx): Emergence of Multiple-Drug Resistant (MDR) Pathogens

J. Viehman,¹ L. Clarke,¹ R. Shields,² C. Clancy,^2,3 M. Nguyen.^1,2
Delayed Kidney Transplant in Combined Liver-Kidney Transplantation Improves GFR and Patient Survival

B. Ekser, W. Goggins, R. Mangus, S. Nagai, C. Kubal, J. Fridell, S. Kinsella, J. Powelson, A. Tector.
Does Ureteric Stent Avoid Urological Complications After Renal Transplantation? A Retrospective Study of 10 Years Experience

R. Kato, W. Nahas, K. Yamaçake, H. Kanashiro, R. Falci, A. Bull, I. Antonopoulos, G. Messi, A. Piovesan.
Donor Derived Transmission Events in 2014: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

D. Kaul,¹ S. Covington,² S. Taranto,² M. Green,¹ C. Wolfe.¹
Early Clinical Indicators of Long Term Survival and Allograft Loss Following De Novo DSA. A 15-Year Longitudinal Study

M. Everly,¹ L. Rebellato,² K. Briley,² A. Maldonado,³ P. Bolin,² C. Haisch,² W. Kendrick,⁴ S. Kendrick,⁴ C. Morgan,² R. Harland,² P. Terasaki.¹
Early Conversion to Everolimus in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

J. de Fijter, H. Holdaas, A. Speziale, G. Junge, Z. Wang, J. Cruzado, M. van der Giet.
Effect of Center Volume On Kidney Transplant Outcomes- Mate Kidney Analysis

T. Klair,¹ P. Friedmann,² L. Kayler.²
Effective Control of Anti-Xenogeneic IL-17 Response for Tolerance Induction in Xenogeneic Islet Cell Transplantation

H. Kang,¹ S. Wang,^1,2 X. Zhang,³ L. Zhang,¹ S. Miller,⁴ B. Hering,⁵ X. Luo.^1,3,4
Enhanced Production of Macrophage Chemoattractant Protein-1 (MCP-1) Within the Kidney in Brain Death Donors Predicts Recipient Allograft Function

J. Chen, S. Antipenko, A. Zmijewska, R. Reed, J. Locke, R. Mannon.
Everolimus and Early Calcineurin Inhibitor Withdrawal Is Associated With Superior Renal Function: 5-Year Follow-Up of the Randomized PROTECT Liver Transplantation Study

M. Sterneck, G. Kaiser, N. Heyne, N. Richter, F. Rauchfuss, A. Pascher, P. Schemmer, L. Fischer, C. Klein, S. Nadalin, F. Lehner, U. Settmacher, D. Gotthardt, M. Loss, S. Ladenburger, P. Wimmer, M. Dworak, H. Schlitt.
Glomerular Disease (GD) After Kidney Transplant (KTx): Etiologies, Risk Factors and Consequences

F. Cosio,¹ A. Grupper,¹ E. Lorenz,¹ M. Alexander,² L. Cornell.²
HLA Broad Antigen and Eplet Mismatches in Determining the Risk of Acute Rejection After Kidney Transplantation

H. Do Nguyen,¹ W. Lim,^1,2 J. Chapman,³ J. Craig,^3,4 G. Wong.^3,4
Identifying Predictors of Organ Donation Among African-American Men

C. Harris,¹ C. Modlin,¹ S. Olden,² A. Nowacki,³ T. Franklin,⁴ J. Canedy,¹ M. Tavaras,¹ A. Harris,¹ Y. Hamilton,⁵ C. Zaramo.¹
Kidney Double Negative TCR αβ + Cells: Newly Described Intra-Renal Kidney Lymphocytes That Respond to Ischemia Reperfusion in Mice

M. Martina,¹ S. Bandapalle,² S. Noel,² A. Saxena,¹ A. Hamad,¹ H. Rabb.²
Natural History of Anti- Human Leukocyte Antigen Antibodies After Hear Transplant

J. Kobashigawa, M. Kittleson, F. Liou, S. Siddiqui, R. Shiozaki, L. Piponniau, D. Geft, M. Hamilton, L. Czer, N. Reinsmoen, J. Patel.
Non-Chimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers

J. Leventhal,¹ J. Mathew,¹ D. Salomon,² S. Kurian,² J. Friedewald,¹ L. Gallon,¹ I. Konieczna,¹ A. Tambur,¹ J. Levitsky,¹ Y. Kanwar,¹ C. Jie,¹ M. Abecassis,¹ J. Miller.¹
Pancreas Transplantation Immunosuppression Induction With Rabbit Antithymocyte Globulin +/- Rituximab and Early Steroid Withdrawal: Experience With >500 Recipients

J. Fridell,¹ R. Mangus,¹ J. Chen,² M. Mujtaba,³ T. Taber,³ M. Goble,¹ J. Powelson.¹
Pediatric Liver Transplantation for Metabolic Diseases: Analysis of Children's Hospital of Pittsburgh (CHP) and United Network for Organ Sharing (UNOS) Databases

A. Ganoza, B. Shneider, R. Sindhi, K. Soltys, G. Bond, G. Vockley, Q. Sun, G. Mazariegos.
Pre-Transplant Donor Specific Antibody With Negative Flow-Crossmatch Was Related to Higher Acute Rejection But Not to Poor Graft Survival

A. Guichard-Romero, L. Marino-Vazquez, M. Lopez, N. Castelan, A. De-Santiago, N. Uribe-Uribe, J. Alberu, L. Morales-Buenrostro.
Predicting Graft Loss in a Population of Kidney Transplant Patients Diagnosed With ABMR/TG

J. Reeve,¹ P. Halloran.¹
Predicting and Preventing 30-Day Readmission Following Kidney Transplantation: A Single Center Study

R. Khaim,¹ V. Nair.^1,2
Pregnancy Outcomes in Female Kidney Transplant Recipients: Does Ethnicity Have an Influence?

S. Constantinescu,^1,2 L. Coscia,² D. Armenti,² P. Axelrod,¹ M. Ghanta,¹ S. Rao,¹ M. Moritz.^2,3
Quantifying the Survival Benefit of HLA-Incompatible Kidney Transplantation: A Multi-Center Study

B. Orandi, X. Luo, A. Massie, J. Garonzik-Wang, B. Lonze, R. Ahmed, K. Van Arendonk, R. Montgomery, D. Segev.
Rational Development of Alloantigen Specific Regulatory T Cell Therapy Requires Insight Into Longevity of Alloimmune Pathways

J. Ali, M. Negus, E. Bolton, J. Bradley, G. Pettigrew.
Reciprocal Relationship Between Cytomegalovirus Infection and Graft Rejection in Intestinal/Multivisceral Transplantation: Impact on Survival and Ideal Immunosuppression Protocol

S. Nagai, R. Mangus, E. Anderson, K. Doan, B. Ekser, C. Kubal, J. Fridell, A. Tector.
Safety and Efficacy of All Oral DAA Therapy for Genotype 1 HCV Post-Liver Transplant: Interval Results from the HCV-TARGET Multicenter Prospective Observational Study

J. O'Leary,¹ R. Brown,² K. Reddy,³ A. Kuo,⁴ G. Morelli,⁵ R. Stravitz,⁶ G. Everson,⁷ C. Durand,⁸ H. Vargas,⁹ P. Kwo,¹⁰ C. Frenette,¹¹ J. Peter,¹² M. Vainorius,¹² L. Akushevich,¹² D. Nelson,⁵ M. Fried,¹² N. Terrault.¹³
The Effects of High-Risk Donors and Recipients on Scientific Registry of Transplant Recipients Program-Specific Outcomes

J. Snyder,¹ N. Salkowski,¹ D. Zaun,¹ J. Schold,² A. Israni,¹ B. Kasiske.¹
The Higher MFI of De Novo Donor-Specific Anti-HLA Antibodies Is Correlated With Graft Fibrosis Progression in Living Donor Liver Transplantation

Y. Fukasaku,¹ R. Goto,¹ S. Emoto,¹ N. Kawamura,¹ Y. Koshizuka,¹ T. Takahashi,¹ M. Ota,³ T. Aoyagi,¹ K. Yamashita,² A. Taketomi,¹ T. Shimamura.³
The Selection Process for Total Artificial Heart

F. Arabia, L. Czer, M. Kittleson, E. Passano, F. Liou, J. Yabuno, H. Henry, D. Chang, F. Esmailian, J. Kobashigawa, J. Moriguchi.
Why Are Pancreas Transplant Volumes Declining?

R. Carrico,¹ J. Fridell,² J. Odorico,³ H. Yeh,⁴ K. Tyler,¹ S. Niederhaus.⁵
miRNA-181 Promotes Graft Prolongation by Plasmacytoid Dendritic Cells By Increasing T Regulatory Cells and Decreasing B Cells as Revealed By Cytometry By Time-Of-Flight

A. Lau,^1,2 M. Vitalone,¹ X. Qu,¹ T. Shawler,¹ O. Martinez,¹ C. Esquivel,¹ S. Krams.¹
Association of Pulmonary Hypertension at Kidney Transplant Evaluation and Subsequent Outcomes Following Transplantation

Y.-L. Lai,¹ H. Wasse,² W. Kim,³ R. Patzer.^1,4
Avoiding Futility in Simultaneous Liver-Kidney Transplantation (SLKT): Analysis of 331 Consecutively Listed Patients

K. Lunsford, A. Bodzin, D. Reino, A. Zarrinpar, F. Kaldas, H. Gritsch, J. Veale, G. Lipshutz, D. Farmer, G. Danovitch, H. Yersiz, J. Hiatt, R. Busuttil, V. Agopian.
Changes in Utilization, Discard, and Outcomes Associated With Hepatitis C (+) Donor Livers in the Era of Direct Acting Anti-Retroviral Therapy

M. Bowring, L. Kucirka, X. Luo, A. Massie, D. Segev, C. Durand.
Chimeric Thymus Versus Antigen Presenting Thymus for the Induction of Tolerance: Donor DCs in Vascularized Thymus Grafts Play an Essential Role in the Induction of Tolerance

K. Yamada, M. Sekijima, A. Kawai, T. Tanabe, M. Tasaki, V. Villani, I. Hanekamp, A. Shimizu, D. Sachs.
Deficiency of Naturally Occurring Anti-Angiogenic Antibodies Associate With the Development of Metastatic Cancer Post Renal Transplantation and Patient Death

R. Carroll,¹ A. Phillippe,² R. Catar,² H. Heidecke,² D. Dragun.²
Dendritic Cells in Kidney Transplant Biopsies Are Associated With Poor Allograft Survival

I. Batal,¹ S. De Serres,¹ K. Safa,¹ A. Waaga,¹ M. Onozato,² N. Najafian,¹ A. Chandraker.¹
Differential Clinical Outcomes in Kidney Transplant Recipients With De Novo C1q+ and C1q- Donor Specific Antibodies

M. Ajaimy,¹ A. Colovai,² S. Calp,¹ J. Lindower,¹ M. Melamed,³ E. Akalin.¹
Disparities in Death and Delisting on the Waitlist for Renal Transplant in the United States

D. Keith, A. Nishio Lucar, G. Vranic.
Distinct Blood and Biopsy Meta-Signatures for Acute Rejection Post Kidney Transplant

W. Zhang,¹ Z. Yi,¹ Z. Li,¹ M. Menon,¹ L. Li,¹ C. Xi,¹ I. Greene,¹ C. Wei,¹ L. Gallon,² M. Samaniego,³ A. Djamali,⁴ S. Alexander,⁵ B. Schroppel,¹ B. Nankivell,⁵ J. Chapman,⁵ I. Rosales,⁶ R. Neal Smith,⁶ R. Colvin,⁶ P. O'Connell,⁵ P. Heeger,¹ B. Murphy.¹
HLA-Cw Mismatches Are Not Associated With Worse Graft Outcomes After Kidney Transplantation Even in High Levels of Antigen Expression

M. Askar,¹ N. Elfadawy,^1,2 S. Flechner,¹ K. Abu-Elmagd,¹ J. Fung,¹ J. Schold.¹
IL-2/IL-2 Ab Complex Leads to Long-Term Tolerance in a Treg Dependent DST Model of Skin Allograft Transplantation in Which DST and Timing of the Antibody Complex Are Crucial

G. Zhang,¹ Y. Wang,¹ M. Hu,¹ A. Sawyer,¹ J. Zhou,¹ S. Grey,² S. Alexander.¹
Impact of Community Risk on Early Hospital Readmission Following Kidney Transplant

E. King,¹ L. Kucirka,¹ M. McAdams-DeMarco,^1,2 A. Massie,^1,2 J. Schold,³ D. Segev.^1,2
Incidence, Timing, and Consequence of De Novo Donor Specific Antibody in Intestinal Transplantation

C. Matsumoto, J. Hawksworth, S. Kozlowski, S. Rosen-Bronsen, A. Kromer, M. Grafals, N. Yazgi, S. Kaufman, K. Khan, R. Girlanda, E. Island, C. Desai, T. Fishbein.
Increased Ratio of Estimated Spleen/Graft Volume Is a Strong Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Significance of Splenectomy On Portal Venous Pressure and Patient Survival

S. Mizuno, K. Gyoten, A. Tanemura, Y. Murata, H. Kato, N. Kuriyama, M. Kishiwada, M. Usui, H. Sakurai, S. Isaji.
Is BMI of 28 an Appropriate Cutoff for Simultaneous Pancreas Kidney Transplant in Type II Diabetes?

E. Ahmed, D. Bruce, I. Carmody, A. Cohen, G. Loss, T. Reichman, J. Seal, H. Bohorquez.
Is Transplant Volume Associated With Survival in Pediatric Liver Transplants?

W. Cherikh,¹ H. Kim,² A. Wilk,¹ C. Flavin,¹ E. Brewer.³
Left Ventricular Assist Device–Associated Allosensitization — Clinical Implications

B.-S. Ko, C. Willis, S. Drakos, D. Hurst, A. Kfoury, G. Snow, J. Delgado, E. Hammond, C. Selzman, R. Alharethi, S. McKellar, J. Nativi-Nicolau, E. Gilbert, P. Revelo, D. Miller, B. Reid, J. Fang, D. Eckles, J. Stehlik.
Long-Term Analysis of a Placebo-Controlled Trial of C1-INH for Prevention of Antibody-Mediated Rejection

A. Vo, J. Choi, J. Kahwaji, D. Puliyanda, A. Peng, R. Villicana, S. Jordan.
Monitoring Intracellular Tacrolimus Concentration in Kidney Transplant Recipients With Stable Graft Function

E. Bae,¹ S. Han,¹ S. Yang,² J. Park,¹ H. Lee,¹ J. Lee,³ D. Kim,¹ Y. Kim.¹
Optimal Induction Therapy (IT) in Pancreas After Kidney Transplantation (PAK) According to Type of Kidney (kd) Donor and Patient Risk – A Registry Analysis

R. Gruessner,¹ A. Gruessner.²
Organ Donation Attitudes of Hispanic College Students in the Rio Grande Valley: Analysis of Free Responses

Y. Tasnif,¹ S. Saladin,² A. Araya,¹ X. Wang.³
Pancreas-Derived Mesenchymal Stem Cells from Chronic Pancreatitis Patients Enhance Islet Graft Function

M. Lawrence,¹ F. Kunnathodi,¹ N. Borenstein-Auerbach,¹ G. Yoshimatsu,¹ M. Kanak,² R. Shahbazov,¹ M. Takita,¹ M. Levy,³ B. Naziruddin.³
Pediatrics & Donor Derived Disease Transmission: The US OPTN Experience

M. Green,¹ S. Taranto,² S. Covington,² M. Michaels,¹ C. Wolfe,³ D. Kaul.⁴
Peritransplant Costimulation Blockade and Rapamycin Therapy Induces Permanent Limb Allograft Survival

L. Wang, A. Samanta, J. Huang, T. Bhatti, Z. Wang, R. Han, L. Levin, M. Levine, W. Hancock.
Post-Kidney Transplant Infections in Desensitized Patients Receiving Thymoglobulin or Daclizumab Induction: Results of a Randomized Clinical Trial

B. Orandi,¹ J. Locke,² E. Kraus,³ B. Lonze,¹ N. Desai,¹ N. Dagher,¹ N. Alachkar,³ C. Simpkins,⁴ F. Naqvi,³ D. Segev,¹ R. Montgomery,¹ R. Avery.³
Pre-Transplant Angiotensin Receptor II Type 1 Antibodies (AT1R) and Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) as Predictors of Post Transpalnt FSGS Recurrence

A. Khalil, T. Tim, A. Sharfuddin, S. Doshi, M. Yaqub, D. Mishler, W. Goggins, M. Mujtaba.
Pre-Transplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Chronic Portal Vein Thrombosis

B. Thornburg, K. Desai, T. Baker, J. Fryer, M. Abecassis, J. Caicedo, L. Kulik, R. Salem.
Prediction of Acute Antibody Mediated Rejection in Antibody Incompatible Renal Transplantation Using Machine Learning for Wide Data

T. Shaikhina,¹ N. Khovanova,¹ S. Daga,^1,3 N. Krishnan,² D. Lowe,³ D. Mitchell,¹ D. Briggs,² R. Higgins.³
Pregnancy Outcomes in Kidney Recipients With Longer Transplant to Conception Intervals

S. Constantinescu,^1,2 L. Coscia,² D. Armenti,² P. Axelrod,¹ M. Ghanta,¹ S. Rao,¹ M. Moritz.^2,3
Remote Ischemic Preconditioning Increases Transplantation of Abdominal Organs in Standard Criteria Neurological Death Donors

A. Bongu,¹ W. Washburn,² J. Oliver,¹ J. Nespral,³ A. Davidow,⁴ C. Kadric,³ G. Dikdan,¹ J. Lewis,² U. Pandit,¹ A.-K. Beidas,¹ C. Tourtellot,³ L. Brown,¹ B. Koneru.¹
Risk of HLA Antibody Sensitization in Pediatric Heart Failure Patients Pre/Post Berlin VAD Procedure and Pre/Post Heart Transplantation

R. Kerman, P. Jindra, A. Jeewa, S. Burki, C. Fraser, I. Adachi.
Stable and Unstable Chimerism During Immunosuppressive Drug Withdrawal in Tolerant Recipients of HLA Matched Combined Kidney and Hematopoietic Cell Transplants

T. Pham,¹ S. Busque,¹ J. Scandling,² J. Shizuru,² S. Asha,¹ S. Strober.²
Tandem P-Selectin Glycoprotein Ligand-Immunoglobulin (TSGL-Ig) Protects Liver Endothelial Cells Against Prolonged Cold Preservation Injury in Mouse Liver Transplantation

C. Zhang,¹ H. Ji,¹ Y. Liu,¹ X. Shen,¹ F. Gao,¹ R. Busuttil,¹ G. Shaw,² J. Kupiec-Weglinski.¹
The Impact of Acute Rejection on Liver Transplant Survival in the New Millennium

J. Levitsky,¹ S. Forney,² B. Gillespie,³ R. Merion,^2,3 A. Lok,³ G. Levy,⁴ L. Kulik,¹ M. Abecassis,¹ A. Shaked.⁵
UNOS KDPI Score Is Significantly Overestimated for Pediatric En-Bloc Kidneys

L. Preczewski, K. Howes, N. Iovenette, A. Needham, B. Gallay.
Umbilical Vein Catheter Versus Double J Stent for Ureteric Anastomosis in Renal Transplantation: A Single Centre, Open Label, Randomized Trial

V. Swaroop, A. Pereira, S. Smith, O. Masood, R. Pararajasingam, T. Augustine, H. Riad, S. Mehra, A. Tavakoli.
A Non-Haematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents the Transplanted Islet Graft Damage

M. Watanabe,¹ T. Lundgren,¹ Y. Saito,¹ A. Cerami,² M. Brines,² C.-G. östenson,³ M. Kumagai-Braesch.¹
A Single Center Study of the Implementation Costs of the New Kidney Allocation System

C. Bostic, T. Stern, S. Niederhaus, J. Bromberg, D. Leeser.
AAV-Mediated TIMP-1 Gene Therapy Ameliorates Hepatic Ischemia/Reperfusion Injury

S. Duarte, T. Fujii, G. Lipshutz, R. Busuttil, A. Coito.
Cardiac Troponin T (cTNT) in the Assessment of Kidney Transplant (KTx) Benefit and Risk

F. Cosio,¹ A. Grupper,¹ P. Dean,² H. Amer.¹
Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients

J. Locke,¹ R. Reed,¹ S. Mehta,¹ C. Durand,² R. Mannon,¹ P. MacLennan,¹ B. Shelton,¹ M. Martin,¹ H. Qu,¹ R. Shewchuk,¹ D. Segev.²
Donor Specific Expansion of Regulatory T-Cells Was Associated With Allograft Tolerance Induced By Transient Mixed Chimerism in Nonhuman Primates

K. Hotta, A. Aoyama, T. Ohura, M. Tonsho, Y. Yamada, J. Allan, J. Madsen, B. Cosimi, G. Benichou, T. Kawai.
Donor-Derived Cell-Free DNA Is Stable in Non-Rejecting Heart Transplant Recipients in the CARGO II Multicenter Trial

D. Hiller,¹ M. Grskovic,¹ J. Beausang,¹ R. Sit,¹ B. Christie,¹ J. Elechko,¹ R. Woodward,¹ J. Yee,¹ H. Eisen.²
Epidemiology of Pneumonia in a Cohort of 5,000+ Abdominal Solid Organ Transplant Recipients

A. Masica, S. Delcroix-Lopes, M. Kouznetsova, C. Spak.
Epstein Barr Virus Modulates Host Cell MicroRNA-194 to Promote IL-10 Production in B Cell Lymphomas

A. Harris-Arnold, S. Schaffert, O. Hatton, C. Esquivel, S. Krams, O. Martinez.
Examining Long-Term Survivors in Combined Heart-Lung Transplantation

S. Kadakia,¹ S. Jayarajan,¹ S. Taghavi,¹ V. Ambur,¹ C. Lewis,¹ A. Shiose,² G. Wheatley III,² L. Kaiser,³ T. Guy,² Y. Toyoda.²
Furthering the Link Between Ischemia and Immunity: Development of New Antibody Following Prolonged Delayed Graft Function

A. Gilbert,¹ E. Hall,¹ O. Timofeeva,² M. Awwad,² M. Grafals,¹ P. Weems,¹ D. Li,² S. Rosen-Bronson,² J. Moore,¹ B. Javaid,¹ M. Cooper.¹
Immunoglobulin G Donor-Specific Anti-HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury

D. Viglietti,^1,2 C. Bentlejewski,³ J.-P. Duong van Huyen,^4,2 D. Vernerey,^5,2 O. Aubert,² J. Verine,¹ X. Jouven,² C. Legendre,⁴ D. Glotz,¹ A. Loupy,^2,4 A. Zeevi,³ C. Lefaucheur.^1,2
Impact of Pretransplant Pregnancy On Immunization and Immunologic Outcome in Kidney Transplantation

O. Staeck,¹ D. Khadzhynov,¹ S. Kreimer,¹ E. Rajakangas,¹ C. Schönemann,² N. Lachmann,² K. Budde,¹ F. Halleck.¹
Impact of Pretransplant Sarcopenia and Sequential Changes in Sarcopenic Parameters After Living Donor Liver Transplantation

T. Kaido,¹ Y. Tamai,² K. Ogawa,¹ Y. Fujimoto,¹ A. Mori,¹ H. Okajima,¹ N. Inagaki,² S. Uemoto.¹
Infections After Transplant Tourism in Organ Transplant Recipients

D. Kumar,¹ A. Humar,¹ H. Crossman,² C. Kotton,³ M. Levi.²
Liver Transplantation for Children With Autoimmune Hepatitis and Primary Sclerosing Cholangitis: An Analysis of the UNOS Database

J. Jossen,¹ R. Annunziato,² J. Chu,¹ H.-S. Kim,² S. Sheflin,¹ J. Lai,¹ R. Arnon.¹
Long Term Follow Up Reveals Satisfactory Renal Outcome in Pacreas After Kidney Transplantation (PAK)

R. Banga, V. Dadlani, W. Kremers, E. Lorenz, P. Dean, M. Stegall, Y. Kudva.
Long-Term Excellent Results of ABO-Incompatible Kidney Transplantations at Multicenter Japanese Case Series

K. Tanabe,^１ H. Ishida,^１ K. Masutani,² Y. Okabe,³ M. Okumi,¹ H. Kitada,² T. Shimizu,⁴ H. Shirakawa.⁵
Long-Term Metabolic Outcomes of Functioning Pancreas Transplants in Type 2 Diabetic Recipients

S. Shin, Y. Kim, B. Choi, J. Choi, J. Jung, H. Cho, D. Han.
Metrics of Global Health Status Signal Early Hospital Readmission Risk After Kidney Transplantation

M. Harhay,¹ A. Hill,² W. Wang,² O. Even-Shoshan,² A. Mussell,¹ J. Karlawish,³ R. Bloom,¹ H. Feldman,¹ J. Silber,² P. Reese.¹
Morphometric Age as a Predictor of Survival Following Kidney Transplantation

M. Terjimanian,¹ D. Cron,¹ D. Cote,² J. Augustine,² K. Noon,² S. Wang,¹ M. Englesbe,¹ K. Woodside.²
National Outcomes of Kidney Tranplantation from Diabetic Donors: A Mate-Kidney Analysis

J. Cohen,¹ P. Reese,¹ P. Porrett,² R. Bloom,¹ K. Forde,³ D. Sawinski.¹
Non-Invasive Panel of MicroRNAs Predict Long-Term Outcomes Post-Kidney Transplantation

J. Suh,¹ D. Maluf,¹ H. Cathro,² R. Gehrau,¹ I. McConnell,¹ K. Brayman,¹ C. Dumur,² V. Mas.¹
Rabbit Antithymocyte Globulin Is Associated With Improved Patient and Graft Survival in Liver Transplantation. Experience With 595 Patients

M. Montenovo,¹ F. Jalikis,² L. Meng,³ Y. Matthew,² D. Andre,¹ H. Ryan,³ R. Jorge.¹
Rat dnIKK2-Treg Derived Exosomes Suppress T Cell Proliferation, Generate T Regulatory Cells and Prolong Kidney Allograft Survival

S. Aiello, F. Rocchetta, N. Azzollini, S. Tomasoni, G. Remuzzi, M. Noris, A. Benigni.
Replacement of Lamivudine By Telbivudine to Improve Renal Function for Post-Transplant Hepatitis B Patients – A Randomized Clinical Trial

W.-C. Lee, H.-S. Chou, R.-S. Soong, T.-J. Wu, C.-H. Cheng, Y.-C. Wang, T.-H. Wu, C.-F. Lee, K.-M. Chan.
Short- and Long-Term Outcomes of Mycophenolate Versus Azathioprine in a Large Cohort of Renal Transplant Recipients

L. Bowman,¹ T. Horwedel,¹ J. Hagopian,¹ D. Brennan.²
Six Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Mismatched Living Donor Renal Transplant Recipients

J. Leventhal, M. Abecassis, L. Gallon, J. Galvin, J. Mehta, K. Ravindra, D. Tollerud, M. Elliott, S. Ildstad.
Successful Management of Post Transplant Focal Segmental Glomerulosclerosis With Plasma Exchange and Rituximab

K. Koutroutsos,¹ R. Charif,¹ C. Roufosse,² J. Galliford,¹ D. Taube,¹ M. Loucaidou.¹
Targeting Complement Pathways During Ischemia and Reperfusion: Implications for the Prevention of Delayed Graft Function

Z. Yu,¹ S. Qi,² M. Lasaro,¹ K. Bouchard,¹ C. Dow,¹ K. Moore,¹ Z. Wu,² A. Barama,² J. Xu,² K. Johnson,¹ A. Marozsan,¹ Y. Wang.¹
The C1q-Binding Assays and Clinical Outcomes in Kidney Transplantation

P. Amico,¹ G. Hönger,¹ H. Hopfer,² R. Liwski.³
The Impact of the New Antivirals Sofosfuvir/Ledipasvir on Liver Transplantation for Hepatitis C Cirrhosis

S. Munoz,¹ D. Reich,² K. Rothstein.¹
Ureteral Length in Living Donor Kidney Transplantation; Does Size Matter?

L. Ooms, I. Slagt, J. IJzermans, T. Terkivatan.
Urinary CXCL10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection

M. Rabant,^1,2 L. Amrouche,^2,3 X. Lebreton,³ F. Aulagnon,³ A. Benon,² V. Sauvaget,² R. Bonifay,² L. Morin,³ A. Scemla,³ M. Delville,³ F. Martinez,³ M. Timsit,⁴ J. Duong Van Huyen,¹ C. Legendre,³ F. Terzi,² D. Anglicheau.^2,3
Vascularised Composite Allografts and Intestinal Transplantation: Does the Skin Component Provide a Pre-Rejection Marker for the Visceral Organ?

G. Vrakas, H. Giele, R. Arantes, S. Reddy, P. Friend, A. Vaidya.
Vascularized Bone Marrow Plays a Critical Role in Inducing Tolerance of Osteomyocutaneous Allografts

C.-H. Lin,¹ M. Anggelia,¹ Y.-L. Wang,¹ H.-Y. Cheng,¹ W. Lee,² G. Brandacher.²
10 Year Experience Using a Steroid Free Three Drug Maintenance Immunosuppression Regimen for Pancreas Transplant Alone: Comparison of Induction With Rabbit Antithymocyte Globulin +/- Rituximab

J. Fridell,¹ R. Mangus,¹ J. Chen,² M. Mujtaba,³ T. Taber,³ M. Goble,¹ J. Powelson.¹
Characteristics and Outcomes of Renal Transplant Recipients With Hemolytic Uremic Syndrome: An OPTN Registry Analysis

B. Tanriover,¹ M. MacConmara,² R. Saxena,¹ Y.-M. Shen.³
Concerted T-Cell Activity Against Early and Late BKV-Antigens Is Necessary for Viral Clearance

B. Weist,^1,2 M. Schmueck,² M. Dziubianau,² P. Reinke,^1,2 N. Babel.^1,2
Controlled DCD Pancreas Transplantation : A Single Centre Experience

M. Voskuil, S. Mittal, A. Muthusamy, J. Gilbert, S. Sinha, I. Quiroga, S. Reddy, P. Friend, E. Sharples, A. Vaidya, R. Ploeg.
Correlation of Serum Creatinine-Based Equations With Radionuclide GFR in Candidates for Liver Transplantation

A. Alqallaf, A. Alam, P. Ghali, M. Cantarovich.
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of Graft Failure and Mortality Among Kidney Transplant Recipients

P. Clayton,^1,2,3 W. Lim,^1,4 S. Chadban.^1,2,3
Diabetic Kidney Transplant Recipients: Impaired Infection Control and Alloreactivity

T. Schachtner,^1,2 M. Stein,² P. Reinke.^1,2
Do CMS Oversight and the Systems Improvement Agreement Really Change Institutional Behavior?

C. Hoopes.
Donor MHC Independent Rejection of Islet Allografts in Autoimmune NOD Mice

A. Burrack,¹ K. Beard,² M. Coulombe,² R. Gill.²
Donor-Specific Alloantibody After Positive Crossmatch Kidney Transplantation With Eculizumab (EC): Correlation With Transplant Glomerulopathy and Graft Failure

C. Schinstock,¹ F. Cosio,¹ L. Cornell,¹ M. Gandhi,¹ M. Everly,² M. Stegall.¹
Dramatic Improvements in Racial Disparities in Kidney Transplant Outcomes in the US

T. Purnell,¹ X. Luo,¹ L. Kucirka,¹ L. Cooper,¹ A. Massie,¹ D. Crews,¹ L. Boulware,² D. Segev.¹
Economic Analysis of Kidney Transplant Tolerance: The Holy Grail Is Less Costly

N. Elias, S. Shao, T. Gift, B. Patel, A. Cosimi, T. Kawai.
Effect of Everolimus on Left Ventricular Hypertrophy in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

M. van der Giet,¹ H. Holdaas,¹ J. de Fijter,¹ A. Speziale,² C. Escrig,² G. Junge,² Z. Wang,³ J. Cruzado.¹
Efficacy and Safety of Three Different Treatment Regimen in De Novo Renal Transplant Patients: Month 48 Follow-Up Results of the HERAKLES Trial

C. Sommerer,¹ K. Budde,¹ V. Kliem,¹ O. Witzke,¹ M. Guba,¹ J. Jacobi,¹ B. Vogt,³ I. Hauser,¹ P. Reinke,¹ R. Stahl,¹ T. Rath,¹ M. Porstner,² D. Baeumer,² M. Zeier,¹ W. Arns,¹ F. Lehner.¹
Efficacy of Low Dose Chemoprophylaxis for Coccidioidomycosis Infection in Liver Transplantation Recipients

R. El Ramahi,² S. Habib,¹ S. Rosen,³ S. Farran,³ C. Walker,³ J. Shubeilat,⁴ S. Yost,⁵ O. McCotter,⁶ M. Cassal,⁶ A. Rana,⁷ T. Boyer,¹ T. Zangeneh.²
Etiology, Incidence and Outcomes of the Highly Sensitized Kidney Transplant Patient

R. Redfield, T. Zens, J. Scalea, M. Rizzari, D. Mandelbrot, D. Kaufman, A. Djamali.
Everolimus Initiation Immediately After Liver Transplantation: A Single-Center Experience

U. Herden, A. Galante, S. Pischke, L. Fischer, J. Li, M. Koch, E. Achilles, B. Nashan, M. Sterneck.
Improved Long-Term Graft Survival in Renal Transplant Recipients With Donor Specific Antibodies (DSA) After Mycophenolic Acid Escalation

L. Rebellato,¹ K. Parker,² F. Rana,³ S. Kendrick,⁴ C. Morgan,⁵ C. Haisch,⁵ M. Everly,⁶ R. Harland,⁵ P. Bolin.³
Interim Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in Living Donor Kidney Transplant Recipients

J. Leventhal,¹ A. LeFever,² A. Skaro,¹ L. Gallon,¹ J. Mathew,¹ D. Stare,¹ I. Konieczna,¹ J. He,¹ G. Johnson.³
Interventional Treatment With Minimal Surgery Is an Effective Way for Acute Portal Vein Thrombosis After Pediatric Liver Transplantation: The Experience of Largest Pediatric Liver Transplantation Center in China

Y. Liu,¹ T. Lu,¹ C. Shen,¹ Q. Xia,¹ Y. Luo,¹ T. Zhou,¹ B. Qiu,¹ M. Zhang,¹ L. Han,¹ Q. Chen.²
Kidney Plasmacytoid Dendritic Cells Display Distinct Cell Surface Markers and May Explain the Induction of Tolerance by Kidney Allografts

N. Oh, M. Tonsho, D. Ndishabandi, R. Colvin, J. Madsen, A. Alessandrini.
Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation

T. Wong, J. Stulak, J. Heimbach, M. Stegall, T. Taner.
Living Donor Liver Transplantation for Biliary Atresia has Equivalent Survival and Shorter Waiting Time Compared to Deceased Donor Liver Transplantation

S. Alexopoulos,¹ V. Nekrasov,¹ L. Matsuoka,¹ K. Chouliaras,² Y. Genyk.¹
Loss of RIPK3 and Caspase-8 Enhance Intrinsic Apoptosis in Tubular Epithelial Cell (TEC) Death and Contributes to Kidney Ischemia Reperfusion Injury (IRI)

B. Sung,¹ Y. Su,³ A. Lau,³ J. Jiang,³ A. Haig,² D. Green,⁴ Z. Zhang,² A. Jevnikar.¹
Molecular Correlates of Endothelial mTOR Activation in Heart Transplants Recipients

M. Racape, A. Loupy, J. Reeve, J. Venner, R. Guillemain, L. Hidalgo, C. Lefaucheur, X. Jouven, P. Bruneval, P. Halloran, J. Duong.
Non-Invasive Diagnosis of Post Kidney Transplant Complications by Urinary Exosomal mRNA Analysis

H. Harada,¹ T. Murakami,² C. Yamamoto,² M. Mitsuhashi.²
Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Co-Infected Recipients: The “Real World” Experience

D. Sawinski,¹ G. David,² E. Blumberg,³ P. Abt,⁴ R. Bloom,¹ K. Forde.²
Patient and Process-Level Factors Associated With Kidney Transplant Readmissions

K. Covert, J. Fleming, C. Staino, J. Casale, K. Boyle, N. Pilch, H. Meadows, C. Mardis, J. McGillicuddy, C. Bratton, T. Srinivas, K. Chavin, P. Baliga, D. Taber.
Post-Transplant Lymphoproliferative Disorders Following Alemtuzumab Induction in Kidney Transplantation

H. Sawhney, R. Charif, J. Galliford, A. Mclean, D. Taube.
Pretransplant Antibodies Against Angiotensin II Type 1 Receptor in Renal Transplantation: Preliminary Data from the KNOW-KT Study

K. Huh,¹ J. Lee,¹ Y. Park,² Y. Kim,¹ C. Ahn.³
Recreational and Lifestyle Infection Risks in Transplant Recipients

R. Avery,¹ D. Ostrander,¹ S. Shoham,¹ S. Alp,² N. Lu,¹ C. Cave,¹ E. Kraus,³ K. Marr.¹
Robotic Kidney Transplantation With Regional Hypothermia: Results from a Prospective Two-Arm Non-Randomized Controlled Trial (Ideal Phase 2b)

R. Ahlawat,¹ A. Sood,² P. Ghosh,¹ V. Kher,¹ M. Bhandari,² M. Menon.²
Surgical Error: A Common, Preventable Threat to Deceased Donor Organs

A. Friedman,¹ T. Diflo,² S. Florman,³ L. Ratner,⁴ E. Marquez,¹ W. Tajik.¹
Surgical Site Infections After Intestinal and Multivisceral Transplantation

K. Etesami, R. Girlanda, J. Steele, Y. Kwon, J. Hawksworth, C. Desai, E. Island, C. Matsumoto, T. Fishbein.
Tolerance to Graft A-Antigens Following ABO-Incompatible Heart Transplantation (HTx) in a Blood Group A-Transgenic Mouse Model

B. Motyka,¹ K. Labonte,¹ F. Rahman,¹ J. Pearcey,¹ K. Tao,¹ M. Mengel,¹ B. Sis,¹ P. Cowan,² L. West.¹
Transplantation of Neonatal En-Bloc Kidneys: Do They Grow and Are They Subject to Hyperfiltration Injury?

J. Woloszyn, C. Santhanakrishnan, C. Troppmann, A. DeMattos, B. Gallay, J. McVicar, J. Sageshima, R. Perez.
1-Year Safety and Efficacy of Eculizumab in Adult aHUS Patients, With or Without a History of Renal Transplant

C. Legendre,¹ J. Kincaid,² C. Bedrosian,² C. Loirat.³
A Prospective and Randomized Study of Conversion from Tacrolimus to Cyclosporine A to Improve Glucose Metabolism in Patients With New-Onset Diabetes Mellitus After Renal Transplantation

K. Wissing,¹ D. Abramowicz,² L. Weekers,³ K. Budde,⁴ T. Rath,⁵ O. Witzke,⁶ D. Kuypers.⁷
A Randomized Study Comparing Parathyroidectomy Versus Cinacalcet to Treat Hypercalcemia in Kidney Allograft Recipients With Persistent Hyperparathyroidism

J. Cruzado,¹ V. Torregrosa,⁵ R. Mast,³ A. García-Barrasa,² O. Bestard,¹ E. Melilli,¹ J. Francos,² J. Torras,¹ C. Polo,¹ C. Gómez-Vaquero,⁴ J. Grinyó,¹ P. Moreno.²
ABO-Incompatible Live Donor Kidney Transplants Inferior to ABO-Compatible Transplants, but Match Deceased Donor Results: Is Kidney Paired Donation the Answer?

J. Verbesey, M. Cooper, A. Gilbert, M. Grafals, P. Weems, J. Moore, S. Ghasemian, C. Nilubol, B. Javaid.
Allogeneic Mature Human Monocyte-Derived Dendritic Cells Generate Superior Alloreactive Regulatory T Cells in an IL-2-Independent Manner

N. Litjens,¹ K. Boer,¹ J. Zuijderwijk,¹ M. Klepper,¹ A. Peeters,¹ E. Prens,² W. Verschoor,¹ R. Kraaijeveld,¹ Z. Ozgur,³ M. van den Hout-van Vroonhoven,³ W. van IJcken,³ C. Baan,¹ M. Betjes.¹
An Economic Analysis of Tolerance Induction for Two-Haplotype Match Kidney Living Donor Transplant Recipients

K. Erickson,¹ W. Winkelmayer,² R. Lowsky,¹ J. Scandling,¹ S. Strober.¹
B Cell MicroRNA as Biomarkers for Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder

A. Harris-Arnold, V. Kaul, S. Shaffert, O. Hatton, C. Esquivel, S. Krams, O. Martinez.
Bridging Therapy With Belatacept in High MELD Liver Transplant Recipients

T. Sparkes,¹ B. Masters,¹ S. Hanish,² D. Potosky,² W. Hutson,² J. LaMattina,² R. Barth.²
Changes in Health Related Quality of Life (HRQOL) in Pediatric Liver Transplant (LT) Recipients During Protocolized Immunosuppression Withdrawal (ISW): The iWITH Trial

S. Mohammad,¹ S. Sundaram,² V. Venkat,³ M. Martinez,⁴ J. Lopez,⁵ J. Magee,⁵ E. Alonso,¹ S. Feng.⁶
Clinical Relevance of C3d-Binding Donor-Specific Antibodies in Late Kidney Allograft Failure

J. Lan, D. Gjertson, Y. Zheng, DeKAF Investigators, E. Reed, M. Cecka.
Clinically Relevant Anti-TCR mAb Induction Plus Brief Rapamycin Therapy Can Achieve Long-Term Vascularized Composite Allograft (VCA) Survival

L. Wang, A. Samanta, J. Huang, T. Bhatti, Z. Wang, R. Han, L. Levin, M. Levine, W. Hancock.
Deceased Donor Kidney Transplantation Without Calcineurin Inhibitors or Steroids

A. Kirk,^1,2 A. Guasch,¹ S. Mead,¹ A. Ghali,¹ A. Mehta,¹ H. Gebel,¹ R. Bray,¹ C. Larsen,¹ T. Pearson.¹
Discard of Kidneys at the Margin: ECD Versus KDPI Era

S. Bae, A. Massie, D. Segev.
Estimation of Glomerular Filtration Rate With Serum Cystatin C Accurately Discriminates Renal Dysfunction in Liver Transplant Candidates With End-Stage Liver Disease

S. Gonzalez,¹ J. Trotter,¹ H. Szerlip,² M. Levy,³ A. Chandrakantan,⁴ A. Yango,⁴ A. Rajagopal,⁴ Y. Barri,⁴ K. Rice,⁴ M. Saim,² L. Melton,⁴ M. Emmett,² G. Klintmalm,³ B. Fischbach.⁴
Heart Transplant for Amyloid Patients in the Current Era of Bortezomib

J. Patel, R. Vescio, M. Kittleson, S. Siddiqui, F. Liou, J. Yabuno, L. Piponniau, B. Kearney, M. Hamilton, L. Czer, J. Kobashigawa.
Hydrogen Sulfide Restores Protective Capacity of University of Wisconsin Solution During Normothermic Preservation

J. Grewal,¹ I. Lobb,¹ M. Whiteman,³ A. Sener.^1,2
Impact of Preoperative MELD Score On Small for Size Syndrome in Living Donor Liver Transplantation

S. Marubashi, A. Tomokuni, Y. Tomimaru, T. Asaoka, H. Wada, H. Eguchi, K. Umeshita, Y. Doki, M. Mori, H. Nagano.
Impaired Autophagy: A Mechanism of Fatty Liver Increases Susceptibility to Ischemia Reperfusion Injury

Q. Zhao, Z. Guo, W. Ju, L. Wu, D. Wang, Y. Ma, M. Chen, R. Deng, X. He.
Is Electron Microscopy Adding a Diagnostic Advantage in the Evaluation of Renal Allograft Biopsies for Antibody Mediated Rejection (AMR)?

J. Papadimitriou, M. Chaudhry, C. Drachenberg, R. Ugarte, D. Klassen, E. Ramos, C. Cangro, B. Thomas, M. Mavanur, A. Haririan.
Kidney and Liver CIT Variations Across OPOs and Their Implications: US Experience Between 2003 and 2011

J. Melancon, N. Koizumi, C. Callender, D. DasGupta, T. Smith.
Mesenchymal Stem Cells Enhance Rejection Free and Overall Islet Allograft Survival

N. Kenyon,¹ M. Willman,¹ H. Dongmei,¹ H. Ana,¹ A. Rabassa,¹ W. Diaz,¹ J. Geary,¹ N. Kenyon,¹ A. Bartholomew,² K. McHenry,³ D. Salomon,⁴ D. Berman.¹
Molecular Correlates of Atrophy-Fibrosis in Human Kidney Transplants Provides a New Model of Renal Fibrosis

J. Venner, K. Famulski, P. Halloran.
Multivisceral Transplantation Without an Ostomy – Experience With 15 Patients

T. Beduschi, J. Garcia, S. Nishida, A. Tekin, J. Fan, G. Selvaggi, P. Ruiz, R. Vianna.
Neighborhood Poverty Modifies Gender Disparities in Kidney Transplant Outcomes

T. Purnell, X. Luo, A. Massie, D. Crews, L. Cooper, D. Segev.
No Significant Outcome Benefit for Brand-Name Versus Generic Tacrolimus in Kidney Transplant Recipients: SRTR Analysis

D. Goldfarb,¹ E. Poggio,¹ S. Flechner,¹ R. Fatica,¹ J. Schold.²
Outcome of Bortezomib/Plasmapheresis for the Sensitized Patient Awaiting Heart Transplant

J. Patel, N. Reinsmoen, M. Kittleson, D. Dilibero, F. Liou, D. Chang, M. Hamilton, L. Czer, F. Esmailian, J. Kobashigawa.
Outcomes Associated With Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) in Solid Organ Transplant (SOT) Recipients

T. Bias,¹ A. Sharma,² G. Malat,³ D. Lee,² A. Doyle.²
Pancreas After Failed Islet Transplantation; a Successful Strategy to Maintain Insulin Independence

J. Gardner,¹ G. Roll,¹ S. Wisel,¹ J. Harbell,¹ B. Hynson,¹ D. Kaufman,² A. Posselt,¹ P. Stock.¹
Post-Donation Outcomes in 46 Live Pancreas Donors

V. Kirchner, D. Sutherland, T. Dunn, E. Finger, T. Pruett, R. Kandaswamy.
Post-Liver Transplant Metabolic Syndrome Increases the Risk of Recurrent Fibrosis in Patients With Hepatitis C

R. Sharma, M. Laurito, R. Brown, Jr., E. Verna.
Pre-Transplant Cardiac Troponin T (cTT) Is a Strong Predictor of Post Kidney Transplant Hospitalizations

H. Amer, P. Geerdes, T. Fettes, R. Walker, E. Lorenz, F. Cosio.
Regulatory Tolerance Across a Full MHC Barrier Is More Robust Than Tolerance Across a Class I MHC Disparity Alone

M. Madariaga, S. Michel, G. La Muraglia II, M. O'Neil, W. Orent, V. Villani, M. Sekijima, E. Farkash, R. Colvin, J. Allan, K. Yamada, J. Madsen, D. Sachs.
The Impact of a Desensitization Protocol Using Plasmapheresis and Intravenous Immunoglobulin On Graft Outcome in Kidney Recipients With Donor Specific Anti-HLA Antibodies

J. Junqueira, T. Leite, A. Junqueira, R. Esmeraldo.
The Significant Association Between the Functional Polymorphism (Rs3761548) of Foxp3 Gene and the Severity of Acute Cellular Rejection in Liver Transplantation

S. Verma, Y. Tanaka, S. Shimizu, L. Das, H. Ohdan.
Treatment of Hepatitis C Virus in Kidney Transplant Recipients With Direct Acting Anti-Viral Agents: Early Results in 12 Cases

A. Sharfuddin,¹ T. Taber,¹ M. Mujtaba,¹ M. Yaqub,¹ D. Mishler,¹ P. Kwo,² R. Vuppalanchi.²
Vaccination to Prevent the High Herpes Zoster Incidence After Renal Transplantation

M. Kho,¹ W. Weimar,¹ D. Boveé,¹ M. Boer-Verschragen,¹ A. van der Eijk,² N. van Besouw.¹
ALDH Expression in Facilitating Cells Plays a Critical Role in Regulatory T Cell Induction and GVHD Prevention

H. Xu,¹ T. Miller,¹ Y. Huang,¹ S. Ildstad.^1,2
Assessment of Circulating HLA-Specific Alloreactive Memory B Cells Reveals Surreptitious Immunized Kidney Transplant Recipients at High Risk of Antibody-Mediated Rejection

M. Lúcia,¹ S. Luque,¹ E. Crespo,¹ J. Cruzado,^1,2 E. Melilli,² J. Martorell,³ J. Torras,^1,2 S. Gil-Vernet,² J. Grinyo,^1,2 O. Bestard.^1,2
Characteristics and Outcomes of Kidneys Procured from Donors With KDPI > 80%

M. Doshi, I. Hall, F. Weng, B. Schroppel, J. Ficek, R. Hasz, H. Thiessen-Philbrook, R. Formica, P. Reese, C. Parikh.
Clinical Subclassifiation of ABMR Phenotypes: Recognizing Variation in Presentation

P. Halloran, M. Lopez, I. Salazar, J. Chang.
Clinical and Radiological Predictors of Transplant Renal Artery Stenosis (TRAS)

H. Wadei,¹ D. Hodge,² L. White,² A. Ayub,³ N. Aslam,³ T. Gonwa,¹ G. Frey,⁴ D. Sella,⁴ M. Mai.¹
Clinically Relevant Wound Events With Everolimus-Based Immunosuppressive Regimen: Post-Hoc Analysis from a Randomized Heart Transplant Study

A. Zuckermann,¹ M. Rinaldi,¹ N. Yonan,¹ S.-S. Wang,¹ G. Dong,² P. Lopez.²
Cumulative Incidence, Risk Factors for and Impact on Survival of Severe Chronic Kidney Disease After Intestinal Transplantation: Analysis of the SRTR Database

G. Huard,¹ K. Iyer,¹ J. Moon,¹ L. Schwartz,¹ J. Doucette,² V. Nair,¹ T. Schiano.¹
Detecting Bowel Cancer in Pre-Dialysis, Dialysis Patients and Kidney Transplant Recipients – The DETECT Study

G. Wong, J. Chapman, J. Craig.
Development of a Risk Assessment Model for HIV Among Increased Risk Deceased Donors With Negative Nucleic Acid Testing

P. Annambhotla, B. Gurbaxani, M. Kuehnert, S. Basavaraju.
Does a History of Diabetes in Deceased Donors Modify the Outcomes of Kidney Transplant Recipients With Diabetes?

T. Rajan, J. Kim.
Donor Specific Antibodies (DSA) Increase the Risk for Rejection After Pancreas Transplantation Qithout Negatively Impacting Survival

M. Marquez, M. Dib, G. Sapisochin, J. Laurence, A. Barbas, F. Bazerbachi, A. Norgate, M. Selzner, P. Greig, I. McGilvray, M. Cattal.
Eculizumab in Prevention of Acute Antibody-Mediated Rejection in Sensitized Deceased-Donor Kidney Transplant Recipients: 1-Year Outcomes

D. Glotz,¹ G. Russ,² L. Rostaing,³ C. Legendre,⁴ S. Chadban,⁵ J. Grinyo,⁶ N. Mamode,⁷ E. Cozzi,¹¹ Y. Lebranchu,⁸ S. Sandrini,⁹ L. Couzi,¹² W. Marks.¹⁰
Effective Long-Term Prophylaxis against De Novo Hepatitis B With Hepatitis B Vaccination in Pediatric Recipients of HbcAb-Positive Liver Grafts

S. Lee, J.-M. Kim, G.-S. Choi, C.-H. Kwon, J.-W. Joh, S.-K. Lee.
Effector T Cell Migration to Pancreatic Islet Allografts Is Dependent On Donor Antigen Recognition and Not Gαi Chemokine Signaling

Q. Zhang, H. Dai, Q. Zeng, A. Williams, M. Oberbarnscheidt, F. Lakkis.
Elevated Cancer Risk Among US Pediatric Solid Organ Transplant Recipients

E. Yanik,¹ J. Smith,² M. Shiels,¹ C. Clarke,³ C. Lynch,⁴ A. Kahn,⁵ L. Koch,⁶ K. Pawlish,⁷ E. Engels.¹
Favorable Results of ABO Incompatible Renal Transplantation Without B Cell Targeted Therapy: Advantages and Disadvantages of Rituximab Pretreatment

M. Okada,¹ K. Futamura,¹ K. Itou,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ Y. Watarai,¹ A. Katayama,² K. Uchida,³ T. Kobayashi.⁴
Gender Disparity in Infections After Kidney Transplantation

S. Bae, L. Kucirka, C. Durand, B. Orandi, R. Avery, D. Segev.
Identifying the “Operational Tolerant” Pediatric Liver Transplant Recipient by Cytometry by Time-of-Flight

A. Lau,^1,2 M. Vitalone,¹ K. Haas,³ T. Shawler,¹ C. Esquivel,¹ O. Martinez,¹ R. Castillo,³ S. Krams.¹
Increased Cytotoxic and Regulatory T Cell and B Cell Associated Gene Transcripts in Transplant Kidney Biopsies With Non-Specific IFTA and Interstitial Inflammation

S. Akten, M. Ajaimy, P. O Broin, Y. Bao, A. Golden, E. Akalin.
Intra-Renal Cytokine Measurement Detected During Kidney Allograft Biopsies Portend Severity of Histological Injury

N. Leca, S. Anderson, K. Muczynski.
Invasive CMV-Infection of the Duodenal Cuff – An Underestimated Entity of CMV Infection and Its Potential Impact On Outcome After Pancreas Transplantation

A. Biglarnia,¹ B. von Zur-Mühlen,¹ S. Yamamoto,¹ D. Berglund,¹ M. Wagner,² A. Sedigh,¹ G. Tufveson,¹ E. Larsson,³ F. Sund.²
Live Donor Liver Transplantation With Older (>50years) Vs Younger (<50years) Donors: Does Age Matter?

N. Goldaracena, G. Sapisochin, J. Echeverri, M. Kaths, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.
MDSC Derived from iPS Cells Regulate the CD8 T Cell Response In Vivo

D. Joyce,¹ M. Morita,² X.-K. Li,³ J. Fung,¹ S. Qian,^1,2 L. Lu.^1,2
MicroRNAs in Kidney Graft Preservation Fluid as Novel Biomarkers for Delayed Graft Function

L. Ooms, H. Roest, S. van den Hoek, R. de Bruin, J. IJzermans, L. van der Laan, F. Dor.
Outcomes Between ABO-Incompatible Living Donor Liver Transplantation (LDLT) and ABO-Compatible LDLT: A Matched Study

J. Kim, S. Lee, W. Cho, J.-Y. Choi, G.-S. Choi, J. Park, C. Kwon, S. Kim, J.-W. Joh, S.-K. Lee.
Outpatient Management of Delayed Graft Function (DGF) Is Associated With Reduced Length of Stay and Acute Rejection

B. Muth,¹ B. Astor,¹ J. Turk,¹ M. Mohamed,¹ S. Parajuli,¹ D. Kaufman,² D. Mandelbrot,¹ A. Djamali.^1,2
Rat Forelimb Allotransplantation: A Novel Microsurgical Model for Optimized Functional Assessment After Reconstructive Transplantation

B. Kern,¹ S. Tuffaha,¹ M. Khusheim,¹ S. Xiang,¹ G. Furtmueller,¹ K. Sarhane,¹ J. Park,² A. Hoke,² W. Lee,¹ G. Brandacher.¹
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus

H. Tedesco-Silva,¹ C. Felipe,¹ A. Ferreira,¹ M. Cristelli,¹ T. Sandes- Freitas,¹ N. Oliveira,¹ W. Aguiar,² G. Bassos,¹ M. Franco,³ M. Gerbase- Lima,⁴ E. Campos,⁴ J. Medina-Pestana.¹
Renal Outcomes of Cross Match Positive Simultaneous Liver Kidney (SLK) Transplant Recipients Compared to Cross Match Positive Kidney Allograft Recipients

S. Vaishnav,¹ T. Taber,¹ W. Goggins,² S. Nagaraju,² J. Fridell,² A. Sharfuddin,¹ M. Yaqub,¹ D. Mishler,¹ M. Mujtaba.¹
Retransplantation of the Elderly Diabetic: To Do Or Not to Do?

A. Naik, A. Sakhuja, D. Cibrik, M. Samaniego.
Standardizing Quality Improvement Practices in Pediatric Liver Transplantation: The SPLIT A3 Project

B. Kelly,¹ R. Himes,² J. Bucuvalas,³ L. Ware,¹ S. Horslen.⁴
The Effect of Influenza Vaccination on Hospital Admission in Solid Organ Transplant Recipients

J. Rago, M. Hurtik, S. Todd, A. Mehta, G. Lyon III.
The Use of Eculizumab to Treat the Highly Sensitized Patient Awaiting Heart Transplant

J. Patel, D. Dilibero, M. Kittleson, S. Sana, F. Liou, D. Chang, A. Hage, L. Czer, A. Trento, N. Reinsmoen, J. Kobashigawa.
Toxoplasmosis Post-Kidney Or Liver Transplantation: A Serie of Cases

L. Pierrotti, R. Salles, M. Rytholz, L. Azevedo, A. Song, L. D'Albuquerque, E. David-Neto, W. Nahas, E. Abdala.
Utility of Anti-Phospholipase A2 Receptor (Anti-PLA2R) ELISA Testing in Predicting Post-Transplant Idiopathic Membranous Nephropathy (IMN)

C. VanBeek,¹ D. Thomas,² A. Jimenez,² A. Vo,² S. Jordan,² M. Toyoda.²
Validation of the Model for End-Stage Liver Disease Score Criteria in Liver Transplantation for Acute Flare Up of Hepatitis B in Non-Cirrhotic Liver

W.-C. Lee,¹ T.-J. Wu,¹ C.-F. Lee,¹ R.-S. Soong,¹ C.-H. Cheng,¹ H.-S. Chou,¹ T.-H. Wu,¹ K.-M. Chan,¹ Y.-C. Wang,¹ C.-S. Lee.²
"In-House" Controlled Oxygenated Rewarming After Initial Static Cold Storage: First Clinical Application in Marginal Donor Livers

D. Hoyer,¹ Z. Mathé,¹ A. Gallinat,¹ A. Canbay,² J. Treckmann,¹ U. Rauen,³ A. Paul,¹ T. Minor.⁴
Activated T Regulatory Cells Escape Death by Increasing Cytoplasmic Serine Protease Inhibitor 6 (SPI6)

A. Radwan, M. Uehara, P. Lukyanchykov, L. Riella, A. Chandraker, R. Abdi, J. Azzi.
Alemtuzumab Induction Is Associated With Higher Risk of Polyomavirrus Associated Nephropathy (PVAN) in Kidney Transplant Recipients

H. Wadei,¹ H. Saull,² C. Enderby,² M. Mai,¹ M. Prendergast,¹ T. Gonwa.¹
Antibody-Mediated Rejection of Renal Allografts by CCR5-/- Mice Does Not Require CD8 T Cells

N. Kohei,¹ T. Tanaka,¹ H. Tsuda,¹ N. Dvorina,¹ K. Tanabe,² W. Baldwin,¹ R. Fairchild.¹
Blood Gene Expression Profiling in a Randomized Controlled Trial of rATG Vs. IL2RA Induction Reveals the Differences in Immune Impact and Mechanisms

K. Chavin,¹ D. Taber,¹ S. Kurian,² T. Gelbart,² N. Pilch,¹ S. Nadig,¹ J. McGillicuddy,¹ T. Srinivas,¹ C. Bratton,¹ P. Baliga,¹ D. Salomon.²
CD28-Directed Therapy Prolongs Survival in a Non-Human Primate Kidney Transplant Model

L. Higginbotham,¹ D. Mathews,¹ C. Breeden,¹ W. Wakwe,¹ C. Larsen,¹ S. Nadler,² A. Adams.¹
Changes in Acceptances Patterns Under Share 35

K. Washburn, E. Edwards, A. Harper.
Development of a Targeted Genetic Renal Disease Panel With NexGen Sequencing for Unbiased Testing of Living Kidney Donors for Genetic Kidney Disease

C. Thomas,¹ Z. Stewart,³ A. Mansilla,² S. Mason,² A. Kwitek,² C. Campbell,² R. Smith,^1,2 R. Smith.^1,2
Educating Hispanic ESRD Patients About Living Donation: Impact of a Brief Intervention

E. Alvaro, J. Siegel, J. Poulsen, E. O'Brien.
Financial Burden of Laparoscopic Living Kidney Donation

J. Wiseman, D. Larson, D. Berglund, C. Jacobs, C. Garvey, H. Ibrahim, A. Matas.
Focal Segmental Glomerulosclerosis Recurrence in Renal Transplant Recipients Treated With Belatacept

W. Kitchens,¹ A. Farris,² S. Pastan,¹ T. Pearson,¹ C. Larsen,¹ A. Adams.¹
Functional Status Predicts Mortality After Liver Transplant

N. Dolgin,^1,2 P. Martins,¹ F. Anderson,^1,2 A. Bozorgzadeh.¹
Immunomodulatory Effects of Neuropilin-2 On T Cells

H. Nakayama,^1,2 N. Kochupurakkal,¹ S. Bruneau,¹ D. Bielenberg,² M. Klagsbrun,² D. Briscoe.¹
Impact of Delayed Graft Function and Number of Dialysis Sessions on Graft Outcome After Kidney Transplantation

L. Lehner, A. Hohberger, L. Marschke, K. Zhang, F. Halleck, D. Khadzhynov, O. Staeck, M. Dürr, D. Schmidt, L. Liefeldt, K. Budde.
Impact of Integrase Inhibitor-Based Antiretroviral Regimen on Outcomes in HIV + Renal Transplant Recipients

C. Kershaw, C. Rogers, M. Pavlakis, H. Tang, C. Alonso, K. Khwaja, A. Evenson, K. Raven, M. Wong.
Independent Prognostic Factors for Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: UNOS Population Study

M. Xing, H. Kim.
Inhibition of RhoA Pathway-Related Macrophage Functions Abrogates Chronic Rejection of Cardiac Allograft

M. Kloc, J. You, N. Tejpal, X. Li, R. Ghobrial.
Is Pretransplant Anti-A/B Antibody Removal Prerequisite for Successful ABO Incompatible Kidney Transplantation in Children?

S. Shishido,¹ T. Kawamura,¹ Y. Hamasaki,² Y. Takahashi,¹ Y. Hyodo,¹ Y. Itabashi,¹ H. Nihei,¹ T. Yonekura,¹ Y. Inaba,² Y. Yoshida,² K. Sakai,¹ A. Aikawa.¹
Long-term Patient and Graft Survival After Kidney Transplantation in Recipients With Hepatitis C Virus Infection

N.-Y. Heo, P. Udompap, A. Mannalithara, W. Kim.
Lymphotoxin Controls Treg Interactions With Lymphatic Endothelial Cells and Interstitial Migration In Vivo

C. Brinkman, Y. Xiong, S. Ahmad, J. Bromberg.
Microvascular Inflammation in Early Protocol Biopsies of Renal Allografts in Cases of Chronic Active Antibody-Mediated Rejection

T. Tsuji,¹ M. Yanai,¹ H. Itami,¹ Y. Ishii,¹ M. Akimoto,¹ N. Fukuzawa,² H. Harada,² Y. Fukasawa.¹
Myeloid Cells as a Key Mediator for Impairment of Transplant Tolerance by CMV Infection

L. Zhang,¹ X. Zhang,² H. Kang,¹ X.-F. Liu,² S. Yan,² J.-J. Wang,² M. Abecassis,² Z. Zhang,² M. Hummel,² X. Luo.^1,2
Negative Effects of Being Obese or Overweight on T Regulatory (Treg) Cell Suppressive Function in Patients Listed for Lung Transplantation (Tx)

T. Akimova,¹ J. Diamond,² D. Wilkes,³ D. Lederer,⁴ J. Christie,² W. Hancock.¹
Noncanonical Anergic Alloreactive B Cells in Transplantation Tolerance

J. Chen, M. Daniels, D. Yin, R. Sciammas, A. Chong.
Predicting Survival of Deceased Donor Kidneys from Children Under Ten

W. Parker, J. Thistlethwaite, L. Ross.
Recipient IL-33 Promotes Type 1 Alloimmunity and Lethal Acute GVHD Following alloHCT

B. Matta,¹ D. Reichenbach,² V. Schwarze,³ V. Tkachev,⁴ L. Mathews,¹ Q. Liu,¹ M. Warncke,⁵ J. Ferrara,⁴ R. Zeiser,³ B. Blazar,² H. Turnquist.¹
Referral for Kidney Transplantation in Georgia: Data from the RaDIANT Community Study

S. Pastan,¹ J. Gander,¹ L. Plantinga,¹ L. Sauls,² E. Gibney,³ L. Mulloy,⁴ J. Krisher,² R. Patzer.¹
Rejection Triggers Liver Transplant Tolerance: Involvement of Mesenchyma-Meidated Immune Control Mechanisms

M. Morita, D. Joyce, C. Miller, J. Fung, L. Lu, S. Qian.
Relationship Between Delayed Graft Function (DGF) Severity and Predicted DGF Risk

E. Squiers,¹ B. Irish,¹ D. Odenheimer,¹ S. Erlich,¹ J. Grinyo, S. Feng, On Behalf of Quark DGF Study Investigators.
Rise in Deceased Donors Labeled "Increased Risk for Disease Transmission" Under New Guidelines

L. Kucirka, M. Bowring, A. Massie, L. Nicholas, X. Luo, D. Segev.
T Cell C5a Receptor (C5aR) Signaling Regulates T Follicular Helper Cell (Tfh) Induction

D. Verghese, P. Heeger.
The Occurrence of v- Lesions Is Not Associated With Decreased Graft Survival

P. Halloran, I. Salazar, M. Lopez, J. Chang.
Thymoglobulin Versus IL2RA: Three Year Results of a Randomized Controlled Trial

N. Pilch, H. Meadows, D. Taber, J. Fleming, C. Mardis, S. Nadig, J. McGillicuddy, T. Srinivas, C. Bratton, P. Baliga, K. Chavin.
Trajectory of Measured GFR Decades After Kidney Donation: Hyperfiltration Never Seems to End!

H. Ibrahim, D. Berglund, R. Foley, A. Matas.
Transplanting Pediatric Livers Into Adult Recipients Is Associated With Increased Rejection and Decreased Survival

V. Fleetwood, J. Harris, M. Hertl, E. Chan.
VLA-4 Blockade Inhibits Endogenous Memory CD8 T Cell-Mediated Rejection of Cardiac Allografts

S. Iida,¹ C. Su,¹ T. Abe,¹ K. Tanabe,² R. Fairchild.¹
Allograft Class II MHC and CD40 Expression Are Required for Endogenous Memory CD8 T Cell Proliferation in Cardiac Allografts Subjected to Prolonged Cold Ischemic Storage

T. Tanaka,^1,2 H. Tsuda,^1,3 N. Kohei,^1,4 D. Kish,¹ W. Baldwin,¹ A. Valujskikh,¹ R. Fairchild.¹
Antibody Response Following Influenza Vaccination in Renal Transplant Recipients

M. Mujtaba, B. Book, A. Sharfuddin, A. Khalil, S. Vaishnav, E. Wiebke, M. Yaqub, D. Mishler, T. Taber.
B7-H1 Deficiency in Liver Allografts Leads to CD8-Mediated Acute Vascular Rejection

M. Morita, D. Joyce, J. Fung, S. Qian, R. Fairchild, L. Lu.
Comparison of Efficacy of Prophylactic Antivirus Therapies on Outcomes of Kidney Transplantation in Hepatitis B Virus Carriers

G. Chen, C. Wang, J. Qiu, J. Li, L. Chen.
Comparison of T Regulatory (Treg) Cell Function Pre- and Post-Lung Transplantation Shows a Major Negative Impact of Immunosuppression on Treg Function

T. Akimova,¹ J. Diamond,² D. Wilkes,³ D. Lederer,⁴ J. Christie,² W. Hancock.¹
DSA MFI Does Not Predict Late Antibody-Mediated Rejection Lesions Or Gene Expression Changes in Kidney Transplants

L. Hidalgo,¹ J. Venner,² P. Halloran.²
Deleterious Effects in Kidney Transplant Outcomes With Pre-Organ Procurement Iodine Contrast Exposure

F. Barrantes,¹ S. Stith.²
Desensitization With Costimulation Blockade and Proteasome Inhibition in a Non-Human Primate Model of Kidney Transplantation

C. Burghuber,^1,2 J. Kwun,¹ E. Page,¹ A. Gibby,¹ F. Leopardi,³ A. Farris,¹ N. Iwakoshi,¹ S. Knechtle.^1,3
Dialysis Facility Kidney Transplant Referral in Georgia: 2005-2012

S. Pastan,¹ J. Gander,¹ L. Plantinga,¹ L. Sauls,² E. Gibney,³ L. Mulloy,⁴ J. Krisher,² R. Patzer.¹
Does DSA Market Competition Influence OPO Performance?

J. Adler,¹ H. Yeh,¹ J. Markmann,¹ L. Nguyen,² D. Axelrod.³
Donor and Recipient Pretransplant Polyoma BK Serostatus: Relationship to BK-Viremia After Renal Transplantation

H. Tseng, R. Lopez-Soler, N. Chandolias, T. Friedrich, J. Eldor, D. Conti.
Early Allograft Dysfunction Causes Inferior Patient and Allograft Survival in Liver Transplantation; an Experience of 1952 Consecutive Liver Transplants

D. Lee, K. Croome, J. Burns, D. Perry, J. Nguyen, H. Crespo, C. Taner.
Evaluation of Donor-Specific Antibodies Through 7 Years With Belatacept in BENEFIT and BENEFIT-EXT

R. Bray,¹ H. Gebel,¹ R. Townsend,² U. Meier-Kriesche,² C. Larsen.¹
Hypothermic Machine Perfusion Improves Kidney Viability through Amelioration of Vasospasm and Edema of Podocytes and Renal Tubular Epithelial Cells

Z. Zhong,¹ Z. Liu,¹ Z. Fu,² Y. Zhang,² D. Ko,³ Y. Wang,¹ Q. Ye.^1,2
Hypothermic Machine Preservation Reduces Inflammatory, Hypoxic and Apoptotic Injuries in Human Liver Transplantation

J. Guarrera, C. Bae, S. Henry.
IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection

C. Baum,¹ M. Khattar,² P. Schroder,¹ W. Chen,³ S. Stepkowski.¹
Impact of Induction Therapy on Outcomes in HIV + Renal Transplant Recipients

C. Kershaw,¹ C. Rogers,^2,4 M. Pavlakis,^1,2 H. Tang,² C. Alonso,^1,2 K. Khwaja,^2,3 A. Evenson,^2,3 K. Raven,^2,3 M. Wong.^1,2
Intrapatient Variability of Tacrolimus Trough Levels and Outpatient Clinic Non-Attendance Rates Predict Poor Renal Allograft Survival

D. Goodall, M. Willicombe, A. McLean, D. Taube.
Kynurenine Assay to Detect Inflammation in Transplant Patient: Clinical Results

D. Abendroth,¹ J. Kaden,² M. Marzinzig,¹ M. Stangl.³
Lack of Utilization of Pre-Emptive Transplantation in Those With Living Donor Kidney Transplants

A. Sakhuja,¹ A. Naik,¹ R. Eikstadt,² P. Shrivastava,¹ D. Cibrik,¹ M. Samaniego.¹
Leukocyte Associated Immunoglobulin-Like Receptor 1 inhibits Th1 But Enhances Th17 Responses

V. Agashe,¹ M. Keller,² L. Haynes,¹ E. Jankowska-Gan,¹ J. Sullivan,¹ J. Kernien,¹ H. Suzuki,³ D. Wilkes,⁴ W. Burlingham.¹
MELD Velocity – An Early Predictor of Increased Mortality Risk

D. Ladner,¹ K. Skibba,² J. Kang,¹ B. Ho,¹ A. Kho,¹ L. Kulik,¹ A. Daud,¹ M. Abecassis,¹ A. Skaro.¹
MELD/PELD 35+ Candidates Benefit from Regional Sharing

E. Edwards,¹ A. Harper,¹ R. Hirose,² D. Mulligan.³
Outcomes of ABO Incompatible Kidney Transplantation in Children

J. Stojanovic,¹ A. Adamusiak,² A. Waters,¹ D. Bockenhauer,¹ N. Kessaris,² C. Barton,³ H. Jones,³ J. Taylor,³ S. Marks,¹ N. Mamode.²
Refinement of Non-Invasive Diagnostic Criteria to Differentiate Tumor from Bland Portal Vein Thrombosis Before Liver Transplant in Patients With Hepatocellular Carcinoma

C. Sherman, S. Behr, J. Dodge, J. Roberts, F. Yao, N. Mehta.
Renal Tubular Dysfunction Following Donor Nephrectomy and Its Impact On Residual Kidney Function

Z. Ahmed,¹ C. Rooney,³ C. Turner,² N. Dalton,² N. Kessaris,¹ N. Mamode.¹
Risk of Cause-Specific ESRD in Live Kidney Donors

S. Anjum, A. Muzaale, A. Massie, S. Bae, D. Segev.
Role of Innate Immune Cells in Chronic Allograft Loss and Novel Strategies to Target Them

C. Wu,^1,2 P. Zhao,¹ W. Liu,¹ X. Xiao,¹ X. Shi,¹ Y. Peng,¹ M. Kloc,¹ X. He,² M. Ghobrial,¹ X. Li.¹
Selective Blockade of the CD28/B7/CTLA4 Pathway With Monovalent Anti-CD28 Antibodies Versus Targeting of B7 With CTLA4-Ig, in Non-Human Primate Kidney Allograft

S. Ville,¹ N. Poirier,^1,2 B. Vanhove,^1,2 G. Blancho.¹
Small RNA Sequencing-Enabled Discovery of Circulating Extracellular MicroRNAs as Noninvasive Biomarkers of Liver Allograft Status

H. Yang,¹ T. Muthukumar,¹ K. Akat,² D. Briskin,² T. Tuschl,² M. Suthanthiran.¹
Stimulating Protease Inhibitor 9 Expression By Human Regulatory T Cells Improve Homeostasis

P. Lukyanchykov, Z. Solhjou, A. Radwan, L. Riella, A. Chandraker, R. Abdi, J. Azzi.
Structure/Function Insights Into Treg Biology: Hdac11 Is a Foxp3 Deacetylase Whose Targeting Promotes and Stabilizes Foxp3 Expression and Leads to Long-Term Allograft Survival

J. Huang,¹ L. Wang,¹ T. Bhatti,¹ A. Samanta,¹ S. Dahiya,¹ R. Han,¹ J. Bergman,² A. Kozikowski,² W. Hancock.¹
Survival Benefit of Kidney Transplantation With Expanded Criteria Kidney from Donors After Circulatory Death

X. Luo, A. Massie, E. Chow, D. Segev.
TGFβ Production By B Cells Is Critical for Transplant Tolerance Induction

J. Kim,¹ W. Liu,^1,2 L. Liu,^1,2 K. Lee,¹ R. Stott,¹ H. Yeh,¹ J. Markmann.¹
Targeted Silencing of TLR Adaptor Genes Using Mannose Liposome to Prolong Cardiac Allograft Survival

X. Zhang,¹ J. Jiang,² X. Zheng,¹ J. Shi,³ T. Zwiep,¹ N. Johnston,¹ D. Quan,^1,2 W.-P. Min.^1,2,3
Vaccine-Induced 'Incognito' CD8+ T Cell Memory Can Disrupt Transplantation Tolerance

M. Nelsen,¹ K. Beard,² R. Kedl,¹ R. Gill.²
APOL1 High-Risk Genotype in African American Live Kidney Donors Is Not Associated With Post-Donation Development of Hypertension and Kidney Disease

M. Doshi,¹ M. Goggines,² C. Winkler,³ J. Kopp.⁴
A Prospective Comparison of the Completeness of Donor Kidney Biopsies

S. Ahmad,¹ E. Siskind,¹ C. Drachenberg,² J. Bromberg,¹ S. Niederhaus.¹
Alloantibody-Dependent Macrophage-Mediated Hepatocellular Damage Is Dependent on FcγRI, FcγRIII, and Reactive Oxygen Species

J. Zimmerer, X. Liu, A. Blaszczak, C. Wright, T. Pham, G. Bumgardner.
Allogeneic Monocyte–Endothelial Cell Interaction Plays a Critical Role in Initiating Early Pro-Fibrosis Responses

E. Gall, H. Xu, K. Samy, A. Kirk.
Anti-Donor T-Cell Immunity Is a Continuum Immune Process Favouring Subclinical Rejection After Kidney Transplantation

E. Crespo,¹ M. Lucia,¹ J. Cruzado,^1,2 S. Luque,¹ E. Melilli,² A. Manonelles,^1,2 N. Sala,² J. Grinyó,^1,2 O. Bestard.^1,2
Associations of Pre-Transplant Prescription Narcotic Use With Clinical Complications After Kidney Transplantation

N. Lam,¹ M. Schnitzler,² J. Tuttle-Newhall,² H. Xiao,² D. Axelrod,³ D. Brennan,⁴ V. Dharnidharka,⁴ M. Nazzal,² K. Lentine.²
CN Inhibition (But Not mTOR Inhibition) of a Novel CD8⁺ T Cell Regulatory Mechanism Results in Higher Alloantibody Posttransplant

J. Zimmerer, S. Elzein, C. Wright, G. Bumgardner.
Closing the Knowledge Gap: The Successful Launch of an Interactive Website Dedicated to Information on Living Kidney Donor Transplantation

D. Slaats,¹ W. Zuidema,¹ J. van de Wetering,¹ D. Hesselink,¹ T. Terkivatan,² M. Betjes.¹
De Novo DSA Would Not Necessarily Cause Graft Rejection After Renal Transplantation: Characteristics of DSA Developing Biopsy-Proven Chronic Antibody-Mediated Rejection

T. Yamamoto, Y. Watarai, A. Takeda, M. Okada, M. Tsujita, H. Takahisa, N. Goto, S. Narumi, T. Kobayashi.
Decline in Living Donor Rates Pervasive Across All Kidney Transplant Candidate Groups

G. Vranic, A. Nishio Lucar, D. Keith.
Determinants and Sequelae of Hepatic Artery Thrombosis After Liver Transplantation: A Registry Study of Recipient Diagnosis and Coagulopathy

J. Garonzik Wang,¹ M. Doyle,¹ K. Collins,¹ J. Lowell,¹ Y. Lin,¹ S. Shenoy,¹ J. Wellen,¹ W. Chapman,¹ D. Segev.²
Distinctive Roles of mTORC1 Vs. mTORC2 in Liver Ischemia-Reperfusion Injury

H. Zhou,^1,2 J. Zhu,^1,3 S. Yue,¹ M. Zhang,³ R. Busuttil,¹ Q. Xia,³ J. Kupiec-Weglinski,¹ Y. Zhai.¹
Effects of Toll Like Receptor (TLR) Signaling on Murine Alloimmunity Are Modulated by Immune Cell Derived Complement

J. Sheen, P. Heeger.
Ex Vivo Expansion With Rapamycin Enhances the Suppressive Function of Regulatory T Cells (Tregs) Isolated from Pediatric Thymus

E. Dijke,^1,2,3 R. Hoeppli,^3,4 T. Ellis,^1,2 J. Pearcey,^1,2 I. Larsen,^1,2 I. Rebeyka,^1,2 D. Ross,^1,2 M. Levings,^3,4 L. West.^1,2,3
Final Results from the BENEFIT-EXT Trial: A 7 Year Follow-Up of Belatacept Treated Patients

S. Florman,¹ J. Medina Pestana,² M. Rial,³ L. Rostaing,⁴ D. Kuypers,⁵ F. Mühlbacher,⁶ M. Polinsky,⁷ U. Meier-Kriesche,⁷ J. Grinyó,⁸ A. Durrbach.⁹
Impact of Abdominal Aortic Calcification in Living Kidney Donors

Y. Yoon,¹ K. Choi,² D. Joo,³ K. Huh,³ M. Kim,³ S. Kim,³ Y. Kim,³ S. Yang,² W. Han.¹
Impact of Human Mutant TGF-β1/Fc Protein On Memory and Regulatory CD4+T Cells Following Lymphodepletion in Rhesus Monkeys

H. Guo,¹ L. Lu,¹ R. Wang,² H. Abdulkerim,² R. Keith,² A. Thomson,¹ M. Ezzelarab.¹
Induction Therapy Improves 15-Year Graft Survival in Kidney Transplant Recipients With Acute Rejection

R. Bajoka, M. Goggins, A. Patel.
Is BK Viral Subtype Distribution of Donor And/Or Recipient Important for Subsequent BK Viral Infection After Living-Donor Transplantation?

A. Schwarz,¹ S. Linnenweber-Held,¹ H. Haller,¹ A. Heim,² C. Schmitt.²
LFA-1 Is Crucial for Germinal Center Reconstruction After T cell Depletion and IL-21 Biased Antibody-Mediated Rejection

J. Kwun,¹ B. Oh,¹ H. Song,¹ A. Farris,¹ A. Kirk,² W. Mahle,¹ S. Knechtle.¹
Organ Procurement Organization Level Changes in Liver Utilization After Share-35

E. Chow, A. Massie, X. Luo, A. Muzaale, D. Segev.
Pharmacoepidemiology of Cytomegalovirus Prophylaxis in a Large Multicenter Cohort of Kidney Transplant Recipients

C. Santos, D. Brennan, V. Fraser, M. Olsen.
Protecting Older Patients from Dialysis: The Survival Benefit of Preemptive Transplant With High KDPI Allografts

C. Jay,¹ K. Washburn,¹ P. Dean,² R. Helmick,² M. Stegall.²
Real-Time Measurements of Tissue Oxygen Microtension as a Marker of Bile Duct Viability in Liver Transplantation

R. Ciria-bru, E. Navarro-Rodriguez, M. Sanchez-Frías, J. Medina-Fernandez, A. Gallardo-Herrera, M. Ayllon-Teran, S. Rufián-Peña, P. Lopez-Cillero, J. Briceño-Delgado.
Selective CD28 Blockade With or Without CD40-CD154 Blockade Promotes Cardiac Allograft Protection in Non-Human Primates

T. Zhang,¹ A. Kronfli,¹ B. Gheorghe,¹ L. Burdorf,¹ E. Rybak,¹ D. Parsell,¹ D. Harris,¹ E. Sievert,¹ S. Dahi,¹ N. Kubicki,¹ J. Whoddal,¹ M. Uluer,¹ X. Cheng,¹ E. Schwartz,¹ K. Quinn,¹ B. Vanhove,² A. Azimzadeh,¹ R. Pierson III.¹
Sensitization Level at Retransplant Among Non-Sensitized Pediatric Recipients of First Deceased Donor Kidney Transplants Not Affected by DR Mismatch Level

W. Cherikh,¹ A. Wilk,¹ H. McGehee,¹ E. Brewer.²
Socioeconomic Determinants of Racial Disparities in Access to Preemptive Live Donor Kidney Transplantation

T. Purnell, X. Luo, A. Massie, D. Crews, L. Cooper, D. Segev.
T-Cell Mediated Vascular Rejection Can Be Identified By the Combined Measurement of Five Specific microRNAs in Blood

M. Matz,¹ K. Fabritius,¹ C. Lorkowski,¹ M. Dürr,¹ J. Gaedeke,¹ P. Durek,² J. Grün,² A. Goestemeyer,¹ F. Bachmann,¹ K. Wu,¹ B. Rudolph,¹ U. Weber,¹ C. Haftmann,² N. Unterwalder,³ N. Lachmann,¹ A. Radbruch,² H.-H. Neumayer,¹ M.-F. Mashreghi,² K. Budde.¹
TIM-4 Identifies IL-17 Expressing Pro-Inflammatory Be-17 Cells That Promote Allograft Rejection

Q. Ding, K. Mohib, D. Rothstein.
Th17 Mediates Inflammatory Responses After Lung Transplantation

J. Xu,¹ L. Wang,¹ Q. Chen,² S. Xia,¹ X. Li,¹ H. Li,² Y. Ding.^1,3
The Economic Impact of Nonimmune Complications in Contemporary Kidney Transplantation

K. Lentine,¹ M. Schnitzler,¹ D. Axelrod,² D. Segev,³ D. Brennan,⁴ J. Tuttle-Newhall,¹ H. Xiao,¹ L. Kucirka,³ V. Dharnidharka.⁴
The Extended Toronto Criteria for Transplantation for Hepatocellular Carcinoma. A Validation Study

G. Sapisochin, N. Goldaracena, J. Laurence, M. Dib, A. Barbas, A. Ghanekar, L. Lilly, E. Renner, M. Selzner, M. Cattral, I. McGilvray, D. Grant, P. Greig.
The Impact of High-Risk Lung Donors on the Survival of Lung Recipients With Interstitial Pulmonary Fibrosis

P. Sanchez,¹ M. Mulligan,¹ C. Evans,¹ I. Timofte,² J. Kim,² K. Rajagopal,¹ A. Iacono,² J. Gammie,¹ R. Pierson III,¹ B. Griffith,¹ S. Pham.¹
The Losing Trifecta: Age ≥70, Deceased Donor Transplant, and Delayed Graft Function

R. Crew, H. Fernandez, S. Mohan, G. Dube, L. Ratner, R. Sandoval, S. Patel.
Tracking T Cell Fate After Antithymocyte Globulin (ATG) Immunotherapy in Infant Heart Transplant (HTx) Patients

S.-I. Wang,^1,2 I. Larsen,^1,2 S. Urschel,^1,2 R. Chinnock,³ J. Rusch,³ L. West.^1,2
Virus Induced CD28 Down-Regulation as a Potential Driver of Costimulation Blockade Resistant Rejection

D. Mou,¹ J. Espinosa,¹ L. Stempora,² J. Kwun,² N. Iwakoshi,¹ A. Kirk.²
A Tool to Estimate Probability of Outcomes on the Liver Transplant Waiting List

A. Hart,^1,2 D. Schladt,¹ J. Zeglin,¹ N. Salkowski,¹ S. Leppke,¹ W. Kim,^1,3 J. Lake,^1,4 A. Israni,¹ B. Kasiske,¹ J. Snyder.¹
Analysis of In-Vitro Effects of Immunosuppression on NK Cell Subsets in the Presence of Cytomegalovirus

S. Keshwani, D. Kumar, S. Han, S. Husain, V. Ferreira, P. Ashton, A. Humar.
Application of Second Generation Sequencing and AlloAntibody Screening to the Organ Transplantation Arena

B. Keating,¹ Y. Li,¹ K. Olthoff,¹ J. Wang,² A. Shaked.¹
Broader Geographic Sharing of Adolescent Lung Donors Improves Allocation Efficiency

W. Tsuang,¹ J. Pyke,² M. Skeans,² K. Chan,⁴ T. Wozniak,³ A. Israni,² M. Hertz,⁴ B. Kasiske,² M. Valapour,¹ J. Snyder.²
CFZ533: Assessment of Immunomodulatory Activity Following Single Doses of a Novel Anti-CD40 mAb in Healthy Volunteers

A. Slade,¹ J. Doucet,² P. Koo,¹ P. Espie,² J. Rush,² C. Tomek,³ J. Klupp.²
Controlling Alloreactive B Cell Responses in Sensitized Recipients With CTLA-4Ig

J. Chen,¹ Q. Wang,¹ D. Yin,¹ V. Vu,¹ R. Sciammas,² A. Chong.¹
Cytotoxic CD8 T Cell Recognition of Acquired, Intact MHC Alloantigen On Host Dendritic Cells Promotes Acute Allograft Rejection

J. Ali, S. Harper, M. Negus, E. Bolton, J. Bradley, G. Pettigrew.
Effects of Late Kidney Graftectomy in Nonhuman Primates (NHPs) Tolerant of Co-Transplanted Heart and Kidney Allografts

M. Tonsho,¹ G. Benichou,¹ R. Smith,² R. Colvin,² J. Madsen.^1,3
Engagement of the Vasopressin Receptor On Hepatocytes Protects Liver from Ischemia-Reperfusion Injury Via the WNT-β-Catenin-SGK1-FOXO Pathway

X. Liu,¹ T. Billiar,² R. Tao.¹
Enhanced Requirement for TNF Signaling on Low Affinity Memory CD8+ T Cells During Heterologous Immunity

S. Krummey,¹ C.-W. Chen,¹ D. Liu,¹ M. Wagener,¹ B. Evavold,² C. Larsen,¹ M. Ford.¹
Failure to Account for Critical Candidate Characteristics Significantly Biases Kidney Transplant Center Report Cards Measuring Time to Transplant

L. Kayler,¹ J. Schold.²
Generation, Cryopreservation, Function and In Vivo Fate of Ex-Vivo Expanded Cynomolgus

H. Guo,¹ H. Zhang,¹ L. Lu,¹ M. Ezzelarab,¹ A. Thomson.^1,2
Germinal Centre Autoimmunity Mediates Progression of Allograft Vasculopathy, With Essential Help Provided By T Follicular Cells

M. Qureshi, R. Motallebzadeh, M. Chhabra, M. Negus, S. Rehakova, E. Bolton, J. Bradley, G. Pettigrew.
Impact of Donor and Recipient BKV Serostatus and the Effect of Ciprofloxacin Prophylaxis on BK Viremia Risk After Kidney Transplant

M. Changala,¹ A. Kistler,² J. Abend,² A. Sathe,² A. Howard,¹ D. Wojciechowski.¹
Implications of Living Donor Kidney Histology, Volume and Function on Post-Donation GFR

Z. Zaky,¹ B. Lankowsky,² S. Shah,¹ L. Herlitz,¹ A. Chiesa-Vottero,¹ K. Wallenfelsz,¹ A. Caplin,¹ D. Goldfarb,¹ S. Flechner,¹ J. Schold,¹ E. Poggio.¹
Innate Immune Memory to Allogeneic Non-Self

H. Dai, A. Williams, M. Oberbarnscheidt, F. Lakkis.
Investigation of Myocardial Function in Pediatric Transplant Recipients

K. Sgambat, S. Clauss, M. Lasota, A. Moudgil.
Living Donor Characteristics Associated With Changes in Post-Donation GFR

E. Poggio,¹ D. Mandelbrot,⁴ P. Reese,⁵ D. Goldfarb,³ S. Flechner,³ J. Schold.²
NKp46 Clusters at the NK Cell Immune Synapse Regulate Specific Effector Functions

U. Hadad,^1,2 T. Thauland,¹ M. Butte,¹ A. Porgador,² O. Martinez,¹ S. Krams.¹
Part II: Rates and Determinants of Progression for De Novo Donor-Specific Antibody Mediated Kidney Allograft Injury

C. Wiebe,^1,2 I. Gibson,³ D. Pochinco,² P. Birk,⁴ T. Blydt-Hansen,⁴ J. Ho,^1,5 M. Karpinski,¹ A. Goldberg,⁴ L. Storsley,¹ D. Rush,¹ P. Nickerson.^1,2,5
Patient Outcomes After Listing for Kidney Alone Transplantation in Potential Recipients Aged Over 70 Years

D. Kanigicherla, M. Morton, I. Zia, J. Worthington, S. Sofia, T. Augustine, M. Picton.
Patients With Severe and Morbid Obesity Benefit from Deceased Donor Kidney Transplant

A. Nishio Lucar,¹ J. Ma,² G. Vranic,¹ D. Keith.¹
Preemptive Deceased Donor Transplant With Kidney Donor Profile Index Scores Greater Than 85 Not Associated With a Survival Benefit

D. Keith, A. Nishio Lucar, G. Vranic.
Pretransplant Elevated Plasma Fibrinogen Level Is Associated With Tumor Recurrence and Poor Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation

G.-Y. Wang, Y. Yang, H. Li, S.-H. Yi, G.-H. Chen.
Process Deviation Tracking and Analysis in an Organ Procurement Organization

B. Schleich,¹ S. Yoon,¹ M. Khasawneh,¹ K. Srihari,¹ H. Irving,² A. Friedman.
Psychiatric Recommendations for Patients Pursing Kidney Transplantation

M. Jesse, A. Eshelman, T. Rosetti, M. Abouljoud, J. Denny, A. Patel, D. Kim.
Regional Mismatch Between Liver Supply and Demand: An Argument for a More Open Market

J. Lai, S. Sen, J. Dodge, H. Hayssen, J. Roberts.
Resolution of Glomerular Fibrin Thrombi in Deceased Donor Kidneys

R. Batra,¹ M. Smith,³ L. Thomas,² H. Khamash,² A. Moss,² J. Huskey,² A. Singer,¹ A. Mathur,¹ N. Katariya,¹ K. Reddy,¹ R. Heilman.²
Risk Stratification in Tailoring Induction Therapy in Kidney Transplant Recipients(KTR): Is It Cost-Effective?

B. Sirandas, A. Carlson, N. Kenyon, C. Truax, L. Smith.
Risk of ESRD Attributable to Live Kidney Donation in Various Subgroups of Donors

A. Muzaale, A. Massie, D. Segev.
Targeting Leukocyte Integrin CD11b/CD18 With a Novel mAb Salvages Renal Function Following an Otherwise Irreversible Ischemic Insult in Cynomolgus Monkeys

A. Cosimi,¹ A. Dehnadi,¹ R. Smith,² D. Ko,¹ X. Li,³ M. Arnaout.³
Th-17 Alloimune Responses in Renal Allograft Biopsies from Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T-Cell Mediated Rejection

M. Matignon,^1,2 A. Aissat,³ F. Canoui-Poitrine,⁴ C. Grondin,² D. Desvaux,⁵ D. Saadoun,⁶ P. Lang,^1,2 J. Cohen,² P. Grimbert.^1,2
The Forgotten Cell: Renal Fibroblasts Are Activated By Anti-MHC Class I Antibody

J. Chen, A. Zmijewska, R. Mannon.
The Gut Microbiota Regulates Murine Cardiac Transplant Outcome

C. Brinkman,¹ L. Hittle,¹ E. Mongodin,¹ W. Fricke,² J. Bromberg.¹
Tobacco Use Is a Significant Risk Factor for Post-Transplant Biliary Complications

D. Dulaney, M. Dokus, M. Orloff, R. Kashyap.
Toll-Like Receptor 4-Signaling Abrogates Inhibitory Effect of Calcineurin Inhibitor on B-Cells Responding to Blood Group A-Antigens

H. Sakai, Y. Tanaka, H. Ohdan.
BAFF Binding to T Cell-Expressed BAFF-R Promotes Follicular Helper T Cell Proliferation and GC B Cell Responses

M. Chen,¹ Q. Li,¹ W. Stohl,² S. Zheng,² X. He,¹ Z. Guo.¹
Constitutively Upregulated Expression of Complement and Matrix Transcripts in Kidney Transplant Recipients Who Develop Acute Rejection

K. Keslar,¹ J. Reid-Adam,⁴ E. Kwon,⁴ D. Hricik,⁵ E. Poggio,^2,3 P. Heeger,⁴ R. Fairchild.^1,3
Costimulation Blockade and Bortezomib to Desensitize Rhesus Macaque and Prolong Renal Allograft Survival

J. Kwun, C. Burghuber, E. Page, A. Gibby, N. Iwakoshi, S. Knechtle.
Cyclosporine Nephrotoxicity Is Associated With Diminished Expression of Heat Shock Protein 27 (HSP27) and Loss of Claudin-2-Dependent Intercellular Adhesion

A. Zmijewska,¹ R. Thuillier,² J. Chen,¹ J. Zmijewski,¹ R. Mannon.¹
DEPTOR Is Expressed in CD4+ T Cells and Modulates Effector Responses and Allograft Rejection

J. Wedel, S. Bruneau, K. Liu, N. Kochupurakkal, M. Laplante, D. Briscoe.
Differences in Genetic Variants That Influence Long-Term Graft Function Between Pancreas Transplant Donors and Recipients

M. Simmonds,¹ C. Duff,¹ A. Hamilton,¹ S. Mittal,^2,3,4 M. Barnardo,^2,3 S. Fuggle,^2,3 P. Friend,^2,3 S. Gough.^1,4
Donor Organ Resident M2 Type Myeloid Cells Protect Murine Orthotropic Liver Transplants from Ischemia and Reperfusion Injury

S. Yue, X. Shen, F. Gao, R. Busuttil, J. Kupiec-Weglinski, Y. Zhai.
Effect of Intrapatient Variability and Mean Tacrolimus Levels in Renal Transplant Patients

D. Goodall, M. Willicombe, A. McLean, D. Taube.
Eomes-Expressing CD8+ T Cells and Th17 Cells Mediate Costimulatory Blockade-Resistant Allograft Rejection in Mice

M. Sabet-Baktach,¹ E. Eggenhofer,¹ P. Renner,¹ M. Lantow,¹ H. Schlitt,¹ E. Geissler,¹ A. Kroemer.^1,2
Everolimus Versus Mycophenolate for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin and Tacrolimus

H. Tedesco-Silva,¹ C. Felipe,¹ A. Ferreira,¹ M. Cristelli,¹ A. Bessa,¹ P. Ueno,¹ T. Sandes- Freitas,¹ G. Bassos,¹ W. Aguiar,² H. Proença,³ J. Medina-Pestana.¹
Excellent Outcomes With Deceased Donor Kidney Transplants With a Terminal Creatinine >= 3

L. Matsuoka,¹ E. Alicuben,¹ K. Woo,¹ H. Shidban,¹ Y. Qazi,² M. Smogorzewski,² S. Alexopoulos.¹
External Validation of Clinical Prediction Models of Patient and Graft Survival in a Canadian Cohort of Kidney Transplant Recipients

S. Singh,^1,2 D. Naimark,^1,2,3 J. Victor,² J. Kim.^1,2,4,5
Functional Decline in Liver Transplant Candidates: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study

J. Lai, K. Covinsky, J. Dodge, S. Sen, S. Feng.
Geographic Variation in Listing Practices Represents Competetive Behaviors and Access to Care Rather Than Differences in Demand for Liver Transplantation

J. Voss,¹ R. Gilroy,¹ D. Goldberg,² T. Schmitt,¹ S. Kumer.¹
Impact of Cold Ischemic Time (CIT) and Distance Traveled (DT) on Shipped Kidneys in the OPTN/UNOS Kidney Paired Donation (KPD) Pilot Program (PP)

M. Aeder,¹ D. Stewart,² R. Leishman,² L. Robbins Callahan,² A. Kucheryavaya,² T. Sandholm,³ R. Formica.⁴
Impact of Donor Specific Antibodies in the Older Kidney Transplant Recipient

S. Patel, J. Loucks-DeVos, R. Knight, S. Kuten, L. Gaber, A. Gaber.
In Vivo Expansion of Donor-Specific Regulatory T Cells by a New Triazolopyrimidine Derivative and Donor-Specific Transfusion

S. Emoto,¹ R. Goto,¹ S. Shibasaki,¹ A. Nagatsu,¹ H. Ono,¹ R. Igarashi,¹ M. Fukai,² T. Shimamura,³ K. Saiga,⁴ M. Murakami,⁵ A. Taketomi,¹ S. Todo,⁶ K. Yamashita.²
Incidence of CMV Viremia in Obese and Morbidly Obese Kidney Transplants Under a Low Dose Valganciclovir Prophylaxis Protocol

J. Thielke,¹ P. West-Thielke,² E. Benedetti.²
Induction of a Costimulation-Susceptible Repertoire: A Case for Depletional Prior to Belatacept

H. Xu,¹ K. Samy,¹ A. Guasch,² S. Mead,² A. Kirk.¹
Inhibition of Endogenous Memory CD8 T Cell Infiltration Into Cardiac Allografts Subjected to Prolonged Cold Ischemic Storage Is Required to Promote Long-Term Graft Survival

N. Kohei,¹ H. Tsuda,^1,3 T. Tanaka,^1,4 S. Iida,² T. Abe,³ C. Su,¹ D. Kish,¹ K. Tanabe,² A. Valujskikh,¹ R. Fairchild.¹
Initial Experience With a Tailor-Made Simulation and Navigation Program Using a 3D Printer Model of Kidney Transplantation Surgery

M. Kusaka,¹ M. Sugimoto,² N. Fukami,¹ H. Sasaki,¹ M. Takenaka,¹ T. Ito,³ T. Kenmochi,³ R. Shiroki,¹ K. Hoshinaga.¹
Interim Safety Experience in Transplant Patients Treated With Belatacept (Nulojix) in the Post-Approval Setting

T. Kou, J. Braga, S. Sibabrata, J. Preston, M. Harler, A. Gomez.
Longitudinal Follow-Up of Cardiovascular Comorbidity in Pediatric Renal Transplant Recipients – Results from the 4C-T Study

A. Melk,¹ D. Thurn-Valsassina,¹ B. Schmidt,¹ A. Duzova,² B. Soezeri,³ A. Bayazit,⁴ S. Caliskan,⁵ U. Querfeld,⁶ K. Ažukaitis,⁷ E. Wuehl,⁷ F. Schaefer.⁷
Multicenter Validation of a Molecular Diagnostic for Antibody-Mediated Rejection in Formalin-Fixed Paraffin-Embedded Human Renal Allograft Biopsies

B. Adam,¹ B. Afzali,¹ N. Shah,¹ K. Dominy,² R. Gill,¹ L. Hidalgo,¹ P. Campbell,¹ C. Roufosse,² M. Mengel,¹ B. Sis.¹
Notch Signaling Mediates Epithelial-to-Mesenchymal Transition in the Development of Marginal Liver Graft Fibrosis

X. Liu, K. Man, K. Ng, C. Lo.
Post-Liver Transplant Delirium Is Associated With Increased Mortality and Prolonged Length of Stay

N. Oliver,¹ S. Anders,¹ A. Freeman,¹ K. Fine,¹ A. Cohen,^1,2 G. Loss,^1,2 H. Bohorquez.^1,2
Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation

A. Bodzin, D. Reino, K. Lunsford, M. Harlander-Locke, D. Markovich, A. Zarrinpar, F. Kaldas, D. Farmer, R. Busuttil, V. Agopian.
Propensity Score-Weighted Analysis of Induction Therapies in Live Donor Kidney Transplantation in Modern Immunosuppression Era

B. Tanriover,¹ S. Zhang,² M. MacConmara.³
Quality of Life, Financial, and Mental Health Outcomes for Individuals Turned Down for Live Kidney Donation

P. Reese,¹ C. Carney,¹ S. Levsky,¹ R. Pendse,¹ D. Leidy,¹ A. Mussell,¹ R. Bloom,¹ M. Allen,¹ D. Collins,¹ S. Keddem,¹ P. Abt,¹ J. Rodrigue,² E. Emanuel.¹
Rejection of an Allograft Through Non-MHC Antigens Does Not Translate to the Rejection of a Different Allograft from the Same Donor in Mixed Chimeras

K. Shinoda,¹ C. Chase,¹ P. Russell,¹ J. Madsen,¹ R. Colvin,² A. Alessandrini.¹
Results of Broader Sharing of Young Pediatric Donor Lungs and Priority Allocation System for Young Pediatric Lung Candidates

W. Cherikh,¹ A. Wilk,¹ L. Edwards,¹ G. Visner,² Y. Cheng,¹ S. Sweet.³
Socioeconomic Status of Local Vs Exported Liver Recipients and Their Donors

J. Adler,¹ J. Hyder,² J. Markmann,¹ H. Yeh.¹
Survival Benefit of ECD Transplantation After Ultra-Long Dialysis Exposure: Implications for Acceptance in the New KAS

C. Kennedy, J. Dong, T. Myint, C. Rose, O. Johnston, J. Gill, J. Gill.
T Cell Receptor Repertoire Analysis of BKV-Specific T Cells in Peripheral Blood Samples By Next Generation Sequencing Reveals Differential Role and Kinetics of CD4 and CD8 T Cell Clones in Viral Control

M. Nienen,¹ W. Benjamin,¹ L. Kuchenbecker,^1,2,3 J. Hecht,¹ P. Reinke,^1,4 A. Neumann,¹ N. Babel.^1,4
The Spleen Is the Primary Site for Breg Induction and Is Required for Anti-TIM-1 Mediated Tolerance

K. Mohib, Q. Ding, A. Cherukuri, D. Rothstein.
Upregulation of Heart Transplant IL-33 Is Critical in Cardiac Tissue Repair

Q. Liu, L. Mathews, J. Lott, B. Matta, H. Turnquist.
A New Diagnostic Tool for Antibody Mediated Rejection in Heart and Lung Transplantation: Intragraft Donor Specific Anti-HLA Antibodies Detection

J. Olagne,^1,2,3 A. Parissiadis,² N. Froelich,² S. Caillard,¹ M.-P. Chenard,³ E. Epailly,⁴ H. Kremer,⁴ T. Degot,⁵ S. Hirschi,⁵ R. Kessler,⁵ B. Moulin.¹
Absence of Allograft TLR4 Receptor Signaling Attenuates Early Inflammation and Promotes Survival of Allografts Subjected to Prolonged Cold Ischemic Storage

N. Kohei,¹ T. Tanaka,¹ H. Tsuda,¹ D. Kish,¹ K. Tanabe,² R. Fairchild.¹
Adherence Time-Profiles of Renal Transplant Patients During the Three First Years Post-Transplantation

C. Villeneuve,^1,2,3 C. Monchaud,^1,2,3 M. Essig,^2,4 M.-L. Laroche,^1,3 A. Coubret,¹ I. Lacroix,⁵ S. Bouchet,^6,7,8 D. Fruit,^1,2,3 P. Merville,⁹ N. Kamar,^10,11,12 P. Marquet,^1,2,3 A. Rousseau.^2,13
Adoptive Transfer of T Cell Receptor-Transgenic (TCR-Tg) Cells Alters Endogenous Immune Responses During Acute Rejection

M. Miller, M. Daniels, Y. Wang, D. Yin, A. Chong, M.-L. Alegre.
Adverse Events of Maintenance Immunosuppression Following Kidney Transplantation Reported in Randomized Controlled Trials: A Systematic Review

M. Howell,^1,2 R. Yeo,² A. Tong,^1,2 J. Craig,^1,2 K. Howard,² G. Wong.^2,3
Alemtuzumab Induction Has Been Safe in the United Kingdom and Achieves Long-Term Steroid Avoidance in More Than 80% of Low Risk Renal Transplant Recipients

A. Seitz,¹ M. Robb,³ S. Balasubramanian,¹ A. McLean,² D. Taube,² R. Johnson,³ R. Baker.¹
Biomarkers of Deceased Donors for the Prediction of Renal Allograft Outcomes

S. Kang,¹ H. Im,¹ J. Lee,¹ T. Koo,¹ S. Lee,² S. Park,³ S.-J. Kim,⁴ C. Ahn,¹ J. Yang.¹
CD4 T Cell Mediated Help Is Required for Endogenous Memory CD8 T Cell Proliferation in Cardiac Allografts Subjected to Prolonged Cold Ischemic Storage

H. Tsuda,^1,4 T. Tanaka,^2,4 N. Kohei,^3,4 D. Kish,⁴ W. Baldwin,⁴ A. Valujskikh,⁴ R. Fairchild.⁴
Clinical and Pathologic Predictors of Response to Belatacept Conversion

S. Patel, H. Morris, D. Cohen, S. Mohan, L. Ratner, R. Crew.
Defining the Epidemiologic Landscape of HIV-Infected Deceased Donors in the United States

A. Cash, A. Shaffer, S. Anjum, A. Massie, D. Segev, C. Durand.
Effect of Patient Functional Status on the Associations Between Kidney Transplant Waitlisting, Race, and U.S. Region

L. Plantinga, R. Patzer, S. Pastan, C. Bowling.
Everolimus Conversion to Treat BK Virus Infection in Kidney Transplant Recipients

D. Wojciechowski, A. Webber, S. Chandran, F. Vincenti.
Extended Life-Supporting Xenogeneic Lung Function With Multi-Transgeneic Donor Pigs and Targeted Drug Treatments

L. Burdorf,¹ E. Rybak,¹ T. Zhang,¹ D. Harris,¹ S. Dahi,¹ N. Kubicki,¹ D. Parsell,¹ E. Sievert,¹ D. Ayares,² A. Azimzadeh,¹ R. Pierson III.¹
Galectin-9 Protects Mouse Liver Transplants Against Ischemia-Reperfusion Injury

H. Ji, Y. Liu, Y. Zhang, X. Shen, F. Gao, R. Busuttil, J. Kupiec-Weglinski.
Hepatic Stellate Cells Directly Inhibit B Cells Via PD-L1

Y. Li, K. Fang, S. Qian, J. Fung, L. Lu, F. Lin.
Immunologic Outcomes in Elderly Kidney Transplant Recipients

D. Khadzhynov, F. Halleck, L. Liefeldt, P. Glander, J. Bamoulid, S. Kreimer, L. Lehner, K. Budde, O. Staeck.
In Vitro Evidence That CTLA4Ig Attenuates Recall Alloantibody Responses

I. Kim,¹ G. Wu,¹ N.-N. Chai,¹ S. Jordan,² A. Klein.¹
Influence of Race on P-Glycoprotein Function in Peripheral Blood Mononuclear Cells

K. Tornatore,¹ H. Minderman,² K. O'Loughlin,² K. Attwood,³ D. Brazeau,⁴ R. Venuto.⁵
Interleukin-1 Receptor Signaling by Graft Stromal Cells Regulates Donor-Reactive CD8 T Cell Responses to Cardiac Allografts

S. Iida,¹ D. Kish,¹ R. Abe,² K. Tanabe,³ W. Baldwin,¹ R. Fairchild.¹
Ischemic Cholangiopathy Following Liver Transplantation from Donation After Circulatory Death Donors: Role of Tissue Plasminogen Activator Flush

C. Kubal,¹ R. Mangus,¹ J. Fridell,¹ M. Wingler,² S. Nagai,¹ B. Ekser,¹ J. Tector.¹
Kidney Transplantation Using Kidneys from Donation After Circulatory Death Donors: Results from the UK Experience

D. Summers,^1,2,3 R. Johnson,² D. Collett,² C. Watson,^1,3 J. Neuberger,² G. Pettigrew,^1,3 J. Bradley.^1,3
Long Term Outcomes of Tocilizumab Therapy for DSA+ Antibody Mediated Rejection (ABMR) Resistant to IVIG + Rituxan (I+R) Treatment

J. Choi,¹ A. Vo,¹ J. Kahwaji,¹ M. Haas,² N. Reinsmoen,³ D. Puliyanda,¹ A. Peng,¹ R. Villicana,¹ S. Jordan.¹
Long-Term Efficacy and Safety of an EVR- Vs. an MMF-Based Regimen After Pediatric Kidney Transplantation (KTX): A Case-Control Study Within the CERTAIN Registry

L. Pape,¹ T. Ahlenstiel-Grunow,¹ B. Hoecker,² M. Bald,³ K. Kruppka,² B. Toenshoff,² L. Brunkhorst.¹
Marked Suppression of Posttransplant Alloantibody Production and Primed B cell Function In Vivo by mTOR Inhibition Compared to Calcineurin Inhibition

C. Wright, J. Zimmerer, T. Pham, G. Bumgardner.
Matching Strategies in Kidney Paired Donation: A 7-Year Analysis of a Multi-Institutional Registry

D. Fumo,^1,2 L. Reece,² S. Stepkowski,¹ V. Kapoor,¹ S. Rees,² J. Kopke,² M. Rees.^1,2
MicroRNA let-7i Targeting IL-10 Via JAK1-STAT3 Signal Pathway Regulates Dendritic Cells Maturation Subsequently Induces Cardiac Allograft Tolerance

J. Wu,^2,3 X. Jin,¹ Y. Sun,^2,3 X. Liu,^2,3 D. Chi,^2,3 B. Yu.^2,3
Multicenter Study to Develop a Novel Prediction Index for Hepatocellular Carcinoma (HCC) Recurrence After Liver Transplant (LT)

N. Mehta,¹ J. Heimbach,² D. Harnois,³ J. Dodge,¹ J. Burns,³ D. Lee,³ W. Sanchez,² J. Roberts,¹ F. Yao.¹
Muscle Mass Measurement Is Objective and More Predictive of Expected Mortality Than Functional Status in High MELD Liver Transplant Recipients

J. Nolte,¹ S. Gordon Burroughs,¹ D. Victor,¹ C. Mobley,¹ N. Yu,² T. Hirase,¹ A. Saharia,¹ A. Rajaraman,¹ L. Moore,¹ A. Gaber,¹ R. Ghobrial.¹
Norovirus Infection in Renal Transplant Recipients – Clinical Severity and Genotype Identification

J. Roodnat,¹ Y. Rakké,¹ J. Beek van,³ M. Koopmans,² M. Betjes,¹ W. Weimar,¹ M. Beersma.²
Reasons for Match Offer Refusals and Efforts to Reduce Them in the OPTN/UNOS Kidney Paired Donation Pilot Program (KPDPP)

R. Leishman,¹ D. Stewart,¹ A. Kucheryavaya,¹ L. Robbins Callahan,¹ T. Sandholm,² M. Aeder.³
Recovery After Living Donor Laparoscopic Nephrectomy

D. Larson, J. Wiseman, D. Berglund, C. Jacobs, C. Garvey, H. Ibrahim, A. Matas.
Regional Variations: Liver Transplant Tourism Within the US

C. Frenette,¹ A. Harper,² R. Schaffer,¹ J. Fisher,¹ A. Baquerizo,¹ C. Marsh.¹
Rewarming of Cold Preserved Livers Decreases Graft Injury and Kupffer Cell Activation by Normothermic Extracorporeal Liver Perfusion (NELP)

B. Banan,¹ R. Watson,² Y. Lin,¹ J. Jia,¹ Z. Xiao,¹ G. Upadhya,¹ W. Chapman.¹
Sequential Monitoring and Stability of Ex Vivo-Expanded Autologous and Non-Autologous Regulatory T Cells Following Infusion in Non-Human Primates

H. Zhang,¹ H. Guo,¹ L. Lu,¹ A. Zahorchak,¹ R. Wiswman,² G. Raimondi,¹ D. Cooper,¹ M. Ezzelarab,¹ A. Thomson.¹
Sevoflurane Based Anesthesia in Recipients Reduces 2 Year Acute Rejection in Living Donor Kidney Transplantation. Results from the VAPOR-Trial

G. Nieuwenhuijs-Moeke,¹ V. Nieuwenhuijs,² M. Seelen,³ R. Ploeg,² H. Leuvenink,² M. Struys.¹
The Molecular Landscape of Atrophy-Fibrosis in Human Kidney Transplants: The Dominant Role of Acute Parenchymal Injury

J. Venner, P. Halloran.
Adoptive Immunotherapy With Liver Allograft-Derived NK Cells Improves Recurrence-Free Survival After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma

N. Tanimine, Y. Tanaka, K. Ishiyama, M. Ohira, S. Shimizu, T. Yano, H. Ohdan.
Association Between Histological Abnormalities in Time-Zero Renal Biopsies and Post-Donation eGFR in Live Donors

L. Fahmy, A. Massie, B. Orandi, S. Bagnasco, J. Alejo, B. Boyarsky, S. Anjum, R. Montgomery, N. Dagher, D. Segev.
B Cell Depletion With an Anti-CD20 Antibody Enhances Alloreactive Memory T Cell Response After Transplantation

J. Marino, P. Crosby Bertorini, J. Paster, A. Trowell, K. Briggs, L. Maxwell, G. Benichou.
Belatacept Based Immunosuppression and Incidence of Proteinuria in Kidney Transplant Recipients

R. Villicana, A. Peng, J. Kahwaji, J. Choi, A. Vo, S. Jordan.
Blocking CD4 T Cell Helper Functions Improves Efficacy of ATG Treatment in Sensitized Transplant Recipients

K. Ayasoufi, X. Wang, H. Yu, V. Gorbacheva, F. Ran, R. Fairchild, A. Valujskikh.
CHBP Suppresses Acute Rejection by Inhibition Maturation of Dendritic Cells though Jak-2/STAT3/SOCS1 Signal in Rat Kidney Transplantation

C. Yang,¹ Y. Zhang,¹ J. Wang,¹ L. Li,¹ L. Wang,² M. Xu,¹ Y. Long,³ R. Rong,¹ T. Zhu.¹
Characteristics and Consequences of Renal Allograft Rejections Due to Nonadherence

S. Patel, S. Kuten, J. Everett, J. Loucks-DeVos, L. Gaber, A. Gaber, R. Knight.
De Novo Donor Specific Antibody (DSA) After Treatment of BK Infection With Intravenous Immunoglobulin (IVIG)

J. Kahwaji, P. Wongsaroj, J. Choi, A. Peng, R. Villicana, S. Jordan, A. Vo.
Defining the Role of CD57+CD4 T Cells in Belatacept-Resistant Rejection

J. Espinosa,^1,2 L. Stempora,^1,2 R. Townsend,³ A. Kirk.^1,2
Distinct Role of Complement Receptors C5L2 and C5aR in Acute Kidney Injury and Renal Fibrosis

A. Thorenz,¹ R. Chen,¹ K. Hüper,³ B. Hensen,³ C. Klemann,⁵ M. Meier,⁴ A. Klos,² F. Güler.¹
Dramatic Primary Expansion of Indirect CD4 T Cells to Allogeneic APCs In Vivo

N. Bishop,¹ M. Nelsen,¹ M. Coulombe,² R. Gill.²
Effectiveness of Protocol-Driven Induction Therapy in Adult Kidney Transplant Recipients

J. Casale, J. Fleming, D. Taber, C. Staino, K. Boyle, K. Covert, N. Pilch, H. Meadows, C. Mardis, K. Chavin, C. Bratton, J. McGillicuddy, T. Srinivas, P. Baliga.
Emotional Bonding in Recipients of Deceased Donor Kidney Transplants (DDRT): Associated Factors and Effect on Medication Adherence

A. Cerrato, M. Salifu, M. Markell.
Gender Differences in Kidney Transplant Delayed Graft Function Are Independent of Donor-Recpient Size Mismatch

M. Levine,¹ A. Thomasson,¹ D. Aufhauser,¹ R. Redfield,² P. Abt,¹ P. Reese.³
Hybrid-Natural Orifice Transluminal Endoscopic Surgery (NOTES) for Laparoscopic Donor Nephrectomy Offers Better Postoperative Pain, Cosmesis and Surgical Outcomes Than Transumbilical Single Site Surgery

M. Miura, H. Higashiyama.
Immunosuppression With Anti-CD40 mAb and Rapamycin for Islet and Kidney Co-Transplantation in Nonhuman Primates

T. Oura, K. Hotta, J. Lei, J. Markmann, A. Dehnadi, G. Benichou, B. Cosimi, T. Kawai.
Intra-Allograft Common Rejection Module (CRM) Expression in Kidney Transplants Diagnoses Acute Rejection and Predicts Long Term Graft Prognosis

Y. Ng, S. Roedder, O. Bestard, T. Sigdel, S.-C. Hsieh, M. Sarwal.
Iron Deficiency Impairs Regulatory T Cell Induction

R. Danger,¹ E. Bonaccorsi-Riani,¹ E. Kodela,¹ H. Collins,² R. Hider,³ M. Martínez-Llordella,¹ A. Sánchez-Fueyo.¹
Kidney Transplant Patients' Attitudes Towards Self-Management Support: A Q-Methodological Study

E. Massey,¹ J. Grijpma,¹ M. Tielen,¹ A. Van Staa,² L. Maasdam,¹ T. Van Gelder,¹ S. Berger,¹ J. Van Busschbach,¹ M. Betjes,¹ W. Weimar.¹
Late Antibody-Mediated Rejection in a Large Cross-Sectional Cohort of Kidney Transplant Recipients – Results of the Screening Phase of the BORTEJECT Study

F. Eskandary,¹ G. Bond,¹ H. Regele,² N. Kozakowski,² Z. Kikic,¹ M. Wahrmann,¹ H. Haslacher,³ R. Oberbauer,¹ V. Ramassar,⁴ P. Halloran,⁴ G. Böhmig.¹
Liver Allograft Utilization Within the United States: 2003-2013

J. Renz,¹ G. Diaz,¹ L. Ratner,² H. Yersiz,³ M. Millis,¹ J. Matthews.¹
National Transplantation Pregnancy Registry: Cholestasis of Pregnancy in Liver Transplant Recipients

M. Moritz,^1,2 L. Coscia,² S. Constantinescu,³ D. Armenti.²
Normothemic Machine Perfusion of Liver Grafts Promotes Liver Regeneration and Inhibits Tissue Inflammation

E. Xystrakis, J. Lozano, R. Danger, M. Martinez-Llordella, P. Srinivasan, N. Heaton, C. Coussios, A. Sanchez-Fueyo, Y. Ma, W. Jassem.
Normothermic Machine Perfusion (NMP) on Discarded Human Livers: The First Model in the US

Q. Liu, A. Nassar, G. Iuppa, D. Urcuyo-Llanes, D. Sexton, T. Okamoto, T. Uso, A. Bennett, W. Baldwin, K. Abu-Elmagd, J. Fung, C. Miller, C. Quintini.
Outcomes of Live Kidney Donors Who Develop End Stage Renal Disease

A. Muzaale, A. Massie, L. Kucirka, D. Segev.
Passive Administration of Antibodies to Cardiac Myosin Immediately Following Syngenic Cardiac Transplantation Result in Rejection

M. Sharma, M. Gunasekaran, N. Benshoff, W. Liu, A. Gelman, T. Mohanakumar.
Patient and Graft Outcomes Following 3^rd, 4^th and 5^th Renal Transplants – A Single Centre Comparative Study

I. Loukopoulos, G. Rompianesi, P. Chandak, N. Mamode, F. Calder, N. Kessaris.
Post Transplant De Novo Donor Specific Antibodies Correlate With the Development of Bronchiolitis Obliterans Syndrome Following Pediatric Lung Transplantation

E. Melicoff, J. Maddox, M. Ebenbichler, J. Heinle, D. McKenzie, P. Jindra, G. Mallory, R. Kerman.
Regulatory T Cells Expanded by Activated iNKT Cells Facilitate Migration of Donor Dendritic Cells Into the Recipient Thymus and Subsequent Establishment of Clonal Deletion

T. Hirai,¹ R. Shibahara,¹ S. Miyairi,¹ M. Ikemiyagi,¹ K. Omoto,¹ Y. Ishii,² K. Tanabe.¹
Risk Associated With DCD Kidney Transplantation Varies by Donor Characteristics

X. Luo, A. Massie, E. Chow, D. Segev.
Should Only Active Candidates Define the EPTS Top 20% in the New Kidney Allocation System (KAS)?

D. Stewart,¹ A. Kucheryavaya,¹ G. Boyle,¹ M. Aeder,² R. Formica.³
Steroid Free Immunosuppression Protocol in Pediatric Kidney Transplant Recipients Using Alemtuzumab: A Retrospective Single Center Study

R. Shah,¹ Z. Kadry,¹ S. Wassner,² D. Kees-Folts,² M. Freeman,² P. Freeman,¹ B. Olenowski,¹ A. Jain.¹
Survival Benefit of Kidney Transplant Among HIV+ Waitlist Candidates

J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3
The Effect of Rituximab Therapy on Regulatory B Cell and Prevention of Chronic Antibody Mediated Rejection in Kidney Transplantation Recipients

M. Ikemiyagi, R. Ishii, S. Miyairi, T. Hirai, K. Omoto, K. Tanabe.
The Role of Hemodialysis Social Networks in Transplantation: Five Year Follow Up of an Urban Hemodialysis Cohort

A. Pai, A. Gillespie.
Use of Tissue Plasminogen Activator (TPA) in Liver Transplantation from Donation After Cardiac Death (DCD) Donors: A Controlled Randomized Trial

B. Eghtesad, K. Hashimoto, M. Watson, M. Nazzal, C. Quintini, D. Kelly, T. Diago, N. Kawamura, G. El-Gazzaz, M. Fujiki, F. Aucejo, C. Winans, C. Miller, J. Fung.
"What's the Mileage?" Determining the Length of Time in Which Renal Function Returns to Pre-Calcineurin Discontinuation Levels in Patients With Interstitial Fibrosis

A. Diez, J. Von Visger, U. Nori, T. Pesavento, M. Henry, E. Davies, R. Pelletier.
100 Protocol Renal Allograft Biopsies at 10 Years: First Look at the Tacrolimus Era

M. Stegall,¹ W. Park,¹ F. Cosio,² L. Cornell.³
12-Month Athena Study: Everolimus Vs. Standard Regimen in De Novo Renal Transplant Recipients

C. Sommerer,¹ B. Suwelack,¹ D. Dragun,¹ I. Hauser,¹ P. Schenker,¹ D. Bäumer,² B. Nashan,¹ F. Thaiss.¹
2-Year Results on Renal Function and Safety for Everolimus plus Reduced-Exposure Calcineurin Inhibitor in Living Donor Kidney Transplant Recipients

T. Yagisawa,¹ N. Ishikawa,¹ N. Goto,² I. Nakajima,³ O. Kamisawa,⁴ S. Fuchinoue.³
24 Month Post Transplantation Follow Up of the Certitem Trial

E. Rondeau,¹ E. Cassuto,² V. Vuiblet,³ C. Legendre,⁴ P. Merville,⁵ Y. Le Meur,⁶ B. Moulin,⁷ P. Westeel,⁸ B. Hurault De Ligny,⁹ A. Lécuyer,¹⁰ M. Tindel,¹¹ N. Kamar.¹²
2B4 Expression on Human CD4+ Memory T Cells Is Associated With Functional Impairment

C. Chen, S. Laurie, J. Lyons, C. Coopersmith, M. Ford.
CYP3A4 Polymorphisms Correlate With Time to Achieve Tacrolimus Steady State Concentration in Lung Transplant Patients

I. Timofte, A. Iacono, J. Kim, P. Sanchez, R. Reed, K. Rajagopal, M. Mclenon, B. Griffith, R. Pierson, S. Pham.
Donor Dendritic Cells – Potential New Therapeutic Target in Transplantation

T. Ueno,^1,2,3 M. Yeung,¹ M. McGrath,¹ H. Iwamoto,³ Y. Nakamura,³ O. Konnno,³ Y. Kihara,³ T. Yokoyama,³ S. Ono,³ T. Ikeda,³ S. Kawachi,³ B. Ibrahim,¹ A. Chandraker.¹
A 52-Week, Multicenter, Prospective, Observational, Non-Interventional, Open-Label Study to Assess the Effectiveness, Safety and Tolerability of Everolimus in Kidney Transplant Patients in Taiwan

S.-M. Wang,¹ P.-C. Lee,² J.-D. Lian,³ K.-H. Shu,⁴ S.-T. Wu,⁵ H.-C. Chen,⁶ C.-C. Huang,⁷ M.-S. Wu,⁸ Y.-C. Tian,⁹ Y.-J. Chiang,¹⁰ Y.-T. Chen,¹¹ H.-P. Wang.¹²
A Comparative Analysis of Histological Scoring in Living Donor Renal Transplants from Donors Above and Below 60 Years of Age

A. Ghazanfar,^1,2 F. Kazmi,² A. Bagul,¹ M. Morsy,¹ J. Popoola.¹
A Critical Analysis of the Impact of Socioeconomic Status on Racial Disparities in Kidney Transplantation

D. Taber, M. Gebregziabher, M. Hamedi, T. Srinivas, K. Chavin, P. Baliga, L. Egede.
A Cross-Organ Tissue Gene Expression Immune Signature Predates Chronicity

Y. Ng, O. Bestard, T. Sigdel, S.-C. Hsieh, T. Tran, M. Sarwal.
A Discrete Choice Experiment to Explore Patients' Preferences for Kidney Transplant Monitoring by Video-Conferencing

S. Brunet-Houdard,¹ M. Giral,² S. Gaboriau,² A. Meurette,² P. Daguin,² P. Tessier.³
A Distinct Glomerular Complement Deposition Pattern in Transplant Glomerulopathy

P. Verghese, R. Reed, A. Matas, Y. Kim.
A Joint Survival Longitudinal Approach to Better Assess the Etiological Role of Risk Factors of Kidney Transplant Graft Failure

M.-C. Fournier,^1,2 E. Dantan,¹ Y. Foucher,^1,2 M. Giral.²
A Mouse Model of Pneumonitis Induced by Candida Albicans Infection After Allogeneic Skin Transplantation

A. Yang, Z. Guo, W. Ju, Y. Ma, A. Hu, Y. Chen, M. Chen, C. Wu, X. He.
A Non-Invasive Urinary Common Rejection Module (uCRM) Gene Expression Score Enables Accurate Discrimination of Acute Rejection in Kidney Transplant Patients

O. Bestard,^1,2 T. Sigdel,¹ Y. Ng,¹ S.-C. Hsieh,¹ S. Roedder,¹ N. Dvorak,¹ T. Tran,¹ M. Sarwal.¹
A Noninvasive Diagnostic Test of Renal Allograft Rejection Using Urinary-Cell mRNA: A Comparison of Droplet Digital and Real-Time PCR

J.-W. Seo, H. Moon, A. Lee, Y.-W. Choi, Y. Kim, J.-Y. Moon, S.-H. Lee.
A Novel Humanized Mouse Model for the Study of Induced Pluripotent Stem Cell-Derived Tissue Transplantation Tolerance and Function

M. Brown, I. Norman, Y. Zhou, J. Sullivan, W. Burlingham.
A Novel Signaling Approach for the Prevention of Ischemia/Reperfusion Injury (IRI)

S. Khalid,¹ M. Haller,¹ K. Koziel,¹ M. Enthammer,¹ M. Hermann,² M. Thurner,¹ L. Kremser,³ H. Lindner,³ J. Troppmair.¹
A Novel Tool to Evaluate Coercion, Pressure, and Motivation in Potential Live Kidney Donors

A. Shaffer,¹ E. King,¹ J. Kahn,² L. Erby,³ D. Segev.¹
A Preliminary Study of Using Small Intestinal Submucosa Scaffolds Coated Islets and Mesenchymal Stem Cells to Built Artificial Pancreas

D. Wang, X. Ding, W. Xue, J. Zheng, X. Feng, X. Tian, Y. Li.
A Primary Cytomegalovirus Infection Post-Transplantation Has a Significant Impact on Circulating T Cells and Renal Allograft Function

R. Meijers,¹ N. Litjes,¹ A. Langerak,² C. Baan,¹ M. Betjes.¹
A Prospective Study of Renal Function and Histological Changes in Renal Transplant Recipients With Acute Clinical and Subclinical Rejection

S. Chen,¹ R. Mehta,¹ P. Sood,¹ P. Randhawa,² N. Shah,¹ C. Wu,¹ A. Tevar,³ S. Hariharan.¹
A Randomized Cross-Over Phase 3b Study of the Pharmacokinetics of Once-Daily Extended Release MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus in African-Americans (ASERTAA)

J. Trofe-Clark,^1,2 D. Brennan,³ P. West-Thielke,⁴ M. Milone,⁵ M. Lim,² R. Bloom.²
A Retrospective Review of a Renal Sparing Protocol in Orthotopic Liver Transplantation

B. Pierce,² J. Levitsky,^1,3 M. McLaughlin,² C. Richardson.²
A Retrospective Study to Describe the Epidemiology and Outcomes of Opportunistic Infections After Solid Organ Transplantation

M. Helfrich,¹ P. Dorschner,¹ M. Ison.^1,2
A Single Center Study on Pregnacy and Allograf Function Outcomes Post Heart Transplant

S. Adams, M. Wigger.
A Single Centre Experience With the Living Donor Kidney Sharing Scheme: More Is Better!

K. Thomas, H. Crawshaw, S. Sinha, P. Mason, P. Harden, C. Winnearls, E. Sharples, S. Reddy, M. Sullivan, J. Gilbert, I. Quiroga, R. Ploeg, A. Vaidya, P. Friend.
A Specific Inhibitor of C1s, TNT003, Prevents Complement-Mediated Enhancement of Monocyte Adhesion to Endothelium in Response to HLA Antibodies

N. Valenzuela,¹ K. Thomas,¹ A. Mulder,² G. Parry,³ S. Parker,³ E. Reed.¹
A Tool for Predicting Long Term Risks of Kidney Donation

S. Reule,¹ R. Foley,¹ A. Matas,² H. Ibrahim.¹
ABCB1 Haplotypes, Sex, Calcineurin Inhibitors and Lipid Profiles Post-Renal Transplant

C. Meaney,^1,2 R. Venuto,³ D. Brazeau,⁴ J. Consiglio,⁵ L. Cooper,¹ G. Wilding,⁵ K. Tornatore.^1,2,3
ABO Incompatible Simultaneous Liver-Kidney Transplant With Positive Crossmatch. A Case Report

T. Heffron,¹ C. Kulig,² P. Gauthier,² B. Bista,² S. Dionne,³ T. Pillen,¹ M. Asolati.¹
ABO-Incompatible Liver Transplantation for Severe Hepatitis B Patients

J. Zhou, W. Ju, X. Yuan, X. Jiao, D. Wang, X. Zhu, X. He.
Absence of Low-Grade Proteinuria Is Associated With Improved Outcomes in Patients With Worse 3 Month Graft Function in Renal Transplantation

A. Seitz,¹ A. Cherukuri,² R. Baker.¹
Absence of Nucleotide-Binding Oligomerization Domain-Containing Protein 1 and 2 Modifies Adaptive Immune Responses

S. Kasimsetty, A. Shigeoka, D. McKay.
Accurate Prediction of High-Resolution HLA-A, -B, -C, -DRB1 and -DQB1 Typing and Low-Resolution HLA-DQA1 Typing by Haplotype Analysis

A. Jaramillo,¹ R. Vaidya,² M. Pando,³ S. Gaitonde.⁴
Acoustic Radiation Force Impulse Measurement in Renal Transplantation

J. Lee,¹ J. Lee,¹ A.-l. Lee,² B. Ma,³ Y. Oh,⁴ K. Huh,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ D. Joo.¹
Activated Protein C Treatment Protects Steatotic and Non-Steatotic Livers Under Ischemia–Reperfusion Injury in Different Manner

A. Matsuda, N. Kuriyama, H. Kato, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, S. Isaji.
Activation and Sequestration of Platelets During Xenogeneic GalTKO.hCD46 Pig Lung Perfusion Is Primarily Mediated By GPIb, GPIIb/IIIa, and VWF

L. Burdorf,¹ A. Riner,¹ A. Shah,¹ E. Schwartz,¹ K. Quinn,¹ E. Kang,¹ E. Sievert,¹ E. Rybak,¹ D. Harris,¹ T. Zhang,¹ D. Parsell,¹ X. Cheng,¹ G. Braileanu,¹ S. De Meyer,² I. Salles,² H. Deckmyn,² C. Phelps,³ D. Ayares,³ R. Pierson III,¹ A. Azimzadeh.¹
Activation of FXR Protects Against Liver Ischemia and Reperfusion Injury (IRI) in Mice Via the PI 3-Kinase/Akt (PI3K/Akt) Pathway

J. Zhang,¹ X. Liu,² D. Li,¹ H. Dai,¹ J. Zhang,¹ T. Lu,¹ Q. Xia.¹
Activation of Th17 and Chronic Renal Allograft Rejection in Nonhuman Primates

K. Hotta, A. Aoyama, P. Putheti, Y. Yamada, T. Ohura, R. Colvin, B. Cosimi, G. Benichou, T. Strom, T. Kawai.
Acute Kidney Injury After Lung Transplantation – Incidence, Risk Factors and Mechanisms

F. Gueler,¹ G. Warnecke,⁵ M. Peperhove,² M.-S. Jang,¹ C. Schroeder,³ S. Tewes,² B. Wiese,⁶ C. Fegbeutel,⁵ R. Lichtinghagen,⁷ B. Jüttner,⁸ F. Wacker,² D. Hartung,² B. Akerstrom,⁴ M. Gram,⁴ H. Haller,¹ A. Haverich,⁹ K. Hueper.²
Acute Kidney Injury and Outcome After Cardiac Transplantation

G. Fortrie,¹ O. Manintveld,² K. Caliskan,² M. Betjes.¹
Acute Kidney Injury in Kidney Transplant Patients According to the KDIGO Criteria

T. Filiponi, A. Silva-Filho, E. Tonato, L. Requiao-Moura, A. Matos, E. Arruda, R. Chinen, L. Pires, M. Durão Junior.
Acute Kidney Injury in the MELD Era of Liver Transplantation. Are Calcineurin Inhibitors So Problematic for Renal Function?

R. Ciria Bru, I. Gómez Luque, M. Cortés Cerisuelo, P. López Cillero, J. O'Grady, M. de la Mata, N. Heaton, J. Briceño Delgado.
Addressing Low Live Kidney Donation Rates in African Americans through the Live Donor Champion Program

E. King,¹ J. Garonzik-Wang,³ M. Bowring,¹ K. Kumar,¹ D. Segev.^1,2
Adoptive Immunotherapy Using Activated NK Cells Ameliorates the FcγRIIIa Gene Polymorphism-Associated Susceptibility to Post Transplant Bloodstream Infection

S. Shimizu, Y. Tanaka, H. Tazawa, S. Verma, H. Ohdan.
Advanced Imaging Modalities for Hepatocellular Carcinoma: Is MRI With Eovist Really Better?

M. Chen, H. Reich, M. Uffenheimer, Y. Nasseri, A. Annamalai.
African American Race Is an Independent Risk Factor for Cytomegalovirus Infection in Renal Transplant Recipients on Low-Dose Valganciclovir Prophylaxis

S. Patel, S. Kuten, J. Loucks-DeVos, R. Knight, A. Gaber.
Age Should Not Be Considered a Contraindication for Living Kidney Donation

D.-A. Moutzouris, R. Charif, J. Galliford, J. McDermott, H. Dulku, H. Orr, D. Taube, M. Loucaidou.
Age, Race and Socioeconomic Factors Have a Strong Influence on Candidates Finding a Living Donor Kidney

G. Vranic, A. Nishio Lucar, D. Keith.
Age-Specific Graft Failure Rates in Pediatric Heart Transplant Recipients

B. Foster,¹ M. Dahhou,¹ X. Zhang,¹ V. Dharnidharka,² V. Ng,³ J. Conway.⁴
Age-Specific Graft Failure Rates in Pediatric Liver Transplant Recipients

B. Foster,¹ M. Dahhou,¹ X. Zhang,¹ V. Dharnidharka,² J. Conway,³ V. Ng.⁴
Aldosterone Acts Directly On T Cells, and Promotes Production of Inflammatory Cytokines

J. Bagley, S. Begum, J. Iacomini.
Alemtuzumab Induction Is Associated With a Lower Risk of Early Rehospitalization After Kidney Transplant

G. Dube,¹ D. Tsapepas,² Y. Coppleson,³ L. Ratner,⁴ D. Cohen,¹ S. Mohan.¹
Alemtuzumab Induction Is Protective Against Acute Rejection in Kidney Recipients With Subtherapeutic Tacrolimus Concentrations

K. Szempruch, R.-A. Lee, R. Dupuis, J. Deyo, T. Kozlowski.
Allo-Stimulated Interferon-γ Release and Natural Killer Cell Function Defines and Risk Stratifies Cancer Development in Kidney Transplant Recipients Who Have Cancer Post-transplantation

C. Hope,^1,2 A. Fuss,^1,2 W. Hanf,¹ P. Coates,^1,2 P. Heeger,³ R. Carroll.^1,2
Allograft Pancreatectomy: Indications and Outcomes

S. Nagai, J. Powelson, R. Mangus, J. Fridell.
Alloimmune Regulation and Long-Term Allograft Survival Induced by Short-Term Administration of Chinese Medicine Cornus Officinalis and Cuscuta Sinensis Lam

Z. Dai, Y. Zeng, X. Liu, Z. Chuan.
Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients

A. Daoud,^1,3 M. Ghobrial,¹ L. Teeter,² E. Graviss,² E. Asham,¹ S. Burroughs,¹ A. Saharia,¹ C. Mobley,¹ S. Mogawer,³ A. Sholkamy,³ M. Elshazly,⁴ M. Boktour,¹ A. Gaber.¹
Alterations in Peripheral Blood B Cell Subpopulations in Kidney Transplant Recipients With DSA

B. Ramaswami,¹ R. Ippolito,² B. Elinoff,¹ M. Marrari,³ K. Hadi,¹ C. Macedo,¹ D. Metes,¹ A. Shields,⁴ R. Alloway,⁵ A. Zeevi,³ F. Lakkis,¹ E. Woodle,⁴ G. Chalasani.^1,2
An Analysis of Health-Related Quality of Life in Liver Transplantion for Hepatocellular Carcinoma

C. Kensinger, H. O'Dell, D. LaNeve, L. Simmons, I. Feurer, D. Moore.
An Orchestrated Sequence of Innate and Adaptive Immune Responses Is Associated With Rejection After Pediatric Liver Transplantation

C. Falk,¹ I. Goldschmidt,² F. Mutschler,² C. Neudörfl,¹ J. Keil,¹ K. Daemen,¹ F. Lehner,³ R. Mikolajzcyk,⁴ A. Karch,⁴ U. Baumann.²
Analysis of Causes of Graft Loss Among Kidney Transplant Patients Receiving Tacrolimus Vs Cyclosporine

M. Kamel,¹ M. Posadas Salas,¹ D. Taber,² M. Kadian,¹ M. Salazar,¹ P. Mohan,¹ T. Srinivas.¹
Analysis of Patient Refusals for Transplantation

A. Reeves-Daniel,¹ A. Palanisamy,¹ G. Orlando,² J. Rogers,² G. Russell,¹ A. Farney,² J. Burkart,¹ R. Stratta,² B. Freedman.¹
Analysis of the Temporal Evolution of Causes of Graft Loss Among Kidney Transplant Recipients in a US Southern State

M. Kadian,¹ M. Posadas Salas,¹ M. Kamel,¹ D. Taber,² M. Salazar,¹ P. Mohan,¹ T. Srinivas.¹
Angiopoietin-2 Associates With Graft Failure and Mortality in Renal Transplant Recipients

W. Westendorp,¹ C. Keyser,² E. van den Berg,² C. Krikke,¹ H. van Goor,³ S. Bakker,² H. Leuvenink.¹
Anti-BTLA Antibody (6B2) Induced Prolongation of Fully MHC-Mismatched Murine Cardiac Allograft and Generation of Foxp3+ Regulatory T Cells

M. Uchiyama,^1,2,3 E. Yin,^3,4 X. Jin,^3,5 T. Shimokawa,¹ H. Yagita,² M. Niimi.³
Anti-LG3 Antibodies Aggravate Ischemia-Reperfusion Injury

B. Yang,¹ K. Hamelin,¹ L. Pomerleau,¹ J. Peng,¹ J. Tremblay,¹ N. Patey,² M.-J. Hébert.¹
Anti-Thymocyte Globulin Induction in Infected Mechanical Circulatory Support Patients: Is It Safe?

G. Jamero, J. Moriguchi, L. Czer, M. Kittleson, S. Siddiqui, F. Liou, D. Arman, L. Lam, D. Chang, P. Zakowski, J. Kobashigawa.
Antibody-Induced Platelet Activation Increases Allograft Hyaluronan Fragmentation

H.-H. Kuo,¹ R. Fan,¹ N. Dvorina,¹ C. De La Motte,² W. Baldwin.¹
Antibody-Mediated Rejection Is Associated With Higher Serum Levels of CXCL13 and CCL21 in Renal Transplant Patients and Altered By Bortezomib/Rituximab Treatment

M. Duerr,¹ K. Daemen,² J. Keil,² K. Budde,¹ C. Falk.²
Antithymocyte Globulin-Induced Platelet Hypercoagulability Is a Consequence of Complement Activation and Microvesicle Release

D. Zecher,^1,4 A. Cumpelik,¹ D. Tsakiris,² M. Dickenmann,³ J. Schifferli.¹
Application of the Clavien Classification of Surgical Complications to Robotic Kidney Transplantation

R. Garcia Roca, C. Martinez Parra, I. Tzvetanov, H. Jeon, E. Benedetti, J. Oberholzer.
Are DQA Antibodies Real?

J. Jones, D. Lucas, M. Leffell, A. Zachary.
Are Living Kidney Donors Who Apply Via a Web-Based Screening Application as Likely to Be Evaluated and Donate as Compared to Phone Applicants?

H. Schaefer, M. Tanaka, I. Feurer, A. Dreher, P. Newbern, D. Moore.
Are We Missing Cardiovascular Disease in Children Awaiting Liver Transplant?

C. Villa,¹ E. Hahn,¹ J. Bucuvalas,² K. Campbell,² R. Hirsch,¹ M. Lake,² A. Lorts.¹
Arterial Hypertension and the Use of Antihypertensive Medication in Pediatric Renal Transplant Patients: An Analysis of the CERTAIN Registry

R. Sugianto,¹ E. Wühl,² B. Schmidt,¹ S. Geyer,³ K. Krupka,² B. Höcker,² B. Tönshoff,² A. Melk.¹
Artificial Neural Networks in Kidney Allocation in Patients With Dual Organ (Liver-Kidney) Failure

V. Rao,¹ R. Behara.²
Assessing Pre-Vaccination Cytokine Levels to Predict Immunogenicity to Seasonal Trivalent Influenza Vaccine in Solid Organ Transplant Recipients

M. Fernandez-Ruiz, A. Humar, S. Keshwani, S. Husain, D. Kumar.
Assessment of Bleeding and Thrombosis in Responders and Initial Non-Responders to Aspirin After Continuous-Flow Left Ventricular Assist Device Placement

C. Floroff, K. Rieger, T. Veasey, S. Strout, H. Meadows, M. Stroud, J. Toole, M. Brisco, J. Cook, J. Lazarchick, W. Uber.
Assessment of Eating Disorders in Altruistic Organ Donor Candidates: Pitfalls, Red Flags and Practical Suggestions

R. Jaiswal, J. Gordon-Elliott, F. Desrosiers.
Assessment of Hospital Readmissions After Mechanical Circulatory Support

F. Arabia, M. Kittleson, L. Czer, J. Hajj, E. Passano, F. Liou, S. Siddiqui, D. Chang, J. Kobashigawa, J. Moriguchi.
Assessment of Renal Function in Kidney Transplant Recipients Through Therapeutic Drug Monitoring of Vancomycin

A. Thamer, N. Elias, C. Varughese, T. Gift, J. Fishman, S. Shao.
Assessment of Viral-Specific Memory T Cell Responses and Infection Rates in HLA-Sensitized (HS) Kidney Transplant Patients (Tx Pts) Treated With Everolimus & Low-Dose Tacrolimus (Eve/Tac)

S. Ge, J. Kahwaji, M. Chu, A. Karasyov, M. Castro, E. Hayrapetyan, D. Lovato, D. Thomas, J. Choi, S. Louie, A. Vo, S. Jordan, M. Toyoda.
Association Between Polymorphisms of PPM1E Gene and Tumor Size of Hepatocellular Carcinoma Patients

M.-S. Park,¹ S.-K. Kim.²
Association Between the Timed Up and Go Test and Waitlisting for Kidney Transplantation

M. Chiles,¹ K. Foley,¹ R. Crew,¹ G. Dube,¹ H. Morris,¹ S. Patel,² J. Camacho,² D. Cohen,¹ L. Ratner,² S. Mohan.¹
Association of IP-10 With Poor Islet Graft Function After Total Pancreatectomy With Islet Autotransplantation

M. Kanak,¹ M. Lawrence,² F. Kunnathodi,² G. Yoshimatsu,² R. Shahbazov,² M. Takita,² M. Levy,³ B. Naziruddin.³
Association of Transplant Volume and Survival in Pediatric Kidney Transplants

W. Cherikh,¹ A. Wilk,¹ C. Flavin,¹ E. Brewer.²
Associations Between Deceased-Donor Urine Biomarkers of Kidney Injury and 6-Month Kidney Transplant Function

C. Parikh, I. Hall, M. Doshi, B. Schroppel, F. Weng, R. Hasz, P. Murray, V. Rao, H. Thiessen-Philbrook, J. Ficek, P. Reese.
Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma

E. Yanik,¹ S. Chinnakotla,² A. Israni,^2,3 J. Snyder,^2,3 S. Gustafson,³ E. Engels.¹
Attenuating Racial Disparities in Kidney Transplantation Through the Use of Potent Immunosuppression Regimens

D. Taber, M. Gebregziabher, N. Pilch, T. Srinivas, K. Chavin, P. Baliga, L. Egede.
B-Cell Activation in Acute Kidney Injury and Delayed Graft Function

M. Schiffer,¹ F. Wiehler,¹ R. Song,¹ R. Chen,¹ L. Schiffer,¹ M. Mengel,² H. Haller,¹ F. Gueler.¹
BK Virus-Specific Polyfunctional CD8+ T Cells Predicts Successful Control of BK Viremia After Kidney Transplantation

J. Schaenman,¹ Y. Korin,² T. Sidwell,² F. Kandarian,² N. Harre,² P.-T. Pham,³ S. Bunnapradist,³ G. Danovitch,³ J. Veale,⁴ H. Gritsch,⁴ E. Reed.²
Banff Criteria Are Inadequate to Assess Chronic Renal Allograft Injury 10 Years Post-Transplantation

L. Cornell, W. Park, F. Cosio, M. Stegall.
Belatacept Treatment Through Home Infusion as a Safe and Reasonable Alternative to Intitution-Based Treatment: A Retrospective Analysis of Medical Records

T. Kou,¹ A. Deshmukh,¹ J. Preston,¹ A. Gomez,¹ S. Rafanelli,² K. Calderon.¹
Belatacept in a Community Hospital Adult Kidney Transplant Program

D. Nikolaenko, Q. Chaudhry, H. Smith, C. Shadur.
Bidirectional Regulation and IL35 Surface Expression By Treg Cells

Y. Tomita, W. Burlingham.
Biliary Complication After Living Donor Liver Transplantation According to Biliary Reconstruction Methods

J. Lee,^1,2 J. Lee,^1,2 D. Han,^1,2 J. Lee,³ M. Ju,^1,2 M. Kim,^1,2 G. Choi,^1,2 J. Choi,^1,2 S. Kim,^1,2 D. Joo.^1,2
Bioengineering Liver Allografts through Organ Scaffold Recellularization

J. Woodall, J. Langford, C. Klassen, J. Harrison, D. Parsell, U. Dhru, R. Barth, J. LaMattina.
Biomarker Panel Profile for Identification of High-Risk Patients After Heart Transplantation

M. Barten,¹ M.-T. Dieterlen,² J. Garbade,² F. Mohr.²
Biomarker for Calcineurin Inhibitors Nephrotoxicity in Solid Organ Transplantation: Validation of a Urine Gene Expression Panel

D. Maluf, R. Gehrau, J. Suh, K. Brayman, C. Bustamante, M. Edmunds, P. Darvishi, V. Mas.
Biopsychronology: Live Confocal Imaging of Biopsies to Assess Organ Function

M. Ashraf,¹ D. Fries,² W. Streif,³ F. Aigner,¹ P. Hengster,¹ J. Troppmair,¹ M. Hermann.²
Birth Weight as a Marker of Nephron Mass: Impact on Renal Allograft Function

T. Schachtner,^1,2 P. Reinke.^1,2
Birth Weight as a Marker of Nephron Mass: Predicting Living Kidney Donor Outcomes

T. Schachtner,^1,2 P. Reinke.^1,2
Bladder Drainage of Pancreas Transplants Alone: Friend or Foe?

M. Bellini,¹ G. Spoletini,² S. Reddy,¹ J. Gilbert,¹ I. Quiroga,¹ R. Ploeg,¹ E. Sharples,³ S. Sinha,¹ A. Vaidya,¹ P. Friend.¹
Blocking CD40/CD154 Co-Stimulation Prevents Acute Antibody-Mediated Renal Allograft Rejection Induced by Memory CD4 T Cells

V. Gorbacheva, R. Fan, A. Valujskikh.
Blood Gene Expression at 3 Months Post-Transplantation Predicts 1-Year Histological Features in Renal Transplantation

R. Danger,^1,2 K. Renaudin,^1,3,4 C. Paul,¹ G. Couvrat-Desvergnes,^1,3 J. Lozano,⁵ A. Sanchez-Fueyo,^2,5 V. Meas-Yedid,⁶ J. Olivo-Marin,⁶ E. Thervet,⁷ J. Dantal,^1,3,4 A. Moreau,^1,3,4 J.-P. Duong Van Huyen,⁸ J.-P. Soulillou,^1,3,4 M. Giral,^1,3,4 S. Brouard.^1,3,4
Blood Pressure Evaluation by Three Different Modalities in Living Kidney Donors

Z. Zaky, G. Thomas, S. Gebreselassie, E. Poggio.
Boosting the Adaptive Immune Response Prevents the High Incidence of Herpes Zoster After Lung or Heart Transplantation

N. van Besouw,¹ S. Roest,² J. Zuijderwijk,¹ R. de Kuiper,¹ J. van Weezel,³ A. van der Eijk,⁴ W. Weimar,¹ P. Hal,³ O. Manintveld.²
Bortezomib-Based Multi-Modality Protocol for Donor-Specific Antibody Treatment in Lung Transplant Recipients

M. Vacha, A. Hulbert, J. Byrns, C. Benedetti, A. Finlen Copeland, A. Gray, S. Palmer, L. Snyder.
Both Preformed and De Novo Cw Donor Specific Antibodies Are Clinically Significant in Renal Transplantation

A. Gueret-Wardle, M. Willicombe, V. Dibbur, P. Brookes, A. McLean, D. Taube.
C1q Reactivity and IgG Subtypes After HLA Antibody Removal Therapy With Carfilzomib in Thoracic Transplant Recipients

A. Zeevi, M. Marrari, C. Bentlejewski, J. Pilewski, M. Morrell, J. McDyer, M. Shullo, J. Teuteberg, C. Bermudez, C. Ensor.
CD28 Saturation by FR104, a Non-Activating CD28 Antagonist Fab in a Non-Human Primate Cardiac Allograft Model

W. Sun,¹ A. Azimzadeh,¹ G. Braileanu,¹ T. Zhang,¹ D. Amoako,¹ L. Burdorf,¹ B. Vanhove,² R. Pierson III.
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment

R. Hotta,¹ M. Ohira,² T. Matsuura,¹ I. Muraoka,¹ P. Tryphonopoulos,¹ J. Fan,¹ A. Tekin,¹ H. Ohdan,² A. Tzakis,³ R. Vianna,¹ S. Nishida.¹
CD8 T Cell Biomarkers Improves the Capacities of the Kidney Transplant Failure Score for the Long-Term Prognostic of Kidney Graft Failures

N. Degauque,^1,2 M. Yap,¹ G. Tilly,^1,3 P. Guerrif,² M. Giral,² S. Brouard,^1,2 Y. Foucher.^2,3
CD8⁺TCR^– Bone Marrow Facilitating Cells Prime Migration and Enhance Homing of Hematopoietic Stem and Progenitor Cells

Y. Wen,¹ Y. Huang,¹ T. Miller,¹ S. Ildstad.^1,2
CHBP in Preservation Solution and Autologous Blood Perfusate Ameliorates Ischemia Reperfusion Injury in Isolated Porcine Kidneys

C. Yang,¹ S. Hosgood,² H. Carly,² P. Meeta,² Y. Long,³ T. Zhu,¹ M. Nicholson,² B. Yang.²
CMV IgG Provides Similar Anti-CMV Efficacy as Valganciclovir in High-Risk Organ Transplant Recipients, With Reduced Costs

N. Pilch, D. Taber, C. Schaffner, S. Nadig, J. McGillicuddy, C. Bratton, P. Baliga, K. Chavin.
CMV prevalence in Mauritian and Indonesian Cynomolgus Macaques: Significance in Transplantation and CMV Disease Models

K. Premanand,¹ E. Szilagyi,¹ J. Yu,¹ R. Patel,¹ A. Antony,¹ M. Willman,² D. Berman-Weinberg,² D. Han,² A. Vaidya,³ E. Silva,³ K. McHenry,³ D. Salomon,⁴ N. Kenyon,² A. Bartholomew.¹
CMV-Specific CD154+T-Cells and CMV Disease Status After Liver Or Intestine Transplantation (LTx, ITx)

C. Ashokkumar,¹ M. Ningappa,¹ G. Mazariegos,¹ K. Soltys,¹ G. Bond,¹ C. Trautz,¹ M. Green,² M. Michaels,² R. Sindhi.¹
CO2 Angiography Provides a Safe Alternative to Iodinated Contrast Agents in the Diagnosis and Endovascular Treatment of Transplant Renal Artery Stenosis

B. Gelb,¹ N. Cayne,² J. Benstein,³ G. Morgan,¹ K. Bortecen,¹ M. Hamshow,¹ L. Teperman.¹
CPRA Values Are Substantially Increased for Some Candidates Subsequent to Inclusion of Unacceptable C-locus (UA-C) Antigens While Listing Practices Remain Unchanged

A. Kucheryavaya,¹ R. Bray,² A. Miller,¹ D. Tyan.³
CTLA4Ig Administered During T-Cell Priming Negates de novo Alloantibody Responses and Modulates Recall Antibody Production

G. Wu, I. Kim, N.-N. Chai, S. Jordan, A. Klein.
Calcineurin (CNI) Exposure Reduces the Risk of Post-Transplant DSA After Deceased Donor Kidney Transplantation

R. Pelletier, A. Rajab, G. Bumgardner, M. Henry.
Calcineurin Inhibitor-Free Immunossupresion After Kidney Transplantation, Using Everolimus De Novo – Single Center Experience

M. Stronka, Z. Adamska, L. Cichanska, J. Kubiak, M. Gamrat, M. Karczewski.
Calcineurin Inhibitors (CNI) Minimization Associated With Mammalian Target of Rapamycin Inhibitors (i-mTOR) to Improve Renal Function in Renal Grafts from Uncontrolled Donation After Cardiac Death Donors (UDCDD)

M. Molina,¹ E. Gutierrez,¹ S. González-Sanchidrian,² E. González,¹ J. Cabrera,¹ N. Polanco,¹ A. Hernández,¹ A. Sevillano,¹ M. Praga,¹ A. Andres.¹
Calcineurin-Inhibitor Conversion to mTOR Inhibitor in Renal Transplant Recipients Leads to Worse Long Term Clinical Outcomes

A. Alvarado,¹ A. Shetty,¹ O. Traitanon,¹ J. Leventhal,¹ V. Mas,² D. Chhabra,³ J. Matthews,¹ L. Gallon.¹
Campath Induction With Triple Maintenance Therapy in African American Kidney Transplant Recipients: Less Infections But Worse Graft Survival

M. Gillespie, F. Rasetto, B. Masters, T. Sparkes, B. Ravichandran, M. Moss, A. Haririan.
Can Gene-Expression Profiling Score Help Explain the Adverse Clinical Outcomes Seen in Gender-Mismatched Heart Transplants?

N. Sulemanjee,¹ P. Prasad,² T. Wolf,² V. Thohan,¹ J. Teuteberg.³
Can We Use MDRD or CKD-EPI Equation for Donor Selection?

B. Moura, D. Machado, F. Agena, F. Paula, W. Nahas, E. David-Neto, F. Lemos.
Can the Need for Graft Nephrectomy After Late Renal Transplant Failure Be Predicted?

K. Bunthof, C. Verhoeks, L. Hilbrands.
Cancer Mortality Among Recipients of Solid Organ Transplant in Ontario

S. Acuna,^1,2,3 K. Fernandes,⁴ C. Daly,^2,3 L. Hicks,³ R. Sutradhar,^1,4 S. Kim,^1,4 N. Baxter.^1,2,3,4
Cardiac Xenotransplantation: Reconstituted B Cells After Rituxan Treatment Maintain Their Repertoire But Have a Muted Response to Xenoantigens

A. Singh,¹ P. Corcoran,¹ B. Lewis,² M. Thomas,² D. Ayers,³ K. Horvath,¹ M. Mohiuddin.¹
Cardiosphere-Derived Cells from Cadaver Can Improve Heart Function in a Model of Non-Ischaemic Dilated Cardiomyopathy

J. Wu,^1,2 Y. Sun,^1,2 M. Tan,³ D. Chi,^1,2 M. Zhang,^1,2 K. Kang,⁴ X. Jin,⁵ B. Yu.^1,2
Causes of Poor Renal Function of Kidney Transplants from Uncontrolled Donation After Cardiac Death Donors (UDCDD)

M. Molina, E. González, E. Gutiérrez, E. Morales, E. Hernández, A. Sevillano, N. Polanco, J. Cabrera, M. Praga, A. Andres.
Cellular Mechanism of Enhanced Alloimmunity by Ischemia Reperfusion Injury

Z. Solhjou, M. Uehara, S. Ohori, M. McGrath, J. Azzi, S. Tullius, R. Abdi.
Center Volume Is Associated With Early Graft Failure After Living Donor Kidney Transplantation

B. Shelton, P. MacLennan, R. Reed, D. Sonnier, M. Hanaway, J. Goodman, C. Young, M. Deierhoi, J. Locke.
Center-Level Variation of Simultaneous Liver-Kidney Utilization

X. Luo, A. Massie, D. Segev.
Change in Frailty Between Evaluation for Kidney Transplantation and Transplantation

M. McAdams DeMarco, E. King, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.
Change in Frailty Status Over Time Among In-Center Hemodialysis ESRD Patients in the ACTIVE/ ADIPOSE Study

B. Tao, J. Gander, N. Kutner, S. Pastan, R. Zhang, R. Patzer.
Change in Physical Function Following Kidney Transplantation

E. Lorenz, A. Cheville, B. Kotajarvi, F. Cosio, N. LeBrasseur.
Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients

A. Yildiz,^1,4 M. Cavusoğlu,¹ S. Adin,² Y. çaliskan,¹ A. Ozkok,¹ H. Tasçi,³ G. Deniz,² M. Sariyar.³
Changing Demographics of HIV+ Liver Transplant Candidates

C. Durand, S. Gustafson, J. Locke, J. Snyder, B. Shelton, R. Reed, P. MacLennan, S. Mehta, A. Nellore, D. Segev.
Characteristics and Outcomes of Patients With Incidental Hepatocellular Carcinoma Detected in the Explanted Liver Following Transplant

M. Goh, J. Ali, G. Pettigrew.
Characteristics of IgGs Produced in Neu5Gc and α1-3 Gal Double Knock-Out Pigs

A. Salama,^1,2 S. Conchon,¹ A. Perota,³ B. Martinet,¹ J.-P. Judor,¹ G. Evanno,¹ S. Le-Bas Bernardet,¹ L. Le Berre,¹ J. Hervouet,¹ D. Minault,¹ J.-P. Concordet,⁴ E. Dugast,¹ B. Vanhove,¹ J. Abadie,⁵ N. Gaide,⁵ I. Lagutina,³ R. Duchi,³ G. Lazzari,³ D. Sachs,⁶ O. Gauthier,⁷ S. Brouard,¹ E. Cozzi,⁸ G. Blancho,¹ H. Perreault,⁹ J.-M. Bach,¹⁰ C. Galli,^3,11 J.-P. Soulillou.¹
Characterization of Natural T Effector Memory Cells Specific for Collagen type V, k-α-1-Tubulin and Vimentin

J. Sullivan,¹ D. Wilkes,² T. Mohanakumar,³ W. Burlingham.¹
Characterization of Peripheral Blood T and B Cells of Sensitized Kidney Transplant Recipients With Long Term Stable Graft Function

N. Galante,¹ M. Fernandes,¹ F. Agena,¹ A. Triboni,¹ G. Freitas,¹ A. Aguirre,¹ W. Nahas,¹ V. Coelho,² E. David-Neto.¹
Characterization of a Nude Mouse Model of Allosensitization Conditioned by Adoptive Transfer of Follicular T Helper Cells

I. Kim, N.-N. Chai, S. Jordan, A. Klein, G. Wu.
Chemokine Receptor 5 Blockade Modulates Inflammation and Immunity in Renal Ischemic Reperfusion Injury

K. Yoo,¹ S. Han,¹ J. Park,¹ E. Bae,¹ J. Park,¹ J. An,¹ J. Lee,¹ D. Kim,¹ Y. Kim,^1,2 S. Yang.²
Chest Wall,Thymus, and Heart Transplant: Pushing the Boundary of Solid Organ Allotransplantation

G. Torregrossa,¹ M. Sosin,² G. Gerosa,³ A. Dorafshar.²
Chimeric Patients Who Undergo Combined Facilitating Cell-Enriched/HSC/Renal Transplant Exhibit Robust TCR Repertoire

I. Konieczna,¹ J. Mathew,¹ J. Miller,¹ S. Ildstad,^2,3 J. Leventhal.¹
Clinical Course of Pre-Existing Monoclonal Gammopathies Following Kidney Transplant

C. Johnson.
Clinical Impact of 18F-FDG-PET/CT in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma

S. Lee, S. Kim.
Clinical Outcomes of Kidney Transplan Recipients After Sirolimus Or Everolimus Conversion. Experience in a Single Center

L. Mesa, E. Manzi, M. Valderrama, J. Posada, J. Schweineberg, C. Duran, G. Echeverri, J. Villegas, O. Serrano, L. Caicedo.
Clinical Outcomes of Living Kidney Donors With Medullary Sponge Kidney

W. Cheungpasitporn, C. Thongprayoon, B. Brabec, W. Kittanamongkolchai, S. Erickson.
Clinical Significance of Estimated DSA MFI Values at 1,000 C1q MFI for Differentiation Between Harmful and Harmless DSA

K. Horimi,¹ T. Akaza,² K. Kuroki,² S. Sakamoto,² Y. Matsuoka,¹ Y. Watarai,² S. Narumi,² A. Katayama,³ K. Uchida,¹ T. Kobayashi.⁴
Clinical Significance of Multidetector Coronary Computed Tomography Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Asymptomatic Kidney Transplantation Recipients

S. Lee,¹ K. Huh,³ B. Kim,² B. Choi,⁴ Y. Kim,⁴ Y. Kim,³ B. Kim.²
Clinical Use of Gene-Expression Profiling to Monitor for Rejection After Cardiac Transplantation – Which Patients and When?

J. Teuteberg,¹ M. Shullo,¹ T. Wolf,² P. Prasad,² G. Ewald.³
Clinical and Biochemical Results of BK Virus Nephropathy in Kidney Allograft Recipients

B. Canbakan,¹ I. Akdağ,¹ ö. Merhametsiz,¹ ö. Yayar,² E. Oğuz,¹ M. Kiliç,³ D. Ayli.¹
Clusterin-Regulated Transcriptome in the Kidney During Ischemia-Reperfusion

G. Dairi, Q. Guan, A. Haegert, C. Collins, M. Gleave, C. Nguan, C. Du.
Combination of Clinical and Genetic Factors for Delayed Kidney Graft Function Prediction

A. Goncalves-Primo,^1,2 E. Campos,^1,2 J. Medina-Pestana,^2,3 H. Tedesco-Silva,³ M. Gerbase-DeLima.^1,2
Combined Anti-IL6R and CTLA4Ig Therapy Attenuates Recall Alloantibody Responses in a Mouse Model of HLA Sensitization

N.-N. Chai, G. Wu, I. Kim, A. Klein, S. Jordan.
Come Again? A Retrospective Cohort Study of Rehospitalization Following Expanded Criteria Donor Renal Transplantation

M. Hung,¹ C. Dunn,¹ A. Holtzman,¹ E. Bellin,² S. Greenstein.²
Come Again? Part 2, Exploring Causes for Increased Rehospitalization in ECD Kidney Recipients

C. Dunn, M. Hung, S. Greenstein.
Comparative Survival Benefits and Costs of an Eplet and Broad Antigen Based Matching System in Deceased Donor Kidney Transplant Allocation Among Indigenous Australians

H. Do Nguyen,¹ G. Wong,^2,3 J. Chapman,² J. Craig,^2,3 L. D'Orsogna,⁴ W. Lim.^1,5
Comparison of Clinical Outcomes Between in the Spousal Donor Kidney Tranplants: Wife-to-Husband Versus Husband-to-Wife

K. Jun,¹ H. Kim,¹ M. Kim,¹ K. Park,² S. Ahn,¹ J. Hwang,¹ S. Kim,¹ S. Park,¹ S. Kim,¹ J. Kim,¹ I. Moon.¹
Comparison of Creatinine Based Estimated Glomerular Filtration Rate (eGFR) and Iothalamate-Measured GFR (mGFR) Following Simultaneous Pancreas – Kidney Transplantation

N. Sarabu, J. Augustine, K. Woodside, D. Hricik, A. Padiyar, E. Sanchez.
Comparison of Efficacy and Renal Function in KidneyTransplant Recipients Receiving Tacrolimus (TAC)-Based Immunosuppressive Regimens in Combination With Everolimus (EVR) or Mycophenolate (MPA)

A. Ferreira,¹ C. Felipe,¹ P. Ueno,¹ P. Hannun,¹ P. Ruppel,¹ T. Sandes-Freitas,¹ H. Proença,³ J. Medina- Pestana,¹ H. Tedesco-Silva.¹
Comparison of Liver Transplant Outcomes for Recipients With MELD <35 Vs. >35

V. Kirchner, S. Chinnakotla, R. Kandaswamy, W. Payne, T. Pruett.
Comparison of Markers of Inflammation Between Dialysis Patients With and Without Failed Kidney Allograft

R. Villca-Gonzales, R. Vazquez-Apodaca, D. Hernandez-Ramirez, L. Llorente-Peters, J. Alberu, L. Morales-Buenrostro.
Comparison of One-Year Outcomes in High Risk Kidney Transplantation: ABO Incompatible and DSA Positive/CDC-AHG Negative

N. Townamchai,¹ W. Chancharoenthana,¹ S. On-Pun,² S. Wattanatorn,¹ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
Comparison of Pharmacokinetics and Pharmacogenomics of Once-Daily Extended-Release MeltDose® Tacrolimus Tablets (Envarsus® XR) Vs. Twice-Daily Tacrolimus Capsules in Stable African American Kidney Transplant Patients: A Randomized Cross-Over Study

J. Trofe-Clark,^1,2 D. Brennan,³ P. West-Thielke,⁴ M. Milone,⁵ M. Lim,² R. Bloom.²
Comparison of Renal Outcomes for Liver Transplant Recipients With Pretransplant Renal Dysfunction Receiving Sirolimus Or Tacrolimus With Rabbit Antithymocyte Globulin Induction

B. Duhart,¹ W. Ally,² V. Rao,³ A. Krauss,⁴ J. Eason,³ J. Vanatta.³
Comparison of Risk Factors and Outcomes of Daptomycin-Susceptible and -Nonsusceptible Enterococcus Infections in Liver Transplant Recipients

J. Lewis, K. Enfield, H. Cox, A. Mathers, C. Sifri.
Comparison of the Clinical Outcome and Surgical Invasiveness for Living Donor Nephrectomy Between Conventional Laparoscopic Surgery and Single-Port Surgery

M. Saito, S. Satoh, R. Yamamoto, H. Tsuruta, S. Akihama, T. Inoue, S. Narita, N. Tsuchiya, T. Habuchi.
Comprehensive Study of 3 Nomenclatures to Discriminate CD8 Subsets in Healthy Volunteers and in Kidney Transplant Recipients

M. Yap,^1,3 G. Tilly,^1,3 M. Giral,^1,2 S. Brouard,^1,2 N. Degauque.^1,2
Consideration of the Futility of Transplant: 50% Mortality at 5 Years

S. Asrani, G. Saracino, J. O'Leary, G. Klintmalm, J. Trotter.
Controlled Hemodilution in Infant Liver Transplants: A Single Center Experience

T. Todo,¹ A. Gallo,¹ J. Mendoza,² T. Pham,¹ C. Esquivel.¹
Controlling for Socioeconomic Barriers Reduces Racial Disparities in Transplant Pursuit

A. Waterman,¹ J. Peipert,¹ C. Kynard-Amerson,¹ A.-M. McSorley,¹ A. Paiva,² M. Robbins,² L. Peace.³
Conversion from Immediate to Prolonged Release Tacrolimus Did Not Change Intra-Patient Variability in Renal Transplant Patients

T. El-Nahhas,^1,2 M. Moreton,² J. Popoola,³ S. Abat,³ A. Johnston,^1,2 I. MacPhee.³
Conversion to Belatacept After Kidney Transplantation Does Not Alter Immunophenotype

M. Matz,¹ K. Fabritius,¹ C. Lorkowski,¹ J. Liu,¹ S. Brakemeier,¹ N. Unterwalder,² H.-H. Neumayer,¹ K. Budde.¹
Correlates and Consequences of Gout Among Living Kidney Donors

N. Lam,¹ A. Garg,¹ D. Segev,² M. Schnitzler,³ H. Xiao,³ D. Axelrod,⁴ J. Tuttle-Newhall,³ D. Brennan,⁵ B. Kasiske,⁶ K. Lentine.³
Correlation Between Level of Biomarkers Measured in Perfusate of Machine-Preserved ECD/DCD Kidneys and Post-Transplant Graft Function

E. Ablorsu,¹ S. Zouwail,² P. Laftsidis,¹ B. Cook,¹ L. Szabo.¹
Correlation of Longitudinal Gene-Expression Profiling Score to Cytomegalovirus Infection: Results from the Outcomes AlloMap® Registry

M. Kanwar,¹ J. Yee,² G. Ewald,³ S. Murali,¹ J. Teuteberg.⁴
Cost-Effective, Simple PTC Tasting Could Be a Useful Adjunct to Selection Criteria of ARLD Patients

K. Bortecen,¹ D. Freitas,¹ C. Teperman,² M. Hamshow,¹ B. Gelb,¹ G. Morgan,¹ L. Teperman.¹
Costimulation Blockade Prevents Rejection of Vascularized Composite Allografts

B. Oh,¹ G. Furtmüller,¹ M. Fryer,¹ J. Grahammer,² S. Schneeberger,² D. Cooney,¹ W. Lee,¹ G. Brandacher.¹
Creation of a Functional Bio-Artificial Intestinal Segment in Rats

T. Corsello, G. Damiano, M. Tuveri, M. Montalbano, C. Rastellini, L. Cicalese.
Cross-Linking of MHC Class I Induces Unique Transcriptional Profiles Associated With Regulation of Both T and B Cells That Precedes Induction of Allo- and Auto-Immunity Leading to Obliterative Airway Disease

D. Nayak, M. Sharma, Z. Xu, A. Gelman, T. Mohanakumar.
Cultural Domains Affecting Organ Donation in Indian Country

T. Bongiovanni,^1,3,4 J. Rawlings,² J. Trompeta,³ M. Nunez-Smith.¹
Current Dialysis, Previous Kidney Transplant, and Autoimmune Disease Increase Risk for Abnormal Pap Smear in Women Undergoing Kidney Transplant Evaluation

K. Chaung,¹ Y. Zheng,¹ A. Martella,² J. Stoecker,¹ D. Cote,¹ J. Augustine,² E. Sanchez,² V. Humphreville,² J. Ammori,² K. Woodside.²
Customized Reminders and Provider Notification to Improve Adherence to Immunosuppression

P. Reese, R. Bloom, J. Trofe-Clark, A. Mussell, D. Leidy, S. Levsky, J. Zhu, Y. Lin, A. Troxel, H. Feldman, K. Volpp.
Cytomegalovirus and BK Infections in Sensitized Kidney Transplant Recipients

S. Parajuli, B. Muth, J. Turk, M. Mohamed, D. Mandelbrot, A. Djamali.
DNA Methylation Classifier Associates With Long-Term Graft Function Post-Kidney Transplantation

J. Suh,¹ D. Maluf, K. Archer,² T. Lee,¹ L. Gallon,³ V. Mas.¹
DNA Methylation of the IFNγ Promoter in CD8+ T Cell Subsets Is Modulated by CMV Infection but not by Alloreactivity in Kidney Transplantation Patients

K. Boer,¹ E. de Wit,¹ L. Hofland,² M. Betjes,¹ C. Baan.¹
Damage Associated Molecular Patterns (DAMPs)-Activated Neutrophil Extracellular Trap Formation Exacerbates Liver Ischemia/Reperfusion Injury

H. Huang, S. Tohme, A. Al-Khafaji, A. Tsung.
Deceased Donor HLA Antibody Incompatible Renal Transplantation Without Antibody Removal: High Incidence of Acute Rejection Reduced By T-Cell Depleting Induction Therapy

E. Jolly,¹ C. Taylor,² H. Morgan,² S. Peacock,² M. Clatworthy,¹ N. Torpey.¹
Decreased Expression of Mitochondrial Aldehyde Dehydrogenase 2 Induces Liver Injury Via Activation of the MAPK Pathway in Grafts from Brain-Dead Donors

Z. Zhong,¹ S. Ye,¹ Y. Xiong,¹ X. Fan,¹ W. Huang,¹ D. Ko,³ Y. Wang,¹ Q. Ye.^1,2
Defining and Directing T Cell Subsets Involved in Rejection of Vascularized Composite Allografts

M. Fryer, G. Furtmùller, B. Oh, S. Reddy, K. Sarhane, G. Raimondi, G. Brandacher, D. Cooney.
Delayed Tacrolimus (TAC) to Rapamycin (RAPA) Conversion in Renal Transplant Recipients With DGF/SGF

A. Haririan,¹ D. Klassen,¹ M. Keshtkar,¹ C. Drachenberg,² T. Dowling,³ E. Ramos,¹ R. Ugarte,¹ C. Cangro,¹ M. Weir.¹
Delivery of Heme Oxygenase-1-Cell Penetrating Peptide (HO-1-CPP) Into Hepatocytes, Kupffer and Islet Cells in In Vitro and Ex Vivo Models of Cold Ischemia

A. Venkatachalam,¹ C. Wood,¹ Q. Hu,¹ I. Alwayn.²
Dengue Virus Infection Among Renal Transplant Recipients: A Series of 10 Cases in a Tropical Country

S. Costa,^1,2 C. Jacinto,¹ L. Martiniano,¹ Y. Amaral,¹ F. Paes,² M. Sales,² E. Daher,^1,2 G. Junior,³ R. Esmeraldo.²
Dermatology Is an Essential Part of Transplant Care: Report of a Two-Year Experience from a Transplant Dermatology Center

E. Pritchett,¹ B. Miller,¹ A. Colasacco,¹ G. Malat,² A. Doyle,² S. Guy,³ C. Cusack,¹ C. Chung,¹ M. Abdelmalek.¹
Descriptive Analysis of Patients Who Travel Away from Home for Orthotopic Liver Transplantation

C. Frenette,¹ A. Harper,³ J. Waalen,² J. Fisher,¹ R. Schaffer,¹ A. Baquerizo,¹ C. Marsh.¹
Desensitization Before Living Donor Kidney Transplantation in Highly Sensitized Patients

E. De Sousa,¹ I. Revuelta,¹ M. Blasco,¹ F. Diekmann,¹ J. Cid,² M. Lozano,² A. Sánchez-Escuredo,¹ J. Martorell,³ E. Palou,³ J. Campistol,¹ F. Oppenheimer.¹
Desensitization Protocol Including Concomitant Bortezomib and Rituximab Did Not Reduce Calculated PRA Nor Mean MFI Values Among Waitlisted Patients for Deceased Donor Kidney Transplantation

S. Kang,¹ H. Lim,¹ J. Jeong,¹ E. Song,² I. Yun,³ C. Ahn,¹ J. Yang.¹
Detection of Donor-Specific Anti-HLA Antibodies Is Associated With Changes in the Peripheral Distribution of NK Cell Subsets in Kidney Allograft Recipients

M. Crespo,¹ D. Redondo,¹ J. Yelamos,² A. Muntasell,² M. Pérez-Sáez,¹ M. Lopez-Montañes,³ C. Garcia,⁴ A. Torío,⁵ J. Hernandez,⁴ M. Mir,¹ M. Lopez-Botet,³ J. Pascual.¹
Detergent-Sonication Method for the Whole Laryngeal Decellularization

N. Nayakawde,¹ K. Methe,¹ M. Berg,² G. Premaratne,¹ H. Ejnell,² M. Olausson.¹
Determinants of Accelerated CAV in Heart Allografts: Major Independent Impact of Circulating DSA

M. Bories, Varnous, Guillemain, Suberbielle, Jouven, Bruneval, Duong, Loupy.
Detriemental Impact of DGF and CIT On Longterm Survival After Kidney Transplantation in Elderly Recipients

C. Denecke,^1,2 M. Biebl,^1,2 C. Bösmüller,² F. Aigner,^1,2 T. Dziodzio,^1,2 R. Sucher,^1,2 S. Weiss,² J. Pratschke,^1,2 R. öllinger.^1,2
Development and Validation of a Genotype Guided Tacrolimus Dosing Equation for African American (AA) Kidney Transplant Recipients

K. Sanghavi,¹ R. Brundage,¹ M. Miller,² D. Schaldt,³ A. Israni,³ W. Guan,⁴ W. Oetting,¹ R. Mannon,⁵ R. Remmel,¹ A. Matas,⁶ P. Jacobson.¹
Development of a Post-Graduate Year 2 Solid Organ Transplant Pharmacy Residency Program at an Academic Medical Center

A. Guyton, D. Clark, M. Todd, J. Peterson, A. James.
Diabetes Exacerbates Liver Ischemia and Reperfusion Injury By Activating the AGE-RAGE Pathway in Kupffer Cells

S. Yue, J. Zhu, J. Rao, J. Kupiec-Weglinski, R. Busuttil, Y. Zhai.
Diabetes Mellitus Predicts Outcome in Obesity After Kidney Transplantation

T. Schachtner,^1,2 P. Reinke.^1,2
Dietary-Associated Trimethylamine N-Oxide (TMAO) Levels Is associated With Coronary Allograft Vasculopathy Following Heart Transplantation

S. Zeltzer,¹ Z. Wang,¹ M. Askar,² J. Coughlin,¹ T. Hudec,¹ D. Taylor,³ L. Li,¹ R. Starling,³ S. Hazen,¹ W. Tang.¹
Differences in Reactivity of HLA-Specific Antibodies May Be Explained By Differences in Their Affinities for Selected Epitopes on HLA Proteins

S. Daga,^1,2 D. Lowe,⁶ R. Buchli,⁵ J. Collard,⁵ A. Mulder,⁸ C. McMurtrey,^4,5 H. Moyse,⁷ N. Evans,⁷ N. Krishnan,² W. Hildebrand,^4,5 F. Claas,⁸ D. Briggs,³ D. Zehnder,^1,2 D. Mitchell,¹ R. Higgins.^1,2
Differentially Expressed Genes in Immunosuppressed Kidney Transplant Recipients

C. Dorr,¹ B. Wu,² W. Guan,² A. Muthusamy,¹ K. Sanghavi,³ P. Jacobson,³ W. Oetting,³ D. Schladt,¹ R. Remmel,³ J. Maltzman,⁵ A. Matas,⁴ For DeKAF Genomics Investigators,¹ A. Israni.¹
Differentially Expressed IL-6Rα and GP130 Genes in Kidney Biopsies (Bxs) Suggests Different Roles of IL-6 Signaling in Antibody (ABMR)- and Cell (CMR)-Mediated Rejection

H. Zhang,¹ D. Thomas,¹ J. Kowalewska,² E. Suviolahti,¹ H. Shafi,² C. Nast,² A. Gertych,² A. Vo,¹ M. Haas,² S. Jordan,¹ M. Toyoda.¹
Discrepancies Between the U.S. Transplant Registry and Cancer Registries Regarding Cancer Diagnoses in Transplant Recipients

E. Engels,¹ D. Segev,² J. Snyder,³ B. Kasiske,³ E. Yanik.¹
Distal Splenorenal Shunt (DSRS): A Durable Bridge to Liver Transplantation

J. Pomposelli, A. Tongyoo, R. Jenkins, M. Akoad, W. Lewis, E. Pomfret.
Distinct Clinical Relevance of BAFF Expression Within the Kidney Graft and Soluble BAFF Serum Levels Indicate Confined Alloimmune Responses Disconnected from the Periphery

E. Campos,^1,2 K. Mine,¹ A. Goncalves-Primo,^1,2 M. Soares,⁴ M. Franco,² J. Medina-Pestana,^2,3 H. Tedesco-Silva,³ M. Gerbase-DeLima.^1,2
Distinct Roles of CD137 and CD137L Bi-Directional Signaling in Candida albicans Infection

H. Cho,^1,2 J. Lee,^2,3 V. Tran,⁴ B. Kwon.^2,4
Distinct Subtypes of Rejection in a Novel Non Human Primate Model of Sensitization

C. Burghuber,^1,2 J. Kwun,^1,3 F. Leopardi,³ A. Gibby,¹ A. Farris,¹ N. Iwakoshi,¹ S. Knechtle.^1,3
Divergence in Risk Factors for Graft Loss and Death Across Race May Mediate Kidney Transplant Outcome Disparity

M. Posadas Salas,¹ D. Taber,² M. Kamel,¹ M. Kadian,¹ M. Salazar,¹ P. Mohan,¹ T. Srinivas.¹
Diverticulitis in Immunosuppressed Patients – A Fatal Outcome Requiring a New Approach?

A. Brandl, T. Kratzer, E. Braunwarth, S. Weiss, M. Maglione, S. Schneeberger, R. Kafka-Ritsch.
Do Community-Solicited NDDs Experience More Coercion to Donate a Kidney Than Traditional NDD Donors?

D. Serur, G. Bretzlaff, P. Christos, F. Desrosiers, M. Charlton.
Do Induction Therapy, Patient-Level and Post-Operative Factors Impact Outcomes in Moderate to High Immunologic Risk Simultaneous Kidney-Pancreas Transplantation in the Era of Stringent HLA Cross-Matching?

V. Rohan, D. Taber, D. Taraskiewicz, S. Nadig, J. Mcgillicuddy, K. Chavin, P. Baliga, C. Bratton.
Do Pre-Procurement Factors Affect Vascular Resistance During Pulsitile Perfusion of Deceased Donor Kidneys?

H. Kay,¹ S. Gates,² P. Shragg,² L. Stocks,² D. McKay,² R. Steiner.²
Does BMI Affect Survival in Cadaveric Liver Transplantation for Benign Conditions?

S. Ayloo, S. Hurton, M. Cwinn, R. Kavanagh, M. Molinari.
Does HLA-Incompatible Transplantation Confer a Survival Advantage in the UK?

M. Manook,¹ Z. Ahmed,¹ R. Johnson,² O. Shaw,¹ N. Kessaris,¹ A. Dorling,¹ N. Mamode.¹
Does Higher Cost Improve Outcome in Pediatric Liver Transplantation?

J. Minneman, J. Grijalva, S. Rangel, H. Kim, K. Vakili.
Does Infection Impact On Tacrolimus Blood Levels in Kidney Transplant Recipients?

N. Kanaan,¹ C. Percy,¹ Z. Hassoun,² M. Mourad,³ C. Beguin,⁴ M. De Meyer,³ E. Goffin.¹
Does PTH Play a Role in Post Kidney Transplant Leukopenia?

R. Dhawan, L. Shin, K. Lee, B. Duong, L. Aguirre, C. Parke, S. Alexopoulos, M. Smogorzewski, A. Gomez, E. Mariscal, L. Matsuoka, Y. Qazi.
Does Prophylaxis Strategy Matter? CMV Reactivation in Moderate Risk (R+) Heart Transplant Recipients

E. Liu, C. Doligalski.
Does Pulmonary Rehabilitation Impact Frailty?

C. Kennedy,¹ P. Novotny,² N. LeBrasseur,³ R. Wise,⁴ F. Sciurba,⁵ R. Benzo.¹
Does Switching Predict Conversion: IgM De Novo Donor Specific HLA Antibodies Class Switch to IgG in Subclinical Antibody Mediated Rejection in Heart Transplant Recipients

M. Askar,¹ R. Rodriguez,¹ L. Klingman,¹ D. Thomas,¹ A. Zhang,¹ H. Morf,² N. Hamon,¹ N. Moazami,¹ E. Hsich,¹ D. Taylor,¹ R. Starling,¹ C. Tan.¹
Does Transversus Abdominis Plane Block Reduce Opioid Analgesic Requirements in the Post-Operative Period in Renal Transplant Recipients?

F. Afridi,¹ R. Coates,¹ S. Wright,² J. French,¹ D. Talbot,¹ S. Rita.²
Does the Site Or Etiology of Renal Artery Stenosis Influence the Sucess Rate of Percutaneous Transluminal Angioplasty?

A. Bull, W. Nahas, K. Yamaçake, R. Kato, I. Antonopoulos, H. Kanashiro, G. Ebaid, A. Piovesan.
Donor Age and Late Rejection Are Associated With the Development of Graft Coronary Artery Vasculopathy in Pediatric Heart Transplant Recipients

W. Zuckerman, M. Richmond, T. Lee, L. Addonizio.
Donor Apolipoprotein L1 Genotype Associates With Glomerular Lesions and Graft Loss in Kidney Transplants

T. Srinivas, P. Baliga, K. Chavin, M. Gebrezhiaber, L. Egede, D. Taber.
Donor CD47 Plays a Critical Role in the Control of Alloreactive T Cell Activation Following Hepatocyte Transplantation

M. Zhang,^1,2 H. Wang,¹ N. Navarro-Alvarez,¹ Y. Zheng,² Y.-G. Yang.¹
Donor Hemodynamic Profile Presages Graft Survival in Donation After Cardiac Death Liver Transplantation

M. Ertreo, C. Desai, R. Girlanda, T. Frias, T. Fishbein.
Donor Lung Preservation With the Organ Care System® Promotes a Tissue Protective and Anti-Inflammatory Response During Transplantation

B. Wiegmann,¹ C. Falk,² M. Seyda,² C. Neudörfl,² A. Akhdar,² C. Kühn,¹ I. Tudorache,¹ M. Avsar,¹ A. Haverich,¹ G. Warnecke.¹
Donor Microbiota and Its Contribution for the Development of Primary Graft Dysfunction Following Human Lung Transplantation

Z. Xu,¹ R. Schuessler,¹ N. Steward,¹ R. Hachem,² E. Trulock,² A. Patterson,¹ D. Kreisel,¹ T. Mohanakumar.¹
Donor Obesity Impact on Simultaneous Kidney-Pancreas Transplantation Outcomes

T. Alhamad,¹ A. Malone,¹ H. Chakkera.²
Donor Serum and Urine Proteomic Signatures Differentiate Between Immediate and Delayed Graft Function in Kidney Transplantation

M. Kaisar,^1,2 H. Huang,^1,2 Z. Akhtar,¹ H. Leuvenink,³ B. Kessler,² R. Ploeg.¹
Donors at Age Extremes for Simultaneous Pancreas-Kidney Transplant (SPKT)

A. El-Hinnawi, R. Pelletier, E. Elkhammas, A. Rajab, G. Bumgardner, R. Plews, T. Pesavento, U. Nori, M. Henry.
Down-Regulation of Autophagy Correlates With Increased Apoptosis in the Kidney, But Not in the Liver, of Brain Dead Rats

A. van Erp,¹ R. Rebolledo,³ P. Ottens,¹ J. Pirenne,² H. Leuvenink,¹ J.-P. Decuypere.²
Dual Induction Therapy With Anti-Thymocyte Globulin and Basiliximab in Simultaneous Pancreas-Kidney Transplantation Reduced Incidence of Acute Rejection

K. Miki, K. Iwadoh, I. Nakajima, S. Fuchinoue.
Dual Kidney Transplantation – Utilising Marginal Kidneys

T. Rana, E. Ablorsu.
Durability of Pancreatic Islets Transplantation in Brittle Type 1 Diabetics- 10 Year Follow Up

Z. Tekin,¹ L. Schenck,¹ M. Garfinkel,⁵ L. Philipson,² J. Thistlethwaite,¹ W. Chon,² K. Golab,¹ O. Savari,¹ S. Ramachandran,¹ K. Rezania,³ S. Hariprasad,⁴ J. Millis,¹ P. Witkowski.¹
Early Detection of HCC Mutations in Indeterminate Lesions Using Liquid Biopsies

Y. Lin,¹ K. Cavaness,² Z. Zhang,¹ S. Lin,³ K. Korenblat,¹ G. Klintmalm,² W. Chapman.¹
Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation

E. King,¹ L. Kucirka,¹ M. McAdams-DeMarco,^1,2 A. Massie,^1,2 D. Segev.^1,2
Early Hospital Readmission and Distance from Transplant Center

E. King,¹ L. Kucirka,¹ M. McAdams-DeMarco,^1,2 A. Massie,^1,2 D. Segev.^1,2
Early Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation Has No Negative Impact on Patients outcome'

B. Lowry,¹ W. El Moghazy,^1,2 G. Meeberg,¹ N. Kneteman.¹
Early Relapse of Atypical HUS Following ABO Incompatible Living Related Paediatric Renal Re-Transplant Successfully Treated With Eculizumab

J. Stojanovic,¹ A. Adamusiak,² N. Sebire,³ S. Marks,¹ N. Mamode.²
Early Steroid Withdrawal and Calcineurin Inhibitor Minimization Protocols for Maintenance Immunosuppression: A Single Center 10-Year Experience

R. Lopez-Soler,¹ L. Park,³ J. Martinolich,² D. Conti.¹
Early Steroid Withdrawal and Infection Risk in Kidney Transplant Recipients

S. Bae, L. Kucirka, C. Durand, B. Orandi, R. Avery, D. Segev.
Early Weight Gain After Transplantation Can Cause Adverse Effect On Transplant Kidney Function

S. Choi, I.-K. Kim, S. Son, M. Ju.
Eculizumab as a Rescue Therapy for Rhinovirus-Induced Antibody Mediated Rejection After Incompatible Kidney Transplantation

E. Tantisattamo, A. Shetty, B. Ho, L. Gallon, J. Friedewald.
Educating the Less Prepared: Transplant Knowledge and Decision-Making Differences by Race at Onset of Evaluation

A. Waterman,¹ J. Peipert,¹ S. Brann,² C. Kynard-Amerson,¹ M. Robbins,³ A. Paiva,³ A. Gaber.²
Education and Employment After Renal Transplantation in Young Adults: An International Study

J. Gralla,¹ P. Murray,² A. Wiseman,¹ P. Harden.³
Effect of Distinct Immunosuppressive Protocols On the Profile of Cytokines Expression in Renal Transplant Recipients of Extended Criteria Donor Kidneys

C. Montoro Mazeti,¹ C. Zangrossi Dezotti,¹ I. Fernandes-Charpiot,^1,2 H. Caldas,¹ M. Baptista,^1,2 M. Abbud Filho.^1,2,3
Effect of Donor Age On Pancreas Transplantation Outcome

A. Rathnasamy Muthusamy,¹ G. Vrakas,¹ S. Mittal,¹ S. Reddy,¹ I. Quiroga,¹ J. Gilbert,¹ R. Ploeg,² E. Sharples,¹ S. Sinha,¹ A. Vaidya,¹ P. Friend.²
Effect of Extension in Submucosal Ureteral Tunnel to Prevent Vesicoureteral Reflux and Its Impact on the Graft Survival in Kidney Transplantation

T. Inoue,¹ S. Satoh,² M. Saito,¹ K. Numakura,¹ H. Tsuruta,¹ S. Akihama,¹ S. Narita,¹ N. Tsuchiya,¹ T. Habuchi.¹
Effect of Fully Laparoscopic Left Hepatectomy on Donor Interest in Living Donor Liver Transplantation (LDLT)

A. Yegiants, D. Santamour, T. Mansour, J. Pisa, J. Emond, B. Samstein.
Effect of Living Kidney Donation on Glucose Metabolism and Insulin Resistance

B. Tanriover,¹ P. Mohan,² S. Cremers,³ I. Lingvay.⁴
Effectiveness of Neovascularization Surrounding Engrafted Islets by Matrigel With Additional Growth Factors in Intramuscular Islet Transplantation

G. Yoshimatsu,^1,2 N. Sakata,² H. Tsuchiya,² M. Takita,³ M. Levy,³ B. Naziruddin,³ M. Unno.²
Effects of Anti-Human Leukocyte Antigen Antibody After Heart Transplantation

F. Liou, M. Kittleson, J. Patel, S. Siddiqui, M. Luu, B. Kearney, D. Ramzy, D. Chang, L. Czer, N. Reinsmoen, J. Kobashigawa.
Effects of Immunosuppressives On Porcine Renal Microvascular Endothelial Cell–Activated Human T Cell Proliferation: A Cellular Model of Kidney Xenotransplantation In Vitro

Z.-Y. Wang, M. Tector, S. Nagai, J. Butler, R. Blankenship, S. Downey, J. Estrada, P. Li, A. Tector.
Effects of the Allo-Immune Response On Nerve Regeneration in Vascularized Composite Allotranplantation

S. Tuffaha,¹ J. Budihardjo,¹ P. Afrooz,² K. Sarhane,¹ R. Jindal,² D. Cooney,¹ G. Brandacher,¹ W. Lee.¹
Efficacy and Safety of Desensitization Protocol Based On Rituximab Plus MMF in ABO-Incompatible Kidney Transplantation Without Splenectomy

K. Takahashi,¹ K. Saito,² S. Takahara,³ S. Fuchinoue,⁴ T. Yagisawa,⁵ A. Aikawa,⁶ Y. Watarai,⁷ N. Yoshimura,⁸ K. Tanabe,⁴ K. Morozumi,⁹ M. Shimazu.¹⁰
Efficacy of Rituximab Sparing Protocol for ABO Incompatible Renal Transplant in Patients With Low Titers

S. Narumi,¹ Y. Watarai,¹ N. Goto,¹ T. Hiramitsu,¹ T. Yamamoto,¹ M. Tsujita,¹ M. Okada,¹ K. Futamura,¹ A. Takeda,² T. Kobayashi.³
Efficacy, Safety and Pharmacokinetics of Once-Daily, MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus (Prograf®) in De Novo Kidney Transplant Recipient Sub-Groups: A 2 Year Phase 3 Randomized, Double-Blind, Double-Dummy, Trial

S. Bunnapradist,¹ J. Denny,² M. Waybill,³ P. West-Thielke,⁴ S. Steinberg.⁵
Efforts to Improve Living Kidney Donor Follow-Up Reporting Have Been Successful

J. Wainright,¹ M. Dew,² C. Lougee,¹ S. Taranto,¹ L. Bolton,¹ C. Thomas.³
Elderly ESRD Patients Have a Significantly Narrowed T-Cell Receptor Repertoire Diversity

L. Huang,¹ A. Langerak,² I. Wolvers - Tettero,² R. Meijers,¹ C. Baan,¹ N. Litjens,¹ M. Betjes.¹
Elderly Transplant Recipients Have Improved Graft Survival

S. Reule,¹ R. Foley,¹ A. Matas,² H. Ibrahim.¹
Elective Allograft Nephrectomy After Transplant Failure

J. Augustine, K. Woodside, K. Noon, D. Hricik, E. Sanchez, J. Schulak.
Electronic Health Service to Improve Therapeutic Drug Monitoring of Immunosuppressants

M. Barten,¹ J. Garbade,² I. Hausladen,² F. Mohr.²
Elevated Pre-Transplant Serum Troponin Is Associated With an Increased Risk of Mortality in Elderly Kidney Transplant Recipients

G. Desbuissons,¹ J. Golmard,² H. Lazareth, M. Timsit,³ H. Kreis, D. Anglicheau, C. Legendre,¹ R. Snanoudj,¹ F. Martinez.¹
Emerging Strategies to Screen Kidney Offers Based on the Kidney Donor Profile Index (KDPI)

D. Stewart,¹ A. Kucheryavaya,¹ G. Boyle,¹ R. Metzger,^2,3 M. Aeder,⁴ R. Formica.⁵
End-To-End Ureteropyelostomy With Ligation of the Native Ureter in Kidney Transplantation: Is It a Safe Procedure?

H. Marinho Neto,¹ B. Leslie,¹ J. Neves Neto,¹ M. Almeida,¹ S. Ximenes,¹ W. Aguiar,¹ H. Tedesco,² J. Medina Pestana,² R. Soler.¹
Endosome-Based Activation of Non-Canonical NF-kB Signaling By Membrane Attack Complexes

D. Jane-wit,¹ Y. Surovtseva,² L. Qin,³ P. Clark,⁴ T. Manes,⁴ M. Kashgarian,⁵ N. Kirkiles-Smith,⁴ R. Liu,⁴ C. Wang,⁴ G. Tellides,³ J. Pober.⁴
Endovascular Salvage of a Pancreas Allograft Having Developed a Large AV Fistula and Aneurysm

N. Katariya,¹ R. Batra,¹ A. Moss,¹ K. Reddy,¹ A. Mathur,¹ E. Huettl,² S. Naidu,² A. Singer.¹
Enhancing Kidney Function Following DCD Donation With Thrombolytic Therapy: A Preliminary Report of a Multicenter Prospective Quasi-Blinded Randomized Trial

K. Woodside,¹ D. Goldfarb,² J. Rabets,² E. Sanchez,¹ D. Lebovitz,³ J. Schulak,¹ J. Fung,² B. Eghtesad.²
Eomesodermin Expression By Alloreactive Non-Human Primate CD8+ Memory T Cells: Influence of CTLA4Ig and Regulatory DC Infusion in Renal Allograft Recipients

M. Ezzelarab,¹ L. Lu,¹ H. Guo,¹ A. Zahorchak,¹ W. Shufesky,¹ D. Cooper,¹ A. Morelli,^1,2 A. Thomson.^1,2
Eosinophilic Gastrointestinal Disease in Pediatric Liver and Kidney Transplant Recipients

S. Mohammad,¹ J. Bush,² K. Amsden,¹ A. Kagalwalla,¹ H. Melin-Aldana,² N. Arva.²
Epidemiologic Change in Pulmonary Hypertension Patients Referred for Lung Transplantation Post Lung Allocation Score Implementation

R. Loyaga-Rendon,¹ B. Shelton,¹ R. Reed,¹ J. Tallaj,¹ E. Diaz-Guzman,¹ G. Heresi,² J. Locke.¹
Epidemiology and Outcomes of Pre-Transplant Methicillin Resistant Staphylococcus Aureus Screening in Pediatric Solid Organ Transplant Candidates

G. Paulsen, S. Blum, L. Danziger-Isakov.
Epidemiology of Early Post Liver Transplant (LT) Infections 2008-12: Time to Reconsider Perioperative Prophylaxis Regimen?

K. Doucette, M. Charles, M. Al Dabbagh, J. Preiksaitis.
Establishment of Diabetes Modeling in Common Marmoset

W. Yuan,¹ S. Fukuda,¹ T. Inoue,² D. Chujo,¹ H. Okochi,¹ E. Sasaki,² M. Shimoda.¹
Establishment of a Novel Model for Hypothermic Machine Perfusion In Vivo in Rabbits

Z. Zhong,¹ Z. Liu,¹ R. Wang,¹ Z. Fu,² Y. Zhang,² Q. Hu,¹ K. Jin,¹ D. Ko,³ Y. Wang,¹ Q. Ye.^1,2
Estimated Prevalence of HIV in Kidney Transplant Candidates

A. Shaffer, X. Luo, L. Kucirka, A. Cash, A. Massie, C. Durand, D. Segev.
Etanercept for Graft Versus Host Disease Following Liver Transplantation

E. Ticehurst,¹ E. Blumberg,¹ F. Vyas,¹ K. Olthoff,¹ A. Shaked,¹ S. Bruno,¹ K. Butcavage,¹ E. Knight,¹ G. Smith,¹ S. Gill.²
Ethnic Barriers in Pediatric Liver Transplant Recipients. A Retrospective Study

M. Asolati,¹ T. Pillen,¹ R. Romero,² T. Heffron.¹
European ELITA ELTR Multicenter Survey On the Management of Bile Duct During Liver Procurement, Preservation and Transplantation

N. Meurisse,¹ D. Monbaliu,¹ P. Muiesan,² A. Pascher,³ M. Oliverius,⁴ G. Berlakovich,⁵ R. Adam,⁶ I. Senesael,¹ J. Pirenne.¹
Evaluating the Benefits of Everolimus on Cardiac Allograft Vasculopathy: Further Evidence from Results of Imputations for Missing IVUS Data from A2310 Study

P. Lopez,¹ G. Dong,² Z. Wang.²
Evaluation of Geographically Distant Living Kidney Donors: A Barrier to Living Donation?

F. Weng, N. Dhillon, L. Davis, R. Goldberg, A. Patel, K. Tibaldi, M. Morgievich, S. Mulgaonkar.
Evaluation of Medication Regimen Complexity Over Time Following Heart Re-Transplantation

B. Bryant,¹ A. Libby,¹ R. Page,¹ J. Lindenfeld,² C. Aquilante.¹
Evaluation of Natural Killer Cell Activation by NK Cell-Specific Interferon-Gamma-Releasing Assay

J. Ryu,¹ K. Park,¹ Y. Kim,² E.-J. Oh.²
Evaluation of Preformed Anti-HLA Antibody of "Unknown Origin" after Kidney Transplant in a Brazilian Center

D. Glasberg,¹ D. Monteiro de Carvalho,² T. Matuck,² G. Fabricio-Silva,³ M. Barbosa,¹ A. Borela,¹ L. Christiani,¹ R. Malta,¹ L. Porto.³
Evaluation of Serum sCD30 as a Predictor in Kidney Transplant Recipients

X.-Z. Wang, W.-J. Xue, X.-H. Tian, J. Zheng, P.-X. Tian, X.-M. Ding.
Evaluation of a Three-Dose Basiliximab Induction Immunosuppression Regimen in Adult Heart Transplant Recipients

L. Donohue, W. Ally, S. Dunn, J. Kennedy, J. Bergin.
Evaluation of the Effects of N-Acetylcysteine Treatment in Adult Liver Transplant Recipients

E. Aldag, S. Farrell, R. Pedersen, A. Sahajpal, J. Clendenon, V. Gunabushanam, D. Kramer.
Everolimus Plus Reduced-Exposure Calcineurin Inhibitor Versus Mycophenolate Mofetil Plus Standard-Exposure Calcineurin Inhibitor: 2-Year Results in Living Donor Kidney Transplant Recipients

Y. Watarai,¹ N. Akutsu,² K. Saito,³ Y. Nakagawa,³ O. Kamisawa,⁴ T. Kenmochi.⁵
Evolution of GFR Outcomes During the First Year of Transplant According to the Kidney Donor Risk Index Transplantation in México. The Experience of a Single Center

J. Aguilar-Frasco, J. Arreola-Guerra, L. Paláu, V. Visag, M. Vilatobá, A. Contreras, A. Sanchez, J. Alberu.
Evolution of Urinary Albumin Excretion in a Large Cohort of Kidney Donors: No Evidence of Progression

H. Ibrahim, D. Berglund, A. Matas.
Ex Vivo Lung Perfusion: Revisit to the Optimal Oxygenation Circulating Lungs for Graft Preservation

K. Noda, S. Haam, J. D'Cunha, J. Luketich, C. Bermudez, N. Shigemura.
Ex Vivo Stem Cell-Mediated Regeneration of Ischemically Damaged Renal Allografts

L. Brasile, N. Henry, A. Meyer, B. Stubenitsky.
Excellent Outcomes With Kidney Transplantation for Patients ≥70 Years of Age

D. Haakinson,¹ K. Reddy,¹ A. Moss,¹ N. Katariya,¹ A. Singer,¹ A. Mathur,¹ J. Huskey,² H. Khamash,² R. Heilman.²
Excessive Weight Gain After Pancreas Transplant: Transitioning from Type 1 to Type 2 Diabetes?

A. Islam,¹ A. Lawless,¹ L. Teeter,³ E. Graviss,³ D. Victor,⁴ A. Sadhu,⁴ S. Patel,⁶ A. Gaber,¹ R. Knight.¹
Expanding the Donor Pool: Comparison of Outcomes in DCD Vs Living Donor Liver Transplantation

G. Sapisochin,¹ J. Seal,² N. Goldaracena,¹ T. Reichman,² J. Laurence,¹ H. Bohorquez,² I. McGilvray,¹ D. Bruce,² P. Greig,¹ I. Carmody,² M. Cattral,¹ A. Ghanekar,¹ D. Grant,¹ G. Loss,² M. Selzner.¹
Expanding the Living Donor Pool: Results of ABO Incompatible Living Related Kidney Transplantation

T. Vowinkel,¹ S. Reuter,² C. Anthoni,¹ N. Senninger,¹ B. Suwelack,² H. Wolters.¹
Expedited Placement of Donor Hearts Increases Morbidity and Mortality Among Bypassed Potential Recipients – A Single Center Experience

M. Peltz,¹ M. Drazner,² M. Jessen.¹
Experimental Study Using Contrast-Enhanced Ultrasonography to Evaluate Rat Chronic Allograft Nephropathy Model and the Relationship Between Hemodynamic Parameters and Renal Allograft Fibrosis

Q. Zhang,¹ Z. Yu,² Y. Xu,¹ S. Zeng,¹ W. Xue,¹ X. Hu.¹
Explorative Analysis of ZEUS After 5 Years: Histological Assessment from Biopsy Analyses

U. Eisenberger,¹ K. Budde,¹ O. Witzke,¹ F. Lehner,¹ C. Sommerer,¹ R. Wuethrich,³ P. Reinke,¹ A. Muehlfeld,¹ K. Heller,¹ R. Stahl,¹ H. Wolters,¹ I. Hauser,¹ M. Porstner,² W. Arns.¹
Expression Patterns of Neuropilin-1 On T Cells and a Potential Role in Transplantation

E. Lee, H. Kim, G. Demirci.
Extracorporeal Life Support: A Rescue Therapy in a Lung Transplantation Program

P. Mohite, D. Gacia-Saez, B. Zych, N. Patil, M. Zeriouh, A. Koch, A.-F. Popov, A. Reed, M. Carby, F. DeRobertis, T. Bahrami, M. Amrani, S. Penn, S. Silver, S. Soresi, A. Simon.
Factors Affecting Efficacy Outcomes at 12 and 24-Months After Kidney Transplantation in Patients from the A2309 Study

C. Escrig,¹ G. Colussi,² R. Roland,² M. Vergara,³ Z. Wang.³
Fast Track of Adult-to-Adult Live Donor Liver Transplant Recipients: Avoiding ICU Admission Reduces Complications and Post Transplant Hospital Stay

J. Echeverri, N. Goldaracena, A. Singh, G. Sapisochin, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, S. McCluskey, M. Selzner.
Favorable Long-Term Outcome of Late-Onset CMV Disease in D+R- Kidney Transplant Recipients Treated With Universal Prophylaxis

H. Kaminski,¹ L. Couzi,^1,2 I. Garrigue,^3,4 J. Déchanet-Merville,² P. Merville.^1,2
Fibrosis, Not Quantitative NGAL-Staining, in Day-10 Protocol Biopsies Predicts Prolonged Duration of Functional Delayed Graft Function in a Cohort of DCD Kidney Transplant Recipients

J. Bank,¹ M. Reinders,¹ M. Mallat,¹ N. Schlagwein,¹ S. van der Kooij,¹ D. van Gijlswijk,¹ I. Bajema,² C. van Kooten,¹ H. de Fijter.¹
First Dose Tacrolimus Level Is Better Than CYP3A5 Genotyping in Prediction of Target Tacrolimus Dose

N. Townamchai,¹ W. Chancharoenthana,¹ S. Wattanatorn,¹ S. Vadcharavivad,² P. Chariyavilaskul,³ A. Leelahavanichkul,⁴ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
Fracture Incidence in Adult Kidney Transplant Recipients

K. Naylor,^1,2 S. Jamal,³ G. Zou,¹ E. McArthur,⁴ N. Lam,^1,2 W. Leslie,⁵ A. Hodsman,² J. Kim,^4,6 G. Knoll,⁷ L.-A. Fraser,¹ J. Adachi,⁸ A. Garg.^1,2,4
Frailty and Length of Stay in KT Recipients

M. McAdams DeMarco, E. King, X. Luo, L. Kucirka, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.
Frailty in Patients Being Evaluated for Kidney Transplantation

M. McAdams DeMarco, I. Olorundare, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.
Frequencies of CD4⁺25^hiFoxp3⁺T Cells in Long-Term Follow-Up of Sirolimus-Converted Kidney Transplant Recipients

O. Traitanon,^1,2 A. Alvarado,¹ E. Tantisattamo,^1,2 A. Shetty,^1,2 M. Ansari,^1,2 J. Mathew,¹ J. Leventhal,¹ V. Mas,³ L. Gallon.^1,2
Gene Expression Profiles Indicate That Many Discarded Kidneys Are Potentially Transplantable

K. Famulski,¹ S. Niederhaus,² J. Reeve,¹ J. Bromberg,² P. Halloran.
Gene Expression of Kidney Biopsies Reveals Common Mechanisms of Rejection and a Cluster of Co-Expressed Genes Predictive of Long-term Outcomes

B. Modena,¹ S. Kurian,¹ J. Friedewald,² F. Harrison,¹ T. Gelbart,¹ S. Head,¹ M. Abecassis,² D. Salomon.¹
Genetic Diversity Epstein-Barr Virus Latent Gene EBNA-1 Among Transplant Patients and Patients With Infectious Mononucleosis

K. Sullivan,¹ S. Isabel,¹ E. Maria,¹ P. Tara,¹ Y. Simon,¹ K. Nasser,¹ N. Vicky,² A. Upton.¹
Geographic Differences in HIV+ Kidney Transplant Waitlist Characteristics

J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3
Glomerulosclerosis Patterns Are Non-Uniform Throughout the KDPI Spectrum With Impact on Biopsy Evaluation of Kidneys for Transplant

M. Jendrisak,¹ K. Mulawa,¹ M. Harmon,¹ D. Cimbaluk.²
Gradual Warming Up Perfusion Post Static Cold Storage Reduces Renal Injury

P. Mahboub,^3,1 P. Ottens,¹ R. Ploeg,² P. Martins,³ H. Leuvenink.¹
Graft Outcome Disparity in a Single Renal Transplant Center Based on Recipient Geographic Origin

R. Flynn, W. Qu, D. Fumo, T. Suttle, S. Selman, M. Rees, J. Ortiz.
Grip Strength, Gait Speed, and Chair Stands Predict Sarcopenia in Male But Not Female Liver Transplant Candidates

C. Wang, S. Feng, K. Covinsky, H. Hayssen, B. Yeh, J. Lai.
HLA Matching Affects Patient Survival, Graft Survival, and Incidence of Rejection Episodes in Largest Analysis to Date

J. Weiner, Z. Cui, S. Mohan, E. Verna, A. Griesemer, J. Emond.
HLA-C, KIR Genotypes and KIR Genotype/HLA –C Ligand Combination in Prediction of Early Acute Rejection After Liver Transplantation

K. Park,¹ J. Ryu,¹ H. Park,³ Y. Kim,² E.-J. Oh.²
HLA-DR Matching Improves Immunologic Outcomes in Elderly Kidney Transplant Recipients

F. Halleck, D. Khadzhynov, L. Liefeldt, P. Glander, J. Bamoulid, S. Kreimer, L. Lehner, K. Budde, O. Staeck.
Hand Assisted Retroperitoneoscopic Donor Nephrectomy in Challenging Cases; Right Sided Donor Nephrectomy With Multiple Renal Arteries

E. Akin,¹ I. Barlas,¹ M. Dayangac,¹ A. Sinangil,² V. Celik,² T. Ecder.²
Health Utilities in Pediatric Liver Transplant Recipients

S. Mohammad, A. Bharij, K. Neighbors, E. Alonso.
Hepatic Stellate Cells Inhibit T Cells Through Active TGFβ1 from a Cell-Surface-Bound Latent TGFβ1/GARP Complex

Y. Li, B.-G. Kim, S. Qian, J. Letterio, J. Fung, L. Lu, F. Lin.
Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients

D. Kumar,¹ P. Campbell,² K. Hoschler,³ A. Humar.¹
High Atherosclerotic Burden in Pediatric Lung Transplant Recipients

A. Melk,¹ D. Thurn-Valsassina,¹ N. Schwerk,² F. Brinkmann,² C. Mueller.²
High Incidence of Masked Hypertension in Pediatric Recipients of Stem Cell Transplantation

A. Melk,¹ D. Thurn-Valsassina,¹ B. Schmidt,² R. Beier.³
High Intra-Patient Variability in Tacrolimus Trough Blood Levels Increases the Risk of Death-Censored Graft Loss After Kidney Transplantation

E. Rodrigo,¹ D. San Segundo,² J. Ruiz,¹ M. López-Hoyos,² A. Benito,¹ M. de Cos,³ Z. Albines,¹ M. Serrano,¹ M. Arias.¹
High Kidney Donor Profile Index (KDPI) Correlates With Calculated Pulsatile Perfusion (PP) Resistance Index (RI) and Delayed Graft Function (DGF)

R. Pelletier, M. Henry.
High Within-Patient Variability in Tacrolimus Levels Is a Predictor of Late Rejection in Young Adult Kidney Transplant Recipients

J. van der Net, P. Harden.
Highly Accurate High-Resolution HLA Imputation Using Dense Genotyping Data

B. Keating,¹ Y. Li,¹ T. Guettouche,² K. Olthoff,¹ A. Shaked.¹
Hispanic/Latino Disparities in Living Donor Kidney Transplantation – Role of a Culturally Competent Transplant Program

E. Gordon, J. Lee, R. Kang, D. Ladner, A. Skaro, J. Holl, D. French, M. Abecassis, J. Caicedo.
Histologic Patterns of C4d Associated With Acute Antibody Mediated Rejection of the Lung Allograft

Y. Butt, J. Hassler, V. Kaza, F. Torres, J. Torrealba.
Histological Analysis in ABO-Compatible and Incompatible Kidney Transplantation By Performing 3-Month and 1-Year Protocol Biopsies

K. Masutani,¹ A. Tsuchimoto,¹ Y. Matsukuma,¹ K. Kurihara,² Y. Okabe,² H. Kitada,² M. Tanaka,² T. Kitazono,¹ K. Tsuruya.¹
Histology of Renal Allografts With DGF Provides Limited Prognostic Information

S. Balasubramanian,¹ A. Cherukuri,² P. Prasad,¹ R. Baker.¹
Histopathological Criteria for Elevated Risk of Delayed Graft Function in German Pretransplantation Kidney Biopsies from Deceased Donors

J. Becker,¹ B. Eggers,² P. Mertens,³ A. Schwarz,⁴ C. Chatzikyrkou.³
Historical Comparison of Projected and Observed Liver Transplants

J. Pyke,¹ D. Schladt,¹ W. Kim,⁵ S. Leppke,¹ J. Lake,⁴ S. Gentry,^2,3 D. Segev,² A. Israni,¹ J. Snyder.¹
Home Dried Blood Spot Monitoring; a New Tool for Measuring Variability in Tacrolimus Blood Levels Over Time

A. Al-Uzri, K. Freeman, K. Clark, L. Bleyle, S. Iragorri, R. Jenkins, D. Rozansky, D. Koop.
Host NK Cell Allorecognition of Passenger Donor Lymphocytes Within Allografts Is Essential for Preventing Augmentation of Recipient Adaptive Alloimmunity

J. Ali, I. Harper, M. Negus, E. Bolton, K. Saeb-Parsy, J. Bradley, G. Pettigrew.
How Long Is Too Long? The Impact of Bridge Donor Waiting Time on Paired Donation Transplants

D. Fumo,^1,2 T. Suttle,¹ R. Flynn,¹ S. Stepkowski,¹ L. Reece,² J. Kopke,² M. Rees.^1,2
Human Bone Marrow Mesenchymal Stem Cell-Derived Hepatocytes Express TIMP-4 and Follistatin

J. Li,¹ J. Xin,¹ W. Ding,² S. Hao,¹ L. Jiang,¹ Q. Zhou,¹ T. Wu,¹ D. Shi,¹ L. Li.¹
Human CMV-Specific CD8 T Cells Exhibit Distinct Phenotypes and Distribution Patterns in Tissues and Circulation

C. Gordon,^1,2,5 J. Thome,^1,3 G. Tomer,¹ D. Farber.^1,3,4
Human Gingival Tissue-Derived Mesenchymal Stem Cells Reduce Murine Acute GVHD Via Killing of Effector CD8+ Cells Through CD39/Adenosine A1R and A2BR Pathways

J. Gu, L. Ling.
Human Hematopoietic Chimeric Cells as a Novel Approach for Tolerance Induction After Transplantation

E. Bryndza Tfaily,¹ J. Cwykiel,¹ K. Dastych,² A. Sklodowska,¹ M. Siemionow.¹
Human Mesenchymal Stromal Cells Improve Survival and Function of Pancreatic Islets by Cell-to-Cell Contact

E. Montanari,¹ R. Mahou,^1,2 S. Passemard,² F. Noverraz,² P. Morel,¹ R. Meier,¹ D. Bosco,¹ J. Seebach,³ C. Wandrey,² S. Gerber,² C. Gonelle-Gispert,¹ L. Buhler.¹
Husband to Wife Renal Transplants Are Associated With a Higher Risk of Early Antibody Mediated Rejection and Transplant Glomerulopathy

H. Sawhney, M. Willicombe, P. Brookes, E. Santos, D. Taube.
Hypothermic Machine Perfusion Improves the Quality of Marginal Donor Pancreata

M. Leemkuil,¹ M. Engelse,² R. Ploeg,³ E. de Koning,² C. Krikke,¹ H. Leuvenink.¹
IFNγ Is Required for nTreg Afferent Lymphatic Migration

S. Ahmad, Y. Xiong, C. Brinkman, J. Bromberg.
IL-2-Dependent Natural Killer Cell Responses to Epstein-Barr Virus B Cell Lymphomas Involve the NKG2A/NKG2C Axis

O. Hatton, D. Strauss-Albee, C. Blish, C. Esquivel, S. Krams, O. Martines.
Identification of CXCR5⁺EBV-Specific CD8⁺ T Cells in Peripheral Blood of Pediatric Heart Transplant Recipients Correlates With IL-21 Production and EBV Reactivation

C. Macedo,¹ K. Hadi,¹ D. Rowe,² J. Luce,³ S. Webber,⁴ B. Feingold,³ D. Metes.¹
Identification of Genetic Variants Associated With Variation of Tacrolimus Levels in African Americans Using GWAS

W. Oetting,¹ D. Schladt,² W. Guan,¹ A. Israni,² R. Remmel,¹ C. Dorr,² K. Sanghavi,¹ R. Mannon,³ B. Herrera,⁴ A. Matas,¹ D. Salomon,⁵ P. Kwok,⁴ P. Jacobson,¹ for DeKAF Genomics.¹
Identification of Mouse Tolerogenic B Cells Expressing PD-L1/PD-L2 in B-1a Subset

T. Hirose,^1,2 Y. Tanaka,¹ H. Sakai,¹ Y. Sasaki,¹ H. Ohdan.¹
Identification of Strategies to Facilitate Organ Donation Among African Americans

J. Locke,¹ H. Qu,² R. Shewchuk,² D. Segev,³ M. Martin.⁴
Identification of miRNAs Associated With Induced Tolerance to Allografts

M. Vitalone, L. Wei, C. Esquivel, S. Busque, O. Martinez, S. Krams.
Identifying Barriers Specific to Xenoislets by Direct Comparison to Alloislets in a Dual Transplant Model

K. Samy,¹ B. Martin,² P. Thompson,² A. Farris,² M. Song,² V. Leopardi,¹ B. Collins,¹ A. Kirk.¹
Identifying Predictors for 30-Day Readmission in Renal Transplant Recipients

J. Weber,¹ B. Astor,² D. Cray,³ A. Djamali,² D. Kaufman,⁴ D. Mandelbrot,² S. Parajuli,² M. Schanning,³ E. Snyder,¹ M. Mohamed.²
IgM+ Antigen Binding B Cells in Peripheral Blood Regulate IFNγ Production in Response to HLA Proteins

L. McLaughlin,¹ K. Shiu,¹ G. Lombardi,¹ J. Spencer,² R. Vaughan,¹ A. Dorling.¹
Immune Phenotyping of Peripheral Blood Samples from the CTOT-10 Belatacept Study

Y. Suessmuth,¹ L. Stempora,¹ B. Johnson,¹ J. Cheeseman,¹ Y. Morrison,⁴ N. Bridges,⁴ D. Ikle,⁵ S. Tomlanovich,³ P. Stock,³ R. Mannon,² K. Newell,¹ C. Larsen,¹ A. Mehta.¹
Immune Rejection of iPS Cells Is Triggered By Gamete-Associated Proteins (GAPs)

E.-M. Kim, G. Manzar, N. Zavazava.
Immunologic Long-Term Outcome of Living Kidney Transplantation Depending On the Donor-Recipient Relationship

D. Khadzhynov, F. Halleck, D. Schmidt, S. Kreimer, K. Budde, O. Staeck.
Immunologic, Proangiogenic and Neurogenic Assessment of Allogenic Epineurium of the Human Peripheral Nerve for Potential Application in Prevention of Neuroma Formation

A. Klimczak,¹ K. Futoma,² A. Jundzill,³ D. Patrzalek,⁴ M. Siemionow.⁵
Immunological Evaluation of Acellular Extracellular Matrix Upon Transplantation

M. Ketaki,¹ P. Pradeep,¹ N. Nikhil,¹ G. Dellgren,³ H. Suchitra, M. Olausson.²
Immunomodulatory Strategies Directed Towards Tolerance of Vascularized Composite Allografts

M. Madariaga, K. Shanmugarajah, S. Michel, V. Villani, G. La Muraglia II, R. Torabi, D. Leonard, M. Randolph, R. Colvin, K. Yamada, J. Madsen, C. Cetrulo, Jr., D. Sachs.
Immunomonitoring By Virus-Specific T Cells After Pediatric Kidney Transplantation (IVIST01-Trial): Study Design and Status

T. Ahlenstiel-Grunow,^1,4 M. Sester,³ U. Sester,² L. Pape.^1,4
Immunosuppression and Reoperation After Simultaneous Kidney Pancreas Transplantation Convey Greatest Risk for Rejection

C. Bratton, V. Rohan, S. Nadig, J. Mcgillicuddy, K. Chavin, P. Baliga, D. Taber.
Impact of Alloreactivity On Intra-Graft T Cell Homeostasis Following Small Bowel Transplantation

J. Zuber, B. Shonts, S. Lau, S. Coley, S. Yang, J. Weiner, S. DeWolf, D. Farber, Y. Shen, M. Martinez, T. Kato, M. Sykes.
Impact of Baseline and Postoperative Isoagglutinin Titer on Clinical Outcomes in ABO-Incompatible Living Donor Kidney Transplantation

E. Shin,¹ H. Cho,¹ H. Kim,¹ C. Baeck,¹ H. Yu,¹ D. Han,² S.-K. Park.¹
Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo

N. Moore,¹ M. Moreno Gonzales,² M. Stegall.¹
Impact of Donor Age on Longterm Outcomes in Asian Kidney Transplant Recipients: A Multicenter Cohort Study

K. Yoo,¹ J. An,² J.-H. Cho,³ C.-D. Kim,³ S.-K. Park,⁴ D.-W. Chae,⁵ Y. Oh,² C. Lim,² Y. Kim,¹ Y. Kim,⁶ J. Lee.²
Impact of Donor Hemoglobin A1c On Pancreas Graft Survival

K. Collins,¹ J. Garonzik-Wang,¹ E. King,² M. Doyle,¹ J. Lowell,¹ S. Shenoy,¹ Y. Lin,¹ J. Wellen,¹ W. Chapman,¹ D. Segev.²
Impact of Donor Post-Extubation O2 Delivery on Recipient Hypoxic Cholangiopathy in Donation After Circulatory Death Liver Transplantation: The University of Colorado Experience

T. Chirichella,¹ C. Dunham,² M. Zimmerman,⁴ K. Conzen,¹ S. Kelley,³ E. Phelan,¹ T. Steinberg,¹ T. Nydam,¹ T. Bak,¹ I. Kam,¹ M. Wachs.¹
Impact of Educational Attainment On Kidney Transplant Outcomes By Race

A. Aguirre-Alarcon,¹ P. Friedmann,¹ A. Gregg,² L. Kayler.³
Impact of Everolimus On the Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation When Used in Early Stage: A Single Center Prospective Study

L. Jeng, A. Thorat, H. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu.
Impact of Machine Perfusion After Long Static Cold Storage On Delayed Graft Function Incidence and Duration and Time to Hospital Discharge

A. Matos,¹ M. Borrelli, Jr.,¹ L. Moura Requiao,¹ M. Nogueira, Jr.,¹ L. Pertusier,¹ G. Clarizia,¹ P. Ongaro,¹ S. Ximenes,¹ M. Durao, Jr.,^1,2 A. Pacheco-Silva.^1,2
Impact of Positive Crossmatch Due to Non-HLA Antibodies on Graft Outcomes in Renal Transplantation

S. Kuten, S. Patel, G. Land, T. Eagar, R. Knight, J. Loucks, L. Gaber, A. Gaber.
Impact of Serial Change of Donor Specific Antibodies On the Graft Outcomes After Liver Transplantation

D. Joo,^1,2 J. Lee,³ J. Lee,^1,2 J. Lee,^1,2 S. Kim,⁴ D. Han,^1,2 M. Ju,^1,2 J. Choi,^1,2 S. Kim,^1,2 M. Kim.^1,2
Impact of Subclinical Rejection (SCR) and Acute Clinical (ACR) in Renal Transplant Recipients

R. Mehta, P. Sood, A. Cherukuri, S. Chen, G. Mour, C. Wu, N. Shah, C. Puttarajappa, P. Randhawa, A. Tevar, S. Hariharan.
Impact of Type of Tacrolimus Assay on Therapeutic Drug Monitoring: Need for Standardization

M. Singh, S. Anwar, D. Brennan, R. Delos Santos.
Impacts of Mycophenolate Mofetile Addition to Very Low Exposure Everolimus and Calcineurine Inhibitor Based Immunosuppression in De Novo Kidney Transplantation

Y. Watarai,¹ M. Okada,¹ K. Futamura,¹ K. Ito,¹ T. Yamamoto,¹ M. Tsujita,¹ T. Hiramitsu,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
Implementation of Evidence-Based Guidelines for Cytomegalovirus Prevention in Pediatric Solid Organ Transplantation

L. Danziger-Isakov, T. Hemmelgarn, R. Kohli, D. Lazear, M. Lake, J. Goebel, C. Castleberry, J. Courter, S. Kacoshis, M. Schecter, D. Witte, E. Clark, J. Bucuvalas.
Implementation of Pre-Transplant Infectious Disease Risk Assessment: Sustained Success With Rapid-Cycle Improvement

L. Danziger-Isakov, S. Blum, D. Dahale, B. Morrow, R. Rengering, D. Schoborg, S. Stark, E. Wells, A. Lorts, U. Kotagal, J. Bucuvalas.
Implication of Intragraft γδ T Cell Profiles in Operational Tolerance After Clinical Transplantation of Highly Immunogenic Intestine -Difference from Immunoprivileged Liver

Y. Li,¹ X. Zhao,¹ H. Ohe,² H. Nafady-Hego,³ A. Bishop,⁴ J. Pirenne,⁵ T. Koshiba.⁶
Import Pancreas Transplants: Good from Far or Far from Good?

J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, A. Palanisamy, H. El-Hennawy, M. Khan, M. Gautreaux, S. Iskandar, R. Stratta.
Improved Bioavailability and Reduced Dose Requirements of Novel, Once-Daily, MeltDose® Tacrolimus Formulation Tablets (Envarsus® XR) Compared to Twice-Daily Tacrolimus Capsules (Prograf®) in De Novo Kidney Transplantation: Results of a Phase 3 Double-Dummy, Randomized Trial

J. Grinyó,¹ S. Bunnapradist,² S. Mulgaonkar,³ S. Steinberg.⁴
Improving Latent Tuberculosis Diagnosis Before Kidney Transplantation in a Developing Country

G. Meinerz,^1,2 C. da Silva,^1,2 E. Keitel,^1,2 A. Pasqualotto,³ J. Goldani,^1,2 C. Zeni,^1,4 F. Vacilotto,^1,4 N. Prado,^1,4 A. Monteiro,^2,3 D. Seelig,¹ F. Klaus,¹ J. Andrade,¹ V. Garcia.¹
Improving the Predictive Value of the Virtual Crossmatch: Is the C1Q Assay Needed?

A. Colovai,¹ C. Savchik,¹ P. Masiakos,¹ S. Calp-Inal,² L. Kayler,³ E. Akalin.²
In House Oxygen Persufflation of Cold Stored Livers Versus Simple Cold Storage in Extended Criteria Liver Grafts: Results of a Randomized Controlled Clinical Trial

A. Gallinat,¹ A. Paul,¹ D. Hoyer,¹ C. Klein,¹ S. Swoboda,¹ C. Ose,² Z. Mathe,¹ J. Treckmann,¹ T. Minor.³
In Pre-Implantation Biopsies Expression of Micro RNAs Is Not a Good Surrogate for Established mRNA Markers of Kidney Injury

K. Famulski,¹ S. Niederhaus,² J. Reeve,¹ J. Bromberg,² P. Halloran.¹
Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients

J. Bank,¹ M. Mallat,¹ P. van der Boog,¹ D. Braat,² J. Ringers,² M. Vergunst,³ S. Heidt,³ F. Claas,³ M. Reinders,¹ J. de Fijter.¹
Incidence and Characteristics of CMV Infection in High Risk (D+R-) Kidney Transplant Recipients and the Utility of Monthly Surveillance After Routine Prophylaxis

M. Bhattarai, C. Puttarajappa, G. Mour, C. Wu, P. Sood, N. Shah, R. Mehta, A. Tevar, S. Hariharan.
Incidence and Clinical Severity of Hypogammaglobulinemia (Hypo-IgG) in Highly-HLA Sensitized Patients (HS) Undergoing Desensitization (DES)

A. Vo,¹ S. Ge,² A. Petrosyan,² M. Toyoda,² J. Choi,¹ J. Kahwaji,¹ A. Peng,¹ R. Villicana,¹ S. Jordan.¹
Incidence and Risk Factors for Emergency Department Visits Following Kidney Transplantation

N. Elfadawy,^1,2 E. Poggio,¹ D. Goldfarb,¹ L. Buccini,¹ S. Flechner,¹ J. Schold.¹
Incidence and Risk Factors of Contrast-Induced Nephropathy in Renal Allograft Recipients

B. Abu Jawdeh, Y. Sharma, S. Katipally, A. Leonard, R. Alloway, E. Woodle, C. Thakar.
Incidence and Risks Associated With Clostridium Difficile Infection in the Pediatric Solid Organ Transplantation Population: A Single-Center Retrospective Review

L. Danziger-Isakov,¹ J. Ciricillo,² S. Blum,¹ M.-O. Kim,¹ C. Liu,¹ G. Paulsen,¹ J. Courter,¹ D. Haslam.¹
Incidence of Hepatitis B Virus Reactivation in Kidney Transplant Patients Who Received Rituximab Administration

K. Omoto, M. Okumi, D. Toki, T. Shimizu, H. Ishida, K. Tanabe.
Incidence, Determinants and Outcome of Kidney Transplantation for End Stage Renal Disease After Heart Transplantation

A. Grupper,¹ A. Grupper,¹ R. Daly,¹ M. Hathcock,² W. Kremers,² F. Cosio,¹ B. Edwards,¹ S. Kushwaha.¹
Incisional Herniation Following Hand Assisted Laparoscopic Donor Nephrectomy: Incidence, Impact and Aetiology

Z. Ahmed, I. Mosca, M. Dirix, R. Tamburrini, N. Kessaris, N. Mamode.
Increase in Neurologic Determination of Death (NDD) Organ Donation in the Donation After Circulatory Death (DCD) Era. The Ontario Experience

J. Zaltzman,^1,2 J. MacLean,² C. Payne,² E. Paltser,² V. Rao,³ S. Dhanani.^2,4
Increased Fibroblast Growth Factor 21 Levels in Biliary Atresia Patients

D. Li, T. Lu, Y. Shan, C. Shen, X. Hua, M. Zhang, Q. Xia.
Increased Frequency of Terminally Differentiated and Exhausted CD8+ T Cells Is Associated With Adverse Clinical Outcome After Mechanical Circulatory Support Device Implantation

J. Schaenman,¹ Y. Korin,² T. Sidwell,² G. Sunga,² G. Bondar,³ N. Wisniewski,³ M. Kwon,⁴ M. Cadeiras,³ M. Deng,³ E. Reed.²
Increased Late Graft Loss in Kidney Recipients With Serum Sickness Disease Following Anti-Thymocyte Globulin Induction: Relation With an Anti-Neu5Gc Response

A. Salama,^1,2 G. Couvrat-Desvergnes,¹ M. Lorent,^1,3 G. Evanno,¹ L. Le Berre,¹ P. Hruba,⁴ P. Vesely,⁵ P. Guerif,¹ A. Nicot,¹ J.-M. Bach,⁶ Y. Foucher,^1,3 S. Brouard,¹ S. Castagnet,⁷ O. Viklicky,⁴ M. Giral,¹ J. Harb,¹ S. Jean-Paul.¹
Increased Length of Stay After Heart Transplant: What Are the Risk Factors?

A. Velleca, M. Kittleson, N. Perry, J. Patel, F. Liou, S. Siddiqui, J. Rush, D. Ramzy, L. Czer, D. Chang, J. Kobashigawa.
Increased Risk of VRE Infection in Liver Transplant Patients With MELD of 35 or Greater

A. Nelson,¹ R. Girlanda.²
Increased Use of Donors After Cardiac Death (DCD) in Pancreas Transplantation: A Safe and Effective Way to Increase a Single Center Program Activity

M. Marquez, G. Sapisochin, J. Laurence, A. Barbas, M. Dib, A. Norgate, M. Selzner, P. Greig, I. McGilvray, M. Cattral.
Increased Vascular Stiffness in Pediatric Renal Transplant Recipients Despite Normal Kidney Function, Blood Pressure, and Body Mass Index

M. Seifert,^1,2 N. Kulsum-Mecci,² L. de las Fuentes,² V. Davila-Roman,² K. Hruska.²
Increasing Tacrolimus Exposure to Minumize Chronic Rejection: How Can We Do It? What Are the Risks?

T. Hsu,¹ J. Yin,¹ L. Awdishu,¹ J. Kerr,¹ R. Steiner.²
Indefinite Survival of Fully MHC-Mismatched Murine Cardiac Allografts by Combination of Anti-BTLA mAb (6B2) and Anti-PD-1 mAb (PIM-2)

E. Yin,^1,2 M. Uchiyama,^1,3,4 X. Jin,^1,5 T. Shimokawa,³ H. Yagita,⁴ M. Niimi.¹
Induction Avoidance in 2-Haplotype-Matched White Living Kidney Transplantation

Z. Brifkani,¹ T. Alhamad,¹ T. Horwedel,² R. Delos Santos,¹ T. Maw,¹ D. Brennan.¹
Induction Therapy With either Anti-Thymocyte Antibodies or Il2 Receptor Inhibitors Appears to Decrease the Risk of Graft Loss in DCD Liver Transplantation Compared to No Induction Therapy

S. Rayhill, J. Haldorson, A. Dick, S. Nazarian, L. Sibulesky, M. Montenovo, L. Yu, I. Javid, T. Pearson, R. Bakthavatsalam, P. Healey, J. Perkins, J. Reyes.
Induction of iNOS Expressed Macrophages from Mouse iPS cells That Contribute to Prolong Same iPS Cells-Derived Graft Survival in Allogeneic Recipients

H. Sasaki,¹ H. Wada,² K. Morita,¹ K.-I. Seino,² N. Shinohara.¹
Industry Payments to Transplant Surgeons

R. Ahmed, E. Chow, A. Massie, E. King, B. Orandi, S. Bae, L. Nicholas, B. Lonze, D. Segev.
Infectious Complications With Plasmapheresis in Combination With Antithymocyte Globulin Compared to Antithymocyte Globulin Alone in the Treatment of Acute Rejection

A. Leino, A. Hulbert, A. Delahunty, A. Rajab, J. Von Visger, H. Winters.
Infectious Complications in ABO Incompatible Kidney Transplantation Recipient According to the Rituximab Dose

J. Lee,¹ J. Lee,¹ S. Kim,² M. Ju,¹ D. Joo,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ H. Kim,² K. Huh.¹
Inflammasome Activation in Hepatocytes and Kupffer Cells Orchestrates the Hepatotoxic Effect of Bile Acids and Can Be Potential Target in the Management of Cholestatic Liver Injury

X. Liu,¹ T. Ma,¹ T. Billiar,² R. Tao.¹
Inflammation in Regions of Tubular Atrophy (IATR) Predicts Adverse Graft Outcome in Patients With Late Graft Dysfunction: A Multicenter Study

J. Grande,¹ R. Leduc,³ A. Matas.²
Inflammatory Profiling of Hypothermic Machine Pumped Kidney Allografts

J. Cohen, E. Ratigan, A. Shigeoka, R. Steiner, L. Stocks, D. McKay.
Influence of CYP3A5 and ABCB1 Genotypes on Pharmacokinetics of Immediate and Prolonged Release Tacrolimus Preparations

T. Elnahhas,^1,2 T. Lee,² M. Moreton,² D. McKeown,² J. Popoola,³ R. Ramkhelawon,³ A. Johnston,^1,2 I. MacPhee.³
Influence of Cold Ischemia Time in Combination With Donor Ischemic Events on Kidney Transplant Outcomes

M. Lubetzky, Y. Xia, P. Friedmann, C. Cortes, L. Kayler.
Influence of POR*28 Genotype on Tacrolimus Disposition in Heart Transplant Recipients

T. Alford,¹ R. Page,¹ J. Lindenfeld,² C. Aquilante.¹
Infusion of Human Factor 7a Restores Circulating Platelets and Prevents TMA in Pig-to-Baboon Liver Xenotransplantation

J. Shah, N. Navarro-Alvarez, H. Yeh, N. Elias, J. Ligocka, J. Markmann, M. Hertl, D. Sachs, P. Vagefi.
Inhibition of T Cell Metabolism Reveals a New Approach to Preventing Graft Rejection

C.-F. Lee,^1,2 Y.-C. Lo,² G. Furtmüller,³ B. Oh,³ V. Andrade-Oliveira,² A. Thomas,⁴ G. Brandacher,³ J. Powell.²
Inhibition of mTOR Modulates SLPI Expression: A Potential Role in Kidney Transplant Patients

N. Ambrosi,¹ A. Dotta,² C. Pizarro,² D. Guerrieri,¹ A. Gonzalez,² C. Leiva,² L. Leon,² J. Mendiberri,³ M. Rial,² C. Incardona,⁴ E. Chuluyan,¹ D. Casadei.²
Inside Out Autologous Neo-Liver Fabrication

P. Than, C. Davis, M. Findlay, W. Liu, T. Le, S. Khong, M. Melcher, G. Gurtner.
Integrated Clinical-Histological (ICH) Score System for the Evaluation of “Marginal” Donors in Kidney Transplantation

M. Fiorentino,¹ M. Rossini,¹ P. Gallo,¹ G. Castellano,¹ A. Schena,¹ G. Grandaliano,² P. Ditonno,³ M. Bataglia,³ L. Gesualdo.¹
Interactions Between Platelets and Liver Sinusoidal Endothelial Cells Initiate Liver Regeneration

J. Meyer,^1,2 E. Lejmi,² P. Fontana,^2,3 P. Morel,^1,2 C. Gonelle-Gispert,² L. Bühler.^1,2
Interference of Therapeutic Antibodies Used in Desensitization Protocols On Lymphocytotoxicity Crossmatch Results

D. Milongo,^1,3 G. Vieu,^2,4,3 S. Blavy,^2,4 A. Del Bello,^1,3 F. Sallusto,⁵ L. Rostaing,^1,3 N. Kamar,^1,3 N. Congy-Jolivet.^2,4,3
Interleukin-17 Deficiency Attenuates Renal Allograft Injury and Prolongs Survival in a Murine Transplantation Model

T. Kwan,^1,2 S. Chadban,^1,2 J. Ma,^1,2 S. Bao,^2,3 S. Alexander,^2,4 H. Wu.^1,2
Interleukin-17A Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function

K. Sivanathan,^1,2,3 D. Rojas-Canales,^1,2 S. Grey,⁵ C. Hope,^1,2 R. Carroll,^1,4 S. Gronthos,^3,6 P. Coates.^1,2,3,4
Intermittent High Dose Intravenous Immunoglobulin as Treatment for Donor Specific Antibodies in Renal Transplant Recipients

P. Bolin,¹ K. Parker,² F. Rana,¹ W. Bryant,¹ P. Jawa,¹ R. Harland.³
Interrogation of Plasma Cell-Rich Acute Rejection in Human Kidney Allografts by Whole Transcriptome Sequencing

L. Mesnard, F. Campagne, H. Yang, D. Dadhania, J. Lee, S. Seshan, M. Suthanthiran, T. Muthukumar.
Interstitial Fibrosis Is the Critical Determinant of Impaired Renal Function in Transplant Glomerulopathy

D. Toki,¹ H. Ishida,¹ M. Okumi,¹ T. Shimizu,¹ H. Shirakawa,¹ M. Inui,¹ K. Omoto,¹ K. Unagami,¹ T. Kanzawa,¹ K. Honda,² J. Koike,³ K. Tanabe.¹
Intra-Lymphocyte Concentrations of Mycophenolic Acid Correlate With the Incidence of Early Graft Rejection in Renal Transplant Recipients

Z. Md Dom,² J. Coller,² R. Carroll,³ A. Somogyi,² B. Sallustio.¹
Intraoperative Renal Replacement Therapy During Liver and Liver-Kidney Transplant: Outcomes of 155 Cases

M. Mai,¹ E. Golan,² K. Croome,¹ A. Keaveny,¹ B. Taner,¹ T. Gonwa,¹ H. Wadei.¹
Intrapatient Variability of Tacrolimus Blood Concentrations Following Renal Transplant – Acute Rejection or No Connection?

D. Katarey,^1,2 E. Ioannou,² I. MacPhee.^1,2
Investigating Role of Early VTE Chemoprophylaxis in Kidney Transplant

D. Kendrick,¹ E. Kudlaty,¹ A. Kim,¹ P. Moorehead,¹ J. Augustine,² E. Sanchez,² V. Kashyap,¹ K. Woodside.²
Is Ex Vivo Liver Perfusion a Safe Alternative to Cold Static Storage for the Preservation of Standard Criteria Grafts?

N. Goldaracena, V. Spetzler, M. Kaths, J. Echeverri, M. Selzner.
Is There a Difference in Patient and Graft Survival in Children Weighing <20 kg Versus Those Weighing >20 kg at the Time of Renal Transplantation?

P. Chandak,¹ J. Stojanovic,² R. Sivaprakasam,³ N. Mamode,¹ F. Calder,¹ J. Olsburgh,¹ M. Drage,¹ C. Callaghan,¹ J. Taylor,¹ G. Koffman,¹ J. Taylor,² S. Marks,⁴ N. Kessaris.¹
Is There a Protective Value for Low Level Donor Specific Antibodies to Prevent Cardiac Allograft Vasculopathy After Heart Transplant?

M. Kittleson, J. Patel, F. Liou, S. Siddiqui, J. Yabuno, D. Chang, D. Ramzy, L. Czer, F. Esmailian, N. Reinsmoen, J. Kobashigawa.
Is the Pulsatile Kidney Preservation Machine a Vaulable Tool in Evaluating Kidney Suitability from Older Donors After Brain Death?

D. Paredes Zapata,¹ A. Ruiz Arranz,¹ C. Rodriguez Villar,¹ L. Peri Cussi,² A. Alcaraz Asensio,² R. Adalia Bartolome,¹ F. Oppenheimer Salinas.³
Ischemia Reperfusion Injury in Orthotopic Liver Transplantation Primes the Adaptive Immune Response and Generation of Proinflammatory Cytokines

A. Zarrinpar,¹ P. Rao,² C. Lassman,² V. Agopian,¹ F. Kaldas,¹ D. Farmer,¹ R. Busuttil,¹ Y. Zhai,¹ J. Kupiec-Weglinski,¹ E. Reed.²
Ischemia-Induced Endoplasmic Reticulum Stress Regulates Autophagy to Determine the Severity of Liver Ischemia Reperfusion Injury

H. Zhou,^1,2 J. Zhu,¹ S. Yue,¹ R. Busuttil,¹ J. Kupiec-Weglinski,¹ Y. Zhai.¹
Kidney Donor Profile Index Variability in Donors With Dialysis Dependent Acute Kidney Injury and the Impact On Organ Allocation

A. Pai,¹ M. Ghanta,¹ S. Rao,¹ A. Gillespie,¹ S. Karhadkar,² K. Lau,² A. Di Carlo,² S. Constantinescu,¹ I. Lee.¹
Kidney Paired Donation: National Activity and Perspectives

T. Dunn,¹ S. Fayek,² C. Marsh,³ P. Abt.⁴
Kidney Retransplantation in the Ipsilateral Iliac Fossa; a Surgical Challenge

L. Ooms,¹ J. Roodnat,² F. Dor,¹ K. Tran,¹ D. Kimenai,¹ J. IJzermans,¹ T. Terkivatan.¹
Kidney Transplant Function After Late Conversion to Belatacept (Nulojix®)

S. Brakemeier,¹ M. Dürr,¹ M. Wiesener,² B. Tobias,² K. Budde,¹ B. Klemens.¹
Kidney Transplant Outcomes in Marijuana Users

P. Shrivastava,¹ A. Naik,¹ A. Sakhuja,¹ Y. Lu,¹ Y. Huang,¹ F. Barrantes,² F. Luan,³ S. Kulshrestha,⁴ M. Samaniego.¹
Kidney Transplant Outcomes in Patients With Amyloidosis

J. Verbesey, M. Cooper, P. Weems, A. Gilbert, M. Grafals, C. Nilubol, J. Moore, S. Ghasemian, B. Javaid.
Kidney Transplant Outcomes in Recipients Older Than 70: A Single Center Experience

M. Yaqub, A. Sharfuddin, M. Mujtaba, D. Mishler, T. Taber, W. Goggins, N. Kassis Akl.
Kidney Transplant Telehealh Clinic Improves Access to Long-Term Follow-Up and Decreases Costs: The Experience of the Iowa City VA Transplant Program

R. Kalil,^1,2 C. Thomas,^1,2 D. Katz.^1,2
Kidney Transplantation After Hematopoietic Cell Transplantation in Plasma Cell Dyscrasias

V. Domínguez-Pimentel,¹ F. Fortich-Barrios,¹ O. Siverio-Morales,¹ E. Martín-Izquierdo,¹ A. Jarque-López,¹ N. Del Castillo-Rodríguez,¹ J. García,¹ P. Ríos,² M. Macía.¹
Kidney Transplantation from Expanded Criteria Deceased Donors With Terminal Acute Kidney Injury

J. Hwang,¹ M.-H. Kim,¹ K. Jun,¹ S. Ahn,¹ S. Kim,¹ S. Park,¹ S. Kim,² J. Kim,¹ C. Yang,² I. Moon.¹
Kidney Transplantation in the Septuagenarian

H. Saucedo Crespo, B. Taner, M. Mai, H. Wadei, P. Perry, M. Prendergast, J. Nguyen, K. Oshel, J. Bruns, D. Lee, T. Gonwa.
Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism in Nonhuman Primates

T. Oura, D. Ko, J. O'Neil, S. Boskovic, O. Nadazdin, K. Hotta, K. Kawai, B. Cosimi, T. Kawai.
Kidney Vs. Heart Calculated PRA (CPRA) for Sensitized Heart Candidates: Does Donor Ethnic Distribution Make a Difference?

A. Kucheryavaya, L. Robbins Callahan, L. Edwards.
Kidneys from Living Donors With High Body Mass Index Do Not Have Inferior Outcomes

K. Koutroutsos, S. Chong, D.-A. Moutzouris, R. Charif, J. Galliford, J. McDermott, D. Taube, M. Loucaidou.
Landscape of Non-Directed Live Donors

K. Kumar, X. Luo, A. Massie, T. Purnell, J. Tonascia, E. King, D. Segev.
Laparoscopic Donor Nephrectomy of Multiple Renal Artery Kidneys: Single Center Experience

A. AlShahrani, M. AlBuagmi, I. AlOraifi, M. Tawfeeq.
Late Recurrent UTIs in Kidney Transplant Patients: Risk Factors , Microbiologic and Antibiotic Resistance Patterns

A. Regmi, D. Kumar, A. King, G. Gupta.
Late Rejection in Pediatric Heart Transplantation: The Importance of Medical Adherence

A. Letica, W. Zuckerman, L. Addonizio, J. McAllister, T. Lee, M. Richmond.
Learning from Failures: A 7-Year Analysis of a Multi-Institutional Kidney Paired Donation Registry

D. Fumo,^1,2 V. Kapoor,¹ L. Reece,² S. Rees,² J. Kopke,² S. Stepkowski,¹ C. Smith,^1,2 M. Rees.^1,2
Legal Issues in Domino Liver Transplantation in Germany

H. Schmidt,¹ A. Barreiros,² H. Schlitt,² T. Gutmann.³
Lessons Learned from the Clinical Use of Normothermic Regional Perfusion (nRP) in Uncontrolled Donation After Circulatory Death (DCD)

C. Antoine,¹ E. Savoye,¹ F. Gaudez,² G. Cheisson,³ M. Videcoq,⁴ B. Barrou,⁵ National Steering Committee of Donation After Circulatory Death.¹
Lifor Organ Preservation Solution Protects Pulmonary Microvasculature in a Rat Model of Ex Vivo Lung Perfusion and Transplantation

T. Okamoto,^1,3 A. Yasuda,^1,2 D. Mathisen,^1,3 H. Ott.^1,3
Ligation of the Native Ureter for Treatment of Urinary Fistula in Kidney Transplantation: Is It Safe?

C. Batagello, K. Yamaçake, R. Falci, H. Kanashiro, R. Kato, G. Ebaid, A. Piovesan, W. Nahas.
Lipid Profiles Over 2 Years Follow-Up in De Novo Kidney Transplant Recipients Randomized to Once-Daily MeltDose® Tacrolimus (Envarsus® XR) Vs. Twice-Daily Tacrolimus (Prograf®): Results from a Phase 3, Double-Blind, Double-Dummy, Multicenter Trial

S. Mulgaonkar, O. Pankewycz, S. Steinberg.
Listing for Liver Transplantation of Patients With Hepatocellular Carcinoma Using the Extended Toronto Criteria; an Intention-to-Treat Analysis

G. Sapisochin, N. Goldaracena, J. Laurence, A. Barbas, M. Dib, A. Ghanekar, M. Selzner, L. Lilly, I. McGilvray, M. Cattral, E. Renner, P. Greig, D. Grant.
Live Donor Kidney Transplantation: Recipient Outcomes When the Donor Developed ESRD

A. Muzaale, A. Massie, D. Segev.
Live Donor Vs Deceased Donor Liver Transplantation Results in Identical Outcome in Recipients With Acute Liver Failure – An Important Choice for Critical Ill Patients

N. Goldaracena, G. Sapisochin, J. Echeverri, M. Kaths, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.
Live Kidney Donor Evaluation: Association of Race With Ineligibility

K. Kumar, A. Poon, A. Massie, A. Muzaale, T. Purnell, J. Tonascia, E. King, D. Segev.
Liver Allografts from Living Donors Demonstrate High Expression of Hepatic Functional Genes Compared With Deceased Donors

R. Gehrau,¹ J. Suh,¹ K. Brayman,¹ S. Rasmussen,¹ C. Dumur,² V. Mas,¹ D. Maluf.¹
Liver Fabrication Using Whole Organ Scaffold for Transplantable Graft in Large Animal

K. Inomata,¹ H. Yagi,¹ K. Tazima,¹ K. Sugiyama,¹ M. Hieda,¹ T. Hibi,¹ Y. Abe,¹ M. Kitago,¹ M. Shinoda,¹ O. Itano,¹ T. Akaike,² Y. Kitagawa.¹
Liver Flushing Using Colloid and Crystalloid Solutions

J. Burg, D. Scott, K. Enestvedt, K. Roayaie, D. Scott.
Liver Transplantation for Hepatocellular Carcinoma inside Milan Criteria: Lower Recurrence in Patients With Hepatitis C Infection

W. Palmer, D. Lee, J. Burns, A. Keaveny, J. Melendez, J. Nguyen, T. Patel, S. Pungpapong, B. Rosser, R. Paz-Fumagalli, R. Nakhleh, K. Musto, D. Harnois.
Liver Transplantation for Primary Liver Malignancies Vs. Neuroendocrine Metastases: Analysis of the UNOS Dataset

V. Vilchez,¹ M. Shah,¹ M. Daily,¹ S. Krohmer,² D. Davenport,¹ E. Maynard,¹ R. Gedaly.¹
Liver Transplantation in Children Using Organ Donation After Circulatory Death– An Analysis of the National Registry

G. El-Gazzaz, K. Hashimoto, M. Fujiki, T. Daigo, C. Quintino, F. Aucejo, D. Kelly, C. Winans, C. Miller, J. Fung, B. Eghtesad.
Liver Versus Kidney. A Functional Study on Pancreatic Islet Implantation Sites

T. Corsello,¹ G. Curcuru,² D. Zorzi,³ M. Montalbano,¹ B. Carr,¹ L. Cicalese,¹ C. Rastellini.¹
Liver-Specific Transcription Factor ATF5 Participates in Regulation of IFN-γ/B7-H1 Signaling Pathway in Liver Mesenchymal Cells

G.-Q. Shen, L. Wang, J. Fung, L. Lu, S. Qian.
Living Donor Gifted Lithiasis: Outcomes in Kidney Transplant Recipients

M. Mujtaba, C. Sundaram, M. Yaqub, T. Taber, J. Powelson, S. Doshi, A. Sharfuddin.
Living Donor Transplant Rates in Children Are Declining

D. Keith, A. Nishio Lucar, G. Vranic.
Living Kidney Donation in the Elderly: The United Kingdom Experience

Z. Ahmed,¹ R. Tamburrini,¹ L. Pankhurst,² N. Kessaris,¹ N. Mamode.¹
Living and Dead Mesenchymal Stem Cells Induce an Immunosuppressive Response in an Experimental Sepsis Model

F. Luk,¹ M. Roemeling-van Rhijn,¹ S. de Witte,¹ S. Korevaar,¹ R. de Bruin,² M. Betjes,¹ C. Baan,¹ M. Hoogduijn.¹
Local Expansion in DCD Kidney Transplant Activity Improves Waiting List Outcomes and Addresses Inequities of Access to Transplantation

B. Mirshekar-Syahkal,¹ L. Bradbury,² P. Sun,¹ M. Aly,¹ M. Berry,¹ J. Norris,¹ J. Bradley,¹ G. Pettigrew.¹
Long Term Patency of Reconstructed Middle Hepatic Vein Extension Conduit Using Autologous Portal Vein Segment Derived from Explanted Liver

S. Kapoor,¹ S. Kalgaonkar,² B. Nath,¹ V. Varma,¹ S. Maheshwari,² A. Raut,² V. Kumaran.¹
Long Term Survival After Single Versus Double Lung Transplantation in Patients With Pulmonary Fibrosis in the Modern Era of the Lung Allocation Score

V. Ambur, S. Jayarajan, S. Taghavi, S. Kadakia, C. Lewis, Y. Furuya, A. Shiose, L. Kaiser, G. Wheatley, T. Guy, Y. Toyoda.
Long-Term Follow-Up After Conversion from Twice-Daily Tacrolimus Formulation to Once-Daily Tacrolimus Formulation in Pediatric Kidney Transplantation

C. Choi, A. Han, S. Min, S.-K. Min, T. Lee, I.-M. Jung, S. Kim, J. Ha.
Long-Term Impact of Live Liver Donation: A Self Report of the Donation Experience

D. LaPointe Rudow,¹ S. DeLair,² S. Florman,¹ J. Guarrera,³ M. Kinkhabwala,⁴ M. Orloff,⁵ Y. Wu,⁶ L. Teperman.⁷
Long-Term Outcome After Liver Transplantation for Unresectable Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment

S. Radunz,¹ T. Benkoe,¹ J. Best,² A. Bockisch,³ T. Lauenstein,⁴ H. Baba,⁵ A. Paul,¹ J. Treckmann.¹
Long-Term Outcomes and Recurrence Risk of Four Common Primary Glomerular Diseases Following Transplantation

L. Maursetter, S. Panzer, S. Waheed, M. Mohamed, S. Parajuli, G. Leverson, B. Astor, D. Mandelbrot, A. Djamali.
Long-Term Outcomes of Spousal Donor Kidney Transplantation According to the Spousal Relationship

J. Kim,¹ K. Jun,¹ M.-H. Kim,¹ S. Ahn,¹ J. Hwang,¹ S. Kim,¹ S. Park,¹ B. Choi,² S. Kim,² C. Yang,² Y. Kim,² I. Moon.¹
Long-Term Outcomes of Transplantation Using Kidneys from Expanded Criteria Donors

O. Aubert,¹ Kamar,² Vernerey,¹ Viglietti,¹ Duong van Huyen,¹ Rabant,¹ Rostaing,² Congy,² Guilbeau-Frugier,² Martinez,¹ Delahousse,¹ Glotz,¹ Jouven,¹ Legendre,¹ Lefaucheur,¹ Loupy.¹
Long-Term Results After Heart Transplantation – A Randomized Trial Comparing Tacrolimus Versus Cyclosporine A in Combination With Mycophenolate Mofetil After a Mean Duration of 15 Years

S. Guethoff,¹ C. Grinninger,¹ B. Reichart,² P. Ueberfuhr,¹ C. Hagl,¹ B. Meiser.²
Long-Term Survival Outcomes of Liver Transplantation for Klatskin Tumour: A Comparative Study With Radical Resection Surgery

A. Hu, X. Zhu, X. He.
Longitudinal Multi-Omic Profiling of Genes and Pathways Underlying Cardiac Allograft Rejection

B. Piening,¹ Y. Li,² A. Shaked,² B. Keating,² M. Snyder.¹
Longitudinal Trends in Wait Times and Use of Bridging Locoregional Therapies in Hepatocellular Carcinoma Patients undergoing Orthotopic Liver Transplantation: UNOS Population Study

M. Xing, H. Kim.
Longterm Outcome in Pancreas Grafts After Polyomavirus Infection in Combined Kidney-Pancreas Transplants: A Single Center Report

C. Boesmueller,¹ C. Margreiter,¹ M. Rudnicki,² R. Oellinger,³ S. Schneeberger,¹ M. Maglione.¹
Low Dose Valganciclovir Prophylaxis Following Renal Transplantation With Steroid Free Immunosuppression

J. Chen,¹ A. Shah,² M. Sauer,¹ T. Taber,³ A. Sharfuddin,³ M. Yaqub,³ D. Mishler,³ J. Powelson,⁴ W. Goggins.⁴
Low Molecular Weight Hyaluronan Increases MIG and MCP-1 Production in Cardiac Allografts

S. Goparaju,¹ A. Kaul,¹ N. Dvorina,¹ S. Iida,¹ K. Keslar,¹ R. Fan,¹ C. de la Motte,² A. Valujskikh,¹ R. Fairchild,¹ W. Baldwin III.¹
Low Vitamin D Exposure Is Associated With Higher Risk of Infection in Renal Transplant Recipients

L. Sacha,¹ H. Kalluri,² A. Ingemi,³ H. Johnson,⁴ D. Landsittel,⁵ M. Shullo,⁴ R. Venkataramanan.^2,6
Lower Frequency of Regulatory T-Cells After Conversion from CNIs or mTORi to Belatacept in a Prospective Matched Controlled Study in Renal Allograft Recipients

M. Dürr, J. Liu, K. Budde.
Lung Biopsy Findings in Pediatric Lung Transplant Patients With Restrictive Physiology

J. Blatter,¹ F. White,² A. Faro,¹ P. Michelson,¹ U. Boston,³ P. Eghtesady,³ S. Sweet.¹
Lung Transplant Patients With Elevated Baseline Pulmonary Arterial Pressures Are More Likely to Recover from Post-Transplant Acute Kidney Injury

B. Stephany,¹ E. Wehbe,² M. Budev.³
Lung Transplantation (LTx) in Patients on Extracorporeal Support – Is It a Bridge Too Far? A Single Centre Cohort Analysis

B. Zych, D. Garcia-Saez, P. Mohite, A. Reed, F. De Robertis, A. Popov, M. Amrani, T. Bahrami, N. Patil, M. Carby, A. Simon.
Lung Transplantation from Donors With Kidney Disease

A. Ganapathi, B. Gulack, A. Castleberry, R. Davis, L. Snyder, M. Hartwig.
Lymphatic Endothelium Uniquely Enhances T Cell Migration to S1P

C. Brinkman, Y. Xiong, J. Bromberg.
MDRD4 Equation Is Better Than CKD-EPI, Cockroft-Gault and Nankivell Equations to Estimate Glomerular Filtration Rate in Renal Transplantation

E. David-Neto,¹ A. Triboni,¹ F. Ramos,¹ F. Agena,¹ F. Lemos,¹ M. Sapienza,² W. Nahas.¹
MELD as a Predictor of Post-Transplant Survival

X. Luo, A. Massie, A. Poon, D. Segev.
MHC-Class-II Specific Sensitization in a Non-Human Primate Model of Sensitzation

C. Burghuber,^1,2 J. Kwun,¹ A. Gibby,¹ N. Iwakoshi,¹ S. Knechtle.¹
MYH9 Polymorphic Variants and Chronic Lesions in Transplanted Kidney Biopsy

J. Pazik,¹ M. Oldak,² Z. Lewandowski,³ D. Ozieblo,⁴ K. Michalska,⁵ A. Perkowska Ptasińska,¹ A. Sadowska,¹ M. Nowaczyk,⁵ J. Malejczyk,⁴ M. Durlik.¹
Macrophage Specific β-Catenin Controls ROCK/PTEN Function and Regulates Innate Immunity in Liver Inflammation

S. Yue,¹ X. Zhou,² M. Zhou,¹ Y. Zhai,¹ R. Busuttil,¹ Q. Ying,² J. Kupiec-Weglinski,¹ B. Ke.¹
Macrophage-Specific SIRT1 Regulates HO-1 Mediated Anti-Inflammatory and Cytoprotective Pathways

K. Nakamura,¹ M. Zhang,² B. Ke,¹ R. Busuttil,¹ J. Araujo,² J. Kupiec-Weglinski.¹
Management of Pancreas Graft Splenic Vein Thrombosis: Is Conservative Management Safe?

J. Harbell,¹ T. Morgan,² V. Feldstein,² G. Roll,¹ A. Posselt,¹ S.-M. Kang,¹ S. Feng,¹ R. Hirose,¹ C. Freise,¹ P. Stock.¹
Marrow Mesenchymal Stem Cells Attenuate Immune Rejection in Murine Lung Allograft

X. Zhang,¹ Y. Gong,² K. Jiang,² C. Wang,² T. Xia,² J. Li,² J. Wang,² J. Nie.²
Matching of Recipient and Donor Age Is the Most Powerful Risk Factor Affecting to Long-Term Graft Survival and Function

J. Lee,^1,2 Y. Lee,² J. Lee,^1,2 D. Joo,^1,2 K. Huh,^1,2 S. Kim,^1,2 Y. Kim,^1,2 M. Kim.^1,2
Measuring Affinity of Polyclonal HLA-Specific Antibodies in Highly Sensitised Cases Can Serve as an Additional Biomarker to Guide Direct Transplantation

S. Daga,^1,2 D. Lowe,⁶ R. Buchli,³ J. Collard,³ A. Mulder,⁸ C. McMurtrey,^3,4 H. Moyse,⁷ N. Evans,⁷ N. Krishnan,² W. Hildebrand,^3,4 F. Claas,⁸ D. Briggs,⁵ D. Zehnder,^1,2 D. Mithcell,¹ R. Higgins.^1,2
Mechanisms Underlying Treg Dysfunction in DAIH- Role for PD-L1?

A. Arterbery,¹ M. Martinez,² S. Lobritto,² Y. Avitzur,³ K. Raddassi,¹ M. Kleinewietfeld,⁴ U. Ekong.¹
Medication Adherence and Treatment Satisfaction in Liver Transplant Recipients

A. Albekairy,¹ A. Alkatheri,² N. Khalidi,² K. Thiab,¹ A. Jarab,² A. Qandil,³ A. Alshaya,² K. BinSaleh.²
Medication Adherence in Adolescents With Kidney Transplant and Chronic Kidney Disease: Patient/Caregiver Report Vs. Provider Perception

C. Pruette,¹ T. Brady,¹ S. Mendley,² B. Fivush,¹ S. Tuchman,³ A. Green,¹ M. Eakin,¹ K. Riekert.¹
Medication Non-Adherence in Those Waiting for a Transplant

M. Wakefield,¹ D. Murillo,² C. Russell,³ C. Ashbaugh,¹ S. Potts,² L. Blakley,² A. Deere.¹
Mesenchymal Stem Cell Therapy to Improve Functional Outcome in Vascular Composite Allotransplantation (VCA)

S. Salgar, J. Bingham, M. DeHart, J. Tercero, T. Brown.
Mesenchymal Stem Cells (MSCs) Transfusion for Desensitization of Positive Lymphocyte Cross Match (LCM) or Panel Reactive Antibodies (PRA) Before Kidney Transplantation – Outcome of 16 Cases

G. Saadi,¹ K. Eweda,² M. Hassaballa,¹ F. Fadel,³ E. Aziz,² M. Roshdi,¹ M. El Ansary,⁴ I. Aziz,⁴ W. Ismail,⁵ A. Atef,¹ S. Hamid.⁴
Mesenchymal Stem Cells Prevent Cold Ischemia-Reperfusion Injury in Lung Transplants

H. Wang,^1,2 W. Tian,¹ Y. Liu,³ X. Dai,¹ G. Li,³ T. Liu,^1,2 Z. Zhang,^1,2 C. Du.⁴
Mesenchymal Stem Cells Suppress Cytotoxicity of Activated Natural Killer Cells in Liver Via the TRAIL-TRAIL Receptor Pathway in Islet Transplantation

N. Ishida, K. Ishiyama, F. Hirata, Y. Saeki, Y. Tanaka, H. Ohdan.
Mesenchymal Stromal Cells (MSCs) Given Post-Transplant Together With C3a and C5a Receptor Antagonists Prevent Engraftment Syndrome and Induce a Mild Not-Significant Prolongation of Graft Survival

F. Casiraghi,¹ M. Todeschini,¹ N. Azzollini,¹ P. Cravedi,² P. Heeger,² P. Cassis,¹ S. Solini,¹ N. Perico,¹ M. Noris,¹ G. Remuzzi.¹
Metabolomic Analysis of Remote Ischemic Preconditioning in Renal Ischemia Reperfusion Injury

A. Han,¹ S.-I. Min,¹ K. Cho,² C. Choi,¹ S.-K. Min,¹ S. Kim,³ M. Park,⁴ J.-Y. Cho,² J. Ha.¹
MiR-26a Regulates Mouse Hepatocyte Proliferation By Directly Targeting Their 3′ Untranslated Region of CCNE2/CCND2

J. Zhou, X. Yuan, W. Ju, X. Jiao, X. Wang, M. Han, D. Wang, X. Zhu, X. He.
MicroRNA-21 (miR-21) Expression in Hypothermic Machine Perfusate May Predict Early Outcomes in Kidney Transplantation

U. Khalid,^1,2 E. Ablorsu,² L. Szabo,² R. Jenkins,¹ T. Bowen,¹ D. Fraser,¹ R. Chavez.^1,2
Microchimerism-Tolerance “Missing Link”: Exosome Acquisition by Host Dendritic Cells

W. Bracamonte-Baran, E. Jankowska-Gan, Y. Zhou, W. Burlingham.
Microvascular (MIA) and Interstitial (i) Inflammation Influence Late Death-Censored Graft Failure (DCGF) After Kidney Transplantation

R. Gaston,¹ A. Fieberg,² R. Leduc,² J. Connett,² F. Cosio,³ S. Gourishankar,⁴ J. Grande,³ L. Hunsicker,⁵ B. Kasiske,⁶ J. Cecka,⁷ A. Matas,² D. Rush.⁸
Mitochondrial Feedback Mechanisms in Kidney Cell Senescence

K. De Vusser,¹ K. Hochstenbach,² E. Winckelmans,² E. Lerut,³ D. Kuypers,¹ T. Nawrot,² M. Naesens.¹
Mitochondrial Hydrogen Sulphide Donor Molecules Are More Effective Against Hypoxic Injury in Renal Tubular Epithelial Cells

G. Aboalsamh,^1,5 M. Saha,² I. Lobb,² J. Grewal,² P. Luke,^1,2,3 M. Wood,⁴ M. Whiteman,⁴ A. Sener.^1,2,3
Modeling the Clinical and Cost-Effectiveness of Dobutamine Stress Echocardiography With Confirmatory Coronary Angiography for the Diagnosis of Pediatric Cardiac Allograft Vasculopathy

D. Nandi, M. O'Connor, K. Lin, S. Paridon, C. Ravishankar, C. Mascio, R. Shaddy, J. Rossano.
Moderate KDPI (35-85) and High KDPI (>85) Grafts Yield Similar Graft Function and Survival

A. Gupta,² G. Francos,² C. Gorn,³ A. Shah.¹
Moderate Rejection Episode of Face Transplant After mTOR Conversion to Preserve Renal Function

R. Barth,¹ B. Bojovic,¹ J. Woodall,¹ M. Uluer,¹ C. Drachenberg,¹ C. Shaffer,¹ N. Kelly,¹ E. Rodriguez,² S. Bartlett.¹
Modified Upper Abdominal Organ Cluster Transplantation: A Serial of 16 Cases in a Single Center

J. Zhou, W. Ju, X. Yuan, D. Wang, X. Zhu, X. He.
Molecular Classifiers Accurately Measure the Degree of Fibrosis in Human Kidney Transplant Biopsies

J. Venner, J. Reeve, P. Halloran.
Molecular Marker Strategies Supporting the Novartis US92 Study- A Discovery Study of Protein Biomarkers for Kidney Function (eGFR) and Acute Rejection in Serum from Renal Transplant Patients

U. Christians,¹ J. Klepacki,¹ A. Karimpour-fard,¹ G. Ingle,² D. Patel,² K. Johnson,³ D. Cibrik,³ J. Klawitter.¹
Molecular Testing for Microcirculation Injury Enhances the Assessment of Antibody-Mediated Rejection in Human Cardiac Allograft Biopsies

B. Afzali,¹ E. Chapman,¹ B. Adam,¹ F. Riesgo Gil,² D. Kim,² L. Hidalgo,¹ P. Campbell,¹ B. Sis,¹ M. Mengel.¹
Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to Assess the Risk of Acute Subclinical Rejection After Kidney Transplantation

O. Bestard,^1,2 E. Crespo,¹ T. Sigdel,² S. Roedder,² Y. Ng,² J. Cruzado,¹ M. Lúcia,¹ S.-C. Hsieh,¹ T. Tran,¹ J. Grinyó,¹ M. Sarwal.¹
Mononuclear Cell Infiltrates Characterization in Scar Tissue from a Bilateral Forearm Transplant Patient: Findings to Think

J. Furuzawa-Carballeda,¹ M. Iglesias,² J. Alberu,³ A. Gamboa,⁴ P. Butrón,² M. Morán-Romero,² Y. Esquivel.¹
Month 48 Follow-Up Results of HERAKLES Trial on Three Different Treatment Regimen and Switching Off Behaviour in De Novo Renal Transplant Patients

W. Arns,¹ K. Budde,¹ C. Sommerer,¹ O. Witzke,¹ M. Guba,¹ J. Jacobi,¹ B. Vogt,³ P. Reinke,¹ I. Hauser,¹ R. Stahl,¹ T. Rath,¹ D. Baeumer,² M. Porstner,² M. Zeier,¹ F. Lehner,¹ V. Kliem.¹
Morphometry of the Epithelial-Mesenchymal Transition (EMT) in Subsequent Biopsies from Transplanted Kidney

R. Świder, A. Perkowska-Ptasińska, A. Stachurska, J. Fabijańska-Mitek, R. Zagożdżon, S. Gruca, J. Gołąb, M. Durlik.
Murine Veno-Arterial Extracorporeal Membrane Oxygenation (mVA-ECMO): A Novel Tool to Study the Molecular Biology of Mechanical Circulatory Support

A. Schenk,¹ J. Fallon,¹ M. Farrell,¹ R. Halter,² J. Yun.³
Mycophenolate Dose Reductions Contribute to Suboptimal Graft Outcomes in Kidney Transplant Recipients

K. Boyle, J. Fleming, D. Taber, K. Covert, J. Casale, C. Staino, N. Pilch, C. Mardis, H. Meadows, T. Srinivas, J. McGillicuddy, K. Chavin, C. Bratton, P. Baliga.
Myeloid Cell-Specific Heme Oxygenase-1 Is Crucial for Hepatoprotection in Liver Ischemia-Reperfusion Injury

K. Nakamura,¹ M. Zhang,² B. Ke,¹ R. Busuttil,¹ J. Araujo,² J. Kupiec-Weglinski.¹
NFAT Regulated Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Recipients

V. Tatapudi, A. Webber, C. Leung, F. Vincenti.
NK Cells of Kidney Transplant Recipients Show a Reduced Capacity to Produce Cytokines But Retain Their Cytotoxic Capacity

U. Hoffmann,¹ C. Neudoerfl,¹ K. Daemen,¹ J. Keil,¹ C. Blume,^2,3 F. Lehner,⁴ H. Haller,² C. Falk.^1,5
National Outcomes of Donation After Cardiac Death (DCD) Liver Transplantation Are Equivalent to Donation After Brain Death (DBD) Liver Transplantation Using Older (DBD) Donor Livers

R. Redfield, M. Rizzari, J. Scalea, L. Fernandez, A. D'Alessandro, J. Mezrich, D. Foley.
National Outcomes of Kidney Transplantation from Diabetic Donors

J. Cohen,¹ P. Reese,¹ P. Porrett,² R. Bloom,¹ K. Forde,³ D. Sawinski.¹
Native Americans and Post-Kidney Transplant Follow-Up: Lower in Quantity and Quality?

S. Stith,¹ F. Barrantes.²
Native Kidney Biopsy Does Not Predict Post Liver Transplant Renal Outcomes

D. Sawinski,¹ A. Ganguli,¹ M. Palmer, R. Bloom,¹ P. Abt.
Neogenin Functions as a Chemokinetic Receptor on Activated CD4+ T Lymphocytes

L. Boneschansker,¹ H. Nakayama,¹ M. Eisenga,¹ M. Klagsbrun,¹ D. Irimia,² D. Briscoe.¹
New Insights in Clinical and Genetic Determinants of Longitudinal Dose-Corrected CNI Exposure in Children After Renal Transplantation

N. Knops,¹ M. van Dyck,¹ E. Levtchenko,¹ D. Kuypers,² J. Herman.¹
No Pharmacokinetic Interaction Between Pantoprazole and Mycophenolic Acid in Renal Transplant Patents: A Randomized Crossover Study

O. Rissling, P. Glander, P. Hambach, M. Mai, S. Brakemeier, D. Klonower, F. Halleck, E. Singer, E. Schrezenmeier, M. Duerr, H. Neumayer, K. Budde.
No Tumor Recurrence After Renal Cell Carcinoma Resected Kidney Transplantation – 5 Year Follow Up

M. Zwierzchoniewska,¹ K. Fong,¹ D. Patel,¹ L. Mou, W. Lim,² B. He,¹ L. Delriviere.¹
Non-Cardiac Surgical Procedures After Left Ventricular Assist Device Implantation

S. Taghavi,¹ S. Jayarajan,¹ A. Mangi,² E. Chan,¹ E. Dauer,¹ L. Sjoholm,¹ A. Pathak,¹ T. Santora,¹ A. Goldberg,¹ J. Rappold.¹
Non-Inferior Outcomes of Third and Fourth Renal Transplant. An Analysis of Our Experience

H. Sharma, P. Yiannollou, O. Masood, G. Giffruda, R. Dhanda, D. Van Dellen, T. Campbell, R. Pararajasingam, T. Augustine, A. Tavakoli, B. Forgacs.
Non-Inferiority of Graft Survival of Living Unrelated Kidney Transplant compared to Living Related Kidney Transplant as Analyzed by First Degree Relative

A. Patel, M. Goggins, D. Kim, P. Rohini, L. Malinzak.
Non-Invasive Imaging Modalities for Immune Monitoring of Vascularized Composite Allografts Using a Translational Large Animal Model

G. Furtmüller,¹ N. Crane,² R. Luthra,² E. Swanson,¹ H.-T. Cheng,¹ B. Oh,¹ M. Fryer,¹ E. Elster,² W. Lee,¹ G. Brandacher.¹
Non-Invasive Immune Monitoring Assay in Transplant Recipients

M. Gasser,¹ I. Tsaur,² K. Lopau,¹ C. Germer,¹ A. Chandraker,³ A. Waaga-Gasser.¹
Nonalcoholic Steatohepatitis as Indication for Liver Transplantation in Europe. Do We Choose the Right Organs for the Right Recipients?

B. Kern,¹ P. Newsome,² V. Karam,³ R. Adam,³ G. Berlakovich,⁴ J. Fritz,⁵ W. Popp,¹ B. Feurstein,¹ A. Pascher,⁶ P. Muiesan,⁷ S. Schneeberger.¹
Noninvasive Diagnostic and Predictive Value in Renal Transplant Recipients by Measurement of Urine BCA-1

D. Chen, J. Chen, W. Peng.
OX40 Gene: A Potential Target for the Care of Chronic T-Cell Mediated Rejection (TCMR)

F. Schena,¹ C. Curci,¹ F. Sallustio,¹ M. Trpevski,¹ G. De Palma,¹ M. Fiorentino,² M. Rossini,² M. Quaglia,³ E. Bozzola,³ S. Zanini,⁴ L. Furian,⁴ A. Toscano,⁵ E. Gallo,⁶ L. Gesualdo,² P. Stratta,³ P. Rigotti,⁴ F. Citterio,⁵ L. Biancone.⁶
Obesity: A Major Risk Factor for Wound and Parietal Complications in Renal Transplantation

H. Andrade, W. Nahas, R. Kato, K. Yamaçake, H. Kanashiro, I. Antonopoulos, A. Bull, R. Falci, A. Piovesan.
Once Daily Dosing Is as Effective as Twice Daily Dosing of Immediate Release Tacrolimus

L. Bowman,¹ T. Horwedel,¹ J. Hagopian,¹ B. Bone,² H. Wijeweera,² D. Brennan.²
Once-a-Day Administration of CNIs, mTOR and MMF Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study

G. Spagnoletti, M. Salerno, E. Favi, J. Pedroso, J. Romagnoli, F. Citterio.
One Year Outcomes and Quality of Life Measurements in 127 Extended Criteria Donor Recipients- A Single Centre Comparative Study

Y. Tabbakh,¹ S. Turner,¹ H. Maple,¹ C. Callaghan,¹ J. Olsburgh,¹ F. Calder,¹ M. Drage,¹ N. Karydis,¹ I. Loukopoulos,¹ G. Koffman,¹ R. Hilton,¹ J. Pattison,¹ C. Farmer,³ S. Shah,² E. Spigler,¹ N. Mamode,¹ N. Kessaris.¹
Operating Room Extubation After Bilateral Lung Transplantation in Cystic Fibrosis Patients: A Single Center Experience

M.-L. Felten,¹ J.-D. Moyer,¹ J.-Y. Marandon,¹ J.-F. Dreyfus,² M. Fischler.¹
Operational Tolerance in Kidney Transplantation: Results of a Europe-Wide Survey

A. Massart,¹ A. Pallier,² O. Viklicky,^3,4 J. Pascual,^3,5 K. Budde,^3,6 S. Sorensen,^3,7 R. Oberbauer,^3,8 M. Klinger,^3,9 C. Dudley,^3,10 M. Sever,^3,11 G. Spasovski,^3,13 P. Guérif,² U. Maggiore,^3,12 M. Abramowicz,¹ M. Giral,² D. Abramowicz,¹⁴ S. Brouard.²
Opportunities in Tacrolimus Therapeutic Drug Monitoring

N. Jandovitz, J. Lee, S. Hammad, J. McKeen, S. Martin, D. Tsapepas.
Optimal Management of Distal Ureteric Stricture Following Renal Transplantation: A Systematic Review

J. Kwong, D. Schiefer, G. Anas, J. Archambault, P. Luke, A. Sener.
Orthotopic Transplantation of a Tissue Engineered Skin Graft in Athymic Mice

N. Nayakawde, P. Patil, K. Methe, M. Olausson.
Outbreak of Pandemic Influenza A (H1N1pdm) in a Kidney Transplant Unit – The Protective Effect of Vaccination

I. Helanterä,¹ V.-J. Anttila,² M. Lappalainen,³ M. Lempinen,¹ H. Isoniemi.¹
Outcome of Adult Kidney Transplant Candidates With Previous Malignancy: Analysis of 14-Year Waiting List Data in the United States

A. Santos, M. Casey, S. Rehman, X. Wen, K. Andreoni, K. Womer.
Outcome of Invasive Aspergillosis in Liver Transplant Recipients Under Current Antifungal Therapy

U. Herden, E. Grabhorn, B. Nashan, L. Fischer.
Outcome of Kidney Transplantation Using Right Versus Three Left Renal Arteries After Retroperitoneoscopic Donor Nephrectomy: A Single-Center Experience of 764 Cases

K. Omoto, M. Okumi, T. Shimizu, D. Toki, H. Ishida, K. Tanabe.
Outcome of Kidney Transplantation from Obese Living Donors: Histological Evaluation Using Zero-Time Biopsy Specimens

K. Omoto,¹ D. Toki,¹ M. Okumi,¹ T. Shimizu,¹ H. Ishida,¹ K. Honda,² J. Koike,³ K. Tanabe.¹
Outcome of Kidney Transplantation from Older Living Donors: Histological Evaluation Using Zero-Time Biopsy Specimens

K. Omoto,¹ D. Toki,¹ M. Okumi,¹ T. Shimizu,¹ H. Ishida,¹ K. Honda,² J. Koike,³ K. Tanabe.¹
Outcome of Renal Sparing Protocol in a Cross-Sectional Analysis After Heart Transplant

J. Kobashigawa, M. Kittleson, P. Patel, F. Liou, S. Siddiqui, D. Chang, B. Azarbal, D. Ramzy, L. Czer, J. Patel.
Outcomes After Right Kidney Living Donor Transplant Are Associated With Center Volume

R. Reed, P. MacLennan, B. Shelton, D. Sonnier, M. Hanaway, J. Goodman, C. Young, M. Deierhoi, J. Locke.
Outcomes Following Endovascular Treatment of Hepatic Artery Stenosis Following Liver Transplantation

J. Seal,¹ H. Bohorquez,¹ L. Le,² W. Terral,² A. Cohen,¹ I. Carmody,¹ D. Bruce,¹ T. Reichman,¹ E. Ahmed,¹ W. Sternbergh,² G. Loss.¹
Outcomes in Liver Re-Transplant Recipients With MELD above 40: A Decade Long Experience

Z. Baghmanli,¹ C. Ortiz,² N. Koizumi,³ J. Ortiz.¹
Outcomes of Hispanic Kidney Transplant Recipients Under a Cyclosporine Versus Tacrolimus Based Immunosuppression Regimen

P. West-Thielke,¹ M. Campara,² A. Ladik,¹ E. Terranova,² E. Benedetti,¹ J. Thielke.²
Outcomes of Kidney Transplant Recipients Minimally Immunosuppressed: A Cohort Study Analysis

A.-H. Querard,^1,2,3 F. Gillaizeau,^2,1 G. Couvrat-Desvergne,^1,2,3 J. Dantal,^1,4,5 P. Daguin,¹ S. Le Floch,¹ S. Castagnet,⁶ S. Brouard,^1,4 Y. Foucher,^2,1 M. Giral.^1,2,4,5
Outcomes of Kidney Transplantation from Hypertensive Living Donors

D.-A. Moutzouris, D. Ellis, K. Koutroutsos, R. Charif, J. Galliford, J. McDermott, D. Taube, M. Loucaidou.
Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score

J. Lee, J. Lee, D. Joo, D. Han, M. Ju, J. Choi, S. Kim, M. Kim.
Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft

W. Goldkamp,¹ J. Vanatta,^2,3 S. Nair,^2,3 E. Wong,³ N. Dbouk.^2,3
Outcomes of Post-Kidney Transplant Leukemias

B. Rouphael, A. Kukla, K. Gillingham, H. Ibrahim, A. Matas, N. Issa.
Outcomes of Simultaneous Pancreas and Kidney Transplantation With a High Level of Preformed Antibodies

H. Sharma, A. El-Bakry, V. Venkat, S. Papachristos, R. Dhanda, D. Van Dellen, T. Campbell, T. Augustine, R. Pararajasingam, A. Tavakoli, B. Forgacs.
Overexpression of 2B4 Inhibits the Expansion and Function of Donor-Reactive CD8+ T Cells in Selective Lymphoid Compartments

S. Laurie, D. Liu, M. Ford.
Oxidative Stress During Organ Recovery Influences Transplant Vasculopathy Development

M. Maglione,¹ G. Riede,¹ B. Cardini,¹ D. Bernhard,² B. Messner,² K. Watschinger,³ C. Steger,⁴ G. Brandacher,⁵ J. Pratschke,¹ E. Werner,³ R. Oberhuber.¹
Paired Match Power and Challenges for O-Patients in Kidney Paired Donation

W. Liu, M. Melcher.
Paired-Donor Exchange Unrelated Living Donor Renal Transplantation With Two Separate Arterial Anastomoses to a Simultaneously Placed Vascular Prosthetic Interposition Graft in an Irradiated Field

D. Haakinson,¹ N. Katariya,¹ A. Singer,¹ A. Mathur,¹ R. Fowl,² S. Money,² W. Stone,² A. Moss,¹ K. Reddy.¹
Pancreas Transplant Sera Improves the Function and Proliferation of Endothelial Cells

J. Pollett, L. Margetich, N. Thai.
Pancreatic Islet Survival Under Confinement

A. Rodriguez, S. Sigrist, E. Maillard.
Parameters of Machine Perfusion Evaluating Quality of Kidneys from DCD/ECD Donors

G. Chen, C. Wang, J. Qiu, M. Han, X. He, L. Chen.
Patient Self-Reported Adherence to and Perceptions Towards Immunosuppressive Medications at the Outpatient Renal Transplant Clinic at St. Joseph's Healthcare Hamilton (SJHH)

K. Kak,¹ C. Burger,¹ D. Treleaven,² C. Wallace.¹
Patients With Spontaneous Bacterial Peritonitis (SBP) Experience Survival Benefit After Live Donor Liver Transplantation (LDLT)

M. Simpson, A. Qamar, F. Gordon, J. Pomposelli, M. Akoad, R. Jenkins, W. Lewis, A. Tien, E. Pomfret.
Pediatric Liver Transplantation from Living Donors in Cali – Colombia

L. Caicedo, V. Botero, J. Villegas, O. Serrano, M. Duque, M. Valderrama, E. Manzi, M. Agudelo, G. Echeverri.
Pediatric Liver Transplantation: An Outcome Analysis of a 30-Year Single Center Experience

A. Weissenbacher,¹ C. Margreiter,¹ R. Oberhuber,¹ M. Maglione,¹ B. Cardini,¹ J. Grahammer,¹ T. Müller,² R. Margreiter,¹ S. Schneeberger.¹
Perfusion Disturbances and Local Infarctions After Experimental Kidney Transplantation Corralte With the Duration of Cold Ischemia Time

S. Rong,¹ R. Chen,¹ M. Meier,⁴ B. Hensen,² H. Haller,¹ K. Hueper,² F. Gueler.¹
Persistent Expansion of DX5- Memory NK Cells in the Liver After Intraportal Islet Transplantation

Y. Saeki, K. Ishiyama, N. Ishida, Y. Tanaka, H. Ohdan.
Perturbation of Polyomavirus Nephropathy-Specific Gene Expression in Kidney Allografts

T. Sigdel,¹ O. Bestard,^1,2 N. Salomonis,³ S.-C. Hsieh,¹ M. Naesens,⁴ J. Torras,² T. Tran,¹ S. Roedder,¹ M. Sarwal.¹
Pharmacogenetic Variation in Renal Calcineurin Inhibitor (CNI) Metabolism and the Response of Allograft-Derived Proximal Tubule Cells

N. Knops,^1,2 L. van den Heuvel,² R. Masereeuw,³ H. de Loor,⁴ E. Levtchenko,^1,2 D. Kuypers.^5,4
Pharmacogenomic Predictors of Acute Rejection in Kidney Transplant Recipients Identified Using a DNA Biobank Linked to Electronic Medical Records

K. Birdwell,¹ D. Velez-Edwards,² G. Vranic,⁵ J. Denny,^1,3 L. Choi,⁴ T. Ikizler,¹ D. Haas.¹
Pharmacokinetics of Everolimus (EVL) in Elderly Recipients Under Low-Tacrolimus(TAC)/Everolimus in the First Year After Renal Transplantation. Data from the NEverOLd Trial

E. David-Neto,¹ P. Romano,² F. Agena,¹ P. Ebner,² A. Triboni,¹ F. Ramos,¹ N. Galante,¹ F. Lemos.¹
Pharmacokinetics of Mycophenolic Acid (MPA) in Elderly Compared to Young Recipients in the First Year After Renal Transplantation. Data from the NEverOLd Trial

P. Romano,¹ F. Agena,² P. Ebner,¹ A. Triboni,² F. Ramos,² N. Galante,² F. Lemos,² N. Sumita,¹ E. David-Neto.²
Pharmacokinetics of Tacrolimus (TAC) in Elderly Compared to Young Recipients in the First Year After Renal Transplantation. Data from the NEverOLd Trial

E. David-Neto,¹ P. Romano,² A. Triboni,¹ F. Agena,¹ P. Ebner,² F. Ramos,¹ N. Galante,¹ F. Lemos.¹
Phenotype Characterization, Migratory Pathways, Engraftment and Safety Evaluation of Human Cord Blood Derived Ex-Vivo Created Di- Chimeric Cells in NOD SCID Mouse Model: A Preliminary Study

J. Cwykiel,¹ A. Sklodowska,¹ W. Malewski,¹ M. Cyran,¹ H. Karagoz,¹ E. Bryndza Tfaily,¹ M. Askar,² M. Siemionow.¹
Phenotype of Renal Tubular Cell Death During Delayed Graft Function

S. Jain,¹ R. Plenter,¹ T. Nydam,¹ C. Ruller,¹ C. Edelstein,^1,2 A. Jani.^1,2
Phenotypic Personalized Medicine: Mechanism-Independent Convergence Into Target Serum Tacrolimus Levels for Optimized Liver Transplant Immunosuppression

A. Zarrinpar,¹ A. Silva,² D.-K. Lee,³ N. Datta,¹ C.-M. Ho,² D. Ho.³
Pilot Study on Safety and Feasibility of Complete Meal Replacement in Liver Transplant Recipients and Potential Donors

F. Bhatti,¹ M. Jesse,³ K. George,² J. Centala,⁴ J. Ehrman,⁵ A. Eshelman,³ M. Abouljoud,³ K. Brown.
Plasma 4β-Hydroxycholesterol Measurement as a Potential Biomarker for CYP3A5 Activity in Informing Tacrolimus Dosing

T. Elnahhas,^1,2 E. de Jonge,⁴ T. Lee,² B. van Zelst,⁴ J. Popoola,³ R. Ramkhelawon,³ R. van Schaik,⁴ A. Johnston,^1,2 I. MacPhee.³
Plasma Cell Infiltration: General Overview of Clinical and Pathological Correlations in Renal Transplantation

C. Nihei, F. Lemos, D. David, P. Souza, F. de Paula, W. Nahas, E. David-Neto.
Portal Flow <1000 cc Is Not Associated With Early Graft Dysfunction in Orthotopic Liver Transplantation

M. Gastaca,¹ M. Prieto,¹ A. Matarranz,¹ A. Valdivieso,¹ P. Ruiz,¹ A. Ventoso,¹ I. Palomares,¹ L. Martinez-Indart,² J. Fernandez,³ J. Ortiz de Urbina.¹
Post Hoc Subgroup Analysis of ZEUS: Outcome on Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion from a Calcineurin Inhibitor to an Everolimus Based Regimen: 5 Year Follow-Up Data

F. Lehner,¹ K. Budde,¹ R. Wuethrich,² P. Reinke,¹ W. Arns,¹ A. Muehlfeld,¹ U. Eisenberger,¹ R. Stahl,¹ K. Heller,¹ O. Witzke,¹ B. Suwelack,¹ H. Wolters,¹ I. Hauser,¹ M. Porstner,³ C. Sommerer.¹
Post-Kidney Allograft Nephrectomy Anti-HLA Immunization Is Not Due to a Release of Anti-HLA Antibodies from the Failed Kidney

D. Milongo,^1,3 N. Congy-Jolivet,^2,3,4 A. Del Bello,^1,3 F. Sallusto,⁵ C. Guilbeau-Frugier,⁶ L. Rostaing,^1,3 N. Kamar.^1,3
Post-Transplantation Immunoadsorption Can Be Safely Withheld After ABO-Incompatible Kidney Transplantation

A. de Weerd,¹ M. van Agteren,¹ J. Ijzermans,² W. Weimar,¹ M. Betjes.¹
Potential Urine Protein Biomarkers for Kidney Transplantation Dysfunction Through Quantitative Proteomics

T. Sigdel,¹ N. Salomonis,² C. Nicora,³ J. He,³ W.-J. Qian,³ D. Camp,³ M. Sarwal.¹
Pre-Existing Coronary Artery Disease in Lung Transplantat Recipients: Does It Impact Outcomes?

S. Khandhar,¹ L. Tefera,² E. Volz,² F. Selzer,³ R. Kormos,² C. Bermudez.²
Pre-Liver Transplant Urinary Proteome Analysis Does Not Predict Development of Chronic Kidney Disease After Transplantation

D. Milongo,^1,3 J. Bascands,^2,3,4 L. Esposito,^1,3 L. Lavayssière,^1,3 A. Del Bello,^1,3 L. Rostaing,^1,3,5 J. Schanstra,^2,3,4 N. Kamar.^1,3,5
Pre-Transplant Desensitization Protocol and Cancer Risk in Kidney Transplantation

I. Revuelta,^1,2,3 R. Ferreira,¹ C. Canha,¹ P. Piselli,⁴ D. Verdirosi,⁴ V. Tubita,² E. De Sousa,¹ F. Diekmann,^1,2,3 M. Lozano,^2,5 J. Cid,⁵ E. Palou,⁶ J. Martorell,⁶ A. Alcaraz,⁷ D. Serraino,⁸ F. Oppenheimer,^1,2,3 J. Campistol.^1,2,3
Pre-Transplant Levels of TFH cell-Inducing Pro-Inflammatory Cytokines Correlate With DSA Formation After Kidney Transplantation

C. Macedo,¹ K. Hadi,¹ B. Elinoff,¹ M. Marrari,¹ A. Zeevi,¹ B. Ramaswami,¹ G. Chalasani,¹ A. Shields,² R. Alloway,³ E. Woodle,² F. Lakkis,¹ D. Metes.¹
Pre-Trasplant Perfusion With Mesenchymal Stromal Cells of Renal Graft Prevents Ischemia Injury Upregulating Gene Involved in Energy Saving

V. Corradetti,¹ S. Milanesi,¹ E. Pattonieri,¹ C. Rocca,¹ T. Valsania,¹ M. Gregorini,¹ L. De Cecco,² I. Benzoni,³ C. Bianco,³ M. Avanzini,⁴ M. Maestri,³ P. Esposito,¹ T. Rampino,¹ A. Dal Canton.
Precision Diagnosis in Kidney Transplantation

P. Kadota, D. Perkins.
Predicting Mental Health After Living Kidney Donation: The Importance of Donors' and Recipients' Medical Process

L. Timmerman,¹ M. Laging,¹ R. Timman,² W. Zuidema,¹ D. Beck,¹ J. IJzermans,³ M. Betjes,¹ J. Busschbach,² W. Weimar,¹ E. Massey.¹
Predicting Renal Recovery After Liver Transplant With Severe Pretransplant Sub-Acute Kidney Injury: The Impact of Warm Ischemic Time

H. Laskey, T. Nydam, A. Wiseman, S. Biggins.
Prediction of Post-Operative Length of Stay and Unplanned Reoperation in Patients Transplanted for Alcoholic Liver Disease: An Artificial Neural Network Approach

E. Wise, K. Williamson, K. Hocking.
Predictive Value of Postoperative CRP and Procalctonin in Kidney Donors Experiencing Surgical Complications

Z. Ahmed, R. Tamburrini, J. Wright, N. Kessaris, N. Mamode.
Predictive Value of Regadenoson Scans After Heart Transplant

J. Kawano, M. Kittleson, J. Patel, B. Azarbal, F. Liou, S. Siddiqui, D. Wong, D. Chang, D. Ramzy, L. Czer, J. Kobashigawa.
Preemptive Rituximab Therapy of Epstein-Barr Virus (EBV) Infection to Prevent Post-Transplant Lymphoproliferative Disease (PTLD) After Pediatric Solid Organ Transplantation (SOT)

Y. Ahn,¹ N.-J. Yi,² S. Min,² I.-S. Ha,¹ H. Cheong,¹ H. Kang.¹
Preemptive Therapy for Cytomegalovirus Disease in Liver Transplant Recipients-A Single Center Experience

N. Alvey,¹ J. Tieman,¹ A. Diamond,² A. Hodowanec,¹ D. Simon,¹ S. Fayek,¹ M. Hertl,¹ O. Olaitan,¹ E. Hollinger,¹ E. Chan.¹
Preferences for Policy Options for Deceased Organ Donation for Transplantation: A Discrete Choice Experiment

K. Howard,¹ S. Jan,² J. Rose,³ G. Wong,^1,4 J. Craig,^1,4 M. Irving,¹ A. Tong,^1,4 S. Chadban,^1,5 R. Allen,⁵ A. Cass.⁶
Preformed IgA Antibodies to B2-Glycoprotein Is an Indepedent Risk Factor for Graft Thrombosis and Early Graft Loss After Renal Transplantation

J. Morales,¹ M. Serrano,³ J. Martinez,² D. Perez,² M. Sevilla,² A. Amdres,³ E. Gonzalez,³ E. Paz-Artal,² A. Serrano.²
Pregnancy After Renal Transplantation: Unfavorable Outcomes in Sensitized Patients

M. Ajaimy, M. Lubetzky, L. Kamal, G. De Bocardo, E. Akalin.
Pregnancy Outcomes in Female Kidney Recipients Who Conceived Before Age 20

L. Coscia,¹ D. Armenti,¹ S. Constantinescu,² M. Moritz.¹
Pregnancy Outcomes in Solid Organ Transplant Recipients With Exposure to Sirolimus Without Mycophenolate

N. Sifontis,¹ L. Coscia,² D. Armenti,² S. Constantinescu,^2,3 M. Moritz.^2,4
Prehypertension and Abnormal Fasting Glucose Are the Main Factors Associated With Progressive Deterioration of Renal Function in Kidney Donors

J. Arreola-Guerra,¹ M. Arvizu-Hernandez,² R. Correa-Rotter,² L. Morales-Buenrostro,² J. Alberu.¹
Preliminary Results of a Novel Induction Regimen Using Anti-Thymocyte Globulin (Rabbit) (rATG) Plus Basiliximab in a Pediatric Patient Population Undergoing Kidney Transplantation

D. Halleran,¹ S. Schurman, T. Welch, V. Whittaker.
Presence of Donor Leukocytes and Donor MHC-Cross-Dressed Recipient Cells and Its Relationship to Direct T Cell Alloresponses After Allotransplantation

J. Marino,¹ P. Crosby Bertorini,¹ M. Uehara,² J. Paster,¹ S. Mordecai,³ W.-H. Liu,¹ L. Liu,¹ R. Abdi,² G. Tocco,¹ J. Kim,¹ J. Markmann,¹ G. Benichou.¹
Preserved Kidney Volume in Living Kidney Donors: Correlation With 2 Year Renal Function Using CKD-EPI Equation to Predict Remaining GFR

A. Khalil,¹ M. Yaqub,¹ T. Taber,¹ J. Powelson,¹ C. Sundaram,¹ W. Goggins,¹ D. Mishler,¹ M. Mujtaba,¹ A. Diez,² A. Sharfuddin.¹
Pretransplant Hepatitis B Viral Infection Increased Risk of Death After Kidney Transplantation

J. Lee,¹ J.-H. Cho,² J. An,³ C.-D. Kim,² C. Ahn,⁴ I. Jung,³ D. Han, C. Lim,³ Y. Kim,⁴ Y. Kim, J. Lee.³
Pretransplant Panniculectomy in Patients Previously Denied Access to Renal Transplantation: Addressing Disparities for Candidates With a High-Risk Abdominal Panniculus After Weight Loss

C. Troppmann,¹ C. Bailey,² J. Kuo,² C. Santhanakrishnan,¹ R. Perez,¹ M. Wong.²
Prevalence and Outcomes of Heart Transplantation in Children With Intellectual Disability

A. Wightman,¹ H. Bartlett,¹ Q. Zhao,² J. Smith.³
Prevalence, Risk Factors, and Clinical Management of Chronic Renal Dysfunction in Heart Transplant Recipients

K. Xhima, O. Famure, Y. Li, J. Kim.
Preventing Cytomegalovirus Infection in Intermediate-High Risk Liver Transplant Recipients: Acyclovir Vs Valganciclovir

S. Dulanya, A. Anamisis, D. Tsapepas.
Pro-Inflammatory Actions of New Non-HLA Antibodies Targeting Protease-Activated Receptor (PAR-1)

R. Catar,¹ C. Luecht,¹ M. Simon,¹ A. Philippe,¹ A. Kusch,¹ M. Szczepek,² P. Hildebrand,² P. Scheerer,² D. Dragun.¹
Profound Effect of HDAC2 Deletion on Renal Ischemia-Reperfusion Injury Is Intrinsic to the Kidney and Includes Protection Against Cold Ischemia

D. Aufhauser, Jr.,¹ Z. Wang,¹ S. Cheraghlou,¹ T. Bhatti,² W. Hancock,^2,3 M. Levine.^1,4
Prognostic Relevance of Rejection Episodes Detected Within the First 3 Weeks After Kidney Transplantation

V. Arelin,¹ H. Schrem,² F. Lehner,² W. Gwinner,¹ H. Haller,¹ M. Schiffer.¹
Program-Effect Attenuation With Time Posttransplant

N. Salkowski,¹ L. Hunsicker,^1,2 J. Snyder,¹ B. Kasiske.^1,3
Prophylaxis of Post-Renal Transplant Urinary Tract Infection With Fosfomycin Trometamol. A Controlled, Randomized Clinical Trial. (Intermediate Analysis)

J. Arreola-Guerra,¹ L. Morales-Buenrostro,³ M. Arvizu-Hernandez,³ E. Mancilla-Urrea,² P. Maria,² M. Vilatoba-Chapa,¹ J. Alberu,¹ J. Sifuentes-Osornio.¹
Prospective Measurement of Plasma Neutrophil Gelatinase-Associated Lipoprotein in Living Kidney Donors

Y. Yoon,¹ K. Choi,² D. Joo,³ K. Huh,³ M. Kim,³ S. Kim,³ Y. Kim,³ S. Yang,² W. Han.¹
Prospective Study of a Steroid Free, Low Dose Tacrolimus and Everolimus Combination Regimen in Kidney Transplant

A. Shetty,¹ J. Leventhal,¹ O. Traitanon,¹ A. Alvarado,¹ V. Mas,² J. Mathew,¹ E. Tantisattamo,¹ L. Gallon.¹
Prospective, 6 Month, Open Label, Conversion Study from Mycophenolate Mofetyl to Mycophenolic Acid Evaluating the Severity of Gastro-Intestinal Symptoms and Mycophenolic Acid Urinary Metabolite as a Surrogate Marker of Plasmatic Area Under the Curve

D. Tran,¹ A. Boucher,¹ L. Senécal,¹ V. Pichette,¹ F. Leblond,² S. Collette.¹
Proteasome Inhibition by Bortezomib Prevents Early Graft Failure After Pancreatic Islet Transplantation

H. Ono,¹ Y. Asahi,¹ T. Yoshida,¹ Y. Koshizuka,¹ M. Watanabe,¹ U. Tomaru,² S. Emoto,¹ M. Fukai,³ A. Taketomi,¹ S. Todo,⁴ K. Yamashita.³
Proteinuria as Non-Invasive Marker for Renal Allograft Histology and Survival: A Population-Based Study

M. Naesens, E. Lerut, M.-P. Emonds, D. Kuypers.
Proteomic Study Identified a Distinct Panel of Protein Expression in the ATP-Competitive MTOR Kinase Inhibitor Conditioned Dendritic Cells Compared to Rapamycin

T. Ma,¹ Y. Pei,¹ Y. Han,² R. Tao.¹
Psychological Benefit After Living Kidney Donation: Is It a Myth?

H. Maple, N. Mamode.
Pubertal Development in Pediatric Kidney Transplant Patients Receiving Everolimus Or Conventional Immunosuppression

L. Pape,¹ T. Ahlenstiel-Grunow,¹ A. Zapf,² M. Mynarek,³ J. Förster.¹
Pyridoxine Deficiency After Solid Organ Transplant

S. Van Arsdale,¹ S. Yost,² M. Meer,¹ S. Schoentag,¹ P. Kadambi,³ S. Habib.³
Quantifying Altruism in Kidney Donors: How Good Are the Current Scales?

M. McLaughlin, D. Berglund, A. Matas, H. Ibrahim.
Quantifying Risk of ESRD in Live Kidney Donors

A. Massie, A. Muzaale, X. Luo, D. Segev.
Racial Differences in Transplant and Waitlist Mortality Rates Among HIV+ Kidney Transplant Candidates

J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3
Racial Disparities in Access to Kidney Re-Transplantation in the United States

C. Garrett, R. Patzer, R. Zhang, A. Adams.
Racial Disparities in Living Donor Liver Transplantation

Y. Nobel,¹ K. Forde,² L. Wood,³ P. Yoo,⁴ P. Abt,³ D. Goldberg.²
Racial Disparities in Preemptive Kidney Transplant Referrals in Georgia: Data from the RaDIANT Community Study

J. Gander,¹ L. Plantinga,¹ M. Basu,¹ L. Sauls,² S. Pastan,¹ E. Gibney,³ L. Mulloy,⁴ R. Patzer.¹
Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End Stage Renal Disease (ESRD) Patients: A Multi-Level Mixed Modeling Approach

K. Newman,¹ S. Fedewa,¹ M. Jacobson,¹ A. Adams,² R. Zhang,² R. Patzer.^1,2
Rapid Effector Function of TEMRA CD8 T Cells in Healthy Volunteers and in Immune-Stimulated Patients Requires Sustained Glycolytic Switch

M. Yap,^1,3 G. Tilly,^1,3 M. Giral,^1,2 D.-A. Laplaud,^1,2 S. Brouard,^1,2 C. Pecqueur,⁴ N. Degauque.^1,2
Re-Evaluate the Transplant Renal Artery Stenosis After Renal Transplantation Based On New Unenhanced Magnetic Resonance Angiography By Using Spatial Labeling With Multiple Inversion Pulses

J. Wen,¹ L. Zhang,² Y. Li,² X. Li,¹ Z. Zhang,¹ J. Chen,¹ D. Cheng,¹ Z. Liu.¹
Reassessing Tubulitis and Interstitial Infiltrate: Creating a New Probabilistic Definition of TCMR

P. Halloran, I. Salazar, M. Lopez, J. Chang.
Recipient Myelomonocytic Cells With Activated Hypoxia-Inducible Factor Alleviate Ischemia-Reperfusion Injury in Mouse Heart Allografts

A. Raissadati, M. Keränen, E. Rouvinen, R. Krebs, K. Lemström.
Reconsideration of Age Limits for Pancreas Transplantation

J. Scalea, H. Sollinger, R. Redfield, M. Rizzari, D. Kaufman, J. Odorico.
Recreational Marijuana Use Is Not Associated With Worse Kidney Allograft Outcomes

G. Greenan, M. Anders, A. Leeser, J. Bromberg, S. Niederhaus.
Recurrence of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) Alone and TACE in Combination With Other Treatment Modalities

J. Balogh, A. Islam, A. Saharia, H. Monsour, S. Gordon Burroughs, M. Weiner, A. Gaber, R. Ghobrial.
Recurrent Cytomegalovirus Infection After Solid Organ Transplant

Y. Natori, A. Humar, S. Husain, C. Rotstein, D. Kumar.
Reduced Intensity Immunosuppression Protocol Lowers Drug Costs and May Decrease Incidences of BK Viremia and Readmissions After Kidney and Kidney/Pancreas Transplant

M. Mariski,¹ A. DeGolovine,² W. Dar,² J. Bynon,² H. Adrogué,² M. Hobeika.²
Reduced Urinary Uromodulin (UMOD)-Levels Are associated With Urinary Tract Infections (UTI) After Renal Transplantion

K. Stahl, J. Beneke, H. Haller, W. Gwinner, M. Schiffer.
Reduction of Tacrolimus With Everolimus Addition in Maintenance Immunosuppression Improves Calcineurin Inhibitor-Induced Arteriolopathy in Kidney Allografts

M. Miura,¹ H. Higashiyama,¹ Y. Fukasawa.²
Remote Ischemic Perconditioning Induces Protection Against Hepatic Ischemia/Reperfusion Injury in Rats Via Downregualtion of Bax and Cleaved Caspase-3 Expression

H. Ahn, M. Park, S. Joo, B. Kim.
Renal Allografts Demonstrate Improved Pathology After Belatacept Therapy

T. Saavedra,¹ O. Opara,¹ R. McLoughlin,¹ B. Philosophe,² C. Drachenberg,¹ M. Weir,¹ S. Bartlett,¹ D. Leeser,¹ J. Bromberg,¹ R. Barth.¹
Renal Cell Carcinoma in the Native Kidney in Dialysis and Kidney Transplantation Recipients. Different Entities?

K. Yamaçake, W. Nahas, H. Kanashiro, R. Kato, A. Bull, I. Antonopoulos, R. Falci, A. Piovesan.
Renal Dysfunction After Liver Transplantation in Recipients With Pre-Transplant Normal Renal Function

S. Lee,² J. Lee,¹ M. Kim,¹ B. Kim,³ D. Joo,¹ G. Choi,¹ J. Choi,¹ S. Kim.¹
Renal Function Difference Between Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy and HBIG Combined With Entecavir in Liver Recipients

J. Lee,^1,2 J. Lee,^1,2 J. Lee,³ M. Kim,^1,2 M. Ju,^1,2 G. Choi,^1,2 J. Choi,^1,2 S. Kim,^1,2 D. Joo.^1,2
Renal Mass as a Determinant Factor of Long-Term Post-Donation Anemia

S. Shah,¹ B. Lankowsky,² Z. Zaky,¹ S. Nurko,¹ R. Fatica,¹ S. Gebreselassie,¹ B. Stephany,¹ E. Poggio.¹
Renal Resistance Measured During Pulsatile Perfusion and Long-Term Kidney Transplant Outcomes

S. Sandal, R. Sapir-Pichhadze, M. Cantarovich, S. Paraskevas.
Renal Retransplantation in Simultaneous Pancreas Kidney Transplant Recipients

W. Shields, J. Zimmerman, P. Mohan, F. Nooh, D. Hickey.
Renal Transplantation in Aged Over 60 Years Demonstrates Compatible Clinical Outcomes to Younger Recipients

H. Cho,¹ H. Kim,¹ C. Baeck,¹ H. Yu,¹ D.-J. Han,² M. Jo,³ S.-K. Park.¹
Renal Vein Elongation in Deceased Right Side Cadaveric Renal Grafts: Does It Increase the Risk of Thrombosis Or Hematoma Formation?

J. Neves Neto, R. Soler, H. Marinho Neto, A. Ferreira, Jr., J. Offerni, S. Ximenes, J. Medina-Pestana, V. Ortiz, W. Aguiar, B. Leslie.
Respiratory Infections Following Lung Transplantation Leads to De Novo Development of Antibodies to Both Donor HLA and Lung Associated Self-Antigens and Increases the Risk for Bronchiolitis Obliterans Syndrome

K. George,¹ M. Gunasekaran,¹ M. Sharma,¹ F. Zhou,¹ A. Limaye,³ R. Hachem,² T. Mohanakumar.¹
Results from the Use of Aortohepatic Conduit in Orthotopic Liver Transplantation: A Single Centre 12-Year Experience

M. Aly, N. Chatzizacharias, A. Gimson, E. Huguet, A. Butler, C. Watson, G. Pettigrew, A. Jah, N. Jamieson, R. Praseedom.
Return to Work and Occupational Infection Risks in Transplant Recipients

R. Avery,¹ D. Ostrander,¹ S. Shoham,¹ S. Alp,² N. Lu,¹ C. Cave,¹ E. Kraus,³ K. Marr.¹
Right-Sided Kidney Transplants Are Associated With Early Graft Failure in the Setting of Delayed Graft Function

I. Hall, W. Jiang, S. Kulkarni, C. Parkih.
Risk Factors Influencing Mammography Screening During Kidney Transplant Evaluation

J. Stoecker, D. Cote, J. Augustine, N. Sarabu, J. Schulak, E. Sanchez, V. Humphreville, J. Ammori, K. Woodside.
Risk Factors for Acute Cellular Rejection for Pediatric Kidney Transplant Recipients

D. Cote,¹ I. Bobanga,¹ B. Vogt,² K. Dell,² R. Cunningham III,² K. Noon,¹ V. Humphreville,¹ E. Sanchez,¹ J. Schulak,¹ K. Woodside.¹
Risk Factors for Graft Loss in Pediatric Renal Transplant Recipients After Transfer of Care

B. Coyne,^1,2 P. Hollen,^1,2 Y. Guofen,³ K. Brayman.⁴
Risk Factors for Infections After Transplant in a Prospective Cohort Study Including Incompatible Kidney Transplant Recipients

R. Avery,¹ H.-L. Tsai,² C.-Y. Huang,² S. Shoham,¹ D. Ostrander,¹ N. Lu,¹ R. Montgomery,³ K. Marr.¹
Risk of End-Stage Renal Disease After Living Donor Liver Transplantation: Overall Incidence and Comparisons to Deceased Donor Recipients

D. Goldberg,¹ R. Ruebner,² P. Abt.³
Risk of Post Liver Transplant (LT) Hepatocellular Carcinoma (HCC) Recurrence Is 2-Fold Higher in Women Compared to Men With AFP Levels at LT Between 101-500

M. Sarkar,¹ J. Dodge,² F. Yao,¹ J. Roberts,² N. Terrault,¹ N. Mehta.¹
Risks for Readmission Post-Renal Transplant: A Co-Morbid Condition

M. John, A. Smith, I. Dortonne, A. Paramesh, M. Killackey, B. Lee, R. Zhang, J. Buell.
Rituximab With Intravenous Immune Globulin in Sensitized Patients Awaiting Heart Transplant: Does It Work?

J. Patel, N. Reinsmoen, M. Kittleson, A. Velleca, D. Dilibero, F. Liou, D. Chang, A. Hage, L. Czer, F. Esmailian, J. Kobashigawa.
Rituximab: Summarizing the Intracacies of the Black Box Warning and Expenses in Transplantation

N. Jandovitz, J. Lee, M. Bezman, D. Tsapepas.
Role of Complement in Mediating Pericyte Trans-Differentiation in Resident Myofibroblasts: A New Hypothesis On Vascular Rarefaction in Renal Ischemia/Reperfusion (I/R) Injury

G. Castellano,¹ R. Franzin,¹ C. Divella,¹ A. Stasi,¹ A. Intini,¹ M. Gigante,¹ G. Lucarelli,¹ P. Ditonno,¹ M. Battaglia,¹ A. Crovace,¹ F. Staffieri,¹ G. Pertosa,¹ B. Oortwijn,² E. Amersfoort,² G. Grandaliano,³ L. Gesualdo.¹
Role of Universal Decolonization After Kidney Transplant: A Pilot Study

D. Lee,¹ G. Malat,² N. Law,¹ A. Sharma,¹ T. Bias,¹ K. Ranganna,¹ A. Doyle.¹
SBRT(Stereotactic Body Radiotherapy) to Bridge or Down-Size HCC for Liver Transplantation

N. Thai,¹ K. Tom,¹ M. Szramowski,¹ P. Abrams,¹ J. Oliva,³ D. Monga,⁴ M. Raj,⁴ D. Parda,² A. Kirichenko.²
Safer and More Effective Treatment of Acute Postoperative Pain in Living Liver Donors

D. Ladner,¹ R. Fisher,² J. Guarrera,³ E. Pomfret,⁴ M. Simpson,⁴ A. Daud,⁵ T. Curtis,⁵ E. Reyes,⁵ A. Skaro,¹ D. Woods.⁵
Safety and Efficacy of Conversion from Conventional Twice Daily Tacrolimus to Once Daily Extended Release Tacrolimus in Stable Pancreas Transplant (SPK and PAK) Recipients

M. Dib, A. Barbas, M. Marquez, J. Laurence, G. Sapisochin, A. Norgate, J. Schiff, I. McGilvray, P. Greig, M. Selzner, M. Cattral.
Safety and Efficacy of Low Dose and Very Low Dose Extended-Release Tacrolimus / MMF in De Novo Kidney Transplant Recipients

Y. Watarai,¹ M. Okada,¹ K. Futamura,¹ K. Ito,¹ T. Yamamoto,¹ M. Tsujita,¹ T. Hiramitsu,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
Safety and Efficacy of Pegylated Interferon and Ribavirin for Chronic Hepatitis C Following Renal Transplantation

G. Chen, L. Zhu, S. Chen, X. Wang, Z. Lin.
Safety and Outcome of Ganciclovir-Resistant CMV Treated With Foscarnet: A Single Center Retrospective Study

B. Pierce,⁴ C. Richardson,⁴ K. Cunningham,⁴ C. D'Agostino,⁴ C. Tseng,⁴ J. Brown,⁴ C. O'Brien,⁴ B. Ho,^1,3,5 M. Ison.^1,2,3
Sarcopenia and Non-Ischemic Cardiomyopathy After Liver Transplantation

A. Mathew,¹ J. Pan,¹ F. Guglielmo,² A. Shah,³ C. Doria,³ D. Sass,¹ D. Halegoua-De Marzio.¹
Screening for West Nile Virus in California: Resolving IgM Anti-WNV in the Area With Dengue Seroprevalence

C. Chinchilla-Reyes,^1,2 D. Tanglao,¹ T. Mone,³ M. Koss,¹ M. Nowicki.^1,2
Serum Osteoprotegerin Levels Positively Correlate With Peripheral Arterial Stiffness in Kidney Transplantation Patients

M.-C. Lee,^1,2 G.-J. Ho,¹ Y.-C. Chen,¹ B.-G. Hsu.²
Serum Phosphorus Level Has Bidirectional Association With Graft Failure and Mortality in Kidney Transplant Recipients

H. Jeon,¹ J. An,² K. Joo,¹ C. Lim,² Y. Oh,² C. Ahn,¹ S.-K. Park,³ Y. Kim,¹ Y. Kim,⁴ J. Lee.²
Severe Sarcopenia and Increased Fat Stores in Pediatric Patients With Liver, Kidney and Intestine Failure

W. Bush, C. Miller, C. Kubal, J. Fridell, A. Tector, R. Mangus.
Sex Differences in Mortality Rate Among Patients Waiting for Liver Transplantation

Z. Cui,^1,2 X. Luo,² A. Massie,² D. Segev.²
Sharp Declines in Access to Live Donor Kidney Transplantation

A. Massie, I. Olorundare, D. Segev.
Short-Term QOL After Live Liver Donation: A New York Center for Liver Transplantation (NYCLT) Report

D. LaPointe Rudow,¹ S. DeLair,² S. Florman,¹ J. Guarrera,³ M. Kinkhabwala,⁴ M. Orloff,⁵ Y. Wu,⁶ L. Teperman.⁷
Significance of an Isolated Elevated PRA in Renal Transplantation

S. Kuten, S. Patel, G. Land, T. Eagar, R. Knight, J. Loucks, L. Gaber, A. Gaber.
Significant Reduction in TRAIL-Expressing NK Cells in Remnant Liver After Partial Hepatectomy Is Strongly Associated With the Impaired Intrahepatic CXCL9–CXCR3 Pathway

T. Yano, M. Ohira, H. Ohdan.
Simultaneous Cadaveric Pancreas, Living-Donor Kidney Transplantation: Single Center Experience

Y. Kim, J. Jung, H. Cho, J. Hong, J. Choi, B. Choi, S. Shin, D. Han.
Single Cell Phospho-Protein Analysis Demonstrates That Immunosuppressive Drugs Inhibit MAPK and mTOR Signaling Molecules in Primary Monocytes After Transplantation

N. Kannegieter, D. Hesselink, R. Kraaijeveld, G. de Graav, M. Betjes, W. Weimar, C. Baan.
Single Center Experience of C4d Staining of Kidney Transplant Biopsies

R. Prashar, L. Yessayan, M. Goggins, V. Karthikeyan, K. Venkat, A. Patel.
Single Nucleotide Polymorphisms (SNPs) Associated With Acute Rejection in European American Kidney Transplant Recipients: A Genome Wide Association Study (GWAS)

A. Israni,¹ C. Dorr,¹ M. Miller,² D. Schladt,¹ K. Sanghavi,³ A. Muthusamy,¹ R. Remmel,³ W. Guan,⁴ B. Wu,⁴ W. Oetting,³ P. Jacobson,³ A. Matas,⁵ For DeKAF Genomics & GEN03 Investigators.¹
Single-Center Analysis of Adult, Combined Heart-Liver Transplant (CHLT) Recipients

H. Monsour Jr,¹ M. Boktour,² A. Abimbola,¹ M. Elnemr,¹ S. Gordon Burroughs,² D. Victor III,¹ A. Saharia,² B. Trachtenberg,³ A. Bhimaraj,³ A. Gaber,² J. Estep,³ R. Ghobrial.²
Sirolimus Based Maintenance Immunosuppression in Pancreas Transplant Recipients

A. Rajab, R. Pelletier, E. Elkhammas, G. Bumgardner, A. El-Hinnawi, M. Henry.
Six-Month Urinary CCL2 Levels Predict Long-Term Renal Allograft Outcome

J. Ho,¹ D. Rush,¹ A. Gao,¹ H. Hopfer,² C. Wiebe,¹ P. Nickerson,¹ S. Schaub,² P. Hirt-Minkowski.²
Social Support After Heart Transplant

E. Stimpson, T. Kao, L. Kim, S. Morrison, J. Patel, M. Kittleson, F. Liou, S. Siddiqui, J. Yabuno, L. Czer, J. Kobashigawa.
Socioeconomic Factors and Early Hospital Readmission After Kidney Transplant at a Single Center

J. Lin, E. King, R. Craig-Shapiro, C. Wickliffe, A. Massie, D. Segev.
Socioeconomic Predictors of Organ Donation in Pediatric Donors

M. Shah, V. Vilchez, A. Goble, E. Maynard, R. Gedaly.
Somatostatin (Eumedica®) Infusion Allows Modulating Graft Flows and Gradients in Liver Transplantation. Results of a Randomized, Double Blind, Placebo Controlled Trial

R. Troisi,¹ A. Croo,¹ E. Codarin,³ E. De Wolf,¹ J. Van Limmen,⁴ G. Antoniali,³ B. Heyse,⁴ L. De Baerdemaeker,⁴ I. Colle,⁵ G. Tell,³ M. Sainz-Barriga.^1,2
South Asians Have a Higher Risk of PTDM and Death After Renal Transplantation

D.-A. Moutzouris, L. Kozia, M. Willicombe, R. Corbett, N. Duncan, J. Galliford, A. McLean, D. Taube.
Spironolactone Prevents Calcineurin Inhibitors Toxicity in Renal Allografts. Preliminary Report

J. Martinez, I. Vargas, B. Chagolla, A. Ramirez, J. Bermudez.
Split and Living Donor Versus Whole Liver Transplantation for Hepatocellular Carcinoma in Adult Recipients: A Single Center Analysis

O. Boillot, O. Guillaud, J. Dumortier.
Stability of Kidney Allograft Function Is Improving Over Time Across All Donor Types

J. Gill, J. Dong, C. Rose, J. Gill.
Stem Cell and Novel Biologic Therapies to Enhance Functional Recovery in Limb Transplantation

K. Kniery, M. DeHart, T. Brown, S. Salgar.
Steroid-Free Quadruple Induction Regimen With Basiliximab, Everolimus, Mycophenolate and Very Low Dose Tacrolimus Reduces Incidence of Biopsy-Proven Acute Rejection and Toxicity Profile Compared to the Standard Triple Regimen

M. Miura, H. Higashiyama.
Structural and Functional Basis for Non-HLA Antibody Mediated AT1R Activation

D. Dragun, D. Postpieszala, N. Zhu, R. Catar, A. Philippe.
Suboptimal Vaccination Coverage After Liver Transplantation: Opportunity for Improvement

L. Danziger-Isakov, S. Blum, G. Paulsen, M. Lake, R. Rengering, M. Duncan, J. Zigmond, K. Campbell, J. Bucuvalas.
Successful Consolidation of Two Kidney/Pancreas Transplant Programs

D. Morgan, A. Tietjen, S. Mulgoankar.
Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 48

K. Budde,¹ C. Sommerer,¹ P. Weithofer,¹ O. Witzke,¹ M. Guba,¹ J. Jacobi,¹ B. Vogt,³ I. Hauser,¹ R. Stahl,¹ P. Reinke,¹ T. Rath,¹ D. Baeumer,² M. Porstner,² M. Zeier,¹ F. Lehner,¹ W. Arns.¹
Survival Benefit of Liver Transplant Among HIV+ Waitlist Candidates

C. Durand,¹ S. Gustafson,² J. Locke,³ J. Snyder,² B. Shelton,³ R. Reed,³ P. MacLennan,³ S. Mehta,³ A. Nellore,³ D. Segev.^1,2
Survival Benefit of Simultaneous Liver Kidney (SLK) Transplant in Liver Transplant Candidates With Renal Dysfunction

B. Tanriover,¹ S. Zhang,² J. Marrero.³
Survival Outcomes of Kidney Transplant Recipients from Expanded Criteria Donors: A Systematic Review and Meta-Analysis

A.-H. Querard,^1,2,3 F. Gillaizeau,^1,3 Y. Foucher,^1,3 E. Dantan,³ D. Larmet,¹ M. Lorent,³ L.-M. Pouteau,¹ C. Combescure,⁴ M. Giral.^1,3,5
Systematic Medical Record Review to Identify Safety Risks in Living Liver Donors

B. Platt,⁵ D. Woods,⁵ R. Fisher,² J. Guarrera,³ E. Pomfret,⁴ M. Simpson,⁴ A. Daud,¹ T. Curtis,⁵ E. Reyes,⁵ E. Wymore,⁵ A. Skaro,¹ D. Ladner.¹
Systemic and Local NK and Regulatory Cell Phenotypes and mTori-Induced Tumor-Specific Effector T-Cell Responses Are Key Players Favoring the Development of Squamous Cell Skin Carcinoma Among Kidney Transplant Patients

E. Crespo,¹ M. Lucia,¹ L. Fernandez,³ E. Melilli,² S. Luque,¹ R. Lauzurica,³ J. Cruzado,^1,2 J. Torras,^1,2 J. Grinyó,^1,2 O. Bestard.^1,2
T Cell Specific Up Regulation of Nrf2 Regulated Antioxidant Response Protects from Kidney Ischemia Reperfusion Injury in Mice

S. Noel,¹ M. Martina,² S. Bandapalle,¹ S. Reddy,³ L. Racusen,² A. Hamad,² H. Rabb.¹
T Cell Transfer With iNKT Cell Activation Facilitate Engraftment of Bone Marrow Cells Without GvHD

R. Ishii,¹ T. Hirai,¹ S. Miyairi,¹ M. Ikemiyagi,¹ K. Omoto,¹ Y. Ishii,² K. Tanabe.¹
T-Cell Depletion Versus Interleukin-2 Antagonists in a Kidney Transplant Model of Sensitized Rhesus Macaques

C. Burghuber,^1,2 J. Kwun,¹ E. Page,¹ F. Leopardi,³ A. Gibby,¹ A. Farris,¹ N. Iwakoshi,¹ S. Knechtle.¹
T-Cell Immune Function Vs. Gene Expression Profiling for Heart Transplant Rejection

M. Luu, M. Kittleson, J. Patel, F. Liou, S. Siddiqui, L. Piponniau, A. Hage, D. Chang, L. Czer, A. Trento, J. Kobashigawa.
T-bet Directs nTreg Homing Into Draining Lymph Nodes by Regulation of Specific Migration and Adhesion Receptors

Y. Xiong, S. Ahmad, D. Iwami, C. Brinkman, J. Bromberg.
TGR5 Regulates Innate Immune Responses in Mouse Liver Ischemia-Reperfusion Injury Through NRF2/HO-1 Signaling Pathway

J. Rao, B. Hao, X. Wang, F. Zhang, L. Lu.
Tacrolimus for the Treatment of Refractory Biopsy-Proven Acute Cellular Rejection in Patients on Belatacept-Based, CNI- and Steroid-Free Immunosuppression Regimens

K. Trobaugh,¹ A. Shields,^1,2 S. Tremblay,¹ R. Alloway,¹ M. Cardi,² D. Witte,¹ F. Paterno,¹ M. Cuffy,¹ E. Woodle.¹
Technical Aspects of Reconstruction of Middle Hepatic Vein and Multiple Inferior Right Hepatic Veins Using Dual Artificial Vascular Grafts in Right Lobe Living Donor Liver Transplantation: “V-Plasty” Technique for Common Outflow Reconstruction Vs Second IVC Anastomosis

P.-C. Li, L. Jeng, A. Thorat, H.-R. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu.
Temporal Increase in the Incidence of Post-Transplantation Lymphoproliferative Disorder in Adult Renal Transplant Recipients: Analysis of 2 US Insurance Administrative Claims Databases

T. Kou, H.-U. Meier-Kriesche, J. Preston, A. Gomez.
Ten-Year Follow-Up After Live Kidney Donation – A Prospective Cohort Study

S. Janki,¹ K. Klop,¹ I. Dooper,² W. Weimar,³ J. IJzermans,¹ N. Kok.¹
The 20S Proteasome Is Active in Apoptotic Nanovesicles and Controls Anti-LG3 Antibody Production

M. Dieudé,^1,4 C. Bell,^2,4 J. Turgeon,^1,4 D. Beillevaire,^1,4 K. Hamelin,^1,4 S. Qi,^1,4 N. Pallet,^1,4 C. Rondeau,³ D. Gingras,³ M. Desjardins,³ P. Thibault,^2,4 M.-J. Hébert.^1,4
The Association Between Donor & Recipient Gene Variants and Tacrolimus Safety & Efficacy in a Diverse Cohort of Kidney Transplant Recipients

D. Taber, T. Srinivas, N. Pilch, M. Gebregziabher, L. Egede, P. Baliga, K. Chavin.
The Association of Basiliximab and Antithymocyte Globulin Induction With Delayed Graft Function

D. Felix,¹ B. Astor,² D. Hager,¹ A. Djamali.²
The Association of Systemic Indoleamine 2,3 Dioxygenase (IDO) Activity Simultaneous With Chronic Rejection On Allograft Kidney Biopsy

V. Dharnidharka, L. Hesemann, J. Mitsios, H. O'Gorman, M. Gunasekaran, D. Dietzen, T. Mohanakumar.
The Burden of Caregiving for Living Kidney Donors

H. Maple, N. Mamode.
The Characteristics of Post-Operative Deep Vein Thrombosis in Kidney Transplant Recipients – Difference from Other Type of Surgery

J. Kim,¹ I. Moon,¹ M.-H. Kim,¹ K. Park,² S. Ahn,³ S. Park,⁴ S.-D. Kim,⁵ S. Kim.⁶
The Clinical Outcome of Plasma Cell-Rich Rejection of Kidney Allograft

J. Hasegawa,¹ K. Honda,² S. Wakai,¹ H. Shirakawa,³ M. Okumi,³ K. Omoto,³ H. Ishida,³ K. Tanabe.³
The Correlation Between Donor Specific Antibodies and Heart Transplant Rejection

R. Bedard,¹ P. Jindra,² M. Manson,¹ M. Moaddab,¹ H. Mallidi,³ W. Etheridge,¹ A. Civitello,³ R. Kerman.²
The Design and Implementation of a Genome-Wide Genotyping Array Tailored for Transplantation

B. Keating,¹ A. Israni,² Y. Li,¹ M. Holmes,¹ K. Birdwell,³ F. Asselbergs,⁴ A. Shaked.¹
The Donor Risk Index Does Not Accurately Classify Patients With or Without Graft Failure

E. Franco,¹ T. Athanasios,² N. Kemmer,³ L. Leone,¹ A. Alsina,¹ B. Djulbegovic.²
The Effect of Changing Candidate Demographics on Living Donor Kidney Transplant Rates

G. Vranic, A. Nishio Lucar, D. Keith.
The Effect of Systemic Catecholamine Application On the Microcirculation in Liver Procurement

M. Strempel,¹ M. Kaths,¹ H. Lang,¹ G. Otto,¹ V. Weyer,² O. Kempski,³ A. Heimann,³ A. Schad,⁴ D. Foltys.¹
The Effects of Dialysis Vintage and Hypertensive Renal Failure on Colonoscopy Findings During Kidney Transplant Evaluation

Y. Zheng,¹ K. Chaung,¹ P. Park,¹ J. Augustine,² N. Sarabu,² J. Schulak,² E. Sanchez,² V. Humphreville,² J. Ammori,² K. Woodside.²
The Effects of Donor Specific Anti- Human Leukocyte Antigen Antibodies Late After Heart Transplantation

M. Kittleson, J. Patel, F. Liou, S. Siddiqui, A. Fong, M. Johnson, D. Chang, L. Czer, F. Esmailian, N. Reinsmoen, J. Kobashigawa.
The Effects of Periostin on Renal Fibrosis After Ischemia-Reperfusion Injury Via p38 MAPK Pathway

J. An,^1,2 S. Yang,³ J. Hwang,⁴ J. Kim,¹ S. Kim,^2,5 C. Lim,^1,2 Y. Oh,^1,2 Y. Kim,² J. Lee.^1,2
The Effects of Various Cardiac Preservation Solutions on Survival After Heart Transplantation

C. Evans, K. Rajagopal, P. Sanchez, S. Rahimpour, F. Cheema, R. Pierson III, B. Griffith, S. Pham.
The Epidemiology of Surgical Site Infections Among Pediatric Liver Transplant Recipients

D. Banach,¹ A. Munoz-Abraham,² L. Dembry,¹ M. Rodriguez-Davalos.²
The Explore Transplant Program in GA: Is Historical Access to Transplantation Associated With Kidney Transplant Knowledge and Preparedness to Educate ERSD Patients?

J. Gander,¹ C. Isenhour,¹ L. McPherson,¹ M. Basu,¹ B. Tao,¹ K. Smtih,¹ S. Pastan,¹ A. Waterman,² R. Patzer.¹
The Feasibility of Utilising DCD Kidneys for Paediatric Recipients: Early Outcomes

Z. Ahmed,¹ R. Batra,¹ S. Marks,³ H. Jones,⁴ N. Mamode.¹
The Immunogenic Perlecan Fragment LG3 Is Released Through Apoptotic Extracellular Vesicles Downstream of Caspase-3 Activation

D. Beillevaire,¹ J. Turgeon,¹ D. Gingras,² é. Boilard,³ M. Dieudé,¹ M.-J. Hébert.¹
The Immunosuppressive Effect of CTLA4Ig Monotherapy Depends On the Presence of Tregs Only at Suboptimally Low Doses

C. Schwarz,¹ L. Unger,¹ B. Mahr,¹ K. Aumayr,² N. Pilat,¹ K. Hock,¹ A. Farkas,¹ I. Kristo,¹ T. Wekerle.¹
The Immunosuppressive Effects of Erythropoietin Do Not Confer Lower Rates of Acute Rejection in Post Kidney Transplant Recipients Receiving Darbepoetin

B. Fischbach,¹ S. Gonzalez,¹ A. Yango,¹ A. Chandrakantan,² A. Rajagopal,² K. Rice,² L. Melton,² Y. Barri,² M. Saim,² N. Onaca,¹ R. Ruiz,¹ M. Levy,¹ G. Klintmalm.²
The Impact of Administrating Everolimus Before Cytomegalovirus Infection to Prevent CMV Recurrence in Heart Transplant Recipients

M. Ishida, K. Toda, T. Nakamura, S. Miyagawa, Y. Yoshikawa, S. Fukushima, S. Saito, D. Yoshioka, K. Kubota, T. Ueno, T. Kuratani, Y. Sawa.
The Impact of Alemtuzumab and Basiliximab Induction On Patient and Graft Survival in Single Lung Transplant Recipients

Y. Furuya,¹ S. Jayarajan,² S. Taghavi,² V. Ambur,² F. Cordova,³ N. Patel,³ Y. Toyoda.⁴
The Impact of CDC High Risk Donors on Patient and Graft Survival After Liver Transplantation

D. Moonka, A. Yoshida, A. Taylor.
The Impact of Center Size on Outcome of Pancreas Transplants

A. Gruessner,¹ R. Gruessner.²
The Impact of Center Volume on Simultaneous Kidney-Pancreas Transplantation Outcomes

A. Malone,¹ D. Brennan,¹ J. Wellen,² T. Alhamad.¹
The Impact of Critical Illness and Pre-Transplant Hospitalization on Cost of Liver Transplantation

S. Knechtle, L. Brummett, S. Perez.
The Impact of Cytokine Release Caused By Induction Immunosupression On Nitric Oxide in Renal transplantation

R. Johns,^1,2 M. Laftsidis,² E. Burrows,² F. Edwards,² E. Ablorsu,² P. James,¹ A. Phillips,^1,2 A. Asderakis.²
The Impact of Delayed Graft Function (DGF) and Acute Rejection (AR) on the Decline in Allograft Function After Kidney Transplantation

J. Gill, J. Dong, C. Rose, J. Gill.
The Impact of Donor Alcohol Intake on Pancreatic Graft Survival

R. Motallebzadeh,¹ M. Drage,² J. Olsburgh,² C. Callaghan.²
The Impact of Donor and Recipient Weight Incompatibility on Outcomes in Renal Transplantation

L. Wong,¹ S. Moran,¹ A. Counihan,² P. Cunningham,² P. O'Kelly,¹ P. Conlon.¹
The Impact of FcγRIIA, FcγRIIIA and C1QA Genes Polymorphism On Infectious Complications Following Renal Transplantation

L. Das, Y. Tanaka, S. Verma, S. Shimizu, K. Ide, H. Ohdan.
The Impact of HCV on Post Transplant Biliary Strictures

N. Kemmer, E. Franco, A. Turner, C. Albers, J. Horkan, E. Parkinson, E. Cece, A. Alsina.
The Impact of Hypertension, Chronic Pain, and Fatigue on Long-Term Quality of Life After Living Kidney Donation

T. Schachtner,^1,2 P. Reinke.^1,2
The Impact of Ischemia/Reperfusion Injury On Liver Allografts from Deceased After Cardiac Death Versus Deceased After Brain Death Donors

B. Sayed, J. Xu, A. Casas-Ferreira, P. Srinivasan, N. Heaton, Y. Ma, C. Legido-Quigley, S. Fuggle, W. Jassem.
The Impact of MYH9 Polymorphic Variant rs5756168 on Kidney Allograft Function

J. Pazik,¹ M. Oldak,² Z. Lewandowski,³ D. Ozieblo,⁴ K. Michalska,⁵ E. Sitarek,¹ A. Sadowska,¹ M. Nowaczyk,⁵ T. Grochowiecki,⁶ J. Malejczyk,⁴ M. Durlik.¹
The Impact of Metabolic Syndrome and Prevalent Liver Disease on Living Donor Liver Transplantation: A Pressing Need to Expand the Pool

W. Al-hamoudi,^1,2 F. Abaalkhail,² A. Bendahmash,¹ N. Allam,² N. Almasri,² H. Al-Bahili,² M. Al-Sebayel,² D. Broering,² H. Elsiesy.²
The Impact of Perioperative Bleeding on Long-Term Outcomes of Mechanical Circulatory Support

K. Lietz,¹ M. Mooney,¹ I. El Lakkis,² C. Derber,² U. Kelly,² C. Wilson,² A. Hoedt,¹ P. Bourassa,¹ B. Smith,¹ M. McGrath,¹ J. Herre.¹
The Impact of Preoperative Antimicrobial Prophylaxis on Device-Related Infections in Recipients of Long-Term Mechanical Circulatory Support (MCS)

I. El Lakkis,¹ K. Lietz,² C. Derber,¹ U. Kelly,¹ C. Wilson,¹ A. Hoedt,² P. Bourasssa,² B. Smith,² M. McGrath,² J. Herre,² M. Mooney.¹
The Impact of Ureteral Complications After Pediatric Renal Transplantation

J. Finkelstein,¹ J. Pak,¹ N. Jain,¹ P. Sandoval,² S. Alam.¹
The Impact of the Arterial Reconstructions On the Living Donor Kidney Graft

T. Hiramitsu, K. Futamura, M. Okada, K. Ito, M. Tsujita, N. Goto, S. Narumi, Y. Watarai.
The Influence of Immunosuppressive Drugs On the Epithelial Microenvironment in Solid Organ Transplantation – Identification of Biomarker Candidates for Rejection Vs. Tolerance

A. Akhdar,¹ B. Mueller,² C. Neudoerfl,¹ F. Lehner,³ M. Stevanovic-Meyer,¹ K. Daemen,¹ J. Keil,¹ H. Haller,⁴ C. Blume,^4,5 C. Falk.^1,6
The Liver X Receptor Alpha (LXRα) Knockout Protect Liver Against Ischemia-Reperfusin Injury in Mice

T. Lu,¹ D. Li,¹ J. Zhang,¹ M. Zhang,¹ X. Cui,¹ H. Dai,¹ X. Liu,² Q. Xia.¹
The Natural History of Kidney Graft Cortical Microcirculation Determined by Real-Time Contrast-Enhanced Sonography (RT-CES)

C. Jiménez,¹ M. López,¹ A. Ros,¹ A. Aguilar,¹ D. Menendez,¹ B. Rivas,¹ M. Santana,¹ R. Madero,² R. Selgas.¹
The Negative Impact of Hepatitis C Infection (HCV+) On Orthotopic Liver Transplantation (OLT) for Hepatocellular Carcinoma (HCC)

A. Daoud,^1,3 L. Teeter,² E. Graviss,² S. Burroughs,¹ A. Gaber.¹
The Onset of Post-Transplant Malignancies Is Related to a Change in Gene Expression Profiles in Peripheral Blood Mononuclear Cells

G. Stallone,¹ R. Federica,¹ P. Pontrelli,² M. Accetturo,² A. Oranger,² M. Gigante,² G. Castellano,² A. Schena,² M. Fiorentino,² B. Infante,¹ L. Gesualdo,² G. Grandaliano.¹
The Outcome of Carbapenemase-Producing Enterobacteriaceae (CPE) Infection in Adult Solid Organ Transplant Population at a University Teaching Hospital

H. Sharma, A. El-Bakry, V. Venkat, S. Papachristos, P. Otilla, R. Dhanda, B. Forgacs, A. Tavakoli, R. Pararajasingam.
The Penalty Faced By Native Americans in Kidney Transplantation: Decreased Access and Reduced Long-Term Survival

S. Stith,¹ F. Barrantes,² K. Piorkowski.¹
The Potential Use of the Plasma Biomarker CXCL9 (MIG), Interleukin 2 Receptor alpha (IL2Rα) and SCGF-b as Predictors of Renal Graft Rejection

C. Blume,¹ S. Michael,² N. Christine,³ H. Hermann,⁴ F. Christine.³
The Potential of E-Health to Improve Adherence: Exploring the Patients' View

D. Slaats,¹ M. Tielen,¹ M. Laging,¹ T. van Gelder,² W. Weimar,¹ E. Massey.¹
The Predictive Value of the Proliferation Marker Ki-67 in Patients With Fulminant Hepatic Failure

A. Shah,¹ U. Joneja,² D. Walls,¹ J. Farber.²
The Preservation Technique Modulates the Immunological Milieu in Lung Transplantation and Affects the Pro-/ Anti-Inflammatory Balance

M. Seyda,¹ B. Wiegmann,³ B. Mueller,² C. Neudoerfl,¹ A. Akhdar,¹ K. Daemen,¹ A. Haverich,^3,4 G. Warnecke,^3,4 C. Falk.^3,5
The Product of Donor Age and Preoperative MELD, D-MELD, Predicts Surgical Outcomes After LDLT, When Using Small Graft

A. Tanemura, S. Mizuno, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, M. Usui, H. Sakurai, S. Isaji.
The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Solid Organ Transplant Recipients: A Systematic Review

M. AlDabbagh,^1,2 M. Gitman,³ D. Kumar, A. Humar, C. Rotstein, S. Husain.^1,3
The Role of Inflammasome Components in Renal Tubular Epithelial Cell Injury

S. Kasimsetty, A. Shigeoka, D. McKay.
The Role of Skin-Specific Immunobiology and Major Histocompatibility Complex Sharing in Vascularized Composite Allograft Tolerance

D. Leonard, K. Shanmugarajah, H. Powell, A. Albritton, C. Mallard, D. Sachs, C. Cetrulo, Jr., J. Kurtz.
The Role of an Intragraft Vascularized Bone Marrow Niche in Establishing Mixed Chimerism and Allograft Acceptance

M. Fryer, B. Oh, G. Furtmüller, G. Raimondi, G. Brandacher.
The Role of the Incretin Effect After Pancreas Transplantation

S. Mittal,¹ R. Franklin,¹ E. Sharples,¹ F. Knop,² J. Holst,² S. Gough,¹ P. Friend.¹
The Synergistic Effect of Class II HLA Epitope-Mismatch and Non-Adherence on Acute Rejection and Graft Survival

C. Wiebe,^1,2 T. Nevins,³ W. Robiner,^3,4 W. Thomas,⁵ A. Matas,⁶ P. Nickerson.^1,2,8
The Use of Bortezomib for Desensitization in ABO Incompatible and Positive Crossmatch Kidney Transplant

J. Benken,¹ S. Akkina,² E. Benedetti.³
The Use of Systems Biology to Identify Mitochondrial Dysfunction and Metabolic Dysregulation as Targets for Intervention in the Brain Dead Organ Donor

M. Akhtar, L. Lo Faro, R. Robelledo, M. Kaisar, H. Huang, H. Leuvenink, P. Friend, S. Fuggle, C. Pugh, R. Ploeg.
The Use of a Nurse Practitioner Led Transitional Diabetes Clinic Following Transplantation

N. Cardinez, P. Segal, S. Trohonel.
The Utility of Non-Invasive Intra Abdominal Pressure Monitoring After Pediatric Abdominal Organ Transplantation

E. Harkin,¹ M. McLeod,¹ K. Khan,² A. Natarajan.³
The Value of Perfusion Fluid Culture Analysis in Deceased Donor Renal Transplants. 5 Years Single Centre Experience

A. Al Midani, S. Collier, K. Welman, B. Fernando, B. Lindsey, C. Forman, N. Banga.
The Value of Surveillance Testing for De Novo Donor Specific Antibodies Following Renal Transplantation

O. Pankewycz,¹ M. Laftavi,² M. Said,² K. Chapin,² L. Feng.²
The use of Donation After Cardiac Death Liver Allografts does not increase Recurrence of Hepatocellular Carcinoma

K. Croome, D. Lee, J. Burns, J. Nguyen, D. Perry, D. Harnois, C. Taner.
Third Party Mesenchymal Stromal Cell Infusion in Kidney Transplant Recipient: 6-Month Safety Interim Analysis

L. Weekers,¹ P. Erpicum,¹ O. Detry,³ C. Lechanteur,² E. Baudoux,² F. Jouret,¹ Y. Beguin.²
Tissue Distribution, Preparation and Phenotype Characteristics of Stem Cells Originated from the Organs of Deceased Human Individuals

A. Klimczak,¹ T. Jurek,² M. Czuba,² U. Kozlowska,¹ M. Rorat,² K. Wrzeszcz.¹
Tissue Engineering Human Kidneys for Costimulation Blockade

L. Brasile,¹ N. Henry,¹ A. Meyer,¹ B. Stubenitsky.²
Toxicity Driven Conversion to Belatacept in Kidney Transplant Recipients

E. Cohen, W. Asch, R. Formica, E. Tichy.
Transient Lymphopenia Breaks Costimulatory Blockade-Based Transplant Tolerance and Initiates Allograft Rejection

S. Iida,¹ T. Suzuki,² K. Tanabe,¹ A. Valujskikh,³ R. Fairchild,³ R. Abe.²
Transplant Glomerulopathy in a Novel Model of Chronic Antibody Mediated Rejection Is Associated With DSA and Glomerular IgM

S. Panzer,¹ S. Reese,¹ N. Wilson Schlei,¹ W. Zhong,² A. Djamali.¹
Transplantation of Kidneys from Donors With Acute Renal Failure: Five-Year Results from Double Center Experience

C. Ramirez,^1,2 A. Safra,¹ A. Shah,^1,2 C. Doria,¹ W. Maley,¹ A. Frank,¹ C. Gorn,¹ L. Lerner.²
Treatment With Everolimus and Reduced-Exposure Cyclosporine Is Efficacious in De Novo Renal Transplant Recipients at Increased Risk for Efficacy Failure: Post-Hoc Analysis from the A2309 Study

M. Carmellini,¹ V. Garcia,¹ Z. Wong,² M. Vergara,² C. Escrig,² G. Russ.¹
Type III Phosphodiesterase (PDE3) Inhibitor Improves Survival Rate After Ischemia Reperfusion Injury of the Liver in Rats

T. Fujii,¹ H. Obara,² N. Fujimura,² K. Matsubara,² Y. Kitagawa.²
Type of Caregiver and Outcome After Mechanical Circulatory Support Placement

H. Henry, F. Arabia, M. Kittleson, L. Czer, E. Passano, J. Yabuno, S. Siddiqui, E. Antifantis, D. Chang, J. Kobashigawa.
U.S. National Experience of Liver Transplantation Using Allografts from Octogenarian Donors

C. Bhati, I. Tzvetanov, R. Garcia-Roca, J. Oberholzer, E. Benedetti, H. Jeon.
U.S. Population Characteristics Impacting Rates of Organ Donation

B. Schleich,¹ S. Yoon,¹ M. Khasawneh,¹ K. Srihari,¹ W. Tajik,² H. Irving.²
Unknown Urological Pathologies in Renal Allografts from Deceased Donors. Should Image Evaluation Be Routinely Performed?

K. Yamaçake, W. Nahas, I. Antonopoulos, H. Kanashiro, R. Kato, A. Bull, R. Falci, A. Piovesan.
Unrecognized Synchronous Hepatocellcular Carcinoma Lesions in Explanted Liver Transplant Specimens

D. Aufhauser, Jr.,¹ K. Eddinger,¹ E. Furth,² P. Abt,¹ M. Levine.¹
Urinary Cell-Free DNA Is a Sensitive Marker of Early Renal Transplant Injury

T. Sigdel, T. Tran, S.-C. Hsieh, M. Sarwal.
Use of MELD Exception Points in Patients With Hepatic Neuroendocrine Tumor Metastases: Variable Use and Proposed Criterion for Approval

Y. Nobel,¹ D. Goldberg.^2,3,4
Use of RNA Sequencing for Discovery of Markers of Accommodation in Surveillance Biopsies from Recipients of an ABO-Incompatible Renal Transplant

A. McLean,² K. Dominy,¹ A. Sosinsky,¹ M. Mueller,¹ J. Galliford,² T. Cook,^1,2 C. Roufosse.^1,2
Utility and Outcomes of Expanded Screening Among Live Solid Organ Donors

A. Rosen, B. Ho, M. Ison.
Utilization and Characteristics of Kidney Donors in the US by OPTN-Defined Increased Risk Donor Status

M. Ison,^1,2 B. Ho,² J. Leventhal,² D. Ladner.²
Utilization and Characteristics of Liver Donors in the US by OPTN-Defined Increased Risk Donor Status

M. Ison,^1,2 M. Abecassis,² D. Ladner.²
Utilization of Kidneys from Deceased Donors With Acute Kidney Injury

M. Aull, S. Sultan, J. Kim, A. Watkins, D. Dadhania, S. Kapur.
Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report

M. Asolati,¹ C. Kulig,² B. Bilir,² T. Pillen,¹ P. Gauthier,² B. Bista,² T. Heffron.¹
Utilization of Medicare Part D Among Transplant Recipients

M. Chisholm-Burns, C. Spivey.
Utilizing CDC High Risk Donors to Improve Outcomes in Liver Transplantation

V. Fleetwood, J. Lusciks, M. Hertl, E. Chan.
Vaccine Responses in Combined Hematopoeitic Stem Cell-Kidney Transplant Recipients

C. Feng,¹ M. Ison,¹ J. Galvin,¹ S. Ildstad,^2,3 D. Stare,¹ J. Leventhal.¹
Validating Outcomes Reported to the Organ Procurement and Transplantation Network for Deceased Donor Kidney Recipients

V. Potluri,¹ C. Parikh,² I. Hall,² J. Ficek,² M. Doshi,³ I. Butrymowicz,² F. Weng,⁴ B. Schröppel,⁵ H. Thiessen-Philbrook,⁶ P. Reese.⁷
Validation of a Blood and Biopsy Gene Expression-Based Molecular Diagnostics for Subclinical Acute Rejection: Comparing DNA Microarrays Vs. Next-Generation RNA Sequencing

S. Kurian,¹ J. Friedewald,² F. Harrison,¹ T. Gelbart,¹ S. Head,¹ P. Ordoukhanian,¹ M. Abecassis,² D. Salomon.¹
Validation of a Peripheral Blood Gene Expression Profile for SubClinical Acute Rejection in Kidney Transplant Recipients – Findings from the CTOT 08 Study

J. Friedewald,¹ S. Kurian,² T. Gelbart,² D. Salomon,² M. Abecassis.¹
Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers

D. Hoyer,¹ A. Gallinat,¹ T. Minor,² F. Saner,¹ P. Kocabayoglu,¹ J. Treckmann,¹ A. Paul.¹
Variability in Incidence of Clostridium difficile Infections and Associated Mortality Among Solid Organ Transplant Recipients

N. Piccicacco, C. Doligalski, A. Logan.
Variants Associated With Tacrolimus Troughs in European American Kidney Transplant Recipients: A Genome Wide Association Study

P. Jacobson,¹ M. Miller,² D. Schladt,³ A. Israni,³ K. Sanghavi,¹ C. Dorr,³ R. Remmel,¹ W. Guan,⁴ A. Matas,⁵ W. Oetting.¹
Verification of OPTN Hepatocellular Carcinoma Recurrence Data

J. George,¹ K. Eddinger,¹ D. Goldberg,² M. Levine,³ P. Abt.³
Vitamin D Deficiency and Hypertension in Pediatric Kidney Transplant Patients: Could We Be Doing More?

K. Twombley,² O. Moussa.¹
Vitamin D Deficiency in Liver Transplant Recipients: Prevalence, Risk Factors, and Outcomes

T. Joson, T. Schiano, A. Mehrotra.
Vitamin D Supplementation and Acute Rejection Following Kidney Transplantation

T. Horwedel,¹ K. Botkin,¹ J. Hagopian,¹ L. Bowman,¹ D. Brennan.²
What Can UNOS Data Tell Us About Patient Outcomes After Primary Renal Allograft Failure?

A. Frank,¹ A. Shah,¹ P. Singh.²
Where Does It End? Outcome of the Rejected Kidney Offers for Potential Renal Transplant and Their Outcome. A Single Centre Experience

A. Ghazanfar, M. Al Azeez, M. Morsy, A. Bagul.
Which Place of Pancreas Graft Biopsy in the Management of Pancreas Transplant Recipients?

F. Buron, M. Rabeyrin, O. Rouvière, S. Reffet, C. Chauvet, O. Thaunat, M. Brunet, R. Cahen, S. Daoud, C. Pouteil-Noble, R. Codas, L. Badet, E. Morelon.
Why Patients Are Unwilling to Ask for a Living Donor: A Mixed Methods Study

A. Waterman,¹ C. Kynard-Amerson,¹ A. Parnicky,¹ E. Schenk,² J. Chahal,¹ J. Peipert.¹
mTOR Inhibitors Reduce the Endothelial Transmigration of Leukocytes After Ischemia

I. Werner, A. Hernandez-Sierra, F. Guo, A. Moritz, A. Beiras-Fernandez.
mTOR-Based CNI Minimization Vs Withdrawal in African American Kidney Transplant Recipients

J. Fleming,¹ D. Taber,² N. Pilch,¹ H. Meadows,¹ C. Mardis,¹ J. McGillicuddy,² S. Nadig,² K. Chavin,² P. Baliga,² C. Bratton.²
miR-155 Different Roles in UCB iTreg and nTreg

Y. Lu, L. Lu.
“2mm” Is Reasonable and Feasible Cutoff Value of Indication for Vascular Reconstruction in a Kidney Allograft With Multiple Arteries

D. Iwami, K. Morita, H. Sasaki, Y. Oishi, H. Higuchi, N. Shinohara.
“Unexpected” Positive Crossmatchs in Zero-HLA-A-B-DR Mismatched or HLA-DR-Matched Organs

K. Haarberg,¹ M. Cusick,¹ M. Abecassis,¹ A. Jaramillo,² B. Kaplan,³ A. Tambur.¹
hTERT, BICD1 and Chromosome 18 Polymorphisms Affecting Telomere Length Are Associated With Kidney Transplantation Outcome

L. Domanski,¹ K. Kloda,¹ K. Safranow,² A. Drozd,³ K. Ciechanowski,¹ A. Ciechanowicz.⁴
A 10 Min “No-Touch” Time – Is It Enough in DCD? A DCD Animal Study

M. Sereinigg,¹ V. Stadlbauer,² T. Seifert-Held,³ F. Iberer,¹ P. Stiegler.¹
A Clinical Signature Surrogate of Histological Lesions to Avoid Unnecessary One Year Surveillance Biopsy After Renal Transplantation

E. Dantan, K. Renaudin, S. Brouard, A. Huneau, C. Paul, M. Giral.
A Comparison of Alemtuzumab and Antithymocyte Globulin Induction in High-Risk, Non-Sensitized African American Renal Transplant Recipients

M. Janusek,¹ S. Patel,² K. Galen,¹ P. West-Thilke,¹ E. Benedetti,¹ J. Thielke.¹
A New Diagnostic and Pronostic Tool for Antibody Mediated Rejection in Kidney Transplantation: Intragraft Donor Specific Anti-HLA Antibodies Detection

J. Olagne,^1,2,3 A. Parissiadis,² S. Caillard,¹ N. Froelich,² L. Marcellin,³ C. Muller,¹ G. Gautier-Vargas,¹ P. Perrin,¹ L. Braun-Parvez,¹ F. Heibel,¹ C. Gachet,² B. Moulin.¹
A Novel DSA Flow Cytometer Crossmatch (DSA-FXM) to Eliminate Ambiguous Auto- and Allo-FXM Results

G. Chen, L. Lin, D. Tyan.
A Novel Maintenance Regimen With Calcineurin Inhibitor, MMF and Everolimus Initiated By Dual Induction Therapy With Anti-CD20/25 Antibodies in Renal Transplantation

N. Masaki, K. Iwado, I. Nakagima, S. Fuchinoue.
A Novel Post-Transplant High-Dose Cyclophosphamide-Based Regimen to Promote Immune Tolerance After VCA

G. Furtmüller,¹ M. Fryer,¹ B. Oh,¹ S. Ganguly,² J. Izzi,³ D. Cooney,¹ G. Raimondi,¹ W. Lee,¹ L. Luznik,² G. Brandacher.¹
A Prospective Pilot Study Evaluating the Safety and Efficacy of Everolimus for the Prevention of CMV and BK Viral Infection (BKV) in Broadly Sensitized Kidney Transplant Recipients Following Desensitization With IVIG and Rituximab: Interim Analysis

J. Kahwaji,¹ S. Louie,¹ A. Vo,¹ J. Choi,¹ M. Toyoda,² S. Ge,² P. Wongsaroj,¹ A. Peng,¹ R. Villicana,¹ S. Jordan.¹
A Relative Survival Model to Compare the Risk of Mortality in Patients Awaiting Kidney Transplantation Versus Already Transplanted Patients

M. Lorent,^1,2 K. Trébern-Launay,^2,1 C. Legendre,⁴ H. Kreis,⁴ G. Mourad,⁵ V. Garrigue,⁵ L. Rostaing,⁶ N. Kamar,⁶ M. Kessler,⁷ M. Ladrière,⁷ E. Morelon,⁸ F. Buron,⁸ M. Giral,^2,3 Y. Foucher.^1,2
A Single Center Comparison of Various BK Viremia Elimination Protocols

Y. Qazi, K. Lee, B. Duong, R. Dhawan, L. Shinn, L. Aguirre, C. Parke, C. Wong, S. Alexopoulos, D. Olson, M. Smogorzewski.
Active Immunization in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Preliminary Report of a Prospective Study

W. Ju, A. Yang, Z. Guo, Q. Ren, D. Wang, A. Hu, Y. Ma, H. Jin, X. Zhu, X. He.
Acute Kidney Injury in the Early Post Kidney Transplant Period: Frequency, Etiology and Significance

B. Kiberd,¹ S. Cimen,¹ K. Tennankore.²
Age-Dependent Decline in Glomerular Filtration Rate: A US Population-Based Study

P. Udompap, N.-Y. Heo, A. Mannalithara, W. Kim.
Aging Enhances Immunosuppressives Capacities of Tacrolimus By Functional Changes of CD4+ T-Cells

F. Krenzien,¹ M. Quante,¹ A. ElKhal,¹ H. Uehara,¹ R. Abdi,² B. Slegtenhorst,¹ H. Biefer,¹ S. Tullius.¹
Alemtuzumab Dose Adjusted for Weight Reduces Infection Post-Renal Transplantation

C.-H. Yoon, M. Willicombe, C. Jogia, R. Charif, J. Galliford, A. McLean, D. Taube.
Alemtuzumab in Elderly Renal Transplant Recipients Is Not Associated With a Poor Outcome

D.-A. Moutzouris, L. Koizia, M. Willicombe, R. Corbett, N. Duncan, J. Galliford, A. McLean, D. Taube.
Allograft Enterectomy as a Life-Saving Procedure and Salvage for Retransplantation

S. Nagai, R. Mangus, B. Ekser, C. Kubal, J. Fridell, A. Tector.
Altered Intestinal Microbiome as a Potential Biomarker for Failed Immune-Regulation in Autoimmune Type 1 Diabetes Mellitus

P. Chhabra,¹ A. Spano,² D. Bowers,¹ M. Wu,² L. Langman,¹ M. Timko,² K. Brayman.¹
An Investigation of 12 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation

K. Unagami,¹ D. Toki,¹ M. Okumi,¹ H. Ishigooka,¹ K. Tsujimura,¹ T. Kanzawa,¹ K. Omoto,¹ H. Ishida,¹ K. Nitta,² K. Tanabe.¹
Analytic Morphomics May Identify Risk Factors for New Onset Diabetes After Kidney Transplantation

D. Cron,¹ M. Terjimanian,¹ J. Augustine,² D. Cote,³ K. Noon,³ V. Vaughn,⁴ S. Wang,¹ M. Englesbe,¹ K. Woodside.³
Angiotensin Receptor Antibody IgG1 Subclass Predicts Accelerated Graft Loss in Those Kidney Transplant Recipients Who Develop Biopsy Proven Transplant Glomerulopathy Irrespective of the Presence Or Absence of Donor Specific Anti HLA Antibodies

R. Carroll,¹ A. Phillippe,² D. Dragun,² T. Coates.¹
Anti-Apoptotic But Not Mitotic Effects of 3,3',5-triiodo-l-thyronine in the Liver of Brain Dead Rats

A. van Erp,¹ R. Rebolledo,² J. Wiersema-Buist,¹ P. Ottens,¹ H. Leuvenink,¹ P. Romanque.²
Anti-CD122 + Costimulation Blockade Prolongs Allograft Survival

D. Mathews,¹ L. Higginbotham,¹ Y. Dong,¹ C. Breeden,¹ C. Larsen,¹ J. Tso,² A. Adams.¹
Antibodies Directed Against HLA-DQ Are Significantly Associated to Complement Activation In Vitro

J. Arreola-Guerra, A. de Santiago, A. Arvizu, N. Gonzalez-Tableros, M. Lopez, M. Vilatoba, L. Morales-Buenrostro, J. Alberu, N. Castelan.
Are AT1R Antibodies as Dangerous as HLA-DSAs in Renal Allografts?

E. Cuevas, J. Arreola-Guerra, E. Hernandez-Mendez, I. Salcedo, M. Vilatoba, A. Contreras, A. Sanchez-Cedillo, J. Ramirez, D. de Rungs, J. Granados, L. Morales-Buenrostro, J. Alberu.
Arteriovenous Fistulas/Grafts for Patients With Intestinal Failure: Innovation or Insanity?

G. Vrakas, A. Vaidya, J. Gilbert.
Assessing Transplant Attitudes: Understanding Minority Men's Perspectives on the Multifarious Barriers to Organ Donation

B. Hinck, B. Naelitz, B. Jackson, M. Howard, A. Nowacki, C. Modlin.
Assessment of Actual Pediatric Organ Donation Potential: Neurologic and Circulatory Determination of Death at a Children's Hospital

C. Aguayo,¹ E. Bennett,² J. Sweney,² C. Myrick,¹ S. Bratton.²
Association of De Novo Antibody-Mediated Rejection and Increased Hospital Costs Following Kidney Transplant in Immunologically Low-Risk Patients

S. Kulkarni,¹ I. Hall.²
Attitudes and Beliefs About Organ Donation: Focus Group Study in Arabic-Speaking Communities in Australia

A. Ralph,^1,2 A. Alyami,^3,4 R. Allen,^3,4 K. Howard,¹ J. Craig,^1,2 S. Chadban,^3,4 M. Irving,^1,2 A. Tong.^1,2
Bariatric Surgery Prolongs Allograft Survival by Promoting Th2 Conditions

M. Quante, A. ElKhal, H. Rodriguez, R. Abdi, F. Krenzien, H. Uehara, S. Tullius.
Basiliximab Induction With Delayed Tacrolimus Initiation up to 14 Days Post Liver Transplantation Maintains Excellent Clinical Outcomes While Preserving Renal Function

J. Werth, W. Ally, D. Maluf, S. Pelletier.
Body Mass Index (BMI) Mismatch in Deceased Kidney Donation Is an Independent Risk Factor for Graft Failure

O. Staeck,¹ D. Khadzhynov,¹ M. Mahn,² K. Budde,¹ F. Fuller,² F. Halleck.¹
Bortezomib Treatment in Antibody Mediated Rejection After Kidney Transplantation

J. Lee,¹ J. Lee,¹ B. Kim,² Y. Park,³ M. Ju,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
Burden of Early Antibody-Mediated Rejection (AMR): Complications, Resource Utilization and Cost-Differential in Treatment of AMR

R. Banga,¹ C. Schinstock,¹ A. Boscoe,⁴ M. Hathcock,³ W. Kremers,³ M. Stegall.²
CXCR4-SDF1α Blockade Reduces the Severity of Murine Heart Allograft Rejection

X. Wang,¹ J. Fu,¹ B. Wilde,¹ L. Jing,¹ J. Zhu,¹ A. Kribben,¹ O. Witzke,¹ A. Hoerning.^2,3
Can MitoQ Improve Renal and Mitochondrial Function Following Cold Storage and Transplantation?

L. MacMillan-Crow,¹ N. Parajuli,¹ D. Borja-Cacho.
Cell Type of the Tolerizing Inoculum Plays a Role in the Formation of of Molecular Chimerism in Murine Neonatal Tolerance

X. Wang,¹ H. Mewhort,¹ S. Wang,¹ S. Tollenaar,¹ K. Tao,¹ L. West.^1,2,3
Change in Health-Related Quality of Life Between Evaluation for Kidney Transplantation and Transplantation

M. McAdams-DeMarco, E. King, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.
Changes in Donor Specific Antibodies (DSA) First Year After Kidney Transplant (KTX): Implications for Graft Histology and Survival

F. Cosio,¹ C. Schinstock,¹ L. Cornell,³ F. de Teresa,¹ M. Stegall.²
Characteristics of HIV Infected Patients Waitlisted for Kidney Transplantation

N. Law,¹ A. Doyle,¹ A. Sharma,¹ G. Malat,² T. Bias,¹ K. Ranganna,¹ D. Lee.¹
Chimerism for Early Detection of Graft Versus Host Disease in Intestinal Transplantation

J. Garcia, T. Beduschi, P. Ruiz, A. Tekin, J. Fan, S. Nishida, G. Selvaggi, L. Cubley, R. Vianna.
Chronic Active Antibody Mediated Rejection (cABMR): Treatment, Outcomes and Predictors of Graft Loss in a Large Case Series

R. Redfield,¹ T. Ellis,¹ W. Zhong,¹ T. Zens,¹ M. Rizzari,¹ J. Scalea,¹ L. Jacobson,¹ D. Mandelbrot,¹ S. Parajuli,¹ B. Muth,¹ M. Mohamed,¹ S. Panzer,¹ B. Astor,¹ M. Samaniego,² D. Kaufman,¹ A. Djamali.¹
Clinical Consequences of Immune-Mediated Allograft Arteriosclerosis: A Population Based Study

A. Loupy, Vernerey, Viglietti, Aubert, Duong van Huyen, Bruneval, Empana, Suberbielle, Glotz, Jouven, Legendre, Lefaucheur.
Clinical Outcome of Patients With De Novo C1q Binding Donor-Specific HLA Antibodies After Renal Transplantation

J. Bamoulid,¹ A. Roodenburg,² O. Staeck,¹ C. Schoenemann,² N. Lachmann,² K. Budde.¹
Clinical Utility of Allospecific CD154+T-Cells in Children With Liver Or Intestine Transplantation (LTx, ITx)

K. Soltys, G. Bond, G. Mazariegos, C. Ashokkumar, K. Dirling, L. O'Toole, P. Kachmar, T. Hartle, D. Martin, C. Trautz, R. Sindhi.
Clinical and Immunologic Risk Factors Associated With Donor-Specific Antibody (DSA) Formation Following Renal Transplantation

C. Johnson,¹ S. Park,¹ J. Schiller.²
Clinicopathological Scenarios (CPS) Defined by Viremia, Creatinine and Histology in Polyomavirus Nephropathy Differ in 1st and 2nd (Follow-Up) Biopsy

C. Drachenberg, M. Chaudhry, F. Yang, R. Ugarte, A. Haririan, M. Mavanur, C. Cangro, B. Thomas, N. Costa, E. Ramos, M. Weir, J. Papadimitriou.
Cognate Events in Antibody- Vs. T Cell-Mediated Rejection: A Molecular Perspective

M. Parkes,¹ P. Halloran,¹ L. Hidalgo.²
Combined Bone Marrow Plus Liver Transplantation in Cynomolgus Monkeys

J. Weiner, Y. Kato, R. Duran-Struuck, M. Martinez, S. Baker, P. Alonso, J. Zitsman, A. Wu, P. Houck, T. Pinyavat, J. Lefkowitch, S. Chaudhry, T. Kato, M. Sykes, A. Griesemer.
Combined Hepatitic/Cholangiopathic Lesion in HIV-HCV Co-Infected Liver Transplant Recipients Associated With Graft Loss

J. Harbell,¹ A. Doherty,² L. Ferrell,² B. Barin,³ N. Terrault,¹ P. Stock.¹
Complement Inhibition Via the Lectin Pathway Improves Experimental Cardiac Graft Survival

J. Kindermann,^1,2 M. Waechter,^1,2 R. Bruno,¹ M. Langenmayer,³ T. Dudler,⁴ W. Schwaeble,⁵ E. Kleinert,¹ T. Mayr,^1,2 H. Christian,² R. Wanke,³ J.-M. Abicht,⁶ S. Guethoff.¹
Conditioning of Mesenchymal Stromal Cells With mTOR Inhibitor Enhances Regenerative Properties of Secretome and Attenuates Vascular Calcification

B. Hegner,¹ C. Kurth,¹ T. Schaub,¹ C. Lange,² D. Dragun.¹
Correlates of Clinical Course of Polyomavirus BK Infection With Long-Term Outcome of BK Virus-Associated Nephropathy in Renal Transplant Patients

G. Huang, C.-X. Wang, J.-G. Fei, J. Qiu, S.-X. Deng, J. Li, G.-D. Chen, Q. Fu, R.-H. Deng, L.-Z. Chen.
Correlation Between C3d-Binding De Novo Donor Specific HLA Antibodies and Rejection in Kidney Transplant Recipients

M. Cusick, K. Haarberg, J. Friedewald, A. Tambur.
Current Status of US Intestinal and Multivisceral Transplantation: An Analysis of the UNOS Intestine Transplant Registry

J. Cai,¹ A. Qing,² G. Wu,³ M. Everly,¹ P. Terasaki.¹
Cyclophosphamide as a Salvage Therapy for Combined Intravenous Immunoglobulins and Plasmapheresis Refractory Antibody-Mediated Rejection

W. Habhab,¹ A. Dada,² M. Alwassia,¹ N. Baz,² N. Zabani,¹ A. Fahmy,¹ A. Abdul Malik.¹
DNA Methytransferase 1 Inhibition Potently Suppresses T Cell Cycle Progression Through Demethylation of the Key Cell Cycle Inhibitors p15, p16, p21 and p27

T. Ma, Y. Pei, R. Tao.
DQB1 Epitope Matching Predicts the Development of De Novo DSA and Antibody Mediated Rejection

M. Willicombe,¹ M. Blow,² P. Brookes,² E. Santos,² D. Taube.¹
DSA Detected by ELISA-PRA Is Associated With High Risk for Development of AMR in Stable Kidney Transplant Recipients

D. Lee,¹ J. Kim,² B. Kim,³ M. Chun,⁴ I. Kim.⁵
DSA Monitoring in Kidney Transplant Recipients

F. Pean,¹ M. Cooper,¹ J. Verbesey,¹ A. Gilbert,¹ B. Javaid,¹ R. Mohammed,¹ O. Timofeeva,² J. Moore,¹ K. Cruz,¹ R. Ghasemian,¹ T. Fishbein,¹ M. Grafals.¹
Day of Week Influences Kidney Utilization

K. Foley, M. Chiles, S. Mohan.
De Novo Donor-Specific HLA Antibodies After Kidney Transplantation Are Associated With Donation After Circulatory Death and HLA-DQ Mismatch

G. Dreyer,¹ D. Roelen,² S. Brand-Schaaf,² O. Dekkers,³ M. Reinders,¹ F. Claas,² J. de Fijter.¹
De Novo Once-Daily Tacrolimus in Liver Transplantation: Long-Term Outcomes of a Single Center Cohort of 150 Patients

M. Gastaca, A. Valdivieso, J. Bustamante, P. Ruiz, J. Fernandez, A. Ventoso, M. Testillano, I. Palomares, P. Salvador, M. Prieto, A. Matarranz, M. Suarez, J. Ortiz de Urbina.
Declaring a Patient Brain Dead on Extracorporeal Membrane Oxygenation (ECMO): Are There Guidelines or Misconceptions?

K. Kreitler,¹ N. Cavarocchi,¹ H. Hirose,¹ S. West,² R. Hasz,² M. Ghobrial,³ R. Bell.³
Delayed Graft Function (DGF) in Kidney Transplant Recipients (KTRs) Is Associated With Early Allograft Inflammation and Progressive Fibrosis Within 3 Months

A. Cherukuri, R. Mehta, P. Sood, S. Chen, G. Mour, A. Tevar, P. Randhava, S. Hariharan.
Delayed Graft Function in Patients Receiving Alemtuzumab Induction Therapy

M. Shindorf,¹ D. Fumo,¹ M. Weis,¹ W. Qu,¹ M. Rees,^1,2 J. Ortiz.¹
Depression of Complement Regulatory Factors in Human and Rat Renal Grafts in Association With Progress of Acute Cellular Rejection

K. Yamanaka,^１ T. Kato,^１ Y. Kakuta,¹ T. Abe,¹ R. Imamura,¹ A. Maeda,² S. Miyagawa,² N. Nonomura.¹
Detection of Donor Specific HLA-Ab (DSA) Against Native HLA Molecules Expressed On Donor Cell Surface to Eliminate False Positive DSA in Luminex Single Antigen Beads (LMX-SAB)

G. Chen, L. Lin, D. Tyan.
Diabetes Mellitus and Prediabetes On Kidney Transplant Waiting List – Prevalence, Metabolic Phenotyping and Risk Stratification Approach

M. Guthoff,¹ D. Vosseler,¹ J. Langanke,¹ S. Nadalin,² A. Königsrainer,² H.-U. Häring,¹ A. Fritsche,¹ N. Heyne.¹
Differential Expression and Function of ASC and Nlrp3 Inflammasome Adaptors in Hematopoietic Stem Cells (HSCs)

A. Scheinok, R. Elahimehr, A. Shigeoka, S. Kasimsetty, D. McKay.
Differential Intragraft Gene Expression Profiles in Patients With Sterile Leukocyturia

M. Ajaimy,¹ P. O Broin,² Y. Bao,¹ J. Lindower,¹ A. Golden,² E. Akalin.¹
Does Smoking Lead to Increased Rates of Acute Cellular Rejection in Liver Transplant Recipients?

B. Rao,¹ D. Montezuma-Calvo,² K. Tosch,² S.-M. Jafri.²
Does the C1q Assay Predict the Result of Lymphocyte Flow Cross-Match (FCxM) in Potential Renal Transplant Recipients With HLA-DSA and AHG-CDC CxM negative?

J. Arreola-Guerra, A. de Santiago, A. Arvizu, N. Gonzalez-Tableros, M. Lopez, M. Vilatoba, L. Morales-Buenrostro, J. Alberu, N. Castelan.
Donor Selection and Prophylactic IVIg for Induction Immunosuppression Improves Outcomes for HIV+ Kidney Transplant Recipients (HIV+ Tx)

G. Malat,^1,2 L. Panarey,³ A. Sharma,³ K. Ranganna,³ D. Reich,² G. Xiao,² A. Doyle.³
Donor Specific Tolerance Can Be Induced by Donor Bone Marrow Transfer With Activation of Invariant Naturel Killer T Cells

S. Miyairi,¹ T. Hirai,¹ R. Shibahara,¹ K. Omoto,¹ S. Nunoda,² K. Yamazaki,² Y. Ishii,³ K. Tanabe.¹
Dual PI3K-mTOR Inhibition on Human T Cell Activation, Proliferation, and Differentiation: The First Step in the Development of New Immunosuppressants

V. Vilchez,¹ A. Castellanos,¹ D. Butterfield,³ M. Mitov,³ C. Hoopes,¹ F. Marti,² R. Gedaly.¹
ECDI Fixed Donor Splenocytes Combined With α-1 Antitrypsin Induce Immune Tolerance in Mice Cardiac Transplantation Model

G. Chen,¹ X. Lai,¹ J. Qiu,¹ L. Qiu,² X. Mai,² L. Chen.¹
Early Antibody Mediated Rejection in HLA Antibody Incompatible Kidney Transplantation – A Treatable Condition Without Heavy Induction Immunosuppression

S. Daga,^1,2 N. Krishnan,¹ D. Lowe,³ F. Lam,¹ C. Imray,^1,2 H. Kashi,¹ L. Tan,¹ D. Briggs,³ R. Higgins.^1,2
Early Use of Anti-Lymphocyte Antibody in Kidney Transplant Recipients With Delayed Graft Function Can Produce Desirable Post-Transplant Results

J. Lee, J. Lee, D. Joo, K. Huh, S. Kim, Y. Kim, M. Kim.
Early Vs. Late Acute Antibody Mediated Rejection Among Renal Transplant Recipients in Terms of Its Response to Rituximab Therapy-Single Center Expereince

N. Nampoory, T. Alotaibi, O. Gheith, M. Halim, T. Mahmoud, P. Nair, M. Abdulmoneim, S. Alwaheb, R. Hasan.
Eculizumab in the Treatment of Early Severe Acute Antibody Mediated Rejection Following HLA-Compatible Kidney Transplantation-Case Series

M. Singh,¹ N. Macias,² V. Tatapudi,¹ B. Lee.¹
Effect of 2007 CMS Conditions of Participation on High Risk Renal Transplantation: A Study of the United States Renal Data System

D. John, A. Brar, F. Tedla, N. Sumrani, E. Timpo, M. Salifu.
Effect of Antibody Mediated Rejection on Long-Term Renal Allograft Function

M. John, A. Smith, I. Dortonne, A. Paramesh, M. Killackey, B. Lee, R. Zhang, J. Buell.
Effect of Everolimus Versus Tacrolimus On Left Ventricular Hypertrophy in Renal Transplant Patients On Maintenance

J. Morales,¹ J. Pascual,² A. Sánchez-Fructuoso,³ D. Serón,⁴ J. Díaz,⁵ F. Oppenheimer,⁶ M. Rengel,⁷ D. Hernández,⁸ J. Cruzado,⁹ On Behalf of Evita Study Group.
Effect of Everolimus on Cardiovascular Parameters in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

H. Holdaas,¹ M. van der Giet,¹ J. de Fijter,¹ A. Speziale,² C. Escrig,² G. Junge,² Z. Wang,³ J. Cruzado.¹
Effect of Induction in Renal Transplant Recipients Aged 70 and Over

M. Lubetzky, M. Ajaimy, L. Kamal, G. DeBoccardo, E. Akalin.
Effects of Early Everolimus Use for Immunosuppression in Living Donor Liver Transplant Recipients- An Analysis of 215 Sequential Patients

A. Thorat, Y.-W. Hsieh, H.-R. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu, L.-B. Jeng.
Effects of Heart and Lung Co-Transplantation Across a Full MHC Barrier in Miniature Swine

M. Madariaga, P. Spencer, S. Michel, G. La Muraglia II, M. O'Neil, E. Mannon, C. Leblang, I. Rosales, R. Colvin, D. Sachs, J. Allan, J. Madsen.
Effects of Mast Cell Stabilization on the Development of Aspiration-Induced Fibrosis in a Rat Model

E. Sapmaz, Z. Sun, J.-C. Chang, N. Sanders, S. Bell, M. Everett, Z. Holzknecht, W. Parker, R. Davis, S. Lin.
Efficacy and Safety of Induction Therapy With Monoclonal Versus Polyclonal Antibodies in Kidney Transplant Recipients in the Last Five Years (2008-2013) in Our Institution

M. Fernández, M. López, M. Ferreira, A. Aguilar, C. Jiménez, R. Selgas.
Efficacy and Safety of Once-Daily Everolimus With Minimized Once-Daily Tacrolimus After Liver Transplantation

P. De Simone,¹ P. Carrai,¹ L. Coletti,¹ A. Precisi,² D. Campani,³ F. Filipponi.¹
Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation

A. Weick,¹ K. George,¹ S.-M. Jafri,² D. Moonka.²
Emerging Application of Active Immune Targeted Delivery in Transplantation

M. Uehara,¹ A. Jamil,¹ M. McGrath,¹ Z. Solhjou,¹ N. Banouni,¹ S. Tullius,² C. Jianjun,³ R. Abdi.¹
End of Treatment Liver Biopsy With Sofosbuvir: Histologic Changes Suggestive of Hepatitis C Activity in Liver Transplant Recipients With Achieved SVR

B. Ismail,¹ X. Zervos,¹ P. Bejarano,² M. Waton,¹ D. Beltran,³ D. Sears,¹ A. Tzakis.¹
Epigenetic Reprogramming of Murine Cytomegalovirus Immediate Early Genes Induced By Renal Transplantation

M. Hummel,¹ X.-F. Liu,¹ C. Jie,¹ Z. Zhang,¹ S. Yan,¹ J.-J. Wang,¹ S. Kurian,² D. Salomon,² M. Abecassis.¹
Evaluating Outcomes in Multi-Organ Liver Transplant Recipients

J. Snyder,¹ N. Salkowski,¹ D. Zaun,¹ B. Thompson,¹ J. Zeglin,¹ D. Schladt,¹ J. Lake,² W. Kim,³ A. Israni,¹ B. Kasiske.¹
Evaluation of Leflunomide for the Treatment of BK Viremia and Biopsy Proven BK Nephropathy: A Single Center Experience

N. Nesselhauf,¹ J. Strutt,² B. Bastani.¹
Evaluation of the Gastrointestinal Tract as a Potential Route of Primary Polyomavirus Infection

G. Huang,¹ G. Zeng,² Y. Huang,² P. Randhawa.²
Evaluation of the Use of Leflunomide for the Prevention of BK Nephropathy in Renal Transplant Recipients- A Single Center Experience

S. Jonchhe, E. Hollinger, S. Jensik, O. Olaitan, A. Hodowanec, M. Hertl, S. Fayek, E. Chan, C. Pullum, N. Alvey.
Everolimus With Low Dose Tacrolimus in Intestinal Transplantation

T. Beduschi, J. Garcia, J. Lugo-Baruqui, J. Fan, S. Nishida, J. Jebrock, A. Tekin, G. Selvaggi, P. Ruiz, R. Vianna.
Everolimus-Based Immunosuppression Is Associated With a Reduced Risk of New-Onset Malignancies After Liver Transplantation

P. De Simone,¹ P. Carrai,¹ L. Coletti,¹ D. Ghinolfi,¹ D. Campani,² F. Filipponi.¹
Excellent Outcomes of Prophylactic Rituximab Administration With Plasmapheresis in Kidney Transplant Recipients With Focal Segmental Glomerulosclerosis

M. Okumi,¹ Y. Miyauchi,² T. Yagisawa,¹ K. Unagami,¹ D. Toki,¹ K. Omoto,¹ H. Ishida,¹ K. Tanabe.¹
Exercise Therapy Improves Body Composition Change After Kidney Transplantation

M. Miura, H. Higashiyama.
Factors Associated With Rehospitalization and High Cost Among Health Plan Members Receiving Kidney Transplants

E. Lee,¹ Y. Zhou,² B. Suehs,² B. Franks,¹ B. Kassman,¹ J. Spalding,¹ G. Thal.¹
Factors Influencing Cost Among Kidney, Liver, and Heart Transplant Patients in a Private Payer Setting

W. Bannister,¹ C. Wu,¹ M. Schnitzler,² F. Irwin,¹ A. Bonagura.¹
Feasibility of Regulatory T Cell Cryopreservation and Banking for Clinical Therapeutic Applications

K. Gołąb,¹ O. Savari,¹ S. Ramachandran,¹ Z. Tekin,¹ M. Tibudan,¹ J. Millis,¹ P. Trzonkowski,² P. Witkowski.¹
Financial Impact of an Advanced Liver Disease Service on a Tertiary Health System

A. Masoumi,¹ S. Hanish,² J. LaMattina,² C. Njoka,¹ W. Hutson,² D. Potosky,² R. Barth.²
First Clinical Data With an Improved C1q-Luminex® Assay

A. Roodenburg,² J. Bamoulid,¹ O. Staeck,¹ C. Schoenemann,² N. Lachmann,² K. Budde.¹
Forty-Seven Consecutive Simultaneous Liver-Kidney Transplants With Steroid Free Immunosuppression After Rabbit Antithymocyte Globulin Induction

D. Hall, V. Puri, S. Mabry, J. Vanatta, J. Eason.
Gene Expression Monitoring in Pediatric Heart Transplant Recipients

C. Sutton,¹ R. Butts,² A. Burnette,³ A. Savage,² W. Uber,¹ A. Haney.¹
Glucose Chemical Exchange Saturation Transfer MRI of Acute Renal Allograft Rejection

D. Kentrup,¹ A. Busch,² H. Pawelski,¹ V. Hoerr,^2,3 S. Reuter.¹
Glycogen Synthase Kinase 3β Inhibition Promotes Human iTreg Differentiation and Suppressive Function

Y. Xia, H. Zhuo, Y. Lu, L. Deng, R. Jiang, L. Zhang, L. Pu, X. Wang.
Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Multivariate Analysis of Risk Factors

M. Elfeki, P. Genco, S. Pungpapong, J. Nguyen, D. Harnois.
HCV Treatment in Liver Transplantation: Changes in Center Attitudes and Practices in the DAA Era

A. Shaffer, A. Cash, S. Anjum, D. Segev, C. Durand.
HO-1 Modified Macrophages Promote Autophagy by Activating Sirt1/TGF-β/Smad4 Signaling in Ischemia-Stressed Mouse Liver Transplants

S. Yue, J. Huang, K. Nakamura, M. Zhou, X.-D. Shen, R. Busuttil, B. Ke, J. Kupiec-Weglinski.
Heart En Bloc Thymus Transplantation Permits Long-Term, Acute Rejection-Free Cardiac Allograft Survival in Nonhuman Primates (NHPs)

M. Tonsho,¹ P. Spencer,¹ T. Millington,¹ A. Muniappan,¹ A. Tena,² R. Smith,³ R. Colvin,³ J. Allan,^1,2 J. Madsen.^1,2,4
Hepatic T Cells Derived from Normothemic Machine Perfused Grafts Contained More Regulatory T Cells and Fewer Proinflammatory Cytokines Producing T Cells Than Those from Cold Storage Grafts

X. Huang, R. Ravikumar, C. Coussios, P. Srinivasan, N. Heaton, P. Friend, W. Jassem, Y. Ma.
High Mortality in Diabetic Recipients of High KDPI Deceased Donor Kidneys

R. Pelletier,¹ T. Pesavento,² A. Rajab,¹ M. Henry.¹
High Prevalence of Allograft Rejection in Kidney Recipients With a Mild Increase in Serum Creatinine: Interim Report of the ANIDAR Study

S. De Serres,¹ J. Ho,² J.-F. Cailhier,³ H. Cardinal,³ O. Désy,¹ P. Vallin,¹ S. Béland,¹ I. Côté,¹ I. Houde,¹ R. Noël,¹ I. Lapointe,¹ M. Agharazii.¹
High Tolerability With Sofosbuvir-Based Direct-Acting Antiviral Therapy in Liver Transplant Recipients With Recurrent Hepatitis C

B. Osborne,¹ A. Modi,¹ M. Gautam,¹ N. Murray,¹ I. Gonzalez,² J. McAfee,² S. Gonzalez.¹
High-Resolution Perfusion Mapping to Detect Heart Transplant Rejection Using Contrast Enhance Ultrasound

K. Fischer,^1,2 S. Ohori,² F. Meral,¹ S. Giannini,² K. Hoffmeister,² H. Athar,² T. Ichimura,² R. Smith,³ M. Giverts,² F. Jolesz,¹ R. Abdi.²
Histologic Findings in Pre-transplant AT1Rab + ve Patients Point to an Increase in Sub-Intimal Fibrosis During Acute Rejection and in 12 mo. Protocol Renal Graft Biopsies

A. González-Almada, J. Arreola-Guerra, E. Cuevas, M. Vilatoba, A. Contreras, A. Sanchez-Cedillo, J. Alberu, N. Uribe-Uribe.
Hospital Characteristics Mediate Variation in Cirrhosis Mortality in Transplant and Non-Transplant Facilities

A. Mathur,¹ A. Chakrabarti,² K. Sheetz,² J. Mellinger,³ M. Volk,³ N. Katariya,¹ A. Singer,¹ W. Hewitt,¹ K. Reddy,¹ A. Moss.¹
Human Adipose Derived Mesenchymal Stem Cells Enhance Bone Marrow Engraftment and Induce Immunological Tolerance

R. Saidi,² B. Rajeshkumar,¹ P. Agrawal,¹ M. Rashighi.¹
Human CD8⁺TCR^– Facilitating Cells Enhance HSC Engraftment In Vivo and Promote HSC Survival In Vitro

Y. Huang,¹ M. Elliott,¹ E. Yolcu,¹ T. Miller,¹ L. Bozulic,² Y. Wen,¹ H. Xu,¹ S. Ildstad.^1,2
Hybrid Ostomy – New Technique in Intestinal Transplantation

T. Beduschi, J. Garcia, P. Ruiz, A. Tekin, G. Selvaggi, S. Nishida, J. Fan, R. Vianna.
Hyperuricemia Takes a Toll in Graft Function, Left Ventricular Diameters and Arterial Stiffness in Renal Transplant Recipients

B. Gurlek Demirci,¹ S. Sezer,¹ C. Oygur,² Z. Bal,¹ E. Tutal,¹ M. Haberal.³
IL-17 Production Influenced by Induction Therapy With ATG

D. Abendroth,¹ M. Marzinzig,¹ J. Kaden.²
IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections Through Induction of IL-13 Production by CD4⁺ T Cells

H. Cho,^1,2 J. Lee,^2,3 V. Tran,⁴ H. Kim,^2,4 J. Kim,^2,4 B. Kwon.^2,4
ILC1 and ILC3 Are the Predominant Intra-Epithelial Lymphoid Populations in Human Small Bowel Grafts

P. Talayero,¹ E. Mancebo,¹ J. Calvo-Pulido,² S. Rodriguez-Muñoz,³ A. García-Sesma,² C. Loinaz,² C. Jiménez,² F. Cano,¹ R. Laguna,¹ E. Paz-Artal.¹
Ideal Versus Total Body Weight Dosing of Rabbit Anti-Thymocyte Globulin Induction Therapy on Patient Outcomes in High Immunological Risk Kidney Transplant

M. Vacha, J. Gommer, A. Rege, S. Sanoff, D. Sudan, M. Harris.
Immune Response to Kidney and Pancreas Self-Antigens Are Associated With Antibody Mediated Rejection in Simultaneous Kidney Pancreas Transplants

M. Gunasekaran,¹ A. Siddiq,² S. Shenoy,¹ J. Wellen,¹ T. Mohanakumar.¹
Immune-Mediated Injury in Kidney Transplant Recipients Treated With Alemtuzumab Induction and a Steroid Avoidance Protocol

R. Sapir-Pichhadze, T. Mahbub, C. Saw, D. Baran.
Immunodeficiency Assessment in Pediatric Intestinal Failure Patients

J. Garcia,¹ T. Beduschi,¹ C. Biaggi,² E. Perez,² A. Tekin,¹ M. McGetrick,³ L. Cubley,¹ P. Ruiz,¹ J. Fan,¹ S. Nishida,¹ G. Selvaggi,¹ R. Vianna.¹
Immunological Aspects of Iron Overload in Heart and Kidney Transplantation

T. Resch,¹ S. Ebner,¹ P. Ritschl,¹ M. Ashraf,¹ C. Fabritius,¹ A. Brunner,² V. Nguyen,¹ J. Günther,¹ J. Pratschke,³ K. Kotsch.¹
Immunomodulation of Human T Cells by a Novel RALG Preparation With Higher Specificity Toward Activating T Cells

K. Samy, H. Xu, A. Kirk.
Impact of HMOX1 Genetic Variation in Pancreas Transplant Recipients On Long-Term Graft Outcome

C. Duff,¹ A. Hamilton,¹ S. Mittal,^2,3,4 M. Barnardo,^2,3 S. Fuggle,^2,3 P. Friend,^2,3 S. Gough,^1,4 M. Simmonds.¹
Impact of Anti-CMV Prophylactic Therapy on the Development of CMV Quantiferon Sero-Conversion in High-Risk Patients

A. Palanisamy, D. Taber, N. Pilch, C. Bratton, J. McGillicuddy, P. Baliga, K. Chavin.
Impact of Early Urinary Tract Infections on Renal Graft Function

J. Rago, L. Bowman, D. Brennan, J. Hagopain, T. Horwedel.
Impact of HLA Antibody Monitoring After Kidney Transplantation

S. Rao,¹ M. Ghanta,¹ H. Parekh,² A. Gillespie,¹ I. Lee,¹ S. Geier,² K. Lau,³ S. Karhadkar,³ A. Di Carlo,³ S. Constantinescu.¹
Impact of Pre-Transplant Panel Reactive Antibody Levels On Renal Graft Survival in Patients With Negative Cross-Match and No Donor Specific Antibody

K. Jun,¹ M. Kim,¹ H. Kim,¹ K. Park,² S. Ahn,¹ J. Hwang,¹ S. Kim,¹ S. Park,¹ S. Kim,¹ J. Kim,¹ I. Moon.¹
Impact of Proton Pomp Inhibitors on Hypomagnesemia and Arterial Stiffness in Renal Transplant Recipients

S. Sezer,¹ B. Gurlek Demirci,¹ M. Erkmen Uyar,¹ S. Uyanik,² M. Haberal.³
Impact of Sirolimus on the Risk of BK Viremia in Simultaneous Pancreas-Kidney Transplant Recipients

D. Wojciechowski, T. Yokoyama, S. Chandran, P. Stock.
Implications of Living Kidney Donor Histology, Volume and Function on Allograft Outcome

S. Shah,¹ B. Lankowsky,² L. Herlitz,³ A. Chiesa-Vottero,³ Z. Zaky,¹ D. Goldfarb,⁴ S. Flechner,⁴ E. Poggio.¹
Improved Renal Function Post-Liver Transplant With Earlier Everolimus Conversion

S. Lin,¹ M. Zimmerman,² V. Lewis,¹ S. Biggins,³ C. Ruller,⁴ I. Kam,⁴ T. Nydam.⁴
Improving ABMR Diagnostics Through Advanced Anti-HLA Antibody Screening Techniques

R. Ponsirenas,^1,2 H. Cazarote,^1,2 S. Shimakura,³ J. Valdameri,¹ F. Contieri,⁴ C. von Glehn,^1,2 M. Susin.^1,2
Incidence and Impact of De Novo Donor-Specific Anti-HLA Antibodies in ABO-Compatible Liver-Transplant Recipients

A. Del Bello,^1,2 N. Congy-Jolivet,^2,3,4 D. Milongo,¹ C. Guilbeau-Frugier,^2,5 L. Lavayssière,¹ F. Muscari,^2,6 L. Rostaing,^1,2,7 N. Kamar.^1,2,7
Incidence and Outcomes of Polyomavirus Infection in 639 Kidney Transplant Recipients: Are High Immunological Risk Characteristics More Relevant Than Specific Induction Or Maintenance Immunosuppressive Regimens?

E. Favi,¹ L. Harris,² J. Worsfold,² R. Cacciola,¹ C. Puliatti,¹ C. Sammartino,¹ R. Sivaprakasam.¹
Incidence and Risk Factors for Infectious Complications in Liver Transplant Patients Converted to Everolimus

A. Islam,¹ J. DeVos,² L. Teeter,³ E. Graviss,³ S. Gordon-Burroughs,¹ A. Saharia,¹ C. Mobley,¹ A. Gaber,¹ R. Ghobrial.¹
Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients

C. Staino, N. Pilch, O. Moussa, K. Boyle, J. Casale, K. Covert, J. Fleming, D. Taber, H. Meadows, C. Mardis, K. Chavin, S. Nadig, J. McGillicuddy, C. Bratton, T. Srinivas, P. Baliga.
Incidence, Risk Factors, and Outcomes of Hospitalized Urinary Tract Infections in Kidney Transplant Recipients

H. Pang, C. Liang, O. Famure, Y. Li, J. Kim.
Incorporating Markers of Donor Organ Intrinsic Biology Into Donor Quality Evaluation

J. Suh, K. Archer, L. Gallon, I. McConell, A. King, D. Maluf, V. Mas.
Increased Precentage of Circulating CD16+ Monocytes Before Transplantation Are Associated With the Occurence of Acute Rejection

T. van den Bosch,¹ L. Hilbrands,² M. Kraaij,¹ E. Vereyken,¹ P. Leenen,³ D. Hesselink,¹ C. Baan,¹ A. Rowshani.¹
Induction With an Interleukin-2 Receptor Antagonist in Sensitized Adult Kidney Transplant Recipients Is Highly Effective and Safe

J. Casale, J. Fleming, D. Taber, C. Staino, K. Boyle, K. Covert, N. Pilch, H. Meadows, C. Mardis, K. Chavin, C. Bratton, J. McGillicuddy, P. Baliga.
Induction of HO-1 High Expression Enhances the Capacity of Immature Dendritic Cells to Modulate Alloimmune Responses

G. Chen, Y. Zhao, L. Wang, S. Chen, X. Huang.
Infections After Alemtuzumab Induction: A Non Issue?

A. Smith, M. John, I. Dortonne, A. Paramesh, M. Killackey, R. Zhang, B. Lee, J. Buell.
Interferon-Free Sofosvir/Ribavirin Treatment Achieves Excellent Sustained Viral Response in Post Liver Transplant HCV Recipients

M. Hamshow, K. Bortecen, R. Layman, A. Winnick, B. Gelb, G. Morgan, L. Teperman.
Intimal Arteritis Associated With Subsequent Graft Dysfunction in ABO-Incompatible Kidney Transplantation

D. Toki,¹ H. Iahida,¹ M. Okumi,¹ T. Shimizu,¹ M. Inui,¹ K. Omoto,¹ H. Shirakawa,¹ K. Unagami,¹ K. Honda,² J. Koike,³ K. Tanabe.¹
Inverse Monocytic Subset Profile in Blood and Tissue During Heart Transplant Rejection

T. van den Bosch,¹ M. Kraaij,¹ K. Caliskan,² A. Constantinescu,² O. Manintveld,² P. Leenen,³ C. Baan,¹ M. van Groningen,⁴ A. Rowshani.¹
Is Organ Transplantation from Trypanosoma cruzi-Infected Donors Safe? An Autopsy-Based Study of Parasite Persistence in Chronic Chagasic Patients

L. Benvenuti, A. Roggério.
Isolated Microcirculation Inflammation Negatively Impacts Renal Graft Function at 5 Years

A. Chapelet,¹ M. Touzot,¹ M. Fournier,² A. Cesbron,³ K. Renaudin,⁴ A. Moreau,⁴ E. Morelon,⁵ D. Anglicheau,⁶ M. Giral.¹
Isotype Switching of Antibodies to Vimentin Following Transplantation Is Associated With Development of Transplant Glomerulopathy Following Renal Transplantation

M. Gunasekaran,¹ T. Maw,³ R. Santos,³ J. Wellen,¹ S. Shenoy,¹ T. Mohanakumar.^1,2
Kidney Allocation Tool of the Future: The Estimated Post-Transplant Survival (EPTS) Score

M. Moss, M. Gillespie, T. Sparkes, B. Ravichandran, R. Ugarte, A. Haririan.
Kidney Patients at High Immunological Risk Can Be Safely Transplanted With a Novel Induction Regimen Using Anti-Thymocyte Globulin (Rabbit) (rATG) Plus Basiliximab

D. Halleran,¹ J. Melancon,² V. Whittaker.¹
Kidney Transplantation (KTx) With Positive Crossmatch (XM) but No Donor Specific Antibody (DSA)

J. Verbesey, O. Timofeeva, L. Dong, B. Javaid, G. Monica, A. Gilbert, J. Moore, P. Weems, S. Ghasemian, S. Rosen-Bronson, M. Cooper.
Largest Single Center Experience of Pre-Transplant Outcomes After Bariatric Surgery in Ethnic Minorities With Chronic Kidney Disease

I. Thomas,² J. Gaynor,¹ T. Joseph,¹ N. De La Cruz,¹ D. Roth,² A. Mattiazzi,² W. Kupin,² L. Chen,¹ G. Burke,¹ M. Goldstein,¹ G. Ciancio,¹ G. Guerra.²
Late Onset Cluster of Pneumocystis Jirovecii Pneumonia (PJP) in Renal Transplant Patients: Re-Examining Prophylaxis Strategies

G. Sekhon,¹ L. Gunaratnam,¹ H. Iyer,¹ J. Johnson,¹ N. Muirhead,¹ A. Newman,² F. Rehman,¹ M. Weir,¹ M. Silverman,³ A. House,¹ A. Jevnikar,¹ S. Hosseini-Moghaddam.³
Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience

P. Vaitla, U. Patel, A. Cruz, S. Guisti, A. Moiz, C.-S. Catherine, A. Cohen, G. Loss, H. Bohorquez, I. Carmody, T. Reichman, D. Bruce, S. Anders, J. Garces.
Long-Term Outcome of Liver Transplant Recipients (OLT) With Hepatitis C Recurrence (HCVR) Who Achieved Postoperative Sustained Virologic Response (SVR) After Combination Antiviral Therapy (Rx) With and Without the Use of Telaprevir (TVR): A Single Center Experience

C. Fasola, P. Mantry, J. Weinstein, H. Nazario, A. Mubarak, M. Barnes, A. Habib, A. Mejia, R. Dickerman, S. Cheng.
Long-Term Persistence of Innate Lymphoid Cells in the Gut After Intestinal Transplantation

J. Weiner, J. Zuber, B. Shonts, S. Yang, M. Martinez, T. Kato, M. Sykes.
Longitudinal Assessment of Endothelial Function Following Kidney Transplantation

C. Kensinger,¹ G. Chen,² A. Bian,² T. Ikizler,³ K. Birdwell.³
Longitudinal eGFR Modelling to Understand Rates of eGFR Decline in Renal Transplantation in the United Kingdom

R. Pruthi,¹ A. Casula,¹ R. Hilton,² R. Ravanan,³ P. Roderick,⁴ I. Macphee.⁵
Losartan Benefits Are Mediated Through SIRT1 Activation in Rat Reduced Size Orthotopic Liver Transplantation

E. Pantazi,¹ M. Bejaoui,¹ M. Zaouali,¹ E. Folch-Puy,¹ A. Rolo,^2,3 A. Panisello,¹ C. Palmeira,² J. Rosello-Catafau.¹
Low Dose Valganciclovir Is an Effective Prophylaxis Against Cytomegalovirus in High Risk (Donor+/ Recipient-) Kidney Transplants Recipients

S. Fayek,¹ E. Beshears,¹ N. Alvey,² A. Sauer,¹ R. Lieber,¹ O. Olaitan,¹ E. Hollinger,¹ S. Jensik,¹ J. Geyston,² M. Brokhof,² A. Hodowanec,³ D. Simon,³ M. Hertl.¹
Low Expanded Criteria Donor Listing Rates by Organ Procurement Organization Is Associated With Increased Differential in Waiting Time for Candidates Willing to Accept Marginal Organs in the US

D. Keith, A. Nishio Lucar, G. Vranic.
Maintaining Immunosuppressive Treatment After Early Allograft Nephrectomy Does Not Reduce the Risk of Anti-HLA Allo-Sensitization

A. Del Bello,^1,2 N. Congy-Jolivet,^2,3,4 I. Cardeau-Desangles,¹ C. Guilbeau-Frugier,^2,5 E. Pambrun,¹ G. Dörr,¹ O. Milioto,⁶ L. Esposito,¹ L. Rostaing,^1,2,7 N. Kamar.^1,2,7
Maximizing Peri-Operative Value-Based Care in Kidney Transplant Induction

J. Fleming,¹ J. Casale,¹ K. Covert,¹ K. Boyle,¹ D. Taber,² H. Meadows,¹ C. Mardis,¹ N. Pilch,¹ M. Posadas-Salas,³ T. Srinivas,³ C. Bratton,² J. McGillicuddy,² K. Chavin,² P. Baliga.²
Membranoproliferative Glomerulonephritis After Kidney Transplantation: A Single Center Experience

S. Alasfar, N. Carter-Monroe, A. Rosenberg, R. Montgomery, N. Alachkar.
Microcirculation Inflammation in Early Surveillance Renal Biopsy in Sensitized Patients Did Not Correlate With Graft Outcome

P. Souza,¹ D. Machado,¹ D. David,¹ G. Bezerra,¹ F. Jota de Paula,¹ H. Rodriges,² W. Nahas,¹ E. David Neto,¹ M. Castro.¹
Molecular Features of Isolated Arteriolar Hyalinosis in Renal Transplant Biopsies

L. Kamal, P. O Broin, Y. Bao, A. Golden, E. Akalin.
Molecular Features of Kidney Transplant Biopsies Without Allograft Injury in Relation With Type of Induction Therapy

M. Ajaimy,¹ P. O Broin,² M. Lubetzky,¹ Y. Bao,¹ A. Golden,² E. Akalin.¹
Monocyte Recruitment to HLA Class I Antibody-Activated Endothelial Cells Is Dependent Upon mTOR

S. Salehi, E. Reed.
Mycophenolic Acid Area-Under-Curve (MPA AUC) Levels Sufficient to Prevent Donor-Specific Antibody (DSA) Formation Are Not Associated With Higher Rates of CMV/EBV/BK Viral Infections

S. Narins, D. Ladie, R. Saylor, E. Richards, H. Yang, M. Waybill.
NK-Cell Subset Distribution, Renal Function and Biopsy Findings in Kidney Transplant Recipients With HLA Donor-Specific Antibodies

M. Crespo,¹ D. Redondo,¹ J. Gimeno,² J. Yelamos,³ A. Muntasell,³ A. Faura,¹ M. Pérez-Sáez,¹ M. López-Montañes,⁴ A. Torío,⁵ C. García,⁶ M. Mir,¹ J. Hernandez,⁶ M. López-Botet,^3,4 J. Pascual.¹
Negative Exercise Myocardial Perfusion Scintigraphy Discards Silent Coronary Artery Disease in High Cardiovascular Risk Patients Awaiting for Kidney Transplantation

E. Melilli,¹ V. Navarro,² O. Bestard,¹ A. Gomez,³ J. Cruzado.¹
Neonatal Tolerance: Donor and Host Cells Fuse in Livers of Newborn Mice Injected With F1-Bone Marrow/Spleen Cells

R. Bascom, K. Tao, S. Tollenaar, L. West.
Neurocognitive Profile of Children Born to Kidney Transplant Recipients Mothers

L. Morales-Buenrostro,¹ S. Sanchez-Roman,¹ S. Lascarez,¹ A. Niebla-Cardenas,¹ D. Lopez-Carrillo,¹ G. Caballero-Andrade,¹ A. Velez,⁴ R. Espinoza,² E. Mancilla-Urrea,³ J. Alberu.¹
Nomogram for Predicting Patient Survival After Withdrawal of Life-Sustaining Treatment in Patients With Devastating Neurological Injury

G. Xu, X. He.
Non-Cytoreductive Immunosuppression Prevents Rejection of Vascularized Composite Allografts

B. Oh, G. Furtmüller, M. Fryer, G. Raimondi, D. Cooney, W. Lee, G. Brandacher.
Not Only CD28null But Also CD28pos T Cells Contribute to Rejection During Belatacept Treatment

G. de Graav,¹ D. Hesselink,¹ R. Kraaijeveld,¹ M. Dieterich,¹ W. Weimar,¹ M. Clahsen-Van Groningen,² C. Baan.¹
Novel Flow Cytometry Method for Detecting Complement-Fixing Blood Group IgG Antibody in ABO-Incompatible Renal Transplantation

T. Ishizuka,¹ M. Yasuo,¹ Y. Ishida,¹ H. Miura,¹ K. Iwadoh,² T. Murakami,² K. Kitajima,² I. Nakajima,² S. Fuchinoue.²
Number of Antigen Targets: A Key Parameter for Accurate Flow Cytometry Crossmatch Interpretation of Weak DSA

L. Hidalgo,¹ S. Hasenbank,¹ A. Halpin,¹ P. Campbell.^1,2
Octogenarian Kidney Transplant Recipients: A Single Center Experience

B. Ravichandran, T. Sparkes, B. Thomas, F. Rasetto, M. Gillespie, M. Moss, S. Bartlett, B. Masters.
Outcomes After Listing for Kidney Transplantation in Adults Aged 70 Or Over

D. Kanigicherla, I. Zia, M. Morton, S. Skampardoni, M. Picton.
Outcomes Following Kidney Transplant With Low Level Positive Flow Cytometric Crossmatch

C. Schinstock, F. Cosio, M. Gandhi, L. Cornell, M. Stegall.
Outcomes in Kidney Transplant Recipients Over Age of 55 by Donor Source: LD, SCD, ECD

V. Kirchner, K. Gillingham, A. Matas, The Div of Tx and Tx Nephrology.
Outcomes of Eculizumab (ANTI-C5) Therapy for Treatment of Refractory Antiobdy-Mediated Rejection (ABMR) and Thrombotic Microangiopathy (TMA)

P. Wongsaroj,¹ J. Choi,¹ A. Vo,¹ J. Kahwaji,¹ A. Peng,¹ R. Villicana,¹ M. Haas,² S. Jordan.¹
Outcomes of Hepatitis C Virus (HCV) Treatment Following Liver Transplantation in the Era of Direct-Acting Antiviral Medications

S. Baggett,¹ D. Jones,¹ M. Shoreibah.²
Outcomes of Solid Organ Transplantation in a National Private Health Plan: Comparison to SRTR Reports

F. Irwin,¹ C. Wu,¹ W. Bannister,² M. Schnitzler,¹ A. Bonagura.¹
Outcomes of Treatment of Late Antibody-Mediated Rejection in Primary Renal Transplant Recipients – A Single Center Experience

R. Prashar, A. Patel, K. Venkat.
PI3Kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization

E. Kefalogianni,¹ M. Mounayar,² B. Smith,² J. Azzi,² L. Chabtini,² P. Fiorina,² M. Kraus,³ R. Briddell,⁴ W. Fodor,⁵ A. Herrlich,¹ R. Abdi.²
Patients Referred to an OPO: Analysis of Potential for Additional DCD Donors

D. Bloomberg, J. Lewis, N. Benavides, M. James, H. Irving, A. Friedman.
Pediatric Living Donor Liver Transplantation at KFSH&RC – Implementation of the Laparoscopic Retrieval in a High Volume Center

M. Boehnert, M. Shagrani, T. Al Goufi, D. Broering.
Perioperative Bacterial Colonization and Postoperative Urinary Tract Infection in Kidney Transplant Recipients

A. Han,¹ C. Choi,¹ S.-I. Min,¹ S.-K. Min,¹ S. Kim,² M. Park,³ J. Ha.¹
Pertubations in the Urinary Exosome in Transplant Rejection

T. Sigdel,¹ Y. Ng,¹ S. Lee,² C. Nicora,³ W.-J. Qian,³ D. Camp II,³ M. Sarwal.¹
Pharmacist-Led Renal-Sparing Conversion to Everolimus After Liver Transplantation

T. Horwedel,¹ L. Bowman,¹ W. Chapman,² J. Hagopian.¹
Plasmapharesis, Intravenous Immunoglobulin and Rituximab Successfully Treat Recurrent Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC-2) After Liver Transplantation

H. Elsiesy,¹ F. Abaalkhail,¹ W. Alhamoudi,^1,2 H. Alhussaini,³ M. Alsebayel,¹ D. Broring,¹ M. Shagrani.¹
Plasmapheresis – A Previously Unrecognised Risk Factor for BK Viraemia

E. Olayos,¹ K. Barraclough,² R. Walker,³ R. Masterson,² H. Peter,² C. Solomon.⁴
Poor Renal Function and Increased Mortality in Elderly Recipients of Deceased Donor Kidneys from Elderly Donors

S. Berger,¹ H. Peters-Sengers,² M. Heemskerk,³ F. Bemelman,² J. Homan van der Heide.²
Post-Transplant Changes in Serum Creatinine and Beta-2 Microglobulin Predict Acute Tubular Necrosis in the Early Post-Transplant Period

P. Liu,¹ A. Djamali,^1,2 D. Kaufman,^2,1 B. Astor.¹
Post-Transplant Recurrence of Calcium Oxalate Crystals in Primary Hyperoxaluria Type 1 Detected by Surveillance Biopsies: Incidence, Risk Factors, and Effect on Graft Function

L. Cornell, N. Pamidi, R. Mehta, M. Stegall, E. Lorenz, J. Heimbach, D. Milliner.
Pre-Operative Assessment of Body Composition in Adult Multivisceral Transplant Candidates

R. Cruz, H. Sogawa, G. Bond, K. Soltys, R. Sindhi, G. Mazariegos, A. Humar, A. DiMartini.
Pre-Transplant Weight Change and New-Onset Diabetes After Kidney Transplantation

E. Huang, B. Abdalla, M. Andre, S. Bunnapradist.
Predicting Obstructive Coronary Artery Disease in Asymptomatic Renal Patients Undergoing Renal Transplantation

D.-A. Moutzouris, C. Baker, A. Malaweera, M. Willicombe, R. Corbett, N. Duncan, J. Galliford, A. McLean, D. Taube.
Prediction of Delayed Graft Function By Means of a Web-Based Calculator in Living Related Kidney Transplant: Mexican Single Center Experience

G. Martinez-Mier,¹ E. Soto-Miranda,¹ M. Mendez Lopez,¹ L. Budar Fernandez,¹ M. Trujillo-Martinez,² A. Uscanga-Montesano,² D. Avila y Falfan.²
Prediction of Long-Term Prognosis of the Kidney Transplantation Using Comorbidity Score

J. Park,¹ E. Bae,¹ S. Kim,² D. Kim,¹ C.-S. Lim,³ K. Joo,¹ Y. Kim,¹ J. Lee.³
Predictive Value of Cardiovascular Risk Assessment Tools in Kidney Transplantation

C. Dunn, A. Holtzman, M. Hung, S. Greenstein.
Predictors of Deceased Donor Lung Utilization in the United States

L. Edwards,¹ L. Robbins Callahan,¹ J. Rogers,² K. Chan.³
Preformed Anti-HLA DP Donor Specific Antibodies Are Clinically Significant in Renal Transplantation

V. Dibbur, M. Willicombe, P. Brookes, R. Sergeant, A. Wardle, D. Taube.
Pretransplant Assessment of Vascular Calcification as a Risk Factor of Mortality, Graft Loss, and Cardiovascular Events in Renal Transplant Recipients

P. Munguia, R. Caramelo, M. Rubio, L. Sahdalá, L. Arnaudas, J. Paul, á. Blasco, L. Lou, M. Aladren, A. Sanjuan, A. Gutierrez-Dalmau.
Prevalence and Clinical Outcomes Associated With Vancomycin-Resistant Enterococcal Colonization Or Infection After Small Intestinal Transplantation

N. Shah,¹ L. Nabha,² R. Teran,³ C. Matsumoto,⁴ R. Farney,⁵ P. Kumar,⁶ J. Timpone.⁷
Primary and Secondary Vaccine Responses in a Non-Human Primate Model of Cardiac Allotransplantation

S. Dahi,¹ E. Kang,¹ T. Zhang,¹ B. Vanhove,² A. Azimzadeh,¹ R. Pierson III.¹
Progression of Coronary Artery Disease in High-Risk Patients Undergoing Renal Transplantation

R. Corbett, N. Kumar, C. Baker, D. Moutzouris, M. Willicombe, J. Galliford, A. McLean, N. Duncan, D. Taube.
Prospects of Differentiating T-Cell Mediated Rejection (TCMR) from BK Virus Nephropathy (BKVN) Using Next Generation Sequencing (NGS) of the T-Cell Receptor (TCR)

G. Zeng, Y. Huang, P. Randhawa.
Proteasome Activation During Renal Cold Storage and Transplantation: A Novel Pathway for Mitochondrial Destruction?

N. Parajuli, L. MacMillan-Crow.
Protocol Donor Specific Antibody Monitoring After Kidney Transplantation: What Is the Utility?

C. Staino, N. Pilch, O. Moussa, K. Boyle, J. Casale, K. Covert, J. Fleming, D. Taber, H. Meadows, C. Mardis, K. Chavin, S. Nadig, J. McGillicuddy, C. Bratton, T. Srinivas, P. Baliga.
Proximal Tubular Dysfunction Is Common After the First Year of Kidney Transplantation

G. Ensergueix,¹ J. Allard,¹ F. Saint-Marcoux,² B. Marin,³ S. Bodeau,² J.-C. Aldigier,¹ P. Marquet,² M. Essig.¹
Quality of Life in Elderly Kidney Transplant Recipients over 70 Years of Age

B. Rouphael, S. Reule, A. Matas, H. Ibrahim.
Recipient Immunity to Murine Cytomegalovirus Influences Natural Killer Cell Responses in Infected Renal Allografts

M. Shimamura,¹ M. Li,¹ B. Chen,² J. George.²
Recurrent IgA Nephropathy in Kidney Transplant Recipients Receiving a Steroid Sparing Immunosuppression Protocol

K. Koutroutsos,¹ R. Charif,¹ D. Goodall,¹ C. Roufosse,² J. Galliford,¹ T. Cook,² D. Taube,¹ M. Loucaidou.¹
Relations Among Hyperuricemia, Inflammation, Oxidative Stress and Arterial Stiffness in Renal Transplant Recipients

B. Gurlek Demirci,¹ S. Sezer,¹ M. Erkmen Uyar,¹ Z. Bal,¹ E. Tutal,¹ F. Ozdemir Acar,² M. Haberal.³
Relationship of Donor Age and Distance in Deceased Donor Lung Offers in the US

L. Edwards,¹ L. Robbins Callahan,¹ W. Cherikh,¹ J. Rogers,² K. Chan.³
Relative In Vitro Immunoregulatory Effects of Everolimus, Sirolimus, Tacrolimus, Mycophenolic Acid and Drug Combinations

J. Mathew, X. Huang, J. Leventhal, L. Gallon, J. Miller, J. Levitsky.
Renal Dysfunction by BK Virus Infection Is Correlated With Activated T Cell Level, Cytokines Level, Gramzymes in Renal Transplantation

W.-Y. Yin.
Renal Function Following Basiliximab Induction in Liver Transplant Recipients

J. Hagopian, T. Horwedel, L. Bowman, K. Collins, M. Doyle.
Repeat Donor HLA Mismatch Antigens and Kidney Transplant Outcome

P. Lokhandwala,¹ M. Wang,² Z. Kadry,³ R. Shah,³ A. Jain,³ J. Gaspari,¹ N. Ghahramani,⁴ C. Abendroth,¹ H. Shike.¹
Responsiveness to Rituximab, Plasmapheresis and Intravenous Immunoglobulins in Antibody Mediated Rejections After Kidney and Pancreas – Kidney Transplantation

E. Minué,¹ L. León,¹ P. Uva,¹ A. Dotta,¹ J. Walther,¹ O. Casanova,¹ F. Togniolo,¹ O. Guardia,¹ M. Rial,¹ E. Chuluyan,² D. Casadei.¹
Results of ABO Incompatible Liver Transplantation Using a Simplified Protocol at a Single Institution

J. Lee,¹ J. Lee,¹ J. Lee,² M. Kim,¹ M. Ju,¹ G. Choi,¹ J. Choi,¹ S. Kim,¹ D. Joo.¹
Retrospective Cohort Study Concerning Efficacy and Safety of Bortezomib in Combination With Or Without Rituximab in Antibody Mediated Rejection in Renal Transplant Recipients

M. Duerr, N. Lachmann, K. Budde, J. Waiser.
Role of CMV, BKV, and Immunosupression Non-Adherence in Early and Late De Novo Donor Specific Anti-HLA Antibody Development and Outcomes

M. Everly,¹ L. Rebellato,² K. Briley,² A. Maldonado,³ P. Bolin,² C. Haisch,² W. Kendrick,⁴ S. Kendrick,⁴ C. Morgan,² R. Harland,² P. Terasaki.¹
Safety and Efficacy of 3-Month Ciprofloxacin for BK Prophylaxis in Kidney Transplantation

S. Patel, R. Knight, J. Loucks, S. Kuten, A. Gaber.
Safety and Efficacy of Early Everolimus in De Novo Orthotopic Liver Transplantation

M. Gastaca,¹ I. Bilbao,² M. Jimenez,³ J. Bustamente,¹ C. Dopazo,² R. Gonzalez,³ R. Charco,² J. Santoyo,⁴ J. Ortiz de Urbina.¹
Serial Changes in Body Composition After Kidney Transplantation

S. Deger,¹ A. Bian,² G. Chen,² T. Ikizler,¹ K. Birdwell.¹
Serum Creatinine Is Most Predictive of Graft Loss in Late Antibody Mediated Rejection

G. Agarwal, D. Diskin, R. Reed, J. Locke, V. Kumar.
Serum Uric Acid Is Associated With Hypertension in Kidney Donors

S. Reule,¹ R. Foley,¹ A. Matas,² H. Ibrahim.¹
Severe Refractory Skin Eruption Treated With Plasmapheresis in a Multivisceral Transplant Patient

J. Garcia,¹ T. Beduschi,¹ A. Tekin,¹ J. Fan,¹ S. Nishida,¹ G. Selvaggi,¹ G. Ciancio,¹ G. Burke,¹ C. Katsoufis,² L. Pizano,³ R. Vianna.¹
Should Current IVIg Preparations Containing High Titers of Anti-HLA-I/-II IgG be Used for Lowering the Anti-HLA IgG in Sensitized Pre-Transplant Patients and Allograft Recipients?

M. Ravindranath, P. Terasaki, C. Maehara, V. Jucaud.
Should We Ever Pay Living Kidney Donors? Focus Group Study of Public Opinion

A. Tong,^1,2 A. Ralph,^1,2 J. Chapman,³ G. Wong,^1,2,3 J. Gill,⁴ M. Josephson,⁵ C. Hanson,^1,2 J. Craig.^1,2
Similar Outcomes Can Be Expected Among HIV (+) Kidney Transplant Recipients (HIV+ Tx) Vs. HIV (-) Kidney Transplant Recipients (HIV- Tx) Receiving Similar Immunosuppression Protocols

L. Panarey,¹ G. Malat,^2,3 A. Sharma,¹ K. Ranganna,¹ D. Reich,² G. Xiao,² A. Doyle.¹
Single Center Experience With the Use of an Abbreviated Anti-Thymocyte Globulin and Basiliximab Combination Protocol in Renal Transplantation

V. Whittaker,¹ D. Halleran,¹ S. Narsipar,¹ J. Melancon.²
Single Infusion of Donor-Type Splenocytes Treated With Extracorporeal Photopheresis Prior to Transplantation Significantly Prolongs Cardiac Allograft Survival in Mice

J. Schneiderman,¹ J. Ye,² X. Yeap,² M. Caralt,² J.-J. Wang,² Z. Zhang.²
Sofosbuvir Therapy in Early and Late Post Liver Transplant Setting: A Single Center Experience

X. Zervos,¹ D. Beltran,² B. Ismail,¹ M. Watson,¹ D. Sears,¹ A. Tzakis.¹
Sofosbuvir-Based Therapy for Hepatitis C Recurrence Post Liver Transplantation

A. Ajlan,¹ A. Aljedai,¹ H. Elsiesy,² D. Alkortas,¹ R. Alarieh,² F. Aba Alkhail.²
Speed of Onset of Donor Brain Death Leads to Differences in Renal Function and Expression of Inflammatory and Oxidative Stress Markers in Rat Kidneys

D. Hoeksma,¹ R. Rebolledo,² M. Hottenrott,³ Y. Bodar,¹ H. Leuvenink.¹
Superior Outcomes of Kidney Transplantation Compared With Dialysis in Korea: A Propensity–Matched Analysis of a National Population-Based Cohort Study Between 2005 and 2008

K. Yoo,¹ C. Kim,² J. Lee,³ M.-H. Kim,⁴ H. Cho,¹ K. Kim,⁵ H. Kim,⁶ D.-R. Ryu,⁷ D. Kim,¹ C. Lim,⁸ Y. Kim,¹ J. Lee.⁸
Survival of Patients With Peripheral Vascular Disease on Kidney Waitlist and After Transplantation: An Analysis of the United State Renal Data System

A. Brar,¹ D. Stefanov,³ R. Jindal,² N. Sumrani,⁴ D. John,⁴ F. Tedla,¹ M. Salifu.¹
Switching from Tacrolimus to Low-Dose Cyclosporine A Preserves Allograft Function in Presumptive and Definitive Polyomavirus-Associated Nephropathy

G. Huang, C.-X. Wang, J.-G. Fei, J. Qiu, S.-X. Deng, J. Li, G.-D. Chen, Q. Fu, R.-H. Deng, L.-Z. Chen.
Tacrolimus Trough Concentrations Increase in Intestinal Transplant Recipients During Episodes of Acute Cellular Rejection

A. Lichvar,¹ D. Deen,² H. Johnson,¹ J. Bonner,³ G. Bond,⁴ G. Costa,⁴ R. Cruz,⁴ K. Abu-Elmagd,⁵ R. Venkataramanan.^6,7
Targeted Rapamycin Nanotherapy Dampens Memory T Cell Function

S. Nadig,¹ S. Esckilsen,¹ A.-M. Broome,² S. Dixit,² C. Atkinson.³
The Benefit of Hepatitis C Donor Kidney Transplantation Is Limited to Hepatitis C Positive Patients Over 50 Years of Age

T. Myint, A. Wright, C. Rose, C. Kennedy, J. Dong, J. Gill, J. Gill.
The Best Regimen With Rituximab for ABO-Incompatible Living Donor Liver Transplantation

H. Egawa,¹ K. Umeshita,² S. Uemoto.³
The Decreasing Rates of Organ Donation in Trauma Patients: An Analysis of the United Network for Organ Sharing Database

H. Aziz, T. Jie.
The Differential Effect of HLA-DQ Mismatching on Renal Allograft Survival in Zero HLA-A,B,DR Mismatched Deceased Donor Transplants

M. Casey,¹ X. Wen,¹ S. Rehman,¹ A. Santos,¹ S. Goldstein,¹ K. Andreoni,¹ B. Kaplan,² K. Womer.¹
The Effect of Compatibility of ABO Blood Type Antigens on Graft Survival of Intestinal Transplants

J. Cai,¹ A. Qing,² G. Wu,³ M. Everly,¹ P. Terasaki.¹
The Effect of Preformed and De Novo Donor-Specific Antibodies (DSA) in Acute Rejection (AR) After Liver Transplantation (LTX)

M. Koch,¹ M. Runnebaum,¹ M. Goebel,² H. Thude,¹ M. Sterneck,¹ M. Marget,² B. Nashan.¹
The Effects of Change in Body Mass Index on Morbidity and Mortality After Liver Transplantation

B. Kashat,² A. Prushani,¹ S. Jafri.¹
The Impact of Baseline and Follow-Up Social Adaptability Index Scores on Outcomes in Kidney Transplantation

D. Taber, M. Hamedi, M. Gebregziabher, T. Srinivas, K. Chavin, L. Egede, P. Baliga.
The Impact of Microcirculation Inflammation in Predicting Treatment Response for Late Onset Antibody Mediated Rejection

J. Lee,¹ J. Lee,¹ B. Lim,² B. Kim,³ M. Ju,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ H. Jeong,² K. Park,⁴ K. Huh.¹
The Impact of Therapy On the Inflammatory Infiltrate in Renal Allografts With Acute and Chronic Antibody Mediated Rejection

W. Mulley,^1,2 D. Nikolic-Paterson,^1,2 A. Longano,³ Y. Han,¹ F. Ma,¹ J. Kanellis,^1,2 S. Ramessur.^1,2
The Outcomes of Second Transplantation in Recurrent IgA Nephropathy

C. Baek,¹ H. Kim,¹ W. Yang,¹ W. Huh,² Y. Kim,³ J. Yang,⁴ D. Han,⁵ S.-K. Park.¹
The Relationship Between Age and Morbidity During the First Year Following Renal Transplantation in Patients Receiving Alemtuzumab Induction

S. LeCorchick, N. Wilson, C. Truscott, D. Shaffer, S. Karp, B. Concepcion, M. Stanley, I. Feurer, S. Bala.
The Role of Immunosuppression on Cardiac Functions of Kidney Transplant Recipients

U. Cakir, O. Cavdaroglu, T. Erturk, E. Gurluler, A. Gurkan, I. Berber.
The Role of Quantitative Assay of Urinary Decoy Cells as a Screening and Follow-Up Tool in Renal Transplant Recipients With Polyomavirus BK Infection

G. Huang, J. Qiu, C.-X. Wang, J.-G. Fei, S.-X. Deng, J. Li, G.-D. Chen, Q. Fu, R.-H. Deng, L.-Z. Chen.
The Use of Inhaled Tobramycin in Pediatric Transplant Patients Without Cystic Fibrosis

C. Pfeifer,¹ M. Keck.²
Three Year Outcomes of Renal Allograft Transplants in African American Recipients Receiving Alemtuzumab for Induction Immunosuppression

P. Vaitla, H. Bohorquez, A. Cohen, A. Cruz, U. Patel, S. Anders, C.-S. Catherine, A. Moiz, S. Guisti, I. Carmody, G. Loss, D. Bruce, T. Reichman, J. Garces.
Thymic Transplantation to Determine Mechanisms of Thymic Involution: Insulin-Like Growth Factor 1 Receptor and Forkhead Box Protein N1 in the Thymus Play a Role in Maintaining the Juvenile Thymus

K. Yamada, M. Tasaki, M. Sekijima, A. Kawai, V. Villani, T. Tanabe, I. Hanekamp, A. Shimizu, D. Sachs.
Thymoglobulin Administration During Multi-Visceral and Isolated Small Bowel Procurement Does Not Adversely Affect the Survival of Harvested Organs

G. Jain, T. Burnett, J. Preheim, L. Vargas, W. Grant, A. Langnas, D. Mercer, G. Jain.
Thymoglobulin Dosing Efficacy: The Role of ALC on Infection and Rejection

H. Sarumi, C. Borscheid, G. Sieger, B. Fast, S. Hogan, K. Vassar, T. Pruett.
Transplant Center Quality Assessment: Correlation Between Early Graft Outcomes and Patient-Centered Assessments of Hospital Care

A. Mathur,¹ A. Chakrabarti,² K. Sheetz,² N. Katariya,¹ A. Singer,¹ W. Hewitt,¹ K. Reddy,¹ A. Moss.¹
Transplant Glomerulitis in Allograft Kidneys Is Correlated With Antibody-Mediated Rejection

W. Xu, T. Deng.
Transport Perfusion Fluid Analysis from Deceased Donor Kidney Transplants (DD KT) and Pancreas Transplants (SPK; PAK; PTA)

C. Taylor, Y. Tabbakh, C. van Nispen tot Pannerden, D. Yershov, F. Calder, C. Callaghan, M. Drage, N. Karydis, N. Kessaris, I. Loukopoulos, N. Mamode, J. Olsburgh.
Transversal Observational Study On Recurrent and Late Urinary Tract Infections (UTIs) in Renal Transplantation (tx)

G. Castellano,¹ M. Fiorentino,¹ M. Martino,¹ M. Rossini,¹ A. Schena,¹ C. Manno,¹ G. Grandaliano,² P. Ditonno,³ M. Battaglia,³ L. Gesualdo.¹
Treatment Patterns, Healthcare Resource Utilization, and Costs in Kidney Transplant Recipients Using a Fixed Source Regimen of Tacrolimus Vs. a Variable Source Regimen

E. Lee,¹ S. Bunniran,² P. Kamble,² B. Suehs,² B. Franks,¹ J. Schwartz,¹ C. Anderson,³ G. Thal,¹ J. Spalding.¹
Treatment of Hypertrophic Osteoarthropathy in an Intestinal Transplant Patient After Acute Cellular Rejection

M. Keck.
Treatment of Subclinical Rejection Identified On Surveillance Biopsy May Prevent the Development of Chronic Alloimmune Injury

M. Willicombe, C. Roufosse, J. Galliford, A. McLean, D. Taube.
Trends in Transplant Patient Safety Situation Reporting

T. Daly,¹ H. Neil,² D. Stewart,² S. Tlusty,² A. Harper,² D. Marshman,³ M. Green.⁴
Utilization and Characteristics of Pancreas and Simultaneous Kidney-Pancreas Donors in the US by OPTN-Defined Increased Risk Donor Status

M. Ison,^1,2 B. Ho,² J. Leventhal,² D. Ladner.²
Utilization of Increased Risk Donors in a Canadian Multi-Organ Transplant Program

K. Doucette,¹ K. Worton,² J. Kutsogiannis,² J. Preiksaitis.¹
Validation of Predictive Nomograms for Delayed Graft Function in Kidney Transplant Recipients

L. Chau, O. Famure, J. Kim.
Viral Prophylaxis Is Unnecessary in CMV Low Risk Kidney Transplant Recipients Who Receive Lymphocyte Depleting Induction

M. Gillespie,¹ B. Sirandas,² A. Carlson,² S. Lee,³ L. Smith.²
Weight Loss, But Not Weight Gain Is a Risk Factor for Graft Loss After Kidney Transplantation

E. Hendren, J. Dong, C. Kennedy, T. Myint, C. Rose, O. Johnston, J. Gill, J. Gill.
When Do DCD Donors Die? Outcomes and Implications of DCD at a High-Volume, Single-Center OPO in the United States

J. Scalea,¹ R. Redfield,¹ M. Rizzari,¹ R. Bennett,² J. Anderson,² M. Anderson,² D. Kaufman,¹ H. Sollinger,¹ L. Fernandez,^1,2 A. D'Alessandro,^1,2 J. Mezrich.¹
microRNA-494 Promotes Cyclosporine-Induced Nephrotoxicity and Epithelial to Mesenchymal Transition By Inhibiting PTEN

J. Yuan,¹ C. Benway,^1,2 J. Bagley,¹ J. Iacomini.^1,2
A Gene Expression Assessment for Improving Disease Activity and Stage in Heart ABMR

A. Loupy, M. Racape, J. Reeve, J. Venner, S. Varnous, A. Gay, R. Guillemain, L. Hidalgo, C. Lefaucheur, X. Jouven, P. Bruneval, J. Duong, P. Halloran.
Differential Role of PI3K Subunits Gamma and Delta in Regulatory T Cells Homeostasis in Allotransplantation

J. Azzi, M. Uehara, Z. Solhjou, P. Lukyanchykov, A. Radwan, L. Riella, R. Abdi.
Plasma Levels of Donor-Derived Cell-Free DNA Increase With Rejection and Often Decrease After Treatment in Organ Transplant Recipients

M. Grskovic,¹ J. Beausang,¹ D. Hiller,¹ R. Sit,¹ B. Christie,¹ J. Elechko,¹ R. Woodward,¹ J. Yee,¹ J. Kobashigawa.²
Th17-Mediated Alloimmune Responses Play a Key Role in Intestinal Allograft Rejection in Humans

A. Kroemer, S. Wanta, J. Diaz, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein.
Beneficial Effects of Controlling Peritransplant Inflammation in Total Pancreatectomy With Islet Autotransplantation: A Single Center Experience With Large Cohort of Patients

M. Takita,¹ M. Kanak,² R. Shahbazov,¹ G. Yoshimatsu,¹ M. Lawrence,¹ A. Dabous,³ P. Kim,³ N. Onaca,³ B. Naziruddin,³ M. Levy.³
Designing a KDPI to Assess Live Donors and Compare Them to Deceased Donors

A. Massie, D. Segev.
Human iPS Cell-Derived Pancreatic β-Cells Correct Hyperglycemia in Diabetic Mice

G. Manzar,^1,2,3 E.-M. Kim,^1,2 P. Rotti,³ N. Zavazava.^1,2,3
Induction With ATG Is Not Associated With Increased Infections After Kidney Transplant Among HIV Positive Patients: Results of a National Study

L. Kucirka,¹ C. Durand,¹ S. Bae,¹ J. Locke,² D. Segev.¹
Erythropoietin (EPO) Has Treg Sparing Immunosuppressive Effects On Human Alloreactive T Cells

C. Purroy, P. Heeger, P. Cravedi.
Hepatocyte-Related miR-193a-3p Is Over-Expressed in Allograft Biopsy from Liver Tolerant Recipients

R. Danger, J. Lozano, E. Bonaccorsi-Riani, E. Kodela, R. Mas-Malavila, M.-C. Londono, M. Martinez, A. Rimola, M. Martinez-Llordella, A. Sanchez-Fueyo.
Immune Reconstitution in Recipients of Living Donor Kidney/Hematopoietic Stem + Facilitating Cell Transplants

J. Leventhal,¹ M. Elliott,² E. Yolcu,² L. Bozulic,³ D. Tollerud,³ J. Mathew,¹ I. Konieczna,¹ M. Ison,¹ M. Badder,³ M. Abecassis,¹ J. Miller,¹ L. Gallon,¹ S. Ildstad.³
Notch-1 Inhibition Promotes Immune Regulation in Solid Organ Transplantation

C. Magee,¹ M. Ohari,¹ T. Shimizu,¹ S. Ohori,¹ N. Najafian,² L. Riella.¹
A Novel, Blocking Anti-CD40 Monoclonal Antibody Prolongs Non-Human Primate Renal Allograft Survival in the Absence of B-Cell Depletion Or Thromboembolic Events

J. Rush,¹ G. Wieczorek,¹ M. Audet,² M. Schneider,¹ P. Espie,³ L. Roth,¹ C. Heusser,¹ C. Bruns,¹ D. Patel,¹ F. Cordoba.¹
Deceased Donor and Class II Donor Specific Antibody Predict Interface Activity While Increased Age at Time of Biopsy Predicts Fibrosis in Long-Term Pediatric Liver Allografts With Normal Liver Tests: iWITH Clinical Trial

S. Feng,¹ J. Bucuvalas,² A. Demetris,³ K. Spain,⁴ G. Mazariegos,³ B. Burrell,⁵ iWITH Investigators.⁶
Diminished Survival After Simultaneous Liver-Kidney Transplant With Increasing Kidney Donor Profile Index Score

C. Jay, G. Halff, G. Abrahamian, K. Washburn.
MicroRNA (miR) 144 Dysregulates TGFβ Signaling Cascade and Contributes to Development of BOS Following Human Lung Transplantation

Z. Xu,¹ S. Ramachandran,¹ D. Nayak,¹ M. Gunasekaran,¹ E. Trulock,¹ R. Hachem,¹ D. Kreisel,¹ T. Mohanakumar.¹
Tolerant Kidney Transplant Patients Display B Cells With Regulatory Properties

S. Brouard,^1,2 M. Chesneau,^1,3 L. Michel,^1,2,3 E. Dugast,^1,3 A. Chenouard,^1,3 A. Pallier,¹ D. Baron,^1,3 J. Durand,^1,3 F. Braza,^1,3 P. Guerif,² D.-A. Laplaud,^1,2,3 J.-P. Soulillou,^1,2,3 M. Giral,^1,2,3 N. Degauque,^1,3 E. Chiffoleau,^1,3 S. Brouard.^1,2
Belatacept-Treated Patients Had Better Graft Survival at 7-Years Post-Transplant Compared With Cyclosporine-Treated Patients: Final Results from BENEFIT

F. Vincenti,¹ J. Grinyó,² L. Rostaing,³ K. Rice,⁴ S. Steinberg,⁵ M. Moal,⁶ M. Polinsky,⁷ U. Meier-Kriesche,⁷ C. Larsen.⁸

« View all sessions from the 2015 American Transplant Congress